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ABSTRACT
This exploratory research is a study of tuberculosis (TB) and health-related stigma which
examines the experiences and perspectives on the disease from the vantage point of the Persons
Affected by Tuberculosis (PATB). Research on the causes and sustainability of stigma will be
useful to guide health and social interventions that reduce its effects. Also of importance is
research that focuses on the behavioral and psychological as well as in the social context and
dimensions of TB-related stigma. The personal experience of tuberculosis illustrates that an
infectious disease entails much more than treatment involving medications, microbes and risk
categories. Stigma associated with TB has been identified as a major barrier to health care
access and to quality of life in TB management. This study of TB and stigma is the result of a
triangulation of data from three different and complementary studies using corresponding
methods of data collection and is organized into three distinct sections: (1) In-depth interviews
with Persons Affected by TB and under treatment using a semi-structured interview guide, (2)
In-depth interviews with TB Photovoice participants, and (3) Measuring TB-related stigma
through the validation of the TB and HIV/AIDS stigma subscales, originally developed by Van
Rie et al., (2008).
The findings of this study may provide the basis for the future development of individual
and structural stigma reduction interventions with Mexican-origin groups in order to ensure that
persons affected by tuberculosis receive crucial preventive, diagnostic and treatment services that
are free of stigma and discrimination.
Study participants reported traditional beliefs and myths about tuberculosis TB
symptoms. The participants presented issues of stigma associated with tuberculosis and
HIV/AIDS. They also reported on reliable and popular sources of health information.
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Participants presented their views regarding the barriers to TB care that include individual and
social obstacles as identified in the “Tuberculosis and Stigma Study.” Finally, the scales used to
measure the phenomenon of stigma related to TB and HIV/AIDS with Mexican-origin groups
demonstrated strong psychometric properties. Factor analysis to identify the items of the scale
that loaded best were performed and the internal consistency by Cronbach’s Alphas were very
good to excellent.
The dissertation concludes that tuberculosis is in many respects a social illness and that
socioeconomic differentials and inequalities are strongly associated with its burden. Study
findings have implications for: (1) informing health services and decision makers about how
persons of Mexican-origin affected with TB in the United States-México border interpret their
illness and stigma, (2) research on health related stigma and interventions, and (3) expanding and
informing health-related theory on tuberculosis stigma and individual and structural stigma
reduction interventions.
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CHAPTER 1
INTRODUCTION
INTRODUCTION
This exploratory study is directed at the study of tuberculosis (TB) and health-related
stigma by examining the experiences and perspectives of the disease from the vantage point of
the Persons Affected by Tuberculosis (PATB). Research on the causes and sustainability of
stigma will be useful to guide health and social interventions to reduce its effects. Also of
importance is research that focuses on the behavioral, psychological, and social contexts and
dimensions of TB related stigma. This would be helpful to guide in the development of multilevel intervention programs.
Traditionally, tuberculosis is described as a disease process resulting from infection by
bacterium (Mycobacterium tuberculosis). It is also understood as a social illness that causes great
suffering, a disease of “at-risk populations,” and a sign of poverty or a global pandemic.
Tuberculosis is a medical and social condition that involves deep emotional experiences,
narratives of illness, alienation from family members, isolation and stigmatization. Tuberculosis
ravages interpersonal connections as much as a person’s body. The experience of tuberculosis
illustrates that an infectious disease entails more than treatment involving medications, microbes,
and risk categories. Tuberculosis is an ancient disease that continues to infect humans. Studies
have identified tuberculosis in mummies from Egypt dating back 5,400 years (Daniel, 2000). TB
is responsible for the highest number of deaths in human populations produced by a single
microbial pathogen (Barnes, 1995; WHO, 2005; PAHO, 2004).
continues to be a major cause of morbidity, mortality, and disability.
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Wolrdwide, tuberculosis

Traditionally, tuberculosis biomedical models focus on diagnosis, contact investigation,
treatment to destroy the bacteria in the body, and cure. In addition, a great deal of research in
public health has centered on a trend to increase focus on individual behaviors while decreasing
or displacing the social determinants of the disease. Vital individual and social dimensions to
addressing tuberculosis include narratives centered on the Persons Affected by TB (PATB), 1 the
relationship to family memebrs, school, employment, community, and society.
Until fifty years ago, there were no medicines known to cure TB. Fortunately, there are
effective bio-medical treatment options available today. Some strains of TB have become
resistant to anti-TB medication and require more expensive and extensive treatment options (e.g.
chemotherapy, and/or second-line drugs). With more than five decades into the modern era of
TB control and more than three decades into the HIV/AIDS epidemic, stigma remains a
significant challenge for HIV and TB control programs across the prevention to care continuum
(Nyblade, MacQuarrie, & Phillip, 2005). Stigma associated with TB has been identified as a
major barrier to health-care and quality of life in TB management (Deacon, 2006; Macq, 2007;
Stop TB Partnership, 2006; Jaramillo, 2002; Van Rie, et al., 2008; Weiss & Ramakrishna, 2001;
Karim et al., 2007; Heijnders & Van Der Meij, 2006; Somma, et al., 2008; Macq, Solis &
Martinez, 2006; Westaway, 1989; Barnhoorn & Adriaanse, 1992). Most of the contributions to
stigma theory are germane to social interactions and social science theory (Durkheim, 1982;
Goffman, 1963; Ritzer, 2006; Falk, 2001). These contributions have informed and inspired
insights into prevention and intervention applications; however, most of the research has not
been applied to health conditions (Weiss & Ramakrishna, 2001).

1

The term Person Affected by (or) with Tuberculosis (PATB) is used in the study instead of the term ‘patient’
which implies a person in clinical or medical care.
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The findings of this dissertation may provide the basis for development of individual and
structural stigma reduction interventions with Mexican-origin populations and other similar
populations to ensure that persons affected by tuberculosis receive crucial preventive, diagnostic,
and treatment services that are free of stigma and discrimination.
Study participants reported traditional beliefs and myths about tuberculosis TB
symptoms. The participants presented issues of stigma associated with tuberculosis and
HIV/AIDS. They also reported on reliable and popular sources of health information. Finally,
they presented their views on the barriers to TB care that include individual and social obstacles
as stated in the “Tuberculosis Related Stigma Study Conceptual Framework” in this chapter and
described in Chapters Four, Five and Six.

STUDY AIMS
The study aims are:
(1) To investigate, through in-depth interviews individual perceptions and experiences of
Mexican-origin individuals affected by TB in El Paso, Texas, and Ciudad Juárez,
México, to illustrate how TB is experienced and the relationship to health-seeking
behaviors;
(2) To investigate the contextual factors that influence health-seeking behaviors in order to
describe the relationship between TB, health services, and individuals’ access to health
care in El Paso, Texas, and Ciudad Juárez, México;
(3) To explore the different ways in which persons affected by TB experience their illness
and respond to challenges in order to mitigate the suffering in El Paso, Texas, and Ciudad
Juárez, México;
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(4) To explore the perceived and internalized stigma by the person affected by tuberculosis
(attitudes toward TB and related stigma, discrimination, perceptions, disclosed behaviors,
and perceived support);
(5) To investigate the actual experiences of social stigma and discrimination (experiences,
treatment, access to health care, health seeking behaviors, and other stigmatized
conditions and coping mechanisms) by persons affected with TB to inform the
development of stigma and discrimination reduction strategies;
(6) To examine the individual impacts of the TB Photovoice Project on persons affected by
TB in order to advance understanding of the factors and promote empowerment and
involvement of persons affected by TB; and
(7) To test the validity and reliability of the TB and HIV/AIDS Stigma Scales developed by
Van Rie et al., (2008) for use with Mexican-origin groups in order to expand and
inform theory of TB related stigma.

RESEARCH QUESTIONS
The research questions of the study are: (1) What are the characteristics of individuals
undergoing TB treatment in El Paso, Texas, and Ciudad Juárez, México? (2) What are the
contextual factors influencing health seeking behaviors and access to care of persons with TB
undergoing treatment in El Paso, Texas, and Ciudad Juárez, México? (3) How do persons
affected by TB experience their illness? (4) How do persons affected by TB perceive stigma? (5)
What are the manifestations and impacts of stigma on persons living with TB? (6) What are the
differences in experiences, pereptions and stigma between individuals living with TB in Ciudad
Juárez, México, and El Paso, Texas? and why? (7) What are the different ways in which persons
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affected by TB respond to challenges of living with TB? (8) What are the ways in which person
affected confront stigma? (9) What are the care experiences of persons affected by TB in Ciudad
Juárez, México, and El Paso, Texas? (10) What are the individual effects of the TB Photovoice
intervention? (11) What are the perceptions of Mexican-origin persons affected with TB in five
study locations in México? and, (12) What are the perceptions toward HIV/AIDS of Mexicanorigin persons affected by TB in five study locations in México?

STRUCTURING THE DISSERTATION
The first chapter is an introduction to the disease of tuberculosis, its epidemiology, the
links between TB and economic development, and an introduction on the conceptualization of
tuberculosis and stigma. Chapter Two addresses the literature that informed the study. This
study draws mostly on the work by Goffman (1959, 1961, 1963), by Parker and Aggleton (2002)
and Sumartajo (1993, 2000), Jaramillo (1999), Liefooghe et al., (1997), Macq (2004), and Van
Rie et al., (2008) and on the literature on stigma (Goffman, 1963; Falk, 2001; Deacon, 2006),
structural violence (Farmer, 1991, 1997, 2004, 2005b) tuberculosis and tuberculosis related
stigma (Kelly, 1999; ACMS Framework for Action, 2006-2015, 2007; Karim et al., 2007;
Heijnders et al., 2006; Somma et al., 2008; Macq et al., 2006; Armijos et al., 2008); and
community based participatory research methods (Wang, 1996, 1998, 1999, 2001; Israel et al.,
2005; Minkler & Wallerstein, 2003).
Three preliminary studies aided the researcher in this study are described in Chapter 2:
(1) “Policies and laws affecting Mexican-origin immigrant access and utilization of substance
abuse treatment in El Paso County” (Moya & Shedlin, 2008); (2) the “Pilot study of tuberculosis
stigma in México,” and (3) the “Border Voices and Images of Tuberculosis Project” (De Heer,
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Moya & Lacson, 2008). The research also builds on the findings of the Amaya-Lacson-TB
Photovoice Project (Redwood & Lacson, 2005), and the “TB-HIV/AIDS Alliance for Social
Action” (Conversations with Ramos, 2005, 2009; De Heer, Moya & Lacson, 2008). Chapter
Three addresses the study’s aims, research questions and methods of data from three different
studies using complementary methods of data collection and organized into three distinct
sections of Chapters Four, Five and Six.
Finally, Chapter Seven illustrates the triangulation of data from the three different
studies, integrates the findings and presents the conclusions and implications for future research.
The dissertation concludes that tuberculosis is in many respects a social illness, and that
socioeconomic differentials and inequalities are strongly associated with burden. Evidence
indicates that behavioral, psychological and environmental factors are major determinants of
health and the way in which health changes with age (Navarro, 2004; Marmot & Bell, 2009;
Wilkinson & Marmot, 2003).

CONCEPTUAL FRAMEWORK
The conceptualization of the TB and stigma study is organized into two sections. The
first section presents the conceptual framework that guided the study.
Tuberculosis Related Stigma Conceptual Framework
The study uses a conceptual framework of TB stigma (Figure 1). Therefore, the
conceptual framework guiding this research is derived from the concept stigma (Goffman, 1959,
1963; Falk, 2001) social theory (Allan, 2007; Freire, 1973; Deacon, Stephney & Prosalendis,
2004),

and concepts of power, dominance, hegemony and oppression (Foucault, 1977;

Bourdieu, 1997; Maluwa et al., 2002); TB and HIV/AIDS related stigma (Sumartajo, 1993;
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Jaramillo, 1999; Liefooghe et al., 1997; Macq, 2007; Macq, Solis & Martinez, 2005, 2006; and
Van Rie et al., 2008).
A description of the literature findings on health and tuberculosis related stigma is
presented in Chapter Two.

The framework also draws on the findings from the “Border

Tuberculosis Alliance Project” (USMBHA, 2007), the “Amaya-Lacson Tuberculosis Project”
(Lacson et al., 2007; Lacson, 2009) and the “Border Voices and Images of TB Project” (De Heer,
Moya & Lacson, 2008) described in Chapter 2.
The study framework addresses three concepts: (1) characteristics of persons affected
with TB (PATB), (2) perceived and internalized stigma by the PATB (attitudes toward
tuberculosis and related stigma and discrimination, perceptions, disclosure behaviors, and
perceived support), and (3) actual experiences of social stigma and discrimination (experiences,
treatment, access to health care, health seeking behaviors, and other stigmatized conditions and
coping mechanisms) by persons affected with TB.

Each of the study concepts has a

corresponding series of measures: (1) experiences with TB diagnosis and treatment, comorbidities, socio-demographic and other characteristics of PATB, and psychological factors
(e.g. knowledge, attitudes, practices, and perceptions); (2) Perceptions and attitudes toward TB
and discrimination, disclosure, perceived support; (3) Stigma and discrimination experiences of
PATB, treatment, access and health seeking behaviors. The study concepts inform the
development and implementation of study instruments (e.g. semi-structure questionnaire, indepth interview guides) and the adaptation of the TB and HIV/AIDS Stigma Scales to Mexicanorigin populations.

7

Figure 1. Tuberculosis Related Stigma Study Conceptual Framework

THEORY AND DEFINITIONS OF STIGMA
There are several definitions of stigma and related phenomena. For the purpose of this study
the following definitions are adopted.
1. Stigma is an attribute, behavior, or reputation which is socially discrediting in a specific
way; this causes the person to be mentally classified by others as “undesirable,” rejected
rather than accepted in a normal way (Goffman, 1963).
2. Stigma is a social process that exists when elements of labeling, stereotyping, separation,
loss of status, and discrimination occur in a power situation that allows them (Link &
Phelan, 2001:363).
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The concept of stigma can be traced to the classical Greek, where it was used to refer or
brand outcast groups with a physical and permanent mark of their moral status (Malcolm et al.,
1998; Marshall, 1998). The signs were bodily cuts or burns which signified that the bearer was a
slave, criminal, traitor, or a blemished person to be avoided especially in public places (Goffman,
1963:1). The first references to the association between stigma and health in the social sciences
literature dates back to the 1880s. Emile Durkheim was the first to explore stigma as a social
phenomenon in the mid 1890s. He wrote:
Imagine a society of saints, a perfect cloister of exemplary individuals. Crimes or
deviance, properly so-called, will there be unknown; but faults, which appear
venial to the layman, will there create the same scandal that the ordinary offense
does in ordinary consciousness. If then, this society has the power to judge and
punish, it will define these acts as criminal (deviant) and will treat them as such
(Durkheim, 1895).
More recently, sociologist Erving Goffman developed what has become the benchmark
social theory of the association between stigma and disease (1961, 1963). Goffman (1959, 1963)
suggested that situations exists which spoil or mark one’s social identity. Goffman (1963)
distinguishes between three types of stigmatizing conditions: (1) “tribal identities” (e.g. race,
gender, religion, or nationality), (2) “blemishes of individual’s character” (e.g. mental illness,
addiction or a history of incarceration), and (3) “abominations of the body” (e.g. physical
disabilities or deformities). Falk (2001) distinguishes between two types of stigmatization
conditions based on the ‘cause or root’ of the stigma: “existential stigma” is when the individual
did not cause the stigma or has very little or no control over the stigma, and “achieved stigma” is
when a person earns the stigma because of conduct or because the individual contributed to
attaining it.
Persons living with TB can be affected by any of these stigmas. Most recently, stigma
studies indicate that stigma is a result from a quality that discredits the individual (Goffman,
9

1963). Stigma has been more specifically conceptualized as prejudice and discrimination
(Goffman, 1963). Drawing from mental health research, physical disabilities, and socially
“deviant” behaviors, Goffman argued that a stigmatized individual is a person who possesses “an
undesirable difference” (Goffman, 1959, 1963). A society utilizes stigma as a way to
conceptualize what constitutes “deviance” or “difference,” In Goffman’s work, “Notes of the
Management of Spoiled Identity” (1959), the author states that stigmatization is a form of
society’s response to a person who has a “spoiled identity,” as defined by its rules and sanctions.
The literature on stigma has grown significantly since the 1960s and has been applied to
multiple situations ranging from leprosy, cancer, homosexuality, mental health and drug
addiction to tuberculosis and HIV/AIDS (Opala & Boillot, 1996; Fife & Wright, 2000; Jaramillo,
2002; Link & Phelan, 2001; Lynch, 2000). Definitions of stigma are frequently vague. Some
authors define stigma simplistically, like a “mark” that links a person to undesirable
characteristics such as “stereotypes” (Stafford & Scott, 1986) while other authors focus on
individualistic social-cognitive aspects (Oliver, 1992).
Interpretations of Stigma
Although Goffman emphasized the importance of studying stigma in terms of
“relationships” rather than individual traits or attributes, subsequent interpretations of stigma
have focused on individuals’ attributes and are separated from broader social processes,
particularly from relationship of power. Anthropological and sociological contributions to
HIV/AIDS, tuberculosis and other health related issues have introduced new components to
Goffman’s definition of stigma and the use of new conceptual frameworks (Weiss &
Ramakrishna, 2001; Parker & Aggleton, 2003; Das, 2001; Alonzo & Reynolds, 1995).
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Social psychology has generated studies of the cognitive processes that lead to labeling
and stereotyping, focusing more on individuals’ perceptions and attributes than on the broader
social context. Most of these studies focus on the implications of these beliefs in terms of
misunderstandings, misinformation and negative attitudes as a way to change the perceptions of
the “stigmatizers” (Hue, 2002; McCauley et al., 2002). These approaches seek to improve
education, enhance sensitivity, and empathy training through personal contact with people
affected by a stigmatized health or social condition (Hebl & Hull, 2003; Hererk et al., 1998).
These efforts place little emphasis on the larger economic and social context in which stigma is
grounded. Exploration of the structural conditions that exclude individuals from social and
economic life has been examined less with more focus on stereotyping.
Certain cultures or settings contest that certain attributes are unworthy or discreditable.
“Spoiled identities” and “undesirable differences” are created by individuals and by communities
through a process of devaluation (Castro & Farmer, 2005; Goffman, 1963; Maluwa, 2002). In the
TB and HIV/AIDS literature, the concept of stigma is not as clearly defined. There is no explicit
conceptualization of stigma related to TB. This impedes an appraisal and comparison of study
findings and restricts the ability to design effective interventions and programs (Aggleton et al.,
2003).
In the past few decades, the introduction of the ideas of critical social theory both from
the disciplines of sociology and social psychology have sparked a debate about theory and
method in stigma research. This discourse suggests that we need to challenge the conceptual
development of stigma (Deacon & Stephney, 2007). Therefore, stigma must be defined more
clearly. Much of the research on stigma has stigmatized beliefs, (e.g. unjustified negative beliefs
that people believe about other people involving moral judgment), responses to stigma, and
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effects of stigma-like discrimination. Stigma has multiple connotations, associations, and
implications entrenched in history, (Durkheim, (1895) 1982), social sciences (Goffman, 1963;
Falk, 2001; Ritzer, 2006), and public health (Weiss & Ramakrishna, 2001; Herek, 1999;
Kleinman 1988 1991; Link, 2001, 2002). Research on the causes and sustainability of stigma is
needed to guide public health interventions to reduce its effects.
To understand stigmatization and discrimination in relation to any other issue (e.g.
tuberculosis, HIV/AIDS, cancer, leprosy, mental health), it is essential to study how some
individuals and groups become socially excluded. Stigma does not occur naturally, but it is
instead a reaction to a social history that influences when and where it appears and the forms it
takes, and understanding that history can help mitigate stigma more effectively. Much of TBrelated stigma builds and is reinforced on earlier prejudices.
Tuberculosis was seen as the inevitable result of a life dedicated to excess, therefore not
in accordance with socially accepted standards even though it was seen in different forms
throughout history (Porto, 2007). HIV/AIDS related stigma also reinforces earlier discrimination
and prejudices. In some countries, for example, people living with HIV and AIDS are often
viewed as having engaged in “illicit sex” or as having been “promiscuous.” In parts of the West,
AIDS may be viewed as a condition of drug users or as a “gay plague” (Oliver, 1992; Maluwa,
2002; Aggelton & Parker, 2002). These perceptions vary and are not accidental. They are
patterned and reinforced in social inequalities that regard women as inferior to men and that are
linked to drug and substance use, to nationality, ethnicity, and sexuality.
TB or HIV/AIDS-related stigmas do not come about from the minds of “bad”
individuals; instead these stigmas are linked to power, domination, and social inequalities in the
community which play a vital role. When this happens, some groups become devaluated and
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others are considered superior. Eventually, social inequalities create and reinforce stigma, and
stigmatization creates even more inequalities.
There is considerable literature suggesting that stigma takes two forms: “felt” and
“enacted” (Oliver, 1992; Mahajan et al., 2008; Maluwa, 2002; Sontag, 1978). “Felt stigma”
refers to the shame associated with a stigmatizing condition and the fear of being discriminated
against. “Enacted stigma” has to do with the actual experience of discrimination (Parker &
Aggleton, 2003). Both of these stigmas have important consequences for individuals and how
they organize their lives (Le Bel, 2008).
Goffman’s premise on the self “face to face” interactions helped to explain the influences
for why people do what they do. For him, the “self” is the core feature of all social encounters
(Allan, 2007:317). The concept of “impression management” and how individuals’ social
arrangements shape the organization of the self is one of the most informative concepts. His
discourse on “Dramaturgy, Fronts, Setting, and Stigma” are relevant to understating how
ailments like tuberculosis, HIV/AIDS, mental illness, and isolation can have special social labels
and reactions of others.
It has long been recognized that various types of illness are associated with stigma or
membership in a social category that results in a spoiled identity, setting the individual apart
from others (Goffman, 1963; Sontag, 1978, 1988; Farmer, 2005b). According to Goffman
(1963), stigma is a type of gap between “virtual social identity” and “actual social identity”
where people who are stigmatized manage their spoiled stigma before normal audiences (Allan,
2007). Several authors argue that stigma is not fixed or inherited and can best be understood by
the experience and meaning of the differences (Goffman, 1963; Shih, 2004).
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Stigma is comprised of two basic components: (1) the recognition of a difference in a
specific characteristic, “mark” “label” or “blemish,” and (2) the devaluation of an individual who
possess that characteristic. The dimensions of stigma are described in Chapter 2.
Following Goffman (1963), several authors defined stigma as an undesirable or
discrediting attribute, reducing an individual’s status in the eyes of society (Falk, 2001; Brown,
Macintyre & Trujillo, 2003; Page, 1984; Weiss & Ramakrishna, 2001; Link & Phelan, 2001).
Parker and Aggleton (2003) argue that stigma must be regarded as a social process in which
people, out of fear of a disease or disorder, want to maintain social control by contrasting those
who are normal with those who are different. In short, stigma exists when: “…elements of
labeling, stereotyping, separation, status, loss, and discriminations occur together in a power
situation than allows them” (Link & Phelan, 2001:377). Medical sociologists and anthropologists
have examined the stigmatizing nature of a number of diseases, including TB, leprosy, cancer,
HIV/AIDS and mental health, among others (Link & Phelan, 2002; Frist, 1996). Goffman’s
discourse on stigma is important for understanding the TB discourse and is consistent with the
themes identified by PATB and HIV/AIDS in the Border TB Photovoice Project (De Heer et al.,
2008).
Social theory helps to explain that stigmatization and discrimination are not isolated
phenomena in the expression of individual attitudes. Instead, it is a social process used to create
and maintain social control and produce (or reproduce) social inequalities. Concepts of symbolic
violence and hegemony highlight the role of stigmatization by establishing social as a part of
social struggle for power (Bourdieu, 1977, 1984), and hegemony, or dominance, is achieved
through the use of social, political and cultural forces to promote dominant meanings and values
that legitimize unequal social structures (Foucault, 1976; Williams, 1982).
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STIGMA SEQUELǼ
Stigma is increasingly recognized to have a major impact on public health interventions.
Stigma and discrimination tend to produce social inequality (Weiss, 2001; Farmer, 2005b). Even
though stigma may appear to be constant, it is more accurately described as a process (Parker &
Aggleton, 2002). New stigmas arise and old ones fade as knowledge and power structures
change. This in turn leads to new hierarchies and social norms. The forms and intensity of
stigmas may also fluctuate (e.g. HIV/AIDS, leprosy, TB, mental health). Stigma is a mechanism
of social control that defines social norms and punishes those who deviate. At the heart of stigma
lies the “fear” that those who are stigmatized threaten society. Frequently underlying that fear is
ignorance such as lack of knowledge concerning the life of persons affected with HIV/AIDS,
tuberculosis, or the way in which diseases is spread.
Discrimination is an important concept that is linked to stigmatization. Discrimination
can be made legitimate (anchored in law or policy). But, it also can refer to exclusion, distinction
or restrictions which violate human rights and fundamental freedoms such as those articulated in
the Inter-American Convention on the elimination of all forms of “Discrimination against
Persons with Disabilities,” (1999). Patterns of stigma and discrimination are not always present
(description in Chapter 2). Occasionally, the impact of stigma is positive, especially when the
individuals being stigmatized successfully adopt an “empowerment” model as opposed to a
“coping” model (Shih, 2004). Examples of several factors that lead individuals affected by TB to
overcome stigma are described in Chapters 4 and 5 (e.g. stories on how individuals affected by
TB manage chronic stressors in their environment and how these stressors help them develop
resilience, gain strengths and learn valuable lessons in confronting adversities (e.g. tuberculosis,
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HIV/AIDS, poverty, substance abuse, minority status). Usually, stigma and fear of
discrimination leads to delay in seeking health services, prolonged risk of transmission, poorer
adherence and increased risk of disability, and drug resistance.
Studies in stigma indicate that it deters people from seeking diagnosis and care and that
woman bear the highest burden of stigma-avoiding behaviors (ACMS Framework for Action
2006-2015, 2007; Heinjnders & Van Der Meij, 2006). Stigma and discrimination are created by
multiple forces including lack of understanding of the disease, myths about how tuberculosis is
transmitted, prejudice, lack of access to services, irresponsible media reporting, and the link
between HIV/AIDS and TB as well as fear of relating the illness to disability and death (Parker
& Aggleton, 2003; Link & Phelan 2001; Bond & Nyblade, 2006).
The negative sequelæ of fear, stigma, and discrimination can prevent people from getting
tested for TB and HIV, from using appropriate health and human services, and from changing
their behavior to avoid the spread of the infections (Jaramillo, 1999, 1998). Stigma is harmful to
the individuals by causing feelings of shame, isolation, and guilt. In addition, negative thoughts
about oneself can lead individuals to do things or omit doing things that harm or discredit others
or even deny services to (i.e. discriminate against) them (Alvarez-Gordillo et al., 2000; Lawn,
2000; Marra et al., 2004). Stigmatization of persons affected by TB alone or in association with
HIV is recognized today as an important issue in TB care, affecting underserved and
underprivileged group, such as women in particular (Atre et al, 2004). Stigma can also be a
determinant in access to care and treatment adherence (Liefooghe et al., 1997; Alvarez-Gordillo
et al., 2000; Lawn, 2000; Needham et al., 2004).

Prejudice and discrimination by health

personnel or society may result in isolation and decreased self-esteem of the persons affected by
tuberculosis, thereby impeding the person’s potential for empowerment (Macq et al., 2004;
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Farmer, 2000; 2005a). Stigma and discrimination related to TB can take different forms and are
manifested at different levels – societal, community and individuals – and in different context
(Malcolm et al., 1998).

SOURCES OF STIGMATIZATION AND DISCRIMINATION IN TUBERCULOSIS
This investigation seeks to measure and explain the way in which TB related stigma
appears and the context in which it occurs. Understanding how stigma and discrimination related
to TB (e.g. HIV/AIDS) interacts with pre-existing stigmas and discrimination (e.g. like sexuality,
gender, race and poverty) is important. This study focuses primarily on individuals affected by
tuberculosis.
Tuberculosis metaphors such as death, horror, punishment, guilt, and shame – (Sontag,
1978, 1988; Gupta et al., 2008; Farmer, 2005a; Weitz, 2007) have enhanced these fears,
reinforcing and legitimizing stigmatization and discrimination. The various metaphors associated
with TB have contributed to the perceptions of it as a disease that affects the “other,” especially
those who are already stigmatized because of their gender, race, class, or socio-economic status
(Sontag, 1988; UNAIDS, 2000; Malcolm et al., 1998; Daniel & Parker, 1993).
Individual and Cognitive Contexts
One of the limitations of this investigation is that the focus is on the individual forms and
manifestations of stigma and discrimination related to TB and not on the community and societal
ones. In individuals, the way in which TB stigma and discrimination are manifested depends on
family and social support and the degree to which people are able to be open about such issues.
If the diagnosis is dual (HIV/AIDS and TB), the stigmatization may be more significant. In
contexts where TB and HIV/AIDS are highly stigmatized, fear of infection or of infecting others
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may cause individuals to isolate themselves to the degree that they may not feel part of the larger
society and are unable to gain access to services and support needed (Daniel & Parker, 1993). In
extreme cases, this internalized stigma has led to premature disability or premature death through
suicide (Hassan, Farag & Elkerdawi, 1994; Gilmore & Somerville, 1994). Health behavior and
health seeking behavior are two important domains in this study. There are several interventions
and strategies to address tuberculosis and health related stigma that draw on theories of behavior
(Janz & Becker, 1984; Janz et al., 1997; Glanz, Rimer & Lewis, 2002; Becker, 1974).
The primary theoretical underpinning of the study is stigma theory. However, further
research on the Health Belief Model (HBM), which seeks to explain and predict health behaviors
by focusing on individual attitudes and beliefs and Social Cognitive Theory (SCT) (Stone, 1999;
Eccles et al., 2005; Keller et al., 1999), describes the dynamic ongoing process in which
individual factors, environmental factors, and human behavior exert influence upon each other. If
tuberculosis was exclusively related to a biological cause and a cure, eradication would be
possible, yet the roots are embedded in society. Successful TB care depends on the behavior of
the individual at all levels: patient, providers, program, and society. Ensuring an early diagnosis,
adherence to treatment, along with culturally appropriate health workers, and incentives
represent important challenges to TB care.

SIGNIFICANCE
Strategies to improve TB care and framing tuberculosis and TB-related stigma has to be
done in its full context. This is a context where demographics, behavioral and social
determinants, other health disparities and incidence of others diseases converge. While an
individual human behavior approach to furthering successes in TB care is needed, a “macro”
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approach to further successes at a structural level is required.

It is important to explore

tuberculosis and health-seeking behaviors in relation to those who are affected by tuberculosis
and who are receiving treatment. The dissertation offers this type of insight and perspectives
through research conducted with and by those “directly” affected with tuberculosis including the
disease, health-seeking behaviors, access, and stigma. Necessary to advancing the understanding
of TB-related stigma, health-seeking behaviors and adherence to treatment is to present evidence
and critique for the theory and highlight the recommendations to understand the impact of TBrelated stigma.
The study findings are designed to help scholars and programs to move from
understanding stigma and its discourse to implementing reduction strategies and interventions
and will offer validation of a measurement tool initially developed by Van Rie et al., (2008) and
adapted to Spanish for use with Mexican-origin groups. This will allow scholars and health
workers will be able to measure tuberculosis and HIV/AIDS stigma and related disadvantages
and to design intervention strategies that will ameliorate them. Study findings have implications
for: (1) informing health services and decision makers about how persons of Mexican-origin
affected with TB in the United States-México border interpret their illness and stigma, (2)
research on health related stigma and interventions.
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CHAPTER 2
BACKGROUND AND SIGNIFICANCE
INTRODUCTION
Stigma is a phenomenon associated with multiple chronic health conditions. The physical
consequences of stigma can cause considerable suffering to those who are stigmatized (Frist,
1996; Jacoby et al., 2004; Nyblade et al., 2003). Stigma also has indirect and strongly negative
implications for public health programs (Link & Phelan, 2001; Piot, 2001; Weiss &
Ramakrishna, 2001; Aggleton, Parker & Malawa, 2003). Both personal effects and negative
public health effects are similar for a wide range of chronic stigmatized conditions. The effects
on the individuals stigmatized includes psychological stress, depression, fear, marital or
relationship problems, social participation restrictions such as the loss of employment or reduced
employment options, reduced education opportunities, increased vulnerability to disability, and
advanced disease.
The complexity of stigma has lead to disagreements on how to define it, how to measure
it, and whether it is associated with discrimination. Manifestations of stigma also vary by
whether the stigma is at the interpersonal or societal levels. The manifestations of stigma by
settings and levels have led to difficulties in measuring the extent of stigma, the impact of stigma
on the effectiveness of programs and interventions to mitigate it. Tuberculosis related stigma has
mainly been studied through qualitative research methods (Johansson et al., 2000; Long et al.,
1999; Rubel & Garro, 1992; Farmer, 1997; Jaramillo, 1999; Liefooghe et al., 1997; Carey et al.,
1997; Uplekar, Rangan & Ogden, 1999).
The majority of the literature reviewed dealt with stigma and sociological theory,
HIV/AIDS and health related stigma, tuberculosis treatment adherence, the influence of culture
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on TB knowledge, behavior, and attitudes and TB program control practices in various settings.
The review found some studies that examined the structural and social determinants that
influence human behavior in HIV/AIDS and fewer were identified that focus on TB. Gaps were
identified in systematic research into TB related stigma theory and frameworks and interventions
that can be applied in diverse and complex social and economic settings. While new tools and
approaches have improved the quality of TB care and services, social scientists and health and
human service professionals play a critical role in mitigating stigma associated with TB and can
strengthen TB prevention and care programs. Much of the literature cites the complexity of
stigma related to TB and other health conditions like HIV/AIDS and its diversity in different
cultural settings as the core reason for the limited response to the phenomenon (Parker &
Aggleton, 2003; Ogden & Nyblade, 2005).

ORGANIZATION OF THE LITERATURE REVIEW AND THE PRELIMINARY
STUDIES
This first section of the chapter describes the background and significant literature
findings on the socio-cultural, behavioral, and structural issues pertinent to tuberculosis and
stigma. The review was conducted using Medline, Pub Med, PsychInfo, Science Direct, over 250
articles and books published between 1980 and the present.
The second section describes three studies that were conducted by the principal
investigator and peers. These studies were instrumental in conceptualizing the research study
because of their focus on Mexican-origin populations, health disparities, border settings and
social norms like stigma and substance use. The studies are: (1) “Policies and Laws Affecting
Mexican-Origin Immigrant Access and Utilization of Substance Abuse Treatment,” (2) “Pilot
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Study on Tuberculosis Stigma with Mexican-origin individuals,” and (3) “Border Voices and
Images of Tuberculosis Photovoice Project.”
The first study used in-depth interviews to illustrated issues associated with access to
treatment and health care such as health risks associated with illegal drug use, infectious
diseases, delayed medical care and health seeking behaviors. The second study, a pilot study on
“Tuberculosis and HIV/AIDS Stigma in México field tested the Spanish translation of the TB
and HIV/AIDS Subscales” (originally developed by Van Rie et al., 2008). This study was
particularly important because of the nature of the investigation. The findings helped to
conceptualize the TB and HIV/AIDS Subscales Study to validate the subscales with Mexicanorigin populations. For a description of the finding of the TB and HIV/AIDS Subscales study see
Chapter 4. The “Border Voices and Images of TB Photovoice Project” (also referred to as TB
Photovoice Project) was the third study. This study was prominent in describing how individuals
affected by TB and stigma are influence by what family members, friends, and other members of
their social networks tell them about their disease and its treatment.

SECTION 1: BACKGROUND AND SIGNIFICANCE
Published articles and books pertaining to tuberculosis-related stigma were reviewed. To
perform the investigation as broadly as possible, the terms “tuberculosis AND stigma” and
“health-related stigma” were used. In addition a search with the term “HIV/AIDS AND stigma”
was also conducted to study the literature on the current state of research because individuals
with TB and/or HIV/AIDS often suffer from similar health related-stigma and social burden of
illness (Westaway 1989; Liefooghe et al., 1997; Nyblade et al., 2005; Macq et al., 2005; Van Rie
et al., 2008). After reviewing each of the abstracts, a set of mutually exclusive categories was
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created to place each of the articles and books. Categories facilitated summarizing the state of the
literature in four groups: (1) tuberculosis; (2) manifestation and impacts of stigma (e.g. negative
and positive); (3) social and cultural factors (e.g. structural violence, inequalities, human rights)
and (4) measurement and description (e.g. quantitative and qualitative studies).
Systematic criteria for each of the categories were created. There were times when the
article met criteria for more than one category so the article was placed into the category that
bears most resemblance to the study objective. Reviews of relevant documents from international
organizations like the WHO, PAHO, and the Stop TB Partnership were conducted. A review of
relevant articles in Spanish was carried out and criteria of articles and books cited are as follows:

Tuberculosis

Epidemiology of TB, the making of a social disease

Theory and definitions

Theoretical underpinnings of stigma, causes, effects,
conceptualization of stigma, definitions

Stigma manifestations

Manifestations, consequences, impacts
negative) related to stigma and TB

(positive

and

Social and cultural research in Behavioral barriers, social implications of TB, structural
tuberculosis care
violence, factor that influence behavior
Measurement tools

Assessments of health related stigma, psychometric
measurement, instrumentation, use of tools in various
contexts. Exploratory studies and assessments on stigma and
TB related stigma

2.1 TUBERCULOSIS
The pathology of tuberculosis is complex and is confounded by the popular belief that the
disease equates illness with a single-celled pathogen. In tuberculosis, there are several bacteria in
the mycobacterium that can generate the signs and symptoms frequently associated with the
disease. Mycobacterium tuberculosis is the most common; however mycobacterium bovis,
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present in some unpasteurized dairy products, and mycobacterium avium, a bacterium that infects
birds, also cause symptoms that define tuberculosis. Any of these bacteria can survive in the
human body without causing any symptoms. Lesions or scars can be found in an infected
person’s lungs, as “primary infection.” These bacteria alone usually cannot reproduce effectively
in a person with a healthy immune system.
TB bacteria are either eliminated or made dormant by the immune system within bundles
of immune cells called granulomas. Health care professionals distinguish between “latent TB”
and “active TB,” when the bacteria reproduce and physical symptoms occur. An active TB can
affect any part of the body. The lungs are the most commonly affected organs. Extra-pulmonary
TB is less common (WHO, 2007; Institute of Medicine, 2000). Active pulmonary TB is the only
form of the TB disease that can be infectious as the bacteria can be in the sputum and coughed
into the air and to be inhaled by someone else. Repeated and prolonged exposure is frequently
required for a person to contact the disease (PAHO, 2004). The World Health Organization
(WHO) estimates that between 10-15% of individuals infected with the mycobacterium will
develop active TB during their lifetime (2007). Active TB can be cured with 95% efficacy
(WHO, 2007), provided the person adheres to a long and strict regimen of antibiotics.
Every minute, four people die from tuberculosis and 15 more become infected worldwide
(Harrington, Morgan & Syed, 2009). In 2008, there were 11,095,750 people living with active
tuberculosis globally (The Henry Kaiser Family Foundation Global Health Facts,

2010).

According to the WHO (2009), one third of the world’s population is infected with the bacilli,
and there were 9.6-13.3 million new prevalent cases of tuberculosis in 2008 (3.6 million of
whom were women) and 1.1-1.7 million deaths from TB among persons and 0.45-0.62 million of
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TB deaths among HIV-positive people. The best estimates for 2008 by the WHO were: 9.4, 11.1,
1.3 and 0.52 respectively.
The 2008 global rate for tuberculosis is 139 per 100,000 (The Henry Kaiser Family
Foundation Global Health Facts, 2010). The epidemiology of TB has an unequal distribution
globally. The highest number of active cases is found in less developed countries, especially in
Southeast Asia, which accounts for 41% of the global TB burden with over 3 million cases per
year. In African nations which are most affected by HIV/AIDS, there are 1.6 million new TB
cases each year, in contrast with nations having established markets and economies which report
roughly 100,000 (WHO, 2008). Rates are falling slowly in five of the WHO regions and are
stabilizing in Europe. The total number of deaths and cases is still rising due to population
growth. For the first time in history, the 85% target for global treatment success (set in 1991) has
been exceeded at 87%. The HIV/AIDS epidemic has greatly contributed to the continuing threat
of TB particularly in Africa and Southeast Asia. In addition, multi-drug resistant TB (MDR-TB)
has emerged as a serious problem in many parts of the world (WHO, 2007).
Directly Observed Treatment Short Course Strategy (DOTS) for TB
The directly observed treatment, short course strategy for tuberculosis control was
launched by WHO in 1995 (Cox, Morrow & Deutschmann, 2008) and remains the cornerstone of
global TB control. The standard protocol from WHO indicates a two month (intensive phase) of
daily doses with four drugs (rifampisin, isoniazid, ethambutol and pyrazinamide) (WHO, 2003).
The intensive two month phase is followed by a four month (sustained phase) of rifampisin and
isoniazid, administered daily, biweekly or twice weekly. If the tuberculosis does not respond
quickly to treatment, a longer treatment might be required consisting of nine to up to 24 months.
Drug resistance, co-morbidities (e.g. diabetes mellitus, HIV/AIDS, substance use, cancer) can
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complicate treatment. Treatment with “second line” drugs can be difficult, expensive, produce
more side effects, and be less effective. Tuberculosis treatment works if the necessary
medications and the resources are available to do the drug susceptibility tests, and if the support
needed is present to manage the multiple side effects.
The Making of a Social Disease
Theories regarding the origins and global spread continue to change as new archeological
discoveries are made (Davis, 2000). There is no single story of tuberculosis; there are stories of
tuberculosis, stories of wealth and poverty, reform and revolution, industrialization and
urbanization, social anxiety and scientific developments. The most significant declines in
mortality and morbidity due to infectious diseases in the nineteen century were associated with
improved sanitation and nutrition. The latest biomedical techniques cannot solve all of the
problems of chronic illness or infectious diseases in society. New research is exploring the
interaction between the physical and social environmental influences like housing, diet, climate,
and ventilation. However, to revolutionize treatments for conditions like tuberculosis, medical
research alone falls short in providing the understanding of the full dimensions of the disease
necessary to guide programs and interventions.
Singer (2004) draws on the work of Frankenberg’s notion of the “making social of
diseases” 2 and the “related concepts of the making of disease” and the “making individuals of
disease,” to review biomedical conceptions of disease from the medical anthropology
perspective. Understanding the social origins of both the biomedical conception of diseases and
the expression of the sickness labeled by doctors is important. Frankenberg distinguished three
processes in the health domain: (1) the “making of diseases,” entails a medical provider grouping
2

Making of a disease is a notion by Ronald Frankenberg’s that reviews the conception of disease from the
perspective of medical anthropology as opposed to biomedicine to treat disease as a category. Singer (2004).
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signs and/or symptoms and constructing a biological or psychiatric diagnosis; (2) the “making
individual of diseases” is the development of patient consciousness about the experience with
being sick, involving clinical test, diagnosis, and interventions on the individual; (3) “making
social of disease,” entails the relationship between social relationships that shape the making of
disease and the social roles, behaviors, locations, and messages involved in making individuals
of disease (Singer, 2004; Singer & Toledo, 1994).
Revealing the “making social of disease” is a fundamental mission of medical
anthropology. It involves research and analysis to help reveal the nature of the social
relationships of making a new disease or converting an old one to new purposes. There are two
examples relevant to this research. One is the construction of the disease AIDS and its historical
analysis at the beginning of the epidemic suggesting that it was a gay plague (Shilts, 1987).
Another was the burden of being labeled as a risk group was extended to other vulnerable and
marginalized groups (e.g. illicit drug users, sex workers). The damage of the stigmas and labels
placed on HIV/AIDS were already embedded in the popular beliefs.
The social making of tuberculosis has involved historic and ethnographic studies. The
truth about TB changed over the course of the nineteen century. Around 1820, during the
Bourbon Restoration, consumption or phthisis was believed to be an individual, inscrutable, and
all but random killer, probably hereditary and somehow related to passion (Barnes, 1995). In the
1830s, under the July Monarchy in France, the disease was for the first time seen as socially
discriminating, a disease that chose its victims from professions and from geographical or
neighborhood areas. In the 1840s, being a consumptive woman signified in certain circles ultrasensitivity and emotion and a redemptive power of suffering. Between 1860s and early 1880s,
the disease was viewed as possibly contagious, lurking around and symptomatic of moral decay.
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It was not until the late 1890s that the “War on Tuberculosis” was launched. These changes
reveal the social context within which that knowledge or ignorance was embedded.
In the mid-20th century, tuberculosis was still considered the “great white plague.” In the
1970-80s, this killer became “silent.” Murray and colleages, (1991) wrote that the neglect of
tuberculosis as a major public health priority over the past three decades has been extraordinary.
Probably one of the core contributors to this state of silence and ignorance was when
tuberculosis was reduced clinically and epidemiologically in terms of importance in wealthy
countries (Murray et al., 1991). Therefore, tuberculosis has not really emerged so much as reemerged from the ranks of the poor (Farmer, Robin & Ramilus, 1991). Tuberculosis hides
among poor people, particularly when the poor are socially and medically segregated from those
whose deaths might be considered more significant.
In the late 1980s, large cities in the United States witnessed a significant resurgence of
TB cases with reversals of downward trends and rates of new cases doubling (Barnes, 1995). The
de-funding of public TB control programs in the United States coincided with upward trends in
urban poverty, increased mobility and migration from countries where TB is endemic, housing
shortages, intravenous drug use, increased homelessness, and overcrowded shelters. Substance
users were disproportionally affected by the new surge of TB in major U.S. cities (Mitnick et al.,
1998). Incarceration served as nexus for further transmission. Finally, the emergence of
HIV/AIDS created a national surge of immune-compromised individuals vulnerable to TB
disease. In the midst of the resurgence of TB was a sub-epidemic of multi-drug resistant (MDR)
TB, originating in large part from widespread non-completion of treatments and inadequate
prescription practices by physicians.
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Industrialization, urbanization, class conflicts, religious piety and charity, morality,
demographic stagnation, wars, and poverty, have contributed to the understanding of
tuberculosis. Tuberculosis, as a disease very much like HIV/AIDS, is understood differently in
relation to society and economics. The distribution of both TB and HIV/AIDS is associated with
social disparities (e.g. wealthy versus poor, majority versus minority) in both access to medical
care and treatments (Ramos et al., 2009; Rhodes et al., 1999, 2005).
In a book subtitled “How the battle against tuberculosis was won – and lost,” Ryan
(1993) argues that “throughout the developed world, with the successful application of triple
therapy and the enthusiasm of health promotion, the death rate of tuberculosis came tumbling
down.” The availability of effective anti-TB therapies has saved the lives of millions of TB
patients, many in industrialized countries. Tuberculosis in the rest of the world, and in pockets of
the United States, remains steadfast and unaffected by effective drugs which unfortunately are
used too late, inappropriately, or not at all (Farmer, 1999). One of the global authorities on
tuberculosis notes, “It is sufficiently shameful that 50 years after recognition of the capacity of
triple-therapy… to elicit 95% cure rates, tuberculosis prevalence rates for many nations
(underdeveloped) remain unchanged” (Iseman, 1999).
The U.S.-México Border Context
Multiple forces move people between communities, across states and countries,
particularly into the United States and other advanced nations (Arreola & Curtis, 1993).
Therefore, when more poor people move or migrate into developed countries like the United
States, an increase of TB incidence is inevitable. In two recent studies of TB among foreign-born
persons in the United States, immigration is basically credited with the increased incidence of
TB related disease (McKenna et al., 1998, 1995; CDC MMWR, 2001). The authors state that in
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some of the immigrants’ countries of origin the rate of infection is up to 200 times higher than
that of the United States.
The study of borders includes the study of social inequalities. Borders are geopolitical
and historical demarcations, and serve as semi-permeable membranes, open to disease and yet
closed to the free movement of people, services and cures. Inequalities of access are created or
reinforcement at borders even when one cannot contain the pathogens. When the borders in
question are between a rich and a poor country as in the case of the U.S-México border, there are
effects that interfere between two very different types of health care systems with advancement
of an emerging disease like TB. Warner (1991:242) notes that “It is unlikely that any other binational border (U.S.-México) has such variety in health status, entitlements, and utilization.”
Probably the most cited definition of the Border (La Frontera) is the La Paz Agreement
of 1983 (USMBHC, 2003) “100 kilometers (62.5 miles) north and south of the international
boundary between the United States and México.”

Despite this “formal” definition there are

multiple formulations of the border region. These definitions account for some of the most
striking differences and disparities accounted for in both countries. The statistics reveal little of
the diversity among the populations that live on the border region; however, each group has
distinct and significant impacts on health and environmental planning and service delivery.
There are also 26 federally recognized Native American tribes on the U.S side of the border, and
on the Mexican side there are seven indigenous groups (USMBHC, 2003).
The majority of the people on either side of the border are permanent residents; some are
“borderlanders,” others are bi-national, others cross the border daily for work, school, and to visit
family members. Other individuals rarely cross the border; some have never crossed and others
are scared of crossing. Some residents are temporary such as international migrants who may
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spend a few days in the border region. Some are ‘”seasonal” including migrants and others are
U.S. “snowbirds” living on both sides of the border.
In México, every day there are 54 new tuberculosis cases and every 6 hours a person dies
from tuberculosis (Castellanos, 2009). Tuberculosis rates continue to affect more communities
and individuals that are most vulnerable (e.g. poor, underserved, malnourished, HIV/AIDS,
diabetics). México’s national TB rate for 2007 was 20 per 100,000 (The Henry Kaiser Family
Foundation Global Health Facts. 2010); this is over three times the rate in the United States of 7
per 100,000. México’s National TB prevalence rate for 2007 was 23 per 100,000; this is eight
times the rate in the United States of 3 per 100,000 (The Henry Kaiser Family Foundation Global
Health Facts, 2010).
Each of the six Mexican states that border with United States has higher TB rates than the
national TB rate and combined represent 31% of the total cases for México in 2008, with the
border municipalities of the states of Baja California, Tamaulipas and Chihuahua having the
largest concentration of tuberculosis cases (Castellanos, 2009; CDC MMWR, 2009). According
to the Centers for Disease Control (CDC), in 2008 in the United States a total of 13,293 new
tuberculosis cases were reported; the TB rate declined 4.2% from 2006 to 4.4 cases per 100,000
(CDC MMWR, 2009). The national TB incidence rate in 2007 was the lowest since national
reporting began in 1953. Despite this improvement, foreign born persons and racial and ethnic
minorities continue to bear a disproportionate burden of the disease in the United States. TB rates
among Hispanics, primary Mexican-origin individuals, blacks and Asians were 7.8, 8.3 and 22.9
times higher than among non-Hispanic whites respectively in 2007 (CDC MMWR, 2009).
Data from U.S.-México Healthy Border 2010 Midterm review (U.S.-México Border
Health Commission, 2009) indicates that from 2000 to 2005, the U.S.-México border population
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increased by 8.2%, from 11, 550,077 to 12, 501,780 people. The ten most populous counties on
the U.S. border comprise close to 98% of the total U.S. border population. The U.S. border
population is comprised primarily of Hispanic, Mexican-American, Mexican-origin (51.5%),
followed by white, non-Hispanic (38.8%). Of these, approximately 50 percent are female
(53.6%). Half of the population along the U.S border is younger than 34 years of age and one in
every five individuals (21%) is under the age of 13. Another 20 percent of the U.S. border
population is older than 55 years. Education levels vary from county to county within the U.S.
and México border counties. Almost 38% of the border population (25 years of age and older) in
Texas have less than a high school education and nearly one-fifth lived below the poverty level.
Fifty-five percent of these individuals were younger than 25 years of age (U.S.-México Border
Health Commission, 2003).
In contrast, the ten most populous Mexican municipalities comprised 91 percent of the
Mexican border population in 2005 (Rangel & Hernandez, 2009; Comision de Salud Fronteriza
Méxicano-Estadounidence de Salud, 2009). Two thirds (65%) of the population in México is
younger than 34 years of age and more than one quarter (28%) are less than 13 years old. Only
8.6% percent of the population is older than 55 years of age. In Mexican border cities or
municipalities, 41% of people of twenty-five years of age and older have only completed
elementary school (six grade schooling) (Comision de Salud Fronteriza MexicanoEstadounidence de Salud 2009).
Poverty is defined through different indicators in each country and the degree of poverty
and socio-economic status varies significantly. More than one fourth of the Mexican border
population lived in poverty in 2005, and one-fifth of the U.S. border population lived below the
federal poverty level.
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The Ciudad Juárez, México, and El Paso, Texas Border
For this study the unit of analysis is El Paso, Texas and Ciudad Juárez, México. Ciudad
Juárez and El Paso are situated at the midpoint of the U.S.-México border, which is more than
2,000 miles long ranging from San Diego to Brownsville (Papademetriou & Meyers, 2001). El
Paso and Ciudad Juárez have become major locations of the internationalization of U.S. capital,
which has forged a strong structural relationship between the two cities. Arreola and Curtis
hypothesize that certain structural characteristics are distinctive to the border region, like tourist
districts, maquiladora (twin plants) industrial park, and street networks oriented toward ports of
entry to facilitate the movement of goods and the mobility of people (1993).
Ciudad Juárez, México, is the fifth most industrialized and wealthy city in México. The
city is densely populated with approximately 1.8 million people with a 1.32% growth rate per
year between 2000 and 2005 (INEGI II Conteo de Población y Vivienda, 2005). Although the
majority of Juarenses are socio-economically poor, their standard of living is higher than many
other communities of its size in México. In 2005, there were 29 million northbound legal
crossings from Ciudad Juárez to El Paso (U.S. Department of Transportation, 2006).
In recent years, the national and international news have broadcast to the world examples
of how violence, death, organized crime, and delinquency have escalated in the border region
and in particular in Ciudad Juárez, naming the city as the most dangerous city in México and
among the most dangerous in the world (CNN International, www.cnn.com retrieved on August
29, 2009; La Red Noticias, 2009). This violence is responsible for the death and disappearance of
thousands of residents in Ciudad Juárez, México, and in El Paso, Texas.
In addition, intense U.S. efforts to strengthen law enforcement in the El Paso area are
evident. El Paso is the third poorest major city in the country. The population is 742,062 (U.S.
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Census Bureau Estimates for 2008). In El Paso, 28.4 percent of the population lives below the
poverty level, and their standards of living are lower than many other communities of its size in
the United States (U.S. Census Bureau American Community Survey, 2009). Anxiety about
illegal drugs, arms, and unauthorized immigration has led to fortifications and an active police
and military presence on both sides of the border. El Paso, Texas enjoys a considerable
continuity and extension of Mexican culture. The use of the Spanish language is widespread
among the Hispanic population of El Paso. Cultural continuity is found in restaurants, stores,
schools, and places of worship. The city has a Spanish language newspaper. There are additional
cultures that bond these two communities that range from a business culture of corporate
practices to political activities, activism around immigration, cross-border utilization of medical
and health care services, law enforcement and border security mechanisms, environmental
issues, and educational needs. El Paso is a major area of undocumented immigration and the
U.S. Immigration and Customs Enforcement (ICE) handles one of the largest numbers of
removals among all the ICE districts in the country.
Many binational families reside in the adjacent border communities of Ciudad Juárez and
El Paso. Adults travel back and forth to work, visit relatives, and go to school, while children
born on one side of the border may be raised on the other. There is a strong binational presence
in El Paso which is reflected of the foreign born population that reached 27.2 percent in 2006
(U.S. Census Bureau American Community Survey, 2009). Most of the immigrant population is
of Mexican origin.
The U.S-México border region is at high risk of elevated TB incidence and other health
issues due to socioeconomic stress, rapid and dynamic population growth, the interrelationship of
cultures (Finch et al., 2001; USMBHC 2003; Moya & Shedlin, 2008), and a young population
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(Harrison & Kennedy, 1994). Studies in public and environmental health point to serious
disparities such as limited access to health care, lower insurance coverage, socioeconomic
disadvantages, higher rates of TB, HIV/AIDS, chronic diseases, addictions to illicit drugs, and
increased violence and human insecurity. Thus, the U.S.-México border represents a natural
environment for other areas of the country experiencing high rates of immigrants of Mexicanorigin as well as other countries experiencing economic and social changes on their borders.
These statistics are well-known among public health workers, but not the general public;
they usually come as a surprise. During the time this research was conducted, the work was
discussed with people with various backgrounds, and it was surprising to hear them say that they
thought that TB no longer existed, that it was eliminated, or that it is a condition of the poor. For
the person affected by TB, these statistics translate into dismay and suffering with signs and
symptoms like weight loss, persistent coughs (with or without blood), fever, night sweats, and
loss of physical strength, stigma of an infectious disease, disability and death. If in addition to
TB, the PATB experiences stigma and discrimination, the burden of the illness can be greater
and more detrimental to the quality of life of the individual. This study focuses on the effects of
stigma related to TB on health seeking behaviors and access. The first section focuses on the
theory and significance of TB related stigma, socio and cultural research on TB, the effects and
manifestations of stigma, and the measurement of health-related stigma.

2.2 STIGMA MANIFESTATIONS AND IMPACTS
The conceptualization of stigma related to TB that underlies most of the literature echoes
the stigma concept for a broader set of health and human issues such as mental illness, disability,
and HIV (Somma & Bond, 2006; Link & Phelan, 2001). Most research on stigma focuses on one
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type at a time (Link & Phelan, 2001). Some persons who are stigmatized are more likely to be
members of several groups, for example, a former drug user, previously incarcerated, member of
a minority group, HIV positive and living with TB (Parker & Aggleton, 2002).
The body of research cited emphasized the origins of stigma in human cognition and the
consequences individuals’ perceptions have for social interactions (Parker & Aggleton, 2003;
Link & Phelan, 2001). This framework limits the scope of stigma interventions to strategies that
increase empathy, unselfishness, and reduction of anxiety and fear of persons living with HIV or
AIDS or affected by TB among the general population, or individual based interventions to assist
the individual to cope with perceived or experienced stigma. Most of the articles and research on
stigma measurement and mitigation interventions utilize a socio-cognitive framework of stigma.
These approaches are important; however, they exclude a vital consideration of the social
structural aspects of stigma that produce and intensify stigma and discrimination that are
grounded in dynamic social, economical, and political processes (Link & Phelan, 2001; Oliver,
1992; Fiske, 1988).
Parker and Aggleton (2003) and Farmer (2005a) further argue that structural or social
power is not only required to enable stigmatization, but that stigmatization has an important role
in producing and/or reproducing relations of power and control. Stigmatization is linked with
social inequality which causes some groups or communities to be devaluated and discredited and
other groups to feel superior (Parker & Aggleton, 2003).
Structure Violence
If stigmatization is at the crossroads of culture, power, and differences, Parker and
Aggleton (2003) argue that stigma is produced and used to help order a society. Cultures produce
“differences” in order to achieve social control. Stigmatization is also used by the dominant
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groups to legitimize and reproduce inequalities; concepts like symbolic violence and hegemony
can help to illustrate how individuals who are stigmatized and discriminated often accept and
internalize the stigma to which they are subjected.

Stigmatization helps to create differences

and plays a role in transforming differences based on class, gender, race, ethnicity, or sexuality
into social inequality. Both symbolic violence and hegemony convince the dominated to accept
the hierarchies and allow social hierarchies to persist over time without generating conscious
recognition from those that are dominated and oppressed. This hinders the ability of oppressed
and stigmatized individuals and groups that result the forces that discriminate against them
(Parker et al., 2002).
Farmer’s ethnographies (1994, 1997) describe cases which center on the experiences of
individuals with TB and HIV. Farmer’s descriptions of persons that are affected by TB and HIV
indicate how community histories, national politics, and broader global trends are manifested in
individual lives. Through his images, Farmer envisions a society in which ethnographies render
testimony about how individuals with TB interact in work-based or economic relationships based
on structural violence, which can be defined as the systemic power enacted against persons
through social, economic, and political forces (2000; 2005a). According to Farmer (1994;
2005a), all members of the social order collectively are implicated in structural violence 3.
The public health discourse primarily understands tuberculosis as a disease which
traditionally is linked with studies of people and places to morbidity and the mortality of
individuals and populations.

This approach influences how groups of people get to be

characterized. For example, public interventions such as DOTS are most of the time
implemented nationally (even globally). Nevertheless, they center on individual responsibility

3

The term “Structural Violence” is used to refer to discrimination, stigma and suffering that finds expression as
symptoms presented for biomedical intervention (Farmer, 2005).
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for health and for adherence to TB treatment and seldom address the social and physical
determinants of tuberculosis.

One cannot frame tuberculosis as a local health problem when

globally there is a series of determinants that frame the problem geographically. The effects of
globalization and the mobility and migration of millions of people are prominent factors in
understanding and managing diseases like TB and HIV/AIDS.
Migration represents the primary mechanism by which TB spreads across regions and the
world. TB treatment services are organized in such a way that people who move are easily lost or
subjected to measures intended to limit their movement. Tuberculosis has been known as a
disease of class and poverty and is now becoming a disease of classes of nations. Poor nations
(referred to as high burden nations by WHO, 2008) with high incidence and few resources have
different standards than countries that are rich and resourceful. Poor countries are frequently
blamed or considered vectors of disease and transmission. This should not be the case. This
distinction between nations is particularly relevant to the United States-México border, but not
exclusively.
Discrimination is a consequence of stigmatization and can be individual, structural or
institutional (Link & Phelan, 2001). Discrimination is defined as unjustifiable differences in
treatment given to different individuals or groups (Aggelton et al., 2003). It is also any measure
leading to a harmful distinction or categorization of individuals based upon their health status
(Carael et al., 2000). Stigma associated with TB, HIV and AIDS and the resultant discrimination
can violate the human rights of people living with TB, HIV and AIDS, as well as the rights of
their families. Stigma, discrimination, and human rights abuses can originate from government,
institutions, and organizations as well as from communities, families, and individuals.
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Effects
Negative effects on public health programs and interventions like delays in TB diagnosis,
seeking care and treatment, result in the continuing risk of disease transmission of infectious
diseases and in a higher morbidity and poorer treatment prognosis in many conditions (Jaramillo
1998; Ngamvithayapong et al., 2001; Nickolls, et al., 2003). In addition, concealment of
diagnosis may result in continued vulnerability and risky behavior and failure to embrace
preventive behavior in conditions like tuberculosis, HIV/AIDS (Rahlenbeck, 2004). Poor
treatment adherence or default from treatment has also been reported (e.g. tuberculosis, leprosy,
HIV/AIDS, mental health and epilepsy) (Conrad, 1995; Heijnders, 2002; Sumartajo 1993;
Weiser, et al., 2003). Poor treatment adherence in TB and/or HIV/AIDS can result in increased
risk of developing MDR (Wahl & Nowak, 2000).
Stigma is invoked as a constant problem in discussions about effective responses to
tuberculosis and other chronic health conditions like HIV/AIDS, mental health, disability and
epilepsy (Foreman, Lyra & Breinbauer, 2003; Holloway et al., 2004). In addition to causing
distress to the individual’s family, social and economic life, stigma can be a major barrier to
accessing prevention, as well as care and treatment services (Mahajan et al., 2008). Most
literature on stigma and interventions on tuberculosis and HIV/AIDS have focused on its selfimposed nature and some aspects of individual discrimination, excluding structural dimensions
of discrimination. Therefore, stigma needs to be analyzed within frameworks that draw on
power, dominance, hegemony, and oppression (Bourdieu, 1977, 1984; Foucault, 1976).
Interventions that are grounded on social, political and economic roots and that target multiple
mechanisms are needed to mitigate stigma and one of its consequences, discrimination.
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Gender Context
Traditionally, women have had to deal with much greater health risks, confront many
more constraints and make do with fewer opportunities when trying to address their health needs
(UNDP/World Bank/WHO, 1996). Gender relations reflect power and the hierarchical ordering
of status that leads to inequity in the health and well-being of women and men. Health risks of
poverty are far greater for females than for males (Uplkar et al., 1999; Hudelson, 1996).
Tuberculosis is the greatest single infectious cause of death in women worldwide (Howson et al.,
1996). Literature on gender and TB is scant with only a few reviews on epidemiological and
socio-cultural gender differentials (Connolly & Nunn, 1996; Holmes et al., 1998). There is no
conclusive evidence to what extent these differences result from biological factors, socio-cultural
context, and from under recognition of TB among women due to poor or limited access to care.
The impact of gender on health has been largely ignored; however, in the last years, as TB reemerged onto the international and national public health agendas, interdisciplinary studies and
control efforts have begun to focus on the role of gender in TB care.
Although the overall prevalence of pulmonary TB is lower in women, the progression
from infection to disease can be 130% higher in women between the ages of 10 and 44, and case
fatality rates are 27-41% higher in women and girls between 5 and 24 (Holmes et al., 1998). The
data indicates that while women may enjoy some type of protection against TB, the protection
may be offset by biological and sociological vulnerabilities across certain life stages. This in
turn could lead to accelerated morbidity and mortality as well as delays in seeking treatment or
differential treatment once they seek care (Fine, 1994). Findings from Hudelson (1996) suggest
that cases of tuberculosis among women may be under-reported in developing countries.
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Studies have reported that women bear the highest burden of stigmatization behaviors
(Uplekar et al., 1999). In some communities, women with TB and women who are suspected of
having TB are likely to be forced to separate or divorce, be sent back to their parents’ homes, and
have fewer chances of getting married (Vlasoff & Bonilla, 1994; Holmes et al., 1998). In studies
from Bangladesh and Vietnam, the fear of social isolation from family or community is a key
factor for delayed care among women. Stigma is suspected to be a contributing cause of why
women are more likely to postpone diagnoses and are offered sputum tests less frequently and
feel more inhibited than men to discuss TB with their families (Balasubramanian, 2004; Long et
al., 1999). Other studies document that gender differences in care seeking behaviors explain
delay differences between men and women. Men postpone care seeking for longer periods than
women, because of fear of costs of diagnosis and treatment (Long et al., 1999), and neglect of
symptoms until serious and then they seek care. Women are more likely than men to seek care
immediately after the symptoms appear. Studies in China and India have demonstrated that
women tend to self-medicate and/or choose private providers as the first point of contact after
deciding to seek care (Xu et al., 2004; Singh et al., 2002).
A gender perspective and analysis is needed for TB in order to move beyond the organic
and biological causality and concentrate on explaining the differential constraints experienced by
women and men in access to health and health care and in the effect of the social meaning,
especially stigmatization of infectious diseases.
Positive Stigma
Shih (2004) writes about the processes that successful by stigmatized individuals use to
overcome the harmful consequences. The process consists of an empowerment model (Corrigan
& Penn, 1999; Corrigan & Watson, 2002), where the individual overcomes adversities associated
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with stigma as an empowering process (positive stigma) as opposed to a depleting coping
mechanism (Shih, 2004). In order to understand how to deflect the negative consequences of
stigma, research and investigators should focus not only on identifying the factors that lead
individuals to be hurt by stigma and stress, but also the factors that help individuals to protect
and overcome stigmas (Garmezy & Masten, 1990). Research on resilience such as done by
Garmezy (1991) has identified mechanisms on how to develop competence and healthy
adjustments outcomes. Shih (2004) argues that stigma can be targeted through compensation
(Miller & Major, 2000), strategic interpretations of the social environment (Crocker & Major,
1989), and focus on multiple identities (Crocker & Major, 1989; Pittinsky, Shih & Ambady,
1999).

2.3 SOCIAL AND CULTURAL RESEARCH IN TB CARE
Research into the meanings and social implications of TB has been limited to a small
number of cultures. Ogden (2000) notes that there is limited use of theoretical frameworks to
investigate behaviors that hinder understanding of the cultural and social factors that surround
TB care. Jaramillo (1998) found that many of the studies are narrow in scope and examine
neither the context of TB care nor the external factors that may influence behavior. In spite of a
scarce theoretical grounding and a limited number of comparison studies that identify patterns
across cultures, the investigation provides valuable information on key issues affecting TB care.
Delayed diagnosis and non-adherence of treatment are two core behavioral challenges
associated with TB. Persons affected by TB and health-care providers are expected to perform
specific behaviors and actions. Success in TB detection requires behaviors from both the persons
affected and the health-care workers to facilitate those practices.
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Understanding health care seeking behaviors
The examination of how local culture interprets TB causes, signs and symptoms can help
providers and researchers understand why individuals delay seeking health care and treatment,
yet there is no conclusive evidence on whether the quality or underutilization of health services
accounts for a larger proportion of delay in TB case finding. Studies identify core factors that
account separately for delay by persons affected with TB and health care service delay. Several
studies have found correlation between delays of persons affected by TB and knowledge,
attitudes, stigma, external constraints and gender differences (Balasubramanian et al., 2004;
Uplekar, Rangan, & Ogden, 1999). When health care services fail to detect TB cases, case
findings depend on voluntary solicitation frequently motivated by symptom recognition, as well
as cultural and social influences.
The “culture of silence” –the tendency to bear pain and suffering silently constrains the
communication and therefore the internalization of symptoms, with a perception that what
cannot be remedied does not need to be reported (Duggal & Amin, 1989; CEHAT, 1999; Vora,
1994). The inclination to seek health care is based on knowledge about and perceived risk of TB
within reference groups (families, neighborhood) and communities (Anibarro et al., 2004);
(Caprara, 2000).

A number of studies have found an association between knowledge and

delayed TB diagnosis. Knowledge refers to the ability to recognize the signs and symptoms,
causes and transition mechanisms, and availability of treatment and cure (Asch et al., 1998).
Knowledge independently may not be the determining factor for care-seeking behavior
according to the evidence. The association between knowledge and timing of diagnosis has been
well documented (Thorson et al., 2001).
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Studies that examine how local culture interprets TB causes and symptoms help to
understand why people delay seeking treatment. In Thailand, research indicates that some people
associate TB symptoms with HIV/AIDS and delay seeking treatment for fear of having HIV and
AIDS (Ngamvithayapong et al., 2001; Diwan & Thorson, 1999). In the Philippines, research
showed that persons affected by TB attributed TB symptoms to “bad habits” like drinking or
smoking, and therefore delayed seeking treatment for their “harmless” symptoms (Auer et al.,
2000). In a study in Nigeria, persons affected by TB who held rigid traditional views that TB
could be spread by eating beef and other high protein foods reported delay in seeking treatment,
frequently waiting until they were malnourished (Emwereji, 1999). Vietnamese refugees in the
United States reported a myriad of separate beliefs regarding the causes of TB, the most frequent
being hard manual work, smoking, alcohol consumption, poor nutrition and germs (Carey et al.,
1997).
A study in Malawi demonstrated that persons affected by TB thought that TB resulted
from breaking sexual taboos or from bewitchment. They believed they could only be treated by
traditional healers, while TB from other causes could be treated with Western medicine
(Banerjee et al., 2000). Other groups expressed significant preferences for treatment from
clinical and biomedical health professionals, with little or no interest in traditional remedies
(Carey et al., 1997). A study in South Africa among the Xhosa speaking people of South Africa
showed that people associated TB with a lack of hygiene and with witchcraft. They sought care
first from a diviner, and only when traditional treatment failed they would seek Western
Medicine (de Villiers, 1981). In rural Haiti, while many persons affected by TB viewed sorcery
as a possible cause of tuberculosis, the etiological beliefs had no impact on adherence with biomedical regimens (Farmer et al., 1991). Western scientific medicine defines TB as a biological

44

phenomenon and Western medicine and does not address the spiritual or philosophical
explanations of TB that is recognized in other cultures (Steen & Mazonde, 1999).
Semantics in illness and treatment is important to explain how people or cultures explain
TB. In the work by Nichter in the Philippines, the term “weak lungs” embraces a range of
respiratory diseases and is used by the lay population and health care practitioners alike to avoid
stigma associated with TB (1994). Practices such as these (stigmatization) can result in delayed
diagnosis and the development of multi-drug resistance. In China, Kleinman (1980) studied the
indigenous ways in which TB was viewed and described, and noted that the popular terminology
merged both the psychological and physical symptoms of the illness. There are multiple
misunderstandings about tuberculosis, the causes and forms of transmission. Findings by Carey
et al., (1997) and Nguyen, et al., (2000) are consistent with the preliminary studies that the PI
and peers conducted in 2008 in the “Border Voices and Images of TB Project” (De Heer et al.,
2008). A study with Latinos in the United States by Ailinger and Dear (1998) corroborated that
family concerns motivated care-seeking behavior and adherence to treatment. In a study by
Mitnick et al., (1998) in the United States, social support contributed to adherence and
completion of TB therapy, and therefore to the reduction of TB incidence among foreign-born
persons, however financial and social disadvantages often outweighed protective factors.
Studies in México (Alvarez Gordillo et al., 2001), Ecuador (Armijos et al., 2008), Perú
(Shin et al., 2004), and India (Atre et al., 2004; Barnhoom & Driaanse, 1992) have documented
that persons affected by TB with low knowledge about symptoms are more likely to postpone
care seeking and get tested. Poor knowledge has been found among older and less educated
people in Nepal (Mathema, 2001) and marginalized groups with limited media access in Vietnam
(Johansson et al., 2000; Johansson & Winkivist, 2002; Hoa et al., 2004). Persons affected by TB
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with higher educational levels are more likely to know symptoms and seek care earlier (Grange
& Festenstein, 1993). On the contrary, a study in India suggested that knowledge was not
sufficient to prompt people to seek care, and that self-motivation was needed to seek care (Atre
et al., 2004; Waisbord, 2005).
Studies in Tanzania found that in some communities, persons affected by TB with low
knowledge are more likely to consult a traditional healer and pharmacists rather than the TB
health-care providers or to visit a health center, delaying diagnosis (Wandwalo & Morkve,
2000). The literature did not analyze the reasons for seeking advice from traditional healers and
pharmacists. This preference cannot be assumed to be the result of low knowledge. It seems to be
a frequent care seeking practice based on trusts and familiarity of the non-health care providers.
Patients with higher perception about the severity of the disease are less likely to delay
care seeking and diagnosis. A study in Gambia found that persons affected by TB with
hemoptysis had shorter delays than persons with less severe symptoms (Eastwood & Hill, 2004).
Studies have also demonstrated a strong association between external barriers and patient delay
and distance from a TB clinic (Sengupta, 2006; Leifooghe et al., 1997; Wandwalo & Morkve,
2000). Transportation expenditures associated with distance between residence and TB clinic,
costs and financial difficulties, the need to borrow money to get to the clinic, loss of daily
income to attend TB clinic and lack of health insurance account for delays have been published
in China (Xu et al., 2004), México (Alvarez Gordillo et al., 2001) and Kenya (Watkins & Plant,
2004; Liefooghe et al., 1997).
Understanding Tuberculosis Treatment and Care
The inability of health-care providers to screen contacts of persons affected by TB
continues to contribute to delayed diagnosis. In addition, poor interpersonal communication and
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inadequate attitudes of health care workers and the lack of attention and support amount to delay
in care in several countries (Anibarro et al., 2004; Auer et al., 2000; Diez et al., 2004;
Ogden,1999; Ogden et al., 2003).
No single predominant pattern of reasons exists for TB non-adherence to medications.
Instead, there are various approaches and methodologies that explain adherence issues. Various
social scientists have identified patient health beliefs or health cultures as the primary “cause” of
non-adherence (DiMatteo & DiNicola, 1981; Barnhood & Adriaanse, 1992; Paluzzi, 2004).
Other studies demonstrate that non-adherence streams from dynamic and complex factors that
are within and beyond the control of the person affected by TB. These factors range from
confusion about the implications of symptoms, social stigma, perceptions of services and healthcare workers, transportation challenges, lack of information and mistrust, high cost of
medications and health care, service access, and delivery problems (Liam et al.,

1999;

Sumartajo, 1993; Rubel & Garro, 1992; Rubel & Moore, 2001; Thompson & Myrdal, 1986).
Operational dysfunctions of TB programs are another important factor that can deter adherence
(Juvekar et al., 1995).
A study by Poss (2000) with Mexican-origin immigrants demonstrated that while trust in
TB care and social support facilitated adherence to treatment, access issues were found to most
affect health care seeking behaviors. In a study by Barnhood and Adriaanse (1992) the
socioeconomic variables were the strongest predictors to adherence, such as a family’s per capita
income, the type of dwelling in which they live, and the family’s income. Measuring adherence
is complex. Studies have failed to identify psychological correlates to adherence (Sumartajo,
1995, 2000). Directly Observed Therapy, Short course has been questioned by researchers for the
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extent to which TB programs have failed to recognize the social and structural determinants in
which persons receive care (Hurtig, Porter & Ogden, 1999).
The literature identifies specific subgroups as vulnerable to treatment default. In the
United States and Europe, the most marginalized sectors of society are more likely to interrupt
TB treatment- such as foreign-born, migrants, refugees, undocumented persons and workers, the
unemployed, the homeless, the mentally ill, and persons who use illegal drugs (Thorson et al.,
2001; Hurtig et al., 1999). In developing countries, rural, older and less-educated individuals are
more likely to default treatment (Barnhoom & Driaanse, 1992; Atre et al., 2004; Harper et al.,
2003). Three of the primary predictors of default are: (1) knowledge about the length of
treatment, (2) misconceptions of well-being which lead to interrupting treatment soon after the
person feels better and or at around two months after initiating medication, and (3) not knowing
about potential side effects of medicines (Grange & Festenstein, 1993; Thorson et al., 2001).
Motivation, perceived severity of disease and self-efficacy were found to be related to
significant differences among individuals who adhere to treatment and those who did not.
Individuals who are more motivated have a higher perception of risk and feel more confident
about their ability to complete treatment are more likely to adhere to treatment (Jaramillo, 1999,
1998; Armijos et al., 2008; Van Rie et al., 2008; Sengupta et al., 2006; Pungrasammi et al.,
2010).

The quality of health-care services, provider and patient interactions account for

variations in treatment adherence (Macq et al., 2008; Johansson & Winkivist, 2002). A study in
South Africa demonstrated that the quality of this interaction coupled with correct causative
belief were strongly associated with adherence behavior whereas knowledge, onset of TB, sociodemographic variables, health care seeking and health beliefs were not associated (Macq, 2007).
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Studies in Haiti and Gambia concluded that regular visits by community health workers or
promoters improved adherence (Farmer, 1997; Eastwood & Hill, 2004).

2.4 MEASUREMENT OF HEALTH RELATED STIGMA
Based on the literature (see Link et al., 2001, 2004; Van Braker, 2006), there are thre
distinct and related approaches to assess health-related stigma. The study PI (Moya) limited the
research to (1) assessing the experience of actual discrimination and/or participation restriction
on the part of the individual stigmatized with a potentially stigmatized health condition, (2)
assessment of perceived or internalized stigma of individuals with a potentially stigmatized
health condition through interviews about their feelings of fear, shame, and guilt they may
experience, (3) assessing the attitudes and practices toward the individual affected.
Various research methods have been used within each of these approaches to include
qualitative and quantitative methods, indicators and scales. The characteristics of the instruments
selected for this review are described. The studies show that stigma related to chronic health
conditions (e.g. HIV and AIDS, leprosy, tuberculosis, mental health, and epilepsy) is a global
and dynamic phenomenon, which occurs in both developed and underdeveloped locations.
Although there is important cultural and linguistic diversity across the world, the areas of life
affected by stigma are similar (Le Bel, 2008; Van Brakel, 2006). These areas are marriage or
partner relationships, employment, education, interpersonal relationships, mobility, and
participation in leisure, social, and religious functions.
Life Domains, Participation Restriction and Stigma
According to the WHO International Classification of Functioning, Disability and Health
(ICF), the consequences of stigma and stigmatization manifest to a large extent as restrictions to
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participation (WHO, 2001). According to the ICF, there are nine life domains in which
participation might be restricted due to stigmatization: (1) learning and applying knowledge, (2)
general tasks and demands, (3) communication, (4) mobility, (5) self-care, (6) domestic life, (7)
interpersonal interactions and relationships, (8) major life areas, and (9) community, social and
civil life (2001). Other important aspects affected by stigma and stigmatization are quality of life
and well-being, self-esteem, and emotions.
Van Brakel grouped the core results of the review of the health related stigma
measurement findings (2006) based on the ICF domains and found striking similarities with this
sudy. Among the top 16 constructs occurring in at least four fields are items related to: (1)
marital problems, (2) social avoidance, (3) concealment of the condition, (4) shame and
embarrassment, (5) thinking less of oneself, (6) visiting or being visited by others, (7) not being
allowed to play with children, (8) reduced employment opportunities, (9) people thinking less of
affected person, and (10) fear of person with the condition. These findings are consistent with
some of the results found in the study that the PI (Moya) conducted on TB-related stigma and the
impact on health-seeking behaviors and access in Ciudad Juárez, México, and El Paso, Texas.
Instruments
There are various stigma instruments. However, the instruments reviewed for the study
are limited to public health-related stigma with a focus on infectious diseases, mental health and
disability. In a review by Van Brakel (2006) of health-related literature search, there were three
generic stigma instruments found. The first in is a scale derived from the Explanatory Model
Interview Catalogue and has been used with a number of health conditions to measure stigma in
terms of negative community attitudes (Weiss et al., 1992). The 12-item scale is part of set of
instruments used to identify various cultural and epidemiological aspects of a health condition.
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The scale covers only certain areas of life that can be affected by stigma, like concealment,
avoidance, pity, shame, being made fun of, and respect and marriage. The psychometric
properties are partially known. The strengths of the instrument are its simplicity, and the utility
in various cultural settings and with various health conditions, such as mental health and leprosy
in India (Weiss et al., 1992), depression (Raguram et al., 1996) and TB (Somma et al., 2008).
The other two scales are: (1) Child Attitude Toward Illness Scale which consists of 13
items and is validated for use with children aged 8 to 12 and with adolescents (Austin &
Huberty, 1993) it is particularly used with samples of children with epilepsy and with asthma;
and (2) the Participation Scale, an 18-item scale with a two-step, five-point response scale (Van
Brakel, 2006) used with samples of adults with leprosy or disability. For a summary of the
psychometric properties of these scales, refer to Van Brakel literature review (2006).
Tuberculosis
Macq, et al, (2005) developed instruments to assess internalized social stigma related to
tuberculosis in rural Nicaragua, and Jaramillo carried out a survey in Colombia exploring the
correlation of prejudice as an attitudinal component of this stigma. Results indicated that local
beliefs about the transmission of the disease were the main predictors of the negative attitudes
(1998). Senguta et al., (2006) and Van Rie et al., (2008) developed a measure of stigma in
persons affected with TB and HIV in Thailand. The psychometric properties of these instruments
were encouraging and are described in Chapter 4 of this study. The instrument by Van Rie et al.,
(2008) was translated into Spanish by Moya and peers in 2008 and filed tested and validated with
a sample of 217 Mexican-origin individuals in treatment for TB. For a description of the
psychometric properties of the instrument, refer to Chapter 6.
Leprosy
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More studies than scales have been developed to assess the attitudes of people affected by
leprosy using a diversity of questionnaires. Large studies in the general population were done in
Ethiopia (Tekle-Haimanot et al., 1992) India (Gopal, 1998) and Nepal (Van Berakel, 1996; de
Stigler, de Geus & Heynders, 2000). Two scales have been developed, but neither is specific for
stigma. The Dehabilitation Scale is a 52-item instrument covering four dimensions related to
stigma: family relationships, vocational conditions, social interaction, and self-esteem
(Anandaraj, 1995). The Participation Scale measures the participation and self-esteem on social
participation for people with leprosy, disability, and other stigmatized conditions. There were no
studies published citing the results of this scale.
HIV/AIDS
Most of the instruments to measure stigma related to HIV/AIDS were developed in the
United States. The Protocol for Identification of Discrimination against Persons Living with HIV
developed by the UNAIDS consists of a checklist of 37-items of possible ways discrimination
may have occurred (2000b). The instrument documents actual instances of discrimination against
persons living with HIV and AIDS. Both the indicator and protocol are not scientific devices
according to the authors. The Discrimination Indicator has not been used in studies, and its
psychometric properties are not known.
The HIV Stigma Scale is a 40-item instrument developed by Berger et al, and measures
perceived stigma and experiences by persons living with HIV/AIDS (2001). The psychometric
properties of this scale have been tested in a large sample of diverse backgrounds and the results
every good. The AIDS Attitude Scale (Froman & Owen, 2001) has been used in a number of
studies. The most recent version assesses attitudes to AIDS among the general public. (Moriya,
Gir & Hayashida, 1994) developed a scale measuring public attitudes in Brazil. It consists of 25

52

items, and the psychometric properties have been good. The Siyam’kela Indicator Set (2003)
developed by the Policy Project in South Africa consists of 41-item indicators to measure stigma
and discrimination both from the perspective of the persons living with HIV and AIDS and the
community. The indicator set provides a profile of stigma and is not a summary measure. The
psychometric properties have not been tested.
Mental Health
Assessment on mental health is probably the field with the most instruments available for
measuring stigma. Measurement has focused primarily on attitudes of the general public toward
individuals with mental illness, as well as internalized stigma as experienced by the individuals
affected. The opinions about Mental Illness Scale, a 51-item instrument, have good construct
validity and international consistency (Cohen & Struening, 1962). A subscale to measure
Community Mental Health Ideology was added to the instrument by Taylor & Dear (1981)
covering four dimensions on authoritarism, generosity, social restrictiveness and community
mental health ideology. The Internalized Stigma on Mental Illness Scale developed by Ritsher et
al., (2003) consists of five subscales with a total of 29-items. The domains are: alienation,
stereotype endorsement, discrimination experience, social withdrawal and stigma resistance.
Measuring Stigma Intensity
The intensity and magnitude of the presence of stigma that results in discrimination is
difficult to measure or quantify. In spite of the cultural diversity, the domains of life (e.g.
marriage, interpersonal relationships, mobility, employment, access to treatment and care,
education, leisure activities, and participation at social and religious functions) affected by
stigma are similar in various health conditions and countries. The findings by Van Brakel (2006)
suggest that the development of a set of generic trans-cultural instruments to assess the intensity
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of stigma and discrimination to conditions like HIV/AIDS, tuberculosis, and leprosy in a
community might be possible.
Because stigma has multiple dimensions and sources of stigmatization, measurement
needs to combine both qualitative and qualitative methods to include an assessment of
knowledge, attitudes, and practice of community members, health and human service
professionals, the media, and an audit of educational materials and policy. In addition, the
perspectives of the persons being stigmatized and their families need to be incorporated. Both
perceived stigma and the impact of stigma to health-seeking behavior, treatment adherence, and
quality of life should be included in the assessment.

2.5

SECTION

2:

PRELIMINARY

INVESTIGATIONS

THAT

INFORM

THE

CONCEPTUALIZATION OF THE STUDY
First Study: Policies and Laws Affecting Mexican-origin Immigrant Access and Utilization
of Substance Abuse Treatment in El Paso, Texas.
The research was carried out by the study PI (Shedlin) and author (Moya) with 30
Mexican-origin immigrants in drug use treatment in the U.S.-México Border City of El Paso,
Texas and findings were published in 2008 (Moya & Shedlin, 2008). The study received
Institutional Review Board approval from the University of Texas at El Paso in 2007. The study
consisted of thirty qualitative, semi-structured interviews implemented to access the dynamic
social and economic factors that affect the delivery and utilization of treatment services, with
emphasis on the impact of recent immigration-related laws and policies.
The exploratory study is relevant to the TB stigma investigation, in that the findings
illustrate the perceptions and experiences of Mexican-origin individuals at high risk for
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infectious diseases (e.g. tuberculosis, HIV/AIDS, hepatitis C) access (or lack of access) to health
care in (El Paso, Texas, or Ciudad Juárez, México). The study consisted of a sample of three
treatment programs (two residential and one outpatient facility) in El Paso County serving
Mexican-origin persons. The interviews took place in the three publicly-funded substance user
treatment facilities and were conducted by the study PI. In addition to the interviews, articles,
documents and reports were collected relating to the areas of treatment programs. Federal
policies for immigrant were identified.
Understanding the characteristics and the contextual factors that influence the community
norms and values associated with poverty, access to health care, substance abuse treatment, and
infectious diseases was important in the conceptual stage of the TB stigma research.
The salient findings of the research relevant to the dissertation are the following: The
County Hospital Emergency Room (ER) was cited as the regular source of care for children, the
elderly and the uninsured. This is one of several findings that are consistent with where the
majority of persons affected by TB and interviewed in El Paso received their diagnosis for TB.
Women reported little use of medical services unless they considered the situation an emergency.
Their visits to health-care facilities were primarily to secure medical services for their children
and rarely for themselves. Men reported even less use of medical services and frequently delayed
care. Most of the participants reported little or no use of preventive care such as pap smears,
physical exams, HIV/AIDS testing, and tuberculosis screenings. Dental and vision treatment
were even less sought by participants.
The research findings evidenced a series of health disparities encountered by Mexicanorigin immigrants that included limited or no access to health care, lack of health insurance,
socioeconomic poverty, substance abuse, risks for HIV/AIDS and tuberculosis. The social and
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cultural norms relating to alcohol use, stigma, and fear of discovery and deportation attached to
substance-use-related problems may also prevent individuals from seeking services.
In addition, the research provided initial data for evidenced-based intervention and
reinforced the need for culturally and gender appropriate health and human services for poor
immigrants and their families. These findings helped to conceptualize the framework for the
study and the semi-structured questionnaire for Mexican-origin individuals affected by TB and in
treatment in a border bi-national context.
Additional findings illustrate how the majority of participants crossed from El Paso,
Texas, to Ciudad Juárez, México. Almost half crossed between the two cities on a regular basis
(biweekly or monthly). The primary reason for crossing on a regular basis included visiting
family and friends, and accessing health care services (private) and pharmaceuticals. It is
important to note that between the periods the research was conducted (2007) violence in Ciudad
Juárez, México related or due to organized crime was not as prevalent. The level of violence in
Ciudad Juárez, México now has increased and cross- border access and utilization of services has
become more difficult and less frequent (conversations with health professionals, workers and
persons affected by TB).
The primary limitations of the study were the size and lack of perspectives of clients
entering substance use treatment on a voluntary basis and those receiving substance use
treatment services though other public or private facilities. Exploration of how acculturation may
affect difference in perspectives and experiences relating to immigration, the use of drugs and
alcohol, treatment utilization, and access to health services would be important to explore in the
future.
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The study evidenced how Mexican-origin immigrants feel socially and geographically
isolated, and how they are fearful of accessing public health and human services. Strategies and
interventions to ensure that immigrants have access to crucial health services and other public
programs are salient. Findings from the research reinforce the need to understand and intervene
to mitigate the negative sequelae of fear in accessing health and human services regardless of
immigration status. Even this small sample of individuals in treatment for drug use provided
valuable insight into some of the contextual structural and individual factors affecting
availability of, and access to, health care and drug use treatment by immigrant men and women.
Ensuring that immigrants and foreign-born individuals have access to crucial services as
tuberculosis screening and diagnosis is even more important given that one of the most salient
risks for TB in the United States is being foreign-born, and if on top of that risk, the person
migrates, is socioeconomically poor, and uninsured, the probability of being exposed to the
tuberculosis infection or the disease is significant.
Second Study: Pilot Study on Tuberculosis Stigma with Mexican-Origin Individuals
Persons affected by TB and HIV often suffer from health-related stigma and the social
burden of illness (Westaway, 1989; Barnhood & Adrianse, 1992; Lawn, 2000). Describing and
measuring stigma remain a significant challenge for both TB and HIV/AIDS programs across the
prevention to care continuum (Nyblade et al., 2005). The negative sequel of fear, stigma, and
discrimination can prevent people from getting tested for TB and HIV from using health and
human services, and from changing their behavior to avoid spread of the infection (Jaramillo,
1998; 1999). The purpose of the current investigation is to examine the use of the validated TB
and HIV/AIDS stigma scales developed by Van Rie and colleagues (2008), and translated by PI
(Moya) and colleagues in 2008, for use with Mexican-origin groups.
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The study builds on the implementation of a community-based participatory research
process conducted in collaboration with the U.S.-México Border Health Association (USMBHA)
and the Amaya-Lacson TB Photovoice Project between 2006 and 2007. This study is the first
pilot in México that investigates TB and stigma and field-tests Spanish TB and HIV/AIDS
Stigma subscales for use with Mexican-origin individuals. The study findings illustrate how a
sample of individuals with TB and in treatment perceives their illness and the stigma associated
with TB and HIV. This study guided the adaptation and implementation of the scales for use
with Mexican-origin populations. Findings from the pilot study helped to advance knowledge to
have a better understanding of the factors that influence health-seeking behavior. It will help in
the design and implementation of stigma reduction interventions.
The pilot study was conducted by the PI (Moya), in partnership with a team of
researchers that included directors of the Technical Division of the USMBHA and Project
Concern International SOLUCION TB Project in 13 locations in México.
The study received Institutional Review Board approval from the University of Texas at
El Paso. The relevance of the study to the investigation on TB stigma is significant in both the
conceptualization of the investigation and in field testing the first instrumentation in Spanish on
TB and HIV Stigma for Mexican-origin populations.
In 2005, Van Rie and colleagues used exploratory factor analysis among 480 TB patients
in southern Thailand to analyze the stigma study findings (Van Rie et al., 2008). On September
18, 2008, Van Rie and colleagues gave authorization to the study PI (Moya) to use, translate,
back translate and adapt the two scales to examine community and patient perspectives related to
TB and HIV and AIDS, for use with Mexican-origin populations. The subscales were field tested
for comprehension and cultural competence by 13 experienced interviewers between November
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and December 2008, with a sample of 30 individuals from their localities in México, where the
PCI SOLUCION TB Expansion Project is in place. The Project titled SOLUCION TB is funded
by USAID to Project Concern International in México. The project employs staff in 13 states in
México where tuberculosis rates are higher than national norms. The SOLUCION Project State
Coordinators administer the questionnaire in person to a convenience sample of adults (18 years
of age or older) in treatment for tuberculosis. The site selection was based on high TB rates,
geographical locations (north, central and south of México), availability of staff to facilitate
interviews (trained interviewers), and service infrastructure in place (facilities and access to
interviewees).
Information on age, sex, socioeconomic status, occupation, marital status, employment
status, education, health insurance coverage, home ownership, type of tuberculosis, time of TB
diagnosis, perceived health status at time of interview and six months prior to interview, and
perceived self-control and perception of support during treatment were collected by trained
interviewers using a standardized questionnaire. The study scales address: community
perspectives toward tuberculosis; PATB perspectives toward tuberculosis; community
perspectives toward HIV and AIDS, and PATB perspectives toward HIV /AIDS. The Spanish
TB and HIV/AIDS Stigma Subscale questionnaires consisted of 45 items. The two scales were
administered in person by experienced and trained PCI Project interviewers.
These scales were first translated into Spanish by PI (Moya) and back translated by the
University of Texas at El Paso Department of Linguistics and Translation. The scales were then
field tested for linguistic comprehension with staff of the SOLUCION Project and then with a
sample of 30 individuals affected by tuberculosis, two or three from each of the 13 states in
México (SOLUCION TB Project Sites), were integrated to the study as well.
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The SOLUCION TB Project Sites are: Tijuana, Baja California; Hermosillo, Sonora;
Ciudad Juárez, Chihuahua; Monterrey, Nuevo León; Saltillo, Coahuila; Reynosa, Tamaulipas;
Guadalajara, Jalisco; Zacatecas, Zacatecas; Morelia Michoacan; Acapulco, Guerrero; Oaxaca,
Oaxaca; Veracruz Puerto, Veracruz; and Tuxtla Gutiėrrez, Chiapas. Upon field testing of study
instruments and approval by an Institutional Review Board, the validation of the subscales was
conducted with a convenience sample of 217 individuals from three regions (five localities, three
in the North, one in the Center and in the South of México) in México. For a detailed description
of the study analysis, results and limitations, refer to Chapter 4 of the dissertation.
The TB and HIV/IDS Spanish scales used to measure the phenomena of stigma related
with tuberculosis and HIV/AIDS at the community level with individuals affected with TB level
with Mexican-origin individuals demonstrated very good psychometric properties. The
researchers performed factor analysis to identify the items of the scale that loaded best. No items
from the scales were excluded. The internal consistency indices were measured by very good to
excellent Cronbach’s alphas.
Third Study: Border Voices and Images of Tuberculosis Photovoice Project
The Border Voices and Images TB Photovoice Project 4 is the third study. A description
of the relevance to the TB and stigma study, the study methods and findings is presented. This
explanation is important in setting the context for the findings of the Voices and Images of TB
Photovoice interviews conducted in the dissertation and described in detail in Chapters 6.
The relevance of the study findings provided support for the premise that tuberculosis
was a stigmatized topic and that community, social, and border conditions and services were
identified as essential themes and issues to participants living with TB. Participants identified the
4

Article published during the time dissertation research was being conducted. The co-authors authorized the
integration of the study in this investigation. De Heer, H, Moya, E., & Lacson, R. (2008) Voices and images of
tuberculosis in a binational setting. Cases in Public Health Communication and Marketing. 2:55-86.
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need to conduct ongoing TB prevention and education in El Paso, Texas and Ciudad Juárez,
Mexico with populations at risk for TB and HIV, persons affected by diabetes, migrant, and
mobile communities in a bilingual manner. Additionally, Photovoice participants agreed that
once an individual is properly diagnosed, timely and patient-centered services are needed on both
sides of the border.
The project findings also offer important contributions for both augmenting the
conceptual understanding of the impact of tuberculosis on participants and suggest tools for
policy change and improved delivery of health and human services in a region that is as
challenging and dynamic as the U.S.-México border region. The findings of the Border TB
Photovoice project provided a glimpse of how 16 individuals (ten individuals from Ciudad
Juárez, México, and six from El Paso, Texas) affected by TB perceived their community. The
current research demonstrated how these perspectives can be used by individuals affected by TB
to empower them to ‘bridge a power gap’ between those affected by a disease and those in power
to change policy related to the disease. The founder of the Amaya-Lacson TB Photovoice Project
(Romel Lacson) selected five different sites 5 based on a number of factors such as TB
prevalence, geographic location, and responsiveness of TB case workers to the Photovoice
method (for details refer to this chapter and references). The first Border TB Photovoice Project,
a participatory based research method, took place in El Paso, Texas, and Ciudad Juárez, México
in 2006-2007. The project was implemented by the USMBHA and funded by the Amaya-Lacson
TB Photovoice Foundation. The TB Photovoice project utilized photographic interviewing to
give “voice” to persons affected by TB by letting them describe and represent and enhance their
5 The TB Photovoice Project’ initiated in 2006 in five sites: El Paso, Texas and Ciudad Juarez, Mexico; Rio de
Janeiro, Brazil; Chiang Mai, Thailand; and Florence, South Carolina. All project sites function independently from
one another and the findings of the first site that completed the project (the only binational site: El Paso, Texas, and
Ciudad Juarez, Mexico) were described as a case study by De Heer, Moya & Lacson (2008).
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community through taking photographs, telling accompanying stories, and presenting their
perspectives to those in power to establish change. Project participants had never been asked to
speak and articulate their perspective to powerful and influential decision makers and health-care
professionals before. Participants affected by TB had no input into conceptualizing, planning or
disseminating their perspectives before the project. While the initial target audience included the
participants themselves, Photovoice emphasizes reaching decision and policy makers.
The Amaya-Lacson TB Photovoice protocol 6 followed the principles and key concepts of
Photovoice (Wang & Burris, 1994; Wang 1999) and applied them to tuberculosis. Core reasons
that were instrumental in the selection include: (1) El Paso, Texas, and Ciudad Juárez, México,
are a border communities with high TB rates, (2) the community has worked in a border and
binational collaborative fashion in the area of infectious diseases, and (3) community leadership
working in TB was receptive to the Photovoice Project. The themes of the photographs and
accompanying stories were grouped by participants into four categories. The first category
included participants’ personal history with TB. Examples of photographs and stories associated
with this category include late diagnosis or misdiagnosis, lack of availability of information once
the diagnosis is made, limited services and lack of support, isolation and loneliness, difficulties
adhering treatment (difficulties), side effects, and length of treatment. Second, social norms and
values emerged as a theme for a number of photographs and stories. Examples included stigma
and discrimination associated with TB, poverty, positive and negative experiences with healthcare workers and undelivered promises by decision makers.

6 The Amaya-Lacson TB Photovoice protocol received Institutional Review Board approval of the University of
South Carolina in 2005. Spanish translations for any material and any additional training materials and adaptations
were developed by the PI (Moya) and Technical Director (Ramos) of the USMBHA.
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The third category included emotional aspects of the disease such as depression, guilt
toward infecting other family members and friends, coping mechanisms, and family support. The
final category included social aspects and ideas for advocacy and action. According to the
participants, advocacy and action should be oriented toward establishment of the same standards
of care on both sides of the U.S.-México border and unity in programs and services. Also,
allocation of adequate financial and human resources for education and treatment on both sides
of the U.S.-México border, development of support services, clinically trained and culturally
competent providers, and addressing other needs of patients beyond TB, like poverty, food
insecurity and housing, were themes identified by the participants.
The strategy described in this research is grounded in the premise that if decisions about
TB will be derived from the integration of local knowledge, skills, and resources, it will more
effectively contribute to public health policy actions. The experiences of the TB Photovoice
Project provided some evidence for the effectiveness of communication strategies that literally
put “a human face and voice to a health problem” and focused not only on increasing awareness,
but on getting to obtain public commitments of those in positions to influence policy. In
summary, the “Border Voices and Images Project” revealed core social norms and values that
emerged from the experiences of persons affected with TB that included stigma, discrimination
associated with tuberculosis, poverty, and negative experiences with health-care professionals
that are salient to this dissertation.
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CHAPTER 3
DESIGN, METHODS AND MATERIALS
The design, methods and materials of the “Tuberculosis and TB-related Stigma Study”
are summarized in this chapter. The theoretical framework, described in Chapter 1 and
references that guided the study, is derived from the work by Goffman (1963), by Parker and
Aggleton (2002), Sumartajo (1993), Jaramillo (1999) Liefooghe et al., (1997), Macq, (2006), and
Van Rie et al., (2008). The study also draws from the research findings of the “Amaya-Lacson
TB Photovoice Project” (Lacson, 2005), the “TB-HIV/AIDS Alliance for Social Action”
(Ramos, 2009; USMBHA, 2007) and the “Border Voices and Images of Tuberculosis Project”
(De Heer, Moya & Lacson, 2008) described in Chapter 2.
The study of TB stigma is the result of the triangulation of data from the three different
and complementary studies identified using complementary methods of data collection and
organized in three distinct sections.

STUDY AIMS
First Section: In-depth Interviews with Persons Affected by TB and under Treatment
Using a Semi-structured Interview Guide
The section consists of in-depth interviews using a semi-structured interview guide of
thirty subjects, of Mexican-origin 18 years of age or older, affected by TB and in treatment or
that completed TB treatment in the past six months: (1) To describe the characteristics of
participants affected by TB undergoing TB treatment in Ciudad Juárez, México, and El Paso,
Texas; (2) To explore the contextual factors (norms and values, institutional resources,
geopolitical settings and epidemiology of TB) that affect persons living with TB to access health
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care in Ciudad Juárez, México, and El Paso, Texas; (3) To investigate, through in-depth
interviews, the perceptions and experiences of Mexican-origin individuals affected by TB in the
Ciudad Juárez, México and El Paso, Texas region to illustrate how the TB is experienced and the
relationship to health-seeking behaviors; (4) To explore the perceived and internalized stigma by
the person affected by tuberculosis (attitudes toward TB and related stigma and discrimination,
perceptions, disclosure behaviors, and perceived support); and (5) To investigate the actual
experiences of social stigma and discrimination (experiences, treatment, access to health care,
health seeking behaviors, and other stigmatized conditions and coping mechanisms) by persons
affected with TB.
Second Section: In-depth interviews with TB Photovoice Project participants
The second section consists of nine in-depth interviews using a semi-structured interview
guide with ten subjects who were affected by TB and who participated as TB Photovoice
participants in 2006-2007 in Ciudad Juárez, México, and El Paso, Texas. The study aims are: (1)
To investigate the contextual factors that influence health-seeking behaviors in order to describe
the relationship between TB, health services and individuals access to health care in El PasoCiudad Juárez Region; (2) To explore the different ways in which persons affected by TB
experienced their illness and responded to challenges of living with TB in order to mitigate the
suffering; (3) To investigate the ways in which persons affected by TB confronted stigma and
discrimination in order to inform the development of stigma and discrimination reduction
strategies; and (4) To examine the individual impacts of the TB Photovoice Project on persons
affected by TB in order to advance understanding of the factors and promote empowerment and
involvement of persons affected by TB.
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Third Section: Measuring TB-Related Stigma Validation of the TB and HIV/AIDS Stigma
Subscales
The third section consists of a study based on the administration of the Tuberculosis and
HIV/AIDS Stigma Subscales originally developed by Van Rie et al., in 2005 and published
(2008) and translated to Spanish for Mexican-origin populations by Moya et al., in 2008 and
administered to a sample of 217 individuals in five locations in México (refer to Chapter 6). The
aims of the investigation are to: (1) To validate the TB and HIV/AIDS Stigma Scales developed
by Van Rie et al., (2008) for use with Mexican-origin groups to expand and inform theory of TBrelated stigma; (2) To assess the perceptions toward TB and HIV/AIDS of Mexican-origin
persons affected with TB in order to inform the development of individual and structural stigma
reduction strategies and interventions to ensure that persons affected by TB receive crucial
preventive, diagnostic and treatment services free of stigma and discrimination.
Approval of this study was obtained from the Institutional Review Board of the
University of Texas at El Paso (Appendix 1). The analysis and the results of each of the substudies are presented in the next three chapters and the triangulation in Chapter 7.

RESEARCH QUESTIONS
The research questions of the study are: (1) What are the characteristics of individuals
undergoing TB treatment in El Paso, Texas, and Ciudad Juárez, México?; (2) What are the
contextual factors influencing health-seeking behaviors and access to care of persons with TB
undergoing in El Paso, Texas, and Ciudad Juárez, México?; (3) How do persons affected by TB
experience their illness?; (4) How do persons affected by TB perceive stigma?; (5) What are the
manifestations and impacts of stigma on persons living with TB?; (6) What are the differences in
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experiences and perceptions of TB and stigma between individuals living with TB in Ciudad
Juárez, México, and El Paso, Texas? and Why?; (7) What are the different ways in which
persons affected by TB respond to challenges of living with TB?; (8) What are the ways in which
persons affected by TB confront stigma?; (9) What are the care experiences like of persons
affected by TB in Ciudad Juárez, México, and El Paso, Texas?; (10) What are the individual
impacts on the participants of the TB Photovoice project? (11) What are the participants
perceptions toward TB of Mexican-origin persons affected with TB in five study locations in
México? (12) What are the perspectives toward HIV/AIDS of Mexican-origin persons affected
by TB in five study locations in México?

STUDY ASSUMPTIONS
The study assumptions on the subject of TB health-related stigma are:
1. Stigma adversely affects persons with TB;
2. Stigma negatively influences health-seeking behaviors among Mexican-origin individuals
with TB;
3. The subjective experience of living with TB is profound and shapes the way individuals
with TB interact with health-care providers, family members and the public.
4. The TB and HIV/AIDS Stigma Scales developed by Van Rie et al., (2008) and translated
to Spanish by Moya and colleagues in 2008 are valid and reliable with Mexican-origin
populations;
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SAMPLE JUSTIFICATION
The size of each of the three samples was based on the purpose of the investigation and
its nature, namely study of TB health-related stigma, research needed to advance theory
development, and validation of the TB and HIV/AIDS Stigma Scale by Van Rie et al., (2008) for
use with Mexican-origin groups. Additional considerations taken into account in justifying the
sample size included: researcher/PI experience in border and bi-national context; expertise in
semi-structured interviews, in-depth interviews and administration of scales; descriptive and
interpretive validity; resources available; time frame; and strong partnerships with national and
state TB programs in México and the United States, and with service providers and researchers.

METHODS AND MATERIALS FOR EACH OF THE THREE STUDIES
3.1 First Section: Perspectives from Persons Affected by TB in El Paso, Texas, and Ciudad
Juárez, México
Type of Study
This investigation uses an exploratory qualitative design to study TB-related stigma and
the impact on access and health-seeking behaviors for TB in a criterion-sample of 30 Mexicanorigin adults (18 years and older) in Ciudad Juárez, México, and El Paso, Texas undergoing
treatment at a health center or tuberculosis program. The in-depth interviews present information
gathered from thirty individuals affected by TB who have first-hand experience on the impact of
TB and TB-related stigma. Little is known about individual experiences with TB-related stigma
and its impact on health seeking behaviors.
This study explores stigma related to TB and factors affecting access and health-seeking
behaviors for TB in El Paso, Texas, and Ciudad Juárez, México. Participants reported frequent
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delays in obtaining a diagnosis of TB and obtaining adequate and timely treatment on either (or
both) sides of the United States-México border. Persons affected by TB also described their
perspectives on TB-related stigma, and they identified and described gaps in knowledge about
TB transmission. Finally, they summarized their attitudes and behaviors related to seeking
treatment. Issues associated with diagnoses, experience with treatment, access to medical care,
awareness of TB information resources, and attitudes about TB-related stigma and discrimination
were also analyzed and are described as well as the study limitations in detail in Chapter 4.
The value of these interviews lies in their ability to demonstrate that some of the
representations of TB need to be revised because they no longer apply, even though the ideas
behind them are still present in how society views people with TB. The old labels are described
in every interview conducted and are cited as the source of the stigma and discrimination.

STUDY SETTING AND PARTICIPANTS
Methods and Materials
The study population consisted of a sample of adults who voluntarily agreed to
participate in the investigation. Eligible participants were recruited by the health personnel of the
El Paso TB program or the Health Jurisdiction No. 2 (TB Program) in Ciudad Juárez, México. A
sample of 30 participants was deemed sufficient to perform the qualitative study. The study
collected data on 30 individuals, half from El Paso, Texas and half from Ciudad Juárez, México.
After informed consent was obtained from participants, a semi-structured interview was
conducted by an experienced interviewer. The criteria for selecting El Paso, Texas and Ciudad
Juárez, México included: higher risk for TB, higher prevalence for TB than national rates,
resources from the Programa de Investigacion en Migracion y Salud (PIMSA Project),
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geographical location, and availability of the principal investigator. Figure 2 displays the TB
cases with risk factors in El Paso, Texas, and Ciudad Juárez, México, in 2008 and 2009.

El Paso-Ciudad Juárez TB Rate in 2008 & 2009
El Paso: 2 5.4 and 8.9 per 100,000

Ciudad Juárez: 1 13.5 and 13.3 per
100,000

New TB Cases in 2008 & 2009
El Paso:2 40 and 67

Ciudad Juárez:1 311 and 306

Percentage of TB Cases with Risk Factors, ages 18 years and up (2008)
El Paso:2 foreign born 76.2%; alcohol use
35.5%; diabetes 15.2%; HIV/AIDS 11.8%;
homeless 3.1% , incarcerated at the time of
diagnosis 11.8%, IVDU 5%, weight <10
67.8%, NIDU 20%.

Ciudad Juárez:1 diabetes 17%; alcohol
use 5%; HIV/AIDS 7%; malnutrition 11%;
IVDU 5%.

Note: Patients can have multiple risk factor

Figure 2. El Paso, Texas and Ciudad Juárez, Chihuahua, Tuberculosis Rate in 2008 and 2009
Source: (¹Plataforma Única de Información, SSA. 10 de Enero 2010;
²http://www.dshs.state.tx.us/idcu/disease/tb/statistics/countbycnty.pdf, retrieved on April 10, 2010)

Inclusion Criteria
The inclusion criteria for participants consisted of individuals 18 or older, male or
female, under treatment for tuberculosis (con-contagious stage) at a Centro de Salud (Public
Health Clinic or TB program), and individuals who completed TB treatment in the past six
months from Ciudad Juárez, México, and El Paso, Texas, of Mexican-origin. Participation was
voluntary.
Instrument Design
The study instrument, referred to the semi-structured interview guide (Tuberculosisrelated stigma) is a bilingual semi-structured questionnaire with both closed-ended and open70

ended questions to guide the data collection process while allowing the participants to determine
the direction of the interview (Appendix 4). The instrument consists of 117 questions, of which
24 are open-ended questions.
The questionnaire is organized in eight sections:
1) Socio-demographic, general characteristics and household data,
2) Tuberculosis diagnosis,
3) Knowledge of TB,
4) Psychosocial factors related to TB,
5) Attitudes and health-seeking practices related with TB and treatment,
6) Awareness on TB and information resources,
7) Attitudes about perceived stigma or internalized stigma related with TB, and
8) Perceptions toward TB and stigma.
The instrument was developed in Spanish first, and then field tested with a sample of four
adults. It was then translated into English by the University of Texas at El Paso Department of
Language and Linguistics and then translated back to Spanish by a bilingual member of the
research team. The English and Spanish versions of the questionnaire were reviewed once again
by the research team (two senior researchers) and by the Directors of the El Paso and Ciudad
Juárez TB Programs before they were used in the study. Only one interview was conducted in
English; all other interviews were conducted in Spanish. In addition to the questions, additional
observations were obtained from the interviewers on the physical and social environment of the
participant’s home, the participant reception to the interview and questions posed for the
interviewer. Field notes were prepared by the interviewer during and after the interviews to
validate accuracy of information
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Study Design
The study sample consisted of qualitative in-depth interviews using a semi-structured
guide. The study uses a convenience sample of persons receiving treatment for TB at the study
locations who met the inclusion criteria. This method of sampling was used because the
objective was to develop an understanding of the subjective experience of people affected by TB
and TB-related stigma.
Study Schedule
The data were collected by experienced interviewers in a three-month period from MayJuly 2009 in the two study locations.
Data Collection
The method used to collect the data in the study was through participant semi-structured
interviews. A research team was formed in spring 2009 with support from the Transborder
Tuberculosis Stigma PIMSA Project. The team consisted of four researchers, two from El Paso,
and two from Ciudad Juárez, two health practitioners and two experienced interviewers from
Ciudad Juárez and one from El Paso. Before any data was collected, meetings were held to
review and finalize the study instruments. Participants included TB program directors as well as
members of the research team from the Universidad Autonóma de Ciudad Juárez (UACJ) and
the University of Texas at El Paso (UTEP). Program directors included personnel from
Programa Compañeros and the Jurisdicción Sanitaria No. 2 and the City of El Paso TB
Program.
Members of the research team and the experienced interviewers participated in reviewing
and field testing the instruments for linguistic and cultural appropriateness in the two study
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locations. The health staff of the TB Program or Clinic staff in Ciudad Juárez and in El Paso
recruited the study participants. The health staff consisted of Direct Observed Therapy (DOT)
workers who explained the study aims to the participants as they supervised the DOT at either
the health clinic or at their home. Once the participants agreed to voluntarily participate in the
study, a list with contact information was provided to the interviewers in Juárez and El Paso. The
interviewers approached each of the potential participants by telephone or through a home visit.
From the list of 15 potential participants in Ciudad Juárez, ten participants were interviewed. The
rest were unavailable, not interested or changed residence. In El Paso, from the initial list of 15
names, 11 agreed to participate; four were unavailable or were too frail to participate in the
study. Additional recruitment was done in both locations until the 30 participants for the study
were confirmed.
Interview Locations
A primary area for conducting the interviews took place at either the health clinics or TB
Program offices in the two locations previously identified. A minority of interviews took place at
the participant’s home.
Sampling Schedule
A total of 30 interviews took place during a 10-week period starting in early May and
ending in mid July 2009. The study was intended to take approximately six weeks once
recruitment started, however, an outbreak of influenza A H1N1 took place. This outbreak
brought domestic and international attention and mobilized communities (public and private) to
abstain from public or crowded spaces, including health-care settings, unless absolutely
necessary. TB health workers as well as the facilities in Ciudad Juárez were not available to
assist with study recruitment during this public health emergency, and persons in TB treatment
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were asked to stay home and avoid public gatherings. This outbreak put a halt on the interviews
in Ciudad Juárez for almost three weeks. In El Paso the study schedule was not altered.
Study Process and Data Collection
Once the participants were informed of the goals of the study, they were asked for their
voluntary participation. An informed consent (Appendix 7) was completed at that time and a
copy was given to the participant. Interviews were audio/digitally recorded and only individuals
who met the study criteria participated in the interviews. A gift card of $20 dollars or the
equivalent in Mexican Currency was presented to the individuals that voluntarily participated in
the study in El Paso and Ciudad Juárez. The interview questionnaire was constructed from
questions that were informed by prior research done on TB using the Photovoice method (De
Heer, Moya & Lacson, 2008) and by the literature on Knowledge, Attitudes and Practices in TB
(ACMS for TB Control, 2008) as well as consultation with experienced qualitative researchers in
social sciences from México and the United States (Amaya, 2005; Kleinman, 1988; Kleinman &
Kleinman, 1991; Shedlin & Hollerbauch, 1981; conversations with Rebeca Ramos during 2005,
2009).
After the first four interviews were conducted, the research team met in person to discuss
the process and to determine if new questions needed to be constructed or modified. Slight
modifications to language were made on Section 6, because some of the questions related to
attitudes toward stigma and discrimination related to TB were difficult for interviewees to
understand. The decision to use common terms for stigma and discrimination was made. Some of
the terms in Spanish to refer to stigma include: ser señalado/a, marcado, tachado, juzgado, que
te hagan el feo o de menos, in English the terms used included: pointed out, marked, judged,
treated inferior or badly. For a complete list of terms for stigma and discrimination in the study
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refer to Appendix 3.
Interviews in Juárez were originally scheduled to take place at a Health Center; however
the facilities were neither optimal nor private. The interviews in Ciudad Juárez, Mexico, were
moved to a community-based organization or to the participant’s residence. If the interview was
conducted at the participant’s home, then the two interviewers were present. This decision was
made by the research team given the elevated risks and violence associated with the violence
experienced in that city during the past year. The second interviewer served as an observer. In
both communities, a principal investigator accompanied the interviewer(s) during the first
interviews as an observer. Interviewers conducted the interviews by themselves after that.
The interviews ranged from 60 to70 minutes. Only one interview was conducted with
each participant. All interviews were conducted in Spanish, with the exception of one in English
(excluded, non-Mexican origin), and there were no interpreters present. In El Paso, Texas the
interviews were conducted at the TB clinic or at the participant’s residence. The interviews were
digitally/audio taped with the participant’s permission in writing, transcribed, and not translated
to English. Transcriptions were done by two experienced professionals, one in Ciudad Juárez and
one bilingual and bicultural transcriber in El Paso. The transcripts were then read and confirmed
by two of the research members. Questions raised during the interpretative process were noted
by the members of the research team and discussed so that these were agreed upon before
moving on to data analysis.
No identifying data were recorded on participants. Only codes were used and participants
were assured that confidentiality would be maintained. The three experienced interviewers were
native Spanish speakers and one is bilingual in English.

The interviewers were trained by the

research team on TB prevention and control; interview skills; study aims; and human subjects
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and ethics. The research team completed the Human Subjects Research and Ethics training and
received a certificate. The training consisted of two days in Ciudad Juárez and included field and
role-playing practices with observers present. The field and role-playing exercises were helpful
and helped adjust some of the questions.
The two interviewers from Ciudad Juárez are affiliated with Programa Compañeros, an
experienced community-based organization with more than 25 years in the service and expertise
qualitative research areas. The interviewer in El Paso is an experienced bilingual community
health worker affiliated with a university.
To secure the 30 participants, interviewers contacted 43 persons affected with TB. From
the 43 contacted, 33 adults diagnosed with TB and in treatment (not in an active stage) agreed to
participate in the study. All of the participants were recruited through the health centers by health
personnel. Three interviews were excluded from the study because they did not meet the
inclusion criteria as previously stated.
Data Analysis
Data collection and analysis were conducted concurrently. Recruitment ceased when the
goal of thirty participants was reached at which time no new information relevant to the main
goal of the study for analysis emerged. The data were digitally recorded and stored on
Ibackup.com (Ibackup Corporation, 2010) with access only to the researchers. Quantitative data
were entered into an Excel database. Descriptive numerical data were reported as means and
categorical data described as percentages (%) (n). Qualitative data were entered in Word and all
audio/digital recordings of interviews were encrypted. These files were than transcribed using
Naturally Speaking 9 Recorder software (Naunce Communications, 2006).
Three researchers participated in the analysis phase. The principal investigator listened
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to all of the digital audio recordings and read the transcripts repeatedly to develop codes and
identify the main themes relating to TB and TB-related stigma and impact to access and health
seeking behaviors. The two other researchers listened to the digitally interviews and read the
transcriptions as well. Once the code themes were developed relating to the research questions,
analysis was completed using qualitative descriptive design by Miles & Huberman (1994), which
involved the use of qualitative content analysis methods to develop codes based on comparing
data from each of the interviews and subsequent groupings of these codes to represent themes.
Codes were then displayed in a matrix. These codes or themes were grouped and mapped using
the TB stigma conceptual framework which was developed using Goffman’s theoretical
framework on stigma (1963) and related conceptualization of stigma (Link & Phelan, 2002), to
assist with the descriptive nature of the analysis. The analysis is descriptive. To ensure the
credibility of the analysis, the second researcher independently coded the interviews and
compared these codes with those identified by the primary researcher. No alternations of or
additions to the main themes identified at the beginning were made. Statements that illustrated
the primary themes in the results were integrated.

Interviewing people in treatment was

important because it provided a more complete view of health-seeking behaviors and treatment
patterns, than individuals who had not received a diagnosis or had commenced TB treatment.

3.2 Second Section: Border Voices and Images of TB Individual Impacts of the TB
Photovoice Intervention.
The “TB Photovoice Voices and Images Project” was initiated by the Amaya-Lacson
Foundation in 2005. The Amaya-Lacson TB Photovoice Project was founded by Romel Lacson
in honor of his wife (Claudia) and unborn daughter, who died from the consequences of TB
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meningitis in 2004. The TB Photovoice project was initiated in five sites: El Paso, Texas, and
Ciudad Juárez, México, Rio de Janeiro, Brazil, Chiang Mai, Thailand, and Florence South
Carolina. The founder of the Amaya-Lacson TB Photovoice Project selected the different sites
based on a number of factors such as TB prevalence, geographic location and responsiveness of
TB case workers to the Photovoice method (for details see references Amaya, 2005). All sites
functioned independently from one another and the findings of the first site that completed the
project (the only binational site: El Paso, Texas and Ciudad Juárez, México) and that informed
this investigation are described in Chapter 2. The TB Photovoice project utilized photographic
interviewing to give a “voice” to individuals affected by TB. The Photovoice project, “Border
Voices and Images” or “Voces e Imágenes Fronteriza,” empowered individuals affected by TB
by letting them describe their experience with the disease and letting them reach out to decision
makers.
The TB Photovoice Project provided the first-ever occasion for people affected by TB in
El Paso, Texas and Ciudad Juárez, Mėxico to meet and exchange ideas, methods and resources to
improve the quality of life of those affected by TB. Photovoice aimed to enable individuals to
participate in representing and enhancing their community through taking photographs, telling
accompanying stories and presenting their perspectives to those in power to establish change.
The intention of the Photovoice methodology is not to measure quantitative behavioral
outcomes, but to empower individuals affected by a health problem who normally do not have
the opportunity to reach decision makers and influence policy. By providing this access, the
Participatory Action Research (PAR) strategy enables these individuals to become advocates for
social action, rather than passive subjects. Valuable changes have occurred in awareness,
empowerment, and social action by TB Photovoice participants in El Paso, Texas and Ciudad
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Juárez, Mėxico. As a result of their efforts, information was disseminated to raise awareness of
TB, and valuable public commitments were procured from decision makers. The findings of the
Photovoice Project provided support for the premise that TB continues to be a stigmatized health
issue. Both in El Paso and Ciudad Juárez, participants reported feeling stigmatized during several
stages of TB detection and treatment. Furthermore, community, social, and border conditions
created a unique context for individuals living with TB in this region. Participants identified the
need to conduct ongoing, bilingual TB prevention and education in El Paso and Ciudad Juárez,
with various populations including: people at risk for TB and HIV, persons affected by diabetes,
and migrant and mobile communities. Additionally, Photovoice participants agreed that once an
individual is properly diagnosed, timely, person-centered services are needed on both sides of the
border. Participants reported that a critical factor in their interest was the opportunity to share
feelings, stories, and perspectives; and to receive support from peers without judgment.
Project findings offered important contributions to aid in understanding the impact of TB
on participants and provide resources for policy change and improved health service delivery in a
challenging and dynamic region. The findings of the “Border TB Photovoice Project” provided a
glimpse into the perceptions of TB patients on their community. In addition, the project
demonstrates that such perspectives can be used to empower these patients to 'bridge the gap'
between those affected by a disease and those in power to change policy related to the disease.
Study Type
The current investigation uses an exploratory qualitative design to study the perceived
impacts of TB and the TB Photovoice Voices and Images intervention on ten individuals (18
years and older) who completed TB treatment and participated in the TB Photovoice (Voices and
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Image of TB) Project in 2006-2007. The objective was to develop an understanding of the
subjective experience of the participants of the TB Photovoice Project.
Study Setting and Participants
Recruitment was done by the investigator/PI, and the data were collected from a
purposive sample (Cuba & Lincoln, 1989, 1994) of ten of the eighteen participants in the first
“Border Voices and Images of TB Photovoice Project” (Project) (2006-2007) in Ciudad Juárez,
México, and El Paso, Texas. Six of the participants live in Ciudad Juárez, México and four in El
Paso Texas.
Inclusion Criteria
The inclusion criteria for participants consisted of individuals 18 or older, male or
female, from Ciudad Juárez, México, and El Paso, Texas, of Mexican-origin who completed TB
treatment from Ciudad Juárez, México and El Paso, Texas and who participated in the “TB
Voices and Images of TB Project” (Photovoice). Participation was voluntary.
Instrument Design
The English and Spanish interview guide was composed of four sections which together
contained 38 items of interest (Appendix 5). The first sections explored the socio-demographic
characteristics of the interview participants and elicited responses that are easily quantified. In
the next three sections, responses were freely associated by participants and needed a qualitative
approach. Section two required participants to speak of their experience with TB; section three
probed into questions about stigma, and section four primarily dealt with the experience with the
Photovoice method itself. The interview guide was developed in English and Spanish by the
investigator/PI (Moya), which contained closed and open-ended questions. Most questions
elicited open-ended responses. The analysis is qualitative and ethnographic.
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Interview Locations
A primary area for conducting the interviews tool place at the health clinic or TB
Program office in El Paso or at Programa Compaňeros, a community based organization in
Ciudad Juárez. One interview took place at the participant’s home
Sample Schedule
The nine interviews with ten participants were conducted between May 9 and May 26,
2009 by the investigator/PI (Moya).
Data Collection
The interviews were conducted with 10 individuals who participated in the TB
Photovoice Project, also known as Border Voices and Images of Tuberculosis. The Photovoice
methodology is not meant to measure quantitative behavioral outcomes, and this analysis is
meant to complement analyses presented in the previous chapters. The Tuberculosis (TB)
Photovoice Project under the auspices of the U.S.-México Border Health Association and with
support of the Amaya-Lacson TB Photovoice Project provided the first-ever occasion for people
affected by TB in the El Paso and Ciudad Juárez region to meet and exchange ideas, methods
and resources for improving the quality of life of those affected by TB.
In Photovoice, photography is a communication tool which can be used to empower
individuals who normally do not have the opportunity to reach decision makers and influence
policy. The discussion of images by the people who produce them gives meaning to the
interpretation of their images and their stories.
The Photovoice Project was coordinated by the U.S.-México Border Health Association.
In this project, persons affected by TB were encouraged to talk about their everyday health and
how TB had affected their lives. Cameras were given to participants (2006) in order to document
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their unique life perspectives. The grounding of the images on everyday experiences made the
photographs and stories more valuable and powerful to communicate the impact of TB, than a set
of images created by outsiders.
The analysis of these 10 interviews documents changes in awareness, empowerment, and
social action by TB Photovoice participants in the El Paso, Texas, and Ciudad Juárez, México.
Empowerment is defined by Photovoice as the increase of individual agency in efforts to address
the “power gap” between the individuals affected by TB and decision makers.
Participants were interviewed to elicit their perceptions of TB, TB-related stigma,
positive and negative impacts on stigma and the impacts of the Photovoice method on the
individuals. The interviews elicited the subjects’ experiences, representations and perceptions of
TB and TB-related stigma.
Interviewees voluntarily agreed to participate and interviews were conducted either in
English or Spanish. The interviews took place at either a health clinic or TB program office. A
gift card of $20 dollars or the equivalent in Mexican Currency was presented as an incentive to
interviewees who participated in the in-depth interviews. A bilingual semi-structured guide with
both closed and open-ended questions was used for the interview (Appendix 5). An informed
consent was completed prior to the interview (Appendix 7).
The interviews ranged from 60 to 90 min. A single interview was done with each subject.
With the exception of two interviews were conducted in English, all interviews were conducted
in Spanish, and primarily in community based offices. Although one couple was given the option
for separate interviews, the participant chose to be interviewed with his spouse. The audio-taped
interviews, in English and Spanish, were transcribed verbatim (in English and Spanish) by a
bilingual, bicultural individual. The transcripts were then read and confirmed by the

82

investigator/PI who is also bilingual and bicultural. Questions raised during the interpretative
process were noted, described and discussed by the investigator/PI and transcriptionist so that all
possible meanings were agreed upon before analysis of the data.
Data Analysis
Interpretation of data in qualitative research required the investigator/PI to create distance
from the data and to critically reflect and identify the dominant discourses on the other sources of
descriptions (Thomas et al., 1993). Data analysis started with searching for patterns in the data.
Credibility of findings was attained through engagement and data triangulation. Prior to
conducting the investigation, prolonged engagement and participation with the community and
culture in El Paso and Ciudad Juárez minimized threats to the true value and contributed to
accurate representation of the investigation findings within the cultural context (Lincoln & Cuba,
1985).
Data was triangulated from the following sources: demographic data, participant
interview and field notes. Data triangulation enriched understanding of the phenomena by adding
rigor, richness, and depth, and grounding the research in the context of the participant’s
environment (Denzin & Lincoln, 2000). Interview transcripts were read multiple times by the
investigator/PI and a consultant with experience in qualitative research to capture the major
elements and themes of the participant’s understanding and perceptions of their experience with
TB and participation in the Photovoice Project. The results and the limitations of the study are
presented in Chapter 7.
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3.3 Third Section: Measuring TB related Stigma: Validation of Two Subscales with
Mexican-origin Groups
This study is a cross-sectional analysis of a convenience sample of 217 individuals of
both sexes affected by TB and under treatment or who completed TB treatment in the past six
months in five study locations in México. They voluntarily agreed to participate in the
investigation.
Study Setting and Participants
The data were collected by experienced interviewers in five urban locations in México,
three in Northern region, one in the Central region and one in the South, where pulmonary TB
morbidity burden of disease is high. Experienced and trained interviewers administered face-to
face the Spanish TB and HIV/AIDS Stigma scale (Van Rie et al., 2008) to adults affected by TB
in treatment or who completed their TB treatment in the past six months in the selected locations.
Eligible participants, irrespective of HIV/AIDS status, were recruited by the health
personnel of SOLUCION TB Expansion (2008, 2009), an initiative of Project Concern
International, in which the investigator/PI (Moya) collaborates. A minimum sample of 110,
using a confidence interval of 95%, was deemed sufficient to perform the study (see Sample
section). However, the study over sampled. The interviewers recruited an additional 107 subjects
who completed the study questionnaire for a total of 217 participants.
The criteria for site selection included high risk for TB and higher TB prevalence than
national rates (México and United States). A city per each selected state was chosen based on
these criteria and the availability of experienced interviewers from SOLUCION TB (2009).
The study collected 201 questionnaires in five localities (three geographic regions:
Northern, Central and Southern) in México, and an additional 16 questionnaires in the remaining
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eight PCI project locations. After informed consent was obtained from participants, they rated
whether they strongly agreed, agreed, disagreed, or strongly disagreed with 23 TB stigma-related
items and 22 HIV/AIDS stigma-related items that asked

about their perception of the

community’s response to people affected with TB (or HIV/AIDS) and the experiences of TB
perspectives within the community.
The criteria for selecting five sites included highest risk for TB, higher prevalence for TB
than national rates, and presence of the SOLUCION TB Project. The Project titled SOLUCION
TB is funded by USAID to Project Concern International in México. The project employs staff in
13 states in México where TB rates are higher than national norms. First, the states with the
highest TB rates were identified by the SOLUCION TB Project; then a municipality was selected
from each of the five locations. The selection was based on TB rates, geographical locations,
availability of staff to facilitate interviews and service infrastructure in place. The five study
locations include three locations in the north (Tijuana, Baja California; Ciudad Juárez,
Chihuahua; and Reynosa, Tamaulipas), one in the central region (Guadalajara, Jalisco) and one
in the south (Tuxtla Gutiėrrez, Chiapas). Figure 3 displays the pulmonary TB morbidity for 2008
in México by state. The five study locations have higher TB morbidity rates than the national
average. Figure 4 displays the municipalities in México with the greatest burden of TB (all cases)
in 2008. Four of the study locations are highlighted in Figure 2 because of the burden of TB in
2008.
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Figure 3. Pulmonary Tuberculosis Morbidity in México, 2008

Figure 4: Municipalities in México with the greatest burden of TB cases in 2008.
Castellanos, M. (2009)
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Inclusion criteria
The inclusion criteria for participants consisted of individuals 18 years or older, male or
female, in treatment for TB (non-contagious stage) at a Centro de Salud (Public Health Clinic or
TB program), and individuals who completed TB treatment in the past six months from Ciudad
Juárez, Chihuahua; Tijuana, Baja California; Reynosa, Tamaulipas; Guadalajara, Jalisco; and
Tuxtla Gutiėrrez, Chiapas. Participation was voluntary. Participants with active TB were not
interviewed because of the risk of exposing themselves or exposing others to additional risk
during the interview.
Training of Interviewers
In October 2008, the preliminary study protocol was presented to 13 PCI state
coordinators during a National Project Meeting. They reviewed the first translation of the TB and
HIV/AIDS Stigma scales and gave input on linguistic and cultural appropriateness. The Project
Coordinators helped finalize the instrument for linguistic and cultural appropriateness. Once the
study sites were selected, training was scheduled at their respective sites and through Elluminate,
a virtual conference mechanism. In January, the Institutional Review Board of the University of
Texas at El Paso approved the study protocol (1000345-1) and data collection was initiated.
Instrument Design
The study instruments, referred to as the TB and HIV/AIDS Related Scales, included
items related to individuals and community perceptions of stigma and TB and HIV/AIDS. As
mentioned in the introduction, the selected scale met a need identified in the implementation of a
community-based participatory research process conducted in collaboration with the U.S.México Border Health Association and the Amaya-Lacson TB Photovoice Project. The validated
Tuberculosis and HIV/AIDS Stigma subscales, developed by Van Rie and collaborators in 2008
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and translated and back translated by PI (Moya) and colleagues in 2008 for use in México. Van
Rie and colleagues used exploratory factor analysis among 480 TB patients in southern Thailand
to analyze the findings. Then the authors did a confirmatory factor analysis and validated the
instruments. On September 18, 2008, Van Rie and colleagues gave the investigator (PI)
authorization to use, translate and adapt the two scales to examine the community perspectives
and patient perspectives related to the two infectious diseases in México.
The instruments were used to measure the level of TB-related stigma from both a
community perspective (attitudes and actions of the community toward individuals with TB) and
the perspective of the person with TB (feelings and experiences with TB). The two scales were
administered in person by experienced and trained PCI Project interviewers. These scales were
first translated into Spanish by project PI (Moya) and back translated by the University of Texas
at El Paso (UTEP) Department of Linguistics and Translation. The scales were then field tested
for linguistic comprehension with staff of the SOLUCION Project and then with a sample of 30
individuals affected by TB, two or three from each of the 13 states in México (SOLUCION TB
Project Sites).
A complete English and Spanish instrument is provided in Appendix 6. The study scales
address: community perspectives toward TB, patient perspectives toward TB, community
perspectives toward HIV/AIDS, and the PATB perspectives toward HIV/AIDS.
Study Design
Sample size for this population survey was obtained using Epi Info v6 software (CDC,
2004). A systematic sampling (every fifth TB case attending the clinic was included in the
sample) was used based on the assumption that the TB cases represent each of the 3 geographical
regions in México from where all the cases came from. We wanted to be 95% confident that in
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our investigation, the difference in opinion for four TB-and HIV/AIDS-related stigma scales
from a population of persons affected by TB would fall within the confidence interval calculated
for the sample.
The study sample size was increased by 18% based on assumptions, non-response of 5%,
and non-participation of 10% including inability to follow up subjects, refusals, missing
information, and data transcription of the answers. Considerations to increase the sample were
due to reach a design effect of 2. A sample of 117 subjects to cover for these assumptions was
established. In addition, the decision to over sample was made to increase study power.
The sample size formula, from (Kish & Leslie, 1965) was calculated as:
S = sample size for a large population, where, S = Z * Z (P (1 – P) / (D * D)
In which D is one half of the width of the desired sample confidence interval. Z is the percentile
of the standard normal distribution determined by the specified confidence level or 1.96 for a
95% confidence level. We then adjusted S by a finite population correction factor to obtain the
final sample size: Sample size = S / (1 + (S / population))
The sample size was then distributed using a factor of 5.3 for each location. See table
below. Size of the TB case population in México and in the five study states was 3,841 and
1,915 in the five study locations.
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Table 1. Validation of Two Subscales with Mexican-origin Groups Sample Size by Site
Total number
Percentage
Number
Jurisdiction
of TB cases in
of total cases in
of cases (n)
study locations
study locations
Tijuana Baja, California
755
39%
40
Tuxtla Gutiėrrez, Chiapas

215

11%

11

Ciudad Juárez, Chihuahua

242

13%

13

Guadalajara, Jalisco

383

20%

20

Reynosa, Tamaulipas

320

17%

17

1915

100%

101

Total

Source: Castellanos, M. (2008). Dirección General de Epidemiología Secretaria de Salud. Módulo de
Tuberculosis Plataforma Única de Información.

The study collected data on a sample of 217 subjects, of which 212 met inclusion criteria.
The reason five questionnaires were excluded was because the subjects were younger than 18. A
sample of 30 individuals affected by TB, two or three from each of the 13 states in México
(SOLUCION TB Expansion Project, 2009), was integrated into the study as well. The study had
a larger sample than originally estimated given the nature of the convenience sample, the
availability of persons with TB, and the interviewers’ ability to recruit participants who met the
inclusion criteria. After informed consent was obtained from student participants, participants
rated whether they strongly agreed, agreed, disagreed, or strongly disagreed with 23 TB stigmarelated items, and 22 HIV/AIDS stigma-related items that asked about the community’s response
to people affected with TB (or HIV/AIDS), and the experiences of persons affected by TB
within the community.
Interview Locations
A primary area for administering the scales took place at either the health clinics or TB
Program offices in the five study locations previously identified. These are areas that are
equipped to see individuals [females and males] affected by latent or active TB. A minority of
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the interviews took place at the participant’s home when the staff of SOLUCCION TB was
supervising the Direct Observed Therapy.
Sampling Schedule
A total of 217 questionnaires were administered in a two month period starting in
January 2009 and ending February 28, 2009.
Data Collection
Information on age, sex, socioeconomic status, occupation, marital status, employment
status, education, health insurance coverage, home ownership, type of TB, time of TB diagnosis,
perceived health status at time of interview and six months prior to interview, perceived selfcontrol, and perception of support during treatment were collected by trained interviewers using
a standardized questionnaire. Four stigma scales (Appendix 6) were administered to all
participants: TB-related stigma from the community perspective (11 items) and TB patient
perspective (12 items), and HIV/AIDS-related stigma from the community perspective (11
items) and TB patient perspective (11 items).
Both the UTEP and the USMBHA provided space, computer equipment and access to
telecommunications. The U.S.-México Border Office of the Pan American Health Organization
(PAHO) provided virtual connectivity through the Elluminate system. This system was used on a
regular basis to establish ongoing communication with project coordinators and interviewers.
Agendas for each of these meetings were established and sessions were digitally recorded.
Among the core themes for discussion were securing informed consent (Appendix 7),
securing privacy for interviews given the limited physical spaces at the health centers,
interviewers concerns about questions and presentation of preliminary findings. This virtual
space was helpful in facilitating communications between the five study locations: National TB
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Program, PCI office in Tijuana, and UTEP. Important elements in the successful implementation
of the study were the partnerships that were put in place prior to the study with core
organizations like Project Concern International, State TB programs and the Health Jurisdictions
in each of the study locations.
These institutions and organizations are all well established and have been in existence
for decades. In addition, the USMBHA and PCI are community-based institutions that have a
track record of work in TB and HIV/AIDS in México and in the United States. The staff of both
institutions is bilingual and bicultural. These institutions are well respected and have ample
experience in service and research bi-national work and have excellent working relationship with
the México National Tuberculosis Program.
The study data were collected primarily by the SOLUCION TB Expansion Coordinator
in each of the study sites. All of the coordinators are physicians, public health professionals or
psychologists with formal research training. The coordinators are employed by SOLUCION TB
and they were responsible for coordinating the study in each site, identifying interviewers as
needed, and recruiting study participants based on inclusion criteria.

In each location the

SOLUCION TB Coordinator recruited a sample of participants in treatment for TB (noncontagious phase) or who completed treatment in the past six months. The sample for each site
was calculated using the national and state TB prevalence rates and the number of pulmonary TB
cases for 2007 (CENAVESE, 2008). The sample for each location varied based on prevalence
rates and case number. Based on state and national prevalence rates in México, it was reasonable
to estimate a sample of 101 participants using a confidence interval of 95%. For a detailed
description of the study sample, refer to sample formula. The inclusion criterion was met by 212
participants. This sample includes 30 (13.8%) individuals affected by TB (two to three from each
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of the 13 states in México SOLUCION TB Expansion Project), which was integrated to the study
as well.
Data Entry
Data entry was conducted using SPSS Version 15.0.1.1 (SPSS Statistics, 2007). The data
entry plan contained checks for skip patterns and allowable responses in order to assure that the
data were as complete as possible. The data from the first 30 questionnaires included a limited
set of variables primarily of general and socio-demographics nature. Additional variables on
health insurance coverage, home ownership, and perceived health status at time of interview and
at six months prior to interview, perceived self-control and perceptions of support during TB
treatment were included after the first 30 questioners were collected to address the study
domains. As a result of this late addition, these (30) questionnaires have some missing values on
participant characteristics.
The original data files were transferred from a PC to compact discs, and back-up copies
were prepared regularly.

The original files were kept under double lock and key at the

University of Texas at El Paso, and information from the hard disks copied onto the PC
computer was encrypted and accessible only with a password. Interview files were passed
directly from the site coordinator to the Project Co-Director in El Paso, Texas. The site
coordinators kept a photocopy of all the files under double lock and key at their respective
project offices.
The 45 Stigma scale items were scored on a four point Likert scale with the following
levels: (0) strongly disagree, (1) disagree, (2) agree, and (3) strongly agree. Higher scores were
related to higher stigma. Summary scores for each scale were completed. Responses were
summed for each scale and summed scores were used in statistical analysis. Item-adjusted scores
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were created for comparison between scales by dividing the summed scores by the number of
items in the scale and creating an item-adjusted score ranging from 0 to 3. In addition, we
consulted with Van Rie and colleagues, and they suggested we compute the raw summary scores
(SSraw) for each scale as the sum of the scale item responses. The raw scores were
mathematically computed into a standardized summary score (SS50) so that the level of stigma on
each of the subscales would be between 0 and 50, with the highest scores representing higher
stigma.
The Standardized sum of scores was calculated by the following formula: SS50 = (SSrawx
50) / (n x 3). The number 3 (three) represents the maximum score that can be given to each item
in the sub scales and the ‘n’ is the number of items in each of the subscales. The mean and
standard deviations of the SS50 were calculated, and the percentile distribution for each of the
scales was prepared. For a description of the statistical analysis and results see Chapter 5.
Statistical Analysis
The descriptive data analysis focused on statistics consisting of frequencies and crosstabulations of key variables, which were used to detect relationships between the dependent
variable (stigma) and the independent variables being, surveyed (e.g. site, age, sex, education,
and occupation). Factor analysis was performed for the 45 TB and HIV/AIDS items. No items
were excluded using SPSS V15.0.1.1 (SPSS Statistics, 2006).
Factor analysis was conducted using the principal component factor extraction method on
the selected set of items to identify the factors and factor loadings (Tabachnick & Fidell, 2001;
Hair, Tatham & Black, 1998). The first round of un-rotated factor analysis yielded screen plots
to determine the number of factors underlining the TB and HIV/AIDS stigma scales followed by
rounds of factor analysis, with rotations to provide a relationship among these items for each
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factor. Items with absolute value loading of 0.30 or greater were identified. Estimates were
conducted of the correlation among the variables of the four stigma scales (or two subscales):
Community Tuberculosis Stigma Perception (11 items), Patient (Person) TB Stigma Perception
(12 items), Community HIV/AIDS Stigma Perception (11 items), and TB Patient (Person)
HIV/AIDS Stigma Perception (11 items), by means of the internal consistency of the variables
using the Cronbach’s alpha statistic.

A scale with an alpha of >0.7 was considered to have a

good to excellent reliability (Nunnally, 1978). The PI (Moya) also assumed that the 45 items in
the 4 scales were linearly related to the total score. The Tukey’s test of non-additivity was used
to assess that there was no interaction between the cases and the items at the 0.95% level
(Chapter 6, Table 14).
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CHAPTER 4
PERSPECTIVES FROM PERSONS AFFECTED WITH TUBERCULOSIS
IN CIUDAD JUÁREZ, MÉXICO, AND EL PASO, TEXAS
INTRODUCTION
This chapter presents information gathered from thirty individuals affected by
tuberculosis who have firsthand experience of the impact of tuberculosis and TB related stigma.
This exploratory study of stigma related to tuberculosis and factors affecting access and health
seeking behaviors for tuberculosis were conducted in the El Paso, Texas, and Ciudad Juárez,
México. The data will add to the limited body of knowledge about individual experiences with
tuberculosis related stigma and its impact on health-seeking behaviors. The value of the data lies
in its ability to demonstrate that some of the traditional interpretations of the tuberculosis
experience need to be revised because they no longer apply, even though the contexts that
formulate these interpretations are still present in how society views people with tuberculosis.
The old labels are described in every interview conducted and are cited as the source of the
stigma and discrimination associated with the disease.
Issues associated with diagnoses, experience with treatment, access to medical care,
awareness of tuberculosis information resources, and attitudes about TB-related stigma and
discrimination emerged in the interviews. Persons affected by TB described their perspectives on
tuberculosis related stigma and they identified and described gaps in knowledge about TB
transmission. Participants reported frequent delays in obtaining a diagnosis of tuberculosis and
obtaining adequate and timely treatment on either side of the United States-México border. The
participants also summarized their own attitudes and behaviors related to seeking treatment. The
following are the findings from the 30 interviews included in the study.
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4.1 RESULTS
Socio–Demographic
Thirty adult individuals with tuberculosis and under treatment or who completed
treatment in the past six months participated in the study. For a complete list of characteristics
see Table 2. All the interviewees are of Mexican-origin. Seventeen of the participants were male
and 13 female, ranging in age from 20 to 96 years old. All of the participants, with the exception
of one in El Paso, were Spanish speakers. About half of the respondents in El Paso speak limited
English and preferred to be interviewed in Spanish. Thirteen participants were single, 13 were
either married or in a type of partnership, and four were either widowed or divorced.
The level of schooling ranged from two years of education to 13 years, with a mean of
seven years. The majority of respondents worked informally outside of their homes and earned
wages. Seven female participants were homemakers, four were unemployed, four were disabled
and one was retired. Most of the participants in Ciudad Juárez reported having difficulties
earning enough money to sustain their family and household needs. In El Paso, half of the
participants had access to some type of public assistance because of their distressed economic
situation or because they were eligible for public assistance programs due to retirement or
disability.

Seven participants owned their house, and 17 are either leasing or living with

relatives, and four are residing in shelters in Ciudad Juárez, México. The number of rooms in the
household’s ranged from two to fifteen (e.g. shelters), and the number of household members
ranged from 1 to 25, with the majority being adults.
Health Care Profile
The majority of the participants identified barriers to accessing health care services when
they needed medical care for their TB condition. One of the barriers was not having the financial
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means to pay for medical care and the lack of health insurance coverage. In El Paso, seven
participants had some type of private health insurance (e.g. Medicaid or Medicare). In Juárez,
five participants had Seguro Popular - a publicly-funded health insurance program in México for
socioeconomically-poor individuals, the other half of the respondents was uninsured.
Table 2. Socio-Demographic Profile of Study Participants
Location of interview (30)

El Paso, Texas
Ciudad Juárez, México

Number
(Percent)
15 (50%)
15 (50%)

Sex (30)

Female
Male

13 (43%)
17 (56%)

Age (30)

20-30
31-50
51> (96 yrs.)

11 (36%)
10 (33%)
9 (30%)

Marital status (30)

Single
Common Law/Married
Other(Divorced,Widow)

13 (43%)
13 (43%)
4 (13%)

Last year of school completed (29)

< 6 years
6th-8th years
9th and more

7 (23%)
14 (46%)
8 (26%)

Occupation (30)

Informal
Formal
Unemployed
Disabled
Retired
Home

12 (40%)
1 (3.3%)
4 (13%)
4 (13%)
1 (3.3%)
7 (23%)

Employment (13)

Regular
Occasional

10 (33%)
3 (10%)

Income (18)

Yes
No

15 (50%)
3 (10%)

Native of (30)

México (Juárez 16)
USA (El Paso 2)

26 (86%)
4 (13%)

Currently living in (30)

México
USA

15 (50%)
15 (50%)

Frequency of border crossings (24)

Weekly
Monthly
Does not cross

2 (6.6%)
7 (23%)
15 (50%)

Home ownership (30)

Yes
No

7 (23%)
23 (76%)

Category (n)*

Characteristic

Semi-structured interviews (n=30) and * is the number of actual responses provided
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Mobility and Migration between the United States and México
Fifteen persons were living in Ciudad Juárez, México and 15 in El Paso, Texas. The
majority of participants were native of México; half of them were born in Ciudad Juárez, four in
the State of Chihuahua and five in another state in México. Three participants were born in El
Paso and two outside of Texas.
Eleven participants visited the United States at least once, and fourteen had never been to
the United States. Three individuals lived in the U.S. from one to five years, and 13 lived in the
U.S, for more than five years. The frequency with which those that lived in El Paso crossed the
border into Ciudad Juárez was weekly (2), monthly (7) or twice a year (1). The following
participants commented on their visits to Ciudad Juárez. Participants spoke about their changes
in behavior regarding crossing to the other side of the border:
… desde antes de que comenzara todo el (crimen y la violencia) allá en
Juárez…una vez al mes íbamos al mandado… ya no cruzamos… ya no mas voy
cada año… por eso de los narcos y ahora los soldados. Mejor aquí
buscamos...Porque más bien era por el jabón, las sopas, todo eso…ya no vamos
ni por la familia, pues ya es muy poquita… cuando vamos es por el día de los
muertos en noviembre… (Female, 52)
… even before the (crime and violence) started there in Juárez… we would go to
get groceries once a month… we don’t cross anymore… I only go once every
year… because of the drug traffickers and now the soldiers; we look here…
because we mostly bought soap, soups, all that… we don’t even go because of the
family, there are just a few now… when we go is for the day of the dead in
November….(Female 52)
In addition, several participants from Ciudad Juárez who crossed to the United States
stopped crossing because of difficulties encountered with stricter immigration enforcement,
expired visas (due to economic distress) or the risk of deportation.
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…viví del otro lado… (United States) como por 12 años… la cruzaba (la frontera)
de mojado…, ya no… ya no puedo. (Male, 31)
… I lived on the other side… (United States) like for 12 years… I crossed (the
border) as a “wetback” (undocumented)… not anymore… I can’t do it anymore.
(Male, 31)
Most of the participants in El Paso, Texas who used to cross the border to Ciudad Juárez
stopped crossing because of the unstable and violent environment. Several participants referred
to Ciudad Juárez as a community that has been ripped by violence and loss. In the three months
that it took to gather the data for this study, a total of 590 individuals were murdered in Ciudad
Juárez (La Red Noticias, 2009).

4.2 HEALTH CARE PRACTICES
Tuberculosis Diagnosis: Severe Symptoms Prompted Treatment
For a list of health care characteristics of study participants see Table 3. More than half of
the participants perceived their health status to be good (24) or fair (4). Participants described the
problems and difficulties associated with tuberculosis prior to treatment as multiple and difficult.
Interviewees referenced a myriad of TB symptoms like: productive cough, cough with phlegm,
cough with blood, fever, weight loss, muscle aches, difficulty breathing, weakness and fatigue,
and general aches and pains.
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Table 3: Health Care Profile of Study Participants

Type of tuberculosis (30)

Pulmonary
Extra pulmonary
Don’t know

Number
(Percent)
11 (37%)
4 (12%)
15 (50%)

Type of case (30)

New
Relapse
MDR-TB

28 (93%)
2 (6.6%)
2 (6.6%)

Time to get TB diagnosis (30)

< 6 months
> 6 months (up to 24 mts)

13 (43%)
17 (57%)

Health insurance coverage(25)

Yes (Medicaid, Medicare,
or Seguro Popular (5))
None

12 (40%)

Category (n)*

Characteristic

13 (43%)

Semi-structured interviews (n=30) and *indicated the number of actual responses provided.

Most of the participants reported that they experienced symptoms associated with TB for
months (6-24 months) from the onset of the condition (TB) before they received treatment.
...pues es que, yo tuve síntomas hace como dos años… pero yo no me daba cuenta
realmente de los síntomas de la tuberculosis... cuando fui al hospital fue porque
me sentí muy mal, pero yo los síntomas ya los sentía desde el año pasado…los
escalofrío...nomás me daba escalofríos, no me dieron calenturas ni nada, no eran
frecuentes y luego retirados, yo pensé que eran como resfríos. (Female, 45)
… well, I had symptoms about two years back but I didn’t really realize the
symptoms of tuberculosis… when I went to the hospital was because I felt very
bad, but I had the symptoms since last year… the chills, I didn’t have fevers or
anything, they weren’t frequent and then far apart, I thought they were like
flues…(Female, 45)

No puedo respirar bien, cuando me hicieron la radiografía me hallaron un hoyo y
de ahí me agarro un dolor, me dobla el dolor, en el pulmón izquierdo me lo
encontraron perforado… hasta ahorita todavía me duele mucho siendo que ya
voy acabar el tratamiento no sé qué pasa. Me agito mucho ya no es igual mi
respiración me canso muy rápido y mi pérdida de peso es excesiva pero a ver,
que pasa…. (Female, 24)
… I can’t breathe well, when they did the X-ray they found a hole and since then I
got this pain, the pain bends me, in the left lung is perforated… even today it still
hurt a lot even though I’m almost done with the treatment, I don’t know what is
happening. I become very agitated my breathing is not the same, I get tired easily
and my weight loss is excessive but we’ll see what happens…(Female, 24)
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Participants displayed an array of emotional and psychological distress due to their
deteriorated physical and emotional condition.
Si pues sí, cuando mi esposo supo (que tenia TB) se fue… como que a él dio
miedo, como que ha de haber dicho pues hay eso, eso es una enfermedad grave,
fea y tuvo miedo yo digo y se fue… (Female, 24)
Yes, well yes, when my husband found out (I had TB) he left… he was very
afraid, like he must have said that is a serious disease, ugly and he was afraid I
think and he left… (Female, 24)

Los problemas que me dio la tuberculosis fueron físicos… me cansaba mucho, me
debilito, pero hasta me dio depresión, porque yo no estoy impuesta a estar nomás
en un cuarto, y tenía que estar en un cuarto con la máscara…y eso me dio mucha
depresión. Separase de la familia no es bueno…ellos venían y me miraban y todo,
pero yo no me sentía igual. Como que yo estaba encerrada… (Female, 52)
The problem I got from TB were physical…I was very tired, debilitated, I even
got depression, because I wasn’t used to being in one room only, and I had to be
in a room with the mask… and that gave me a lot of depression. Being separated
from the family is not good… they came and they saw me and everything, but I
didn’t feel the same. It was like I was locked up… (Female, 52)
The majority of participants indicated that this was the first time they had been diagnosed
with TB. Two respondents abandoned the initial TB treatment and developed multi-drug
resistance (MDR). The following statement describes how a participant develops an MDR
condition.
…es que yo fui con un médico particular y yo traía los síntomas esos ya (TB),
entonces el médico particular me dio medicamento para tuberculoso pero a mí
nunca me especifico que yo tenía TB. Entonces , yo la compraba el medicamento
por mi cuenta y ya como a los dos meses ya se me quito la tos y le dije yo y le
hable oiga, me dijo no ya déjelo entonces yo me fui Aguascalientes y de regreso
ya traía de vuelta la tos, entonces cuando llegue volví hablarle por teléfono y me
dijo pues si ya sabes el medicamento con que se le quito vuélvalo a usar, lo volví
a tomar y se me volvió a quitar pero duraba yo como 15 o 20 días tomándolo
para que se calmara a penas la tos, entonces cuando fui con otro médico que me
detecto él, el me dijo sabe que usted trae TB y dijo ese tratamiento pos es caro si
usted se lo quiere tratar váyase al seguro (Seguro Social), entonces en el seguro
me pusieron un tratamiento de seis meses pero yo a estaba inmune al
medicamento. Haga de cuenta que me tuvieron estable ni me subía ni me bajaba,
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me hacían el examen de aquí y salí positivo, positivo, positivo ya cuando fueron
los seis meses ya me dijeron no pues es que ya no podemos hacer y de ahí me
pasaron al centro de salud, pero después de que ya estaba yo inmune al
medicamento ya fue cuando me dijeron de este otro (medicamento) para la MDRTB. (Male, 49)
… I went to a private doctor, and I already had those symptoms (TB) so then the
private doctor gave me medications for tuberculosis but never told me I had TB.
So I lasted, I bought it on my own, and after two months, the cough went away,
and I told him I told him hey, he said leave it and I went to Aguascalientes, and on
the way back, I had the cough again. So when I got back, I called him on the
phone again, and he said, well you have the medication that took it away so use it
again. I took it again and it went away again but I would use it for 15 to 20 days
taking it so that it would calm down the cough barely. Then I went to another
doctor who detected it. He said do you know you have TB and he said that
treatment it’s expensive, and if you want to treat it go to the Social Security
(Seguro Social), so at the Social Security they treated me for six months, but I
was immune to the medication. Imagine they kept me stable, it didn’t go up or
down, they would do the test here and I came out positive, positive, positive, so
after six months they said well we can’t do anything for you anymore and they
sent me to the Health Clinic, but after I was immune to the medication was when
they told me of this other (medication) for the MDR-TB. (Male, 49)
Ten of the participants had or have a relative (in some cases more than one) with
tuberculosis. In some cases, their relatives had died from tuberculosis.
Yo tenía 11 años cuando nos cambiamos de casa… metieron a mi papa al
sanatorio, ese lugar era muy feo y me acuerdo que íbamos a verlo...era muy
triste. Estábamos solos aquí (EUA), no conocíamos a nadie, fueron tiempo muy
difíciles. Mi tío Herminio y mi tío Agustín se murieron de eso (TB)...Yo pensaba
que esa enfermedad solo le daba a la gente sucia...yo tengo ese tipo de TB que
esta… en los ganglios….yo no sé como la ‘cogí’, yo no ando en esos lugares
sucios... (Female, 52)
I was 11 years old when we moved to another house… they put my father in the
sanatorium, that place was very ugly and I remember that we went to see him… it
was very sad. We were alone here (U.S.), we didn’t know anyone, they were very
difficult times. My uncle Herminio and my uncle Agustin died of that (TB)… … I
thought only dirty people got that disease… I have that type of TB which they
said is in the lymph nodes…I don’t know how I got it; I do not go to those dirty
places. (Female, 52)
Once participants were able to receive medical care for the TB, it took anywhere between
one week to six months to initiate treatment. Participants did not report seeking treatment outside
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of traditional medical facilities. Twenty individuals were diagnosed for TB in a medical facility
such as a hospital (emergency room) clinic, health center or a private doctor’s office. Half of the
respondents in El Paso were first diagnosed with TB through a hospital emergency room,
requiring hospitalization (three days to four weeks) before they were referred to the TB Program
for treatment. Three participants indicated that they received medications in Ciudad Juárez
through local pharmacies.
The primary reasons why participants delayed care included: did not feel very ill or they
became accustomed to the cough and fatigue. As one participant from El Paso stated: “Uno se
actostumbra a la tos” (One becomes used to coughing). In addition, lack of information (where
to seek medical care) was mentioned as one of the primary reasons for not seeking medical care.
Eighteen participants went to a health center or a health clinic to get checked. Participants who
sought care through a private doctor, at clinics or through a pharmacy indicated that they were
diagnosed and treated for other conditions like pneumonia; allergies; upper respiratory
conditions; or diabetes first and not for TB.
Cuando me sentí muy mal, dicen que tenia anemia, me fui al hospital. Ahí estuve
10 días...Ahí me dieron un chorro de pastillas. Yo me fui primero con mi doctor
pero él me despacho con otro por que dijo que tenía anemia, no me dijo nada de
la TB. (Male, 96)
When I felt very bad, they said I had anemia, I went to the hospital. I was there
ten days…. They gave me a bunch of pills there. I first went to my doctor but he
sent me with another one because he said I had anemia, he didn’t say anything
about TB. (Male, 96)
All participants reported delays in seeking treatment for several months (up to 24
months) between the onset of the symptoms and the initiation of tuberculosis treatment in both
study locations. Some respondents delayed treatment because they believed that their signs and
symptoms were from something other than tuberculosis. In addition, several of the respondents
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self-medicated or went to a pharmacy for treatment; this also delayed the appropriate treatment.
… como le dije empecé a toser y arrojaba sangre por la nariz y la boca… pero
pues yo no sabía que era tuberculosis... pensaba que era porque no comía… pero
ya después que fui al doctor pos ya, entonces me dijeron eso…Primer, me
recetaron muchos jarabes para la tos, para calmarla, pero no me decían que
tenia. (Male, 53)
Like I told you I started coughing and I would hurl blood through the nose and
mouth… but well I didn’t know it was tuberculosis… I thought it was because I
didn’t eat… but later I went to the doctor then they told me that… first they
prescribed a lot of cough syrups for the cough, to calm it, but they didn’t tell me
what was wrong with me. (Male, 53)
In other cases they went to a doctor or a clinic where they received another diagnosis
which contributed to further delays in treatment.
Yo no sabía lo que tenia… dure muchos meses…yo decía es la tos…pos ahorita
anda mucha gente tosienta, yo también, y me llegue a poner inyecciones que para
los… para…pero como de esas de eucalipto con… combinadas… no me
ayudaron, tomaba y tomaba medicina…seguía con la tos día y noche, no dormía
por la tos, primeramente dijeron que tenía neumonía. (Female, 52)
I didn’t know what was wrong… It took many months… I would say it’s the
cough… there are a lot of people with coughs right now, me too, and I even got
shots for the… like they said eucalyptus with… combined… they didn’t help me,
I took and took medicine… the cough continued day and night, I couldn’t sleep
because of the cough, they first told me I had pneumonia! (Female, 52)
Other participants delayed care to the point at which they no longer could endure the pain
or discomfort and sought care at a hospital, where they were initially diagnosed, hospitalized (for
up to two weeks) and then referred to TB clinic for treatment.
...lo que pasa es que a mí siempre me ha dolido mucho la cabeza… muy seguido
siempre, mi papa tiene migraña entonces para mí eso era normal pero ya era
todos los días… todos los días como por dos semanas seguidas y fue cuando me
empecé a sentir muy débil... Entonces como un mes después fui al doctor, si fue
como al mes… Primero me fui a Juárez con unos doctores conocidos de mis
papas, pero me dijeron que era otra cosa…me sentí mas y mas mal... y decidí
venirme para acá (El Paso). Me hicieron varios estudios, una biopsia del cerebro
para asegurase de lo que tenia. Yo pregunte que por qué me daban tanto
medicamento, yo estaba prácticamente inconsciente, yo les dije que era lo que
tenia…no me podían decir… Yo no sabía en qué día vivía en el hospital…no le
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puedo decir cuánto dure. Luego me dijeron que mi TB era pulmonar pero que ya
había caminado, que por eso se me corrió para la columna y que se me subió al
cerebro, eso fue lo que me dijeron, mira ahora como estoy que ni puedo caminar.
(Male, 24)
… I always have had a headache… very frequently, always, my father has
migraines so that was normal for me but it became a daily thing… every day like
for two weeks and that is when I started feeling very weak… so after a month I
went to the doctor, yes it was like a month… first I went to Juárez with some
doctors my parents knew, but they told me it was something else… I felt worse
and worse… so I decided to come over here (El Paso). They did several studies, a
brain biopsy to make sure what I had. I asked them why they gave me so much
medication, I was practically unconscious, and I asked them what was wrong with
me… they couldn’t tell me… I didn’t know what day I was living in the
hospital… I can’t tell you how long I was in. Then they told me that my TB was
pulmonary but that it had already gone to my spine and had gone up to my brain,
that’s what they told me, look how I am now that I can’t walk. (Male, 24)
The decision to seek medical care was primarily influenced by family members who
encouraged the interviewee to seek care.
Sí, yo me di cuenta ya hasta al último que ya me sentía sin caminar, sentía todos
los huesos caídos o sea yo no me levantaba de la cama, fue por una tía que me
llevo, me mandaron hacer unas placas de pulmón, me dijeron que tenía algo,
como le quiero decir…si o sea todavía no estaba seguro que yo tenía TB verdad
pero ya cuando vine aquí al centro de salud ya me dijo el no ya es el 90% de que,
si lo tienes. (Female, 27)
Yes, I knew the last day when I couldn’t walk, I felt all my bones had fallen, I
couldn’t get out of bed, it was because of an aunt who took me, they had some Xrays of my lung, they told me I had something, like I want to tell you… it wasn’t
clear that I had TB but when I came here to the Health Clinic he said it is 90%
that you have it. (Female, 27)
The sources of support during treatment included: family members (parents, siblings,
spouses and children), peers, and health care workers (TB Program). Most participants indicated
that they were informed about tuberculosis. Only half of the respondents knew the type of
tuberculosis they have.
The most frequent sources of other health and medical services (not related to TB) are
Centros de Salud (Health Centers), community clinics or private physicians. The majority of
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participants sought medical care (not for TB) when they felt very ill or when they could no
longer carry out their daily activities. Very few of the participants received regular medical care
(monthly to quarterly) for any of the co-morbidities they had (e.g. cancer, diabetes, HIV/AIDS,
or hypertension). Not all participants received DOT for TB at their residence. In Ciudad Juárez,
the treatment is primarily supervised at a health center; in other cases, the DOT workers take the
medication to the person’s residence on a daily basis. In the case of persons receiving treatment
for MDR-TB in Ciudad Juárez, the health worker administers the medications daily, five times
week for up to 24 months. In El Paso, the majority of participants receive the first two months of
treatment at home through a DOT worker and the rest of the treatment at the clinic. There were a
few exceptions where the participants went to the clinic on a daily basis to receive the
medication.
Tuberculosis Co-Morbidities
Tuberculosis is a condition that “likes the company” of other diseases. Twenty-two of the
participants indicated they were aware of other co-morbidities they had, like diabetes (9),
HIV/AIDS (4), illicit drug use (6), depression (4) cancer or hypertension (6). Diabetes was the
number one co-morbidity with TB. This is consistent with the 2008 TB data from México; this is
also the number one risk factor for TB in the El Paso region. The number of TB cases with DM
is growing in the United States (Castellanos, 2008; 2009).
The following statements illustrate these associations:
Tengo…diabetes, alta presión…y también cáncer. Bueno el cáncer ya me lo
quitaron me están tratando por si las dudas y me llega a regresar, es un cáncer
de colon. Ah, y también tengo mi TB (Female, 34)
I have… diabetes, high blood pressure… and also cancer. Well, the cancer they
have taken it away, they are treating me just in case it comes back, it’s colon
cancer. Oh, and I also have my TB. (Female, 34)
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In addition, TB and HIV/AIDS is the most common co-infection and the leading cause of
death of persons living with HIV/AIDS globally. Twenty-four participants were tested for
HIV/AIDS; 18 received the results and six not. Four participants disclosed their HIV/AIDS
status and indicated that they were presently receiving care at an HIV/AIDS facility. One
participant received a dual diagnosis for TB and HIV/AIDS on the day of admission to the
hospital. Most of the participants living with HIV/AIDS indicated that they knew that eventually
they could get the disease because of the lifestyle (excesses and exposure to the disease) and
risks (drugs, alcohol or unprotected sex). One participant was particularly distressed with the
dual diagnosis.
Aquí (en el hospital) me descubrieron todo eso. Por lo mismo, pues si, por la
caída (entrada) es que di en el hospital. No esperaba esa noticia, pues ya, que
hacemos. (En la clínica de TB) me siento protegido aquí, por el medicamento que
me dan. Porque si no, me cuidan mucho, estoy muy contento. (Male, 56)
Here (in the hospital) they discovered all this. Because of the fall (admission) in
the hospital, I didn’t expect that news, but now, what can we do? Here (the TB
clinic), I feel protected because of the medication they give me. Because if not,
they take very good care of me, I’m very happy. (Male 56)
Treatment Experiences and Support Received
Most of the participants received some type of support during their treatment. The
primary types of support (physical or emotional) provided by their family and friends during
treatment included: moral and psychological support, followed by comprehensive support (e.g.
financial, emotional, physical), financial help, and physical support (e.g. transportation, child
care).
(La familia me ayuda) económicamente y… me ayudan con los niños... les daban
de comer, los bañaban, los vestían y los llevaban a la escuela y mi esposo dejo
hasta de trabajar para cuidarme a mí. (Female, 28)
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… economically and they help me with the kids (family)… they fed them, the
bathe them, dress them and take them to school and my husband even stopped
working to take care of me. (Female, 26)
One participant indicated that she did not feel supported during treatment.
…no recibí apoyo de nadie, por eso me agarro la depresión, nadie a nadie le he
dicho de mi enfermedad. (Female, 24)
… I didn’t get support from anyone, that’s why I became depressed, I have not
told anyone, anyone, about my illness. (Female, 24)
Provision of medications was cited as the primary support given by the health care
workers. A small number (4) of participants cited receiving emotional or psychological support.
Todo, lo máximo. El trato que le dan a uno, la manera que le explican las cosas
que viene todo una desorientada la tratan de calmar, ósea no la tratan de hacer
como… sentirla humillada a uno y luego la consienten a uno, la hacen sentir
como si estuvieran como en su familia no vienen y dicen hay no te voy a tocar
porque tiene esto (TB). (Female, 45)
Everything’s the greatest. The treatment that they give one, the way that they
explain things one comes in all disoriented they try to calm you down, that is,
they don’t try to like humiliate you, and then they spoil you, they make you feel
like you are in your family hey come in and they don’t say like I’m not going to
touch you because you have that (TB).
The majority of participants are not offered support services during the TB treatment in
either of the two study locations. Treatment for TB focused almost exclusively on the
administration of the medications, laboratory, X-ray services and medical consults. Of the four
participants who were offered some type of support services, all, with the exception of one,
received a food basket and a referral to the Seguro Popular Program.
Treatment for tuberculosis was perceived as effective by the participants as long as the
person affected by TB adheres to it. The TB treatment is rough, has adverse effects, is lengthy,
causes additional medical complications, tastes awful, may not heal all the physical harm and
could leave scars.
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Most participants received an explanation on how the TB treatment medications work.
The responses ranged from: “I received a pretty good explanation of the medication” to “I
received a ‘little’ explanation” (me dieron poquita explicación). About half of the respondents
indicated that they received an explanation on the side effects of the TB medications, and the
other half did not. Most participants knew about the importance of adhering to treatment in order
to cure the disease.
Participants described their relationship with the TB health care workers as very good or
excellent. Only three participants in Ciudad Juárez received a copy of the Charter of Patient
Rights and Responsibilities in TB treatment. In El Paso, the TB clinic staff does not distribute the
Charter of Rights and Responsibilities; instead they use a Bill of Health which every person
signs at the beginning of treatment. Very few of the respondents recalled what the Bill of Health
consisted of. They only remember signing the form.
El Paso participants reported that their DOT nurse or worker supervised the TB treatment
at either their residence or at the clinic five days a week during the initial phase of treatment (two
months) and then three days a week in the ‘fase de sosten” continuation phase (four months).
The majority of the participants received either a six-to a nine-month treatment for
tuberculosis. Two participants were treated for extra-pulmonary tuberculosis, which requires an
extended treatment (between 9-12 months), and four individuals were treated for MDR-TB,
which requires a 12 to 24 months treatment. Participants are frequently reminded about the
importance of the sputum smear exams to rule out the presence of the TB bacterium.
The perception of the quality of health services received was described as very good to
excellent by the majority of participants in both study locations. A minority of participants rated
the quality as average.
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Haga uno de cuenta que uno está en su casa (servicios de salud), yo al principio
llegaba muy desesperada porque fue un tormento para mi porque principalmente
a mi no me gusta tomar medicina, nunca ni para un dolor de cabeza me gustaba,
tomarme doce pastillas o catorce pastillas, doce pastillas fueron diarias. Aquí me
hicieron sentir bien, me decían…calmadita no se preocupe mire que se le va a
pasar pronto. (Female, 45)
It’s like being at home (health services) in the beginning, I came in very desperate
because it was a torment for me because I didn’t like to take the medicine, never,
not even for a headache so taking 12 pills or 14 pills daily. They made me feel
well here, they would tell me… calm down don’t worry, it will go away soon.
(Female, 45)
Curability, Adherence and Severity of Tuberculosis
Participants knew that tuberculosis was curable and cited taking medication (for TB) as
prescribed by a physician and completing the treatment as the two requirements for cure. A small
number of respondents indicated that even if TB is cured, one can develop the disease again.
Two participants in Juárez abandoned their first TB treatment. One received treatment without
supervision through a public facility and another individual stopped the treatment when feeling
better, which appear to be associated with the limited understanding of how the medication
works and the length of treatment. In addition, two individuals developed MDR, which might be
an indication of incorrect treatment or miss-diagnosis.
Perceptions of the severity of TB indicated that respondents consider TB to be a serious
condition. The importance of completing and adhering to the TB treatment were cited important
in curing TB. Tuberculosis was described by interviewees as “muy grave y peligrosisima” (very
serious and very dangerous). Participants also agreed that tuberculosis was a serious health
condition in their community. The following response describes the severity of the disease.
… como yo estaba pensando de mi niñez…yo pensaba que era algo normal
porque allá en México usualmente si tiene hepatitis, si tienes TB, si tienes alguna
enfermedad contagiosa te dicen tus padres en aquel tiempo… si se te va a
pegar… se te va a pegar así decían los papas se cría uno con la mentalidad esa,
hasta ahora que yo me di cuenta. Ahorita se me hace, hace algo grave, uno tiene
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que tener prevención por los niños...a mí me preocupaba mucho mis nietos.
Gracias a Dios nadie salió contagiado de mi casa, a los trabajadores con los que
yo estuve trabajando se les hicieron pruebas y gracias a Dios no salieron mal.
(Female, 45)
The way I thought in my childhood… I thought it was something normal because
back in México you usually have hepatitis, if you have TB, if you have an
infectious disease, your parents tell you from that time… if you are going to get it,
your parents raise you with that mentality, it isn’t until now I realize it. Now, I
think it is something serious; you have to prevent it because of the children… I
was very concerned because of my grandchildren. Thank God nobody was
infected at my house, the workers with whom I was working were tested, and
thank God they didn’t come out bad. (Female, 45)
Challenges Associated with Access to Treatment and Health Seeking Behaviors
Health-seeking behaviors could have an effect on access and may contribute to treatment
delays. Health seeking behaviors were influenced primarily by the low perception of risk, lack
of information of where to go for treatment, procrastination to seek services (once feeling ill)
until the pain becomes unmanageable, false perception of feeling healthy, fear of rejection, lack
of insurance coverage, financial difficulties, denial, or the lack of transportation.
Muchas de las veces es porque andamos drogados, en la pachanga, por que se
tienen miedo… me explico porque si en realidad si hay personas que no saben la
situación del riesgo que están tomando...sin hacer caso de la TB es bastante
peligrosa…falta de información. (Male, 31)
Many times it’s because we are drugged, partying, because we are afraid… I’m
explaining because I know there are people who don’t know the risk they are
taking… if you don’t pay attention to TB it is very dangerous… there is lack of
information. (Male, 31)

…a veces es el dinero, porque yo me he visto en esas situaciones que a veces no
tengo ni para la ruta para ir o ya ve que va uno y se está ahí uno casi todo el día
y no hay pos para echarse algo de comer… (Female, 28)
Sometimes it’s the money, because I have seen myself in those situations that
sometimes I don’t even have money for the bus to go, and you know you have to
wait her, all day, and there’s like nothing to eat…(Female, 28)
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Cost was identified as a factor why some do not access health services when needed.
Participants in Ciudad Juárez indicated that TB treatment was free of charge at the Centros de
Salud. Participants in El Paso indicated that the TB treatment was free, however X-rays were
not. Some participants said that there was a minimal fee ($5 dollars) for services, and services
were not denied regardless of ability to pay. Three of the participants with MDR-TB indicated
that their medication was (very) expensive (e.g. 240,000 Mexican Currency or $22,000 U.S.
annually). The Mexican National TB Program does not administer MDR-TB treatments. The
participants in Ciudad Juárez receiving MDR-TB medication were doing so under the auspices
of the first state-funded TB Bi-national Project. Two participants indicated that if it was not for
these medications, they would not be in treatment and would most likely die.
The high costs associated with treating TB through a private doctor’s office was
mentioned as a reason why individuals finally decided to go to either a hospital, county clinic or
health center to receive treatment. The primary concerns associated with tuberculosis included
fear of infecting others (e.g. family members, children, and peers), followed by the adverse
effects of the medications, the risk of a TB relapse, rejection by family or friends, and fear of
dying.
…hay que es lo que más me preocupo cuando pienso, pues en que pueda
contagiar a otra persona, en que le pueda dar a un familiar mío, a mis padres,
hay eso es lo que me preocupa, en que no quisiera contagiar a muchísima gente,
muchísima, muchas personas no pues no (Female, 20)
What do I worry most about? Well when I think that I may infect another person
that I may give it to a relative, my parents, that is what I worry about, that I
wouldn’t want to infect a lot of people, many, many people, well, no. (Female,
20)
Participants described class differences in treatment when a person had tuberculosis:
Yo si he visto como a la gente demasiado humilde si ni si quiera lo voltean a ver
(servicios de salud). Me ha tocado que voy al centro de salud y son tan así tan
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discriminativos con la gente más humilde me ha tocado verlo en laboratorio de
salud B (centro de salud), que son muy “fellitos.” (Female, 20)
I have seen that the poorest people they don’t even look at them (health services).
I have been to the health clinic they are so discriminating with the poor people I
have seen it in the lab of the clinic; they are very “ugly.” (Female, 20)

4.3 KNOWLEDGE ABOUT TUBERCULOSIS
Awareness about Tuberculosis
Most participants reported that they heard about tuberculosis for the first time through a
family member.
Si. Yo si había oído de la tuberculosis, por mi papa, mi mama porque ellos lo
tuvieron ó sea si yo tuve el contagio por ellos (Female, 45)
Yes. I had heard about TB, from my father, my mother, because they had it, that
is I had the infection from them. (Female, 45)
Some participants indicated that they heard their parents or grandparents talk about the
severity of the disease when they were growing up. Participants mentioned a couple of the
Spanish terms used to refer to persons affected by TB as “tuberculoso or tisico” and referred to
isolation and fear of infection. These comments were not very different from those expressed by
the participants now. Some of these comments included: avoid contact with a TB patient,
children should not have contact with a person affected with TB, do not share utensils or eat
meal with persons with TB.
…Esta tuberculoso? No pobre hombre, este no se alimenta, no tiene trabajo, su
familia son pobres, etcétera…y luego el rechazo verdad, no te acerques ni… si
comían hasta cuchara…ni la misma familia, verdad. (Male, 68)
…He has tuberculosis, poor man, he doesn’t feed himself, he doesn’t have a job,
his family is poor, etc. and then there is the rejection right, don’t get close and…
even your spoon you used… not even your own family… (Male, 68)
Other participants had not heard about TB until they were diagnosed with the condition.
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La vez que me dijeron que salí positiva (para TB) el doctor lo que me explico fue
la primera vez que yo escuche eso. (Female, 24)
The time that they told me I was positive (for TB), the doctor explained to me,
was the first time I ever heard (about) that.
The second source of TB information was from the community through neighbors and friends.
Hace que unos seis años porque a mi cuñada le dio esa enfermedad, fuimos
nosotros a visitarla y yo casi estoy seguro que me llego (TB) a mi porque no me
acuerdo haber tenido contacto con otra persona así que estuviera y fue cuando oí
que mi cuñada tenia eso. (Male, 49)
About six years ago because my sister-in-law had that illness, we went to visit
her, and I’m almost certain that it got to me because I don’t remember having any
contact with another sick person, and that’s when I heard that my sister-in-law
had that. (Male, 49)
Mass media (television) and health-care settings or clinics were cited as the next most
frequent source of information where they first heard about tuberculosis.
Knowledge about Tuberculosis
A majority of participants had heard ‘something’ about TB before being diagnosed, but
were not aware of the magnitude of the condition until they began treatment. Ten of the
participants had a family member (parent, sibling or other relative) who was treated for
tuberculosis. According to one participant,
Fíjese que muy pocas veces había oído yo de eso (TB), por eso yo no me trataba
de primero cuando me paso a mí eso, no me trataba yo pensaba que era una tos
así de esas de las que hay, pero ya se fue agravando más, más, más ya dure un
mes, ya dure dos meses con la tos y dije ‘ah jijo’ esto no está bueno ya fue
cuando fui con el médico este. (Male, 49)
I heard about that (TB) only a few times, that’s why I didn’t get treatment when I
first happened to me, I didn’t get treatment I thought it was a cough like the ones
that go around, but then it got more serious, more, and more and it lasted a month,
two months with the cough and I said ‘good grief’ this is not good and that’s
when I went to that doctor. (Male, 49)
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Having information about TB did not seem to make a difference in seeking treatment
when they first experienced the symptoms. Most participants did not remember the information
they received about what causes tuberculosis or the way in which the disease is spread. Even
though participants reported symptoms frequently associated with TB, seeking treatment was by
and large delayed until the disease advanced or until it interfered with their work or life style.
The most prevalent signs and symptoms associated with tuberculosis mentioned included: cough,
cough with blood, and cough with phlegm, loss of weight, fever, constant fatigue, and chronic
pains in muscles, nausea or vomiting.
Transmission of Tuberculosis Bacterium
Multiple ways of getting tuberculosis were cited: One can get TB through the air when
someone coughs or sneezes, by sharing meals and utensils with someone who has TB, by having
physical contact with person with TB (handshake, kissing, or touching the person) or through
sexual intercourse.
Cuando se comparten los alimentos, se usa el mismo plato o por
relaciones sexuales, es una enfermedad que realmente se desarrolla en el
cuerpo y luego sale… (Male, 29)
When you share food, you use the same plate and through sexual relations,
it’s an illness that develops in the body and then comes out… (Male, 29)

Puede ser por el contacto con la saliva, besar a una persona o dormir
con ella con su mismo sudor o algo o hacer el amor, el sexo o como se le
llame puede ser que eso si se le contagie. (Male, 45)
It can be through contact with saliva, to kiss a person or to sleep with her
with her perspiration or something or through lovemaking, sex or however
you call it that can transmit it. (Male, 45)
Environmental factors like crowded places, door handles, and funerals, using the same
tissue or towel from a person with TB were cited by half of the participants as ways of
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contracting tuberculosis. One participant believed that the disease can be inherited. Only a few of
the participants mentioned that tuberculosis is caused by bacteria. A small number of participants
believed that excesses in their life style (heavy smoking, excessive work, lack of rest, poor
health, alcoholism and drug use, or bad nutrition) could cause the disease.
The primary ways to prevent infection include covering the mouth and nose when
coughing or sneezing (9); avoiding sharing meals (6); avoiding all type of physical contact with a
person with TB or suspected of having TB (6), staying in good physical shape and eating
healthy.
Venues for Seeking Health Information and other Resources
Participants cited mass media (television) as the primary source of health information,
followed by brochures or other printed materials, health-care settings (health workers), the
internet and the family. The most trusted sources of health information were television followed
by the health-care workers, and then the internet. After looking at a list given them, participants
identified tuberculosis information available to the community. Health workers and printed
educational materials were identified as the two primary sources of TB information followed by
television, and then the family. Minimal responses were cited for friends, the radio, at school, or
through the internet. Billboards, religious leaders, neighbors, newspapers or magazines were not
cited. Television was cited as the most effective mechanism of presenting TB information to the
general public, followed by health workers, printed materials and then the internet.
The least effective means of informing the general public included: family members,
neighbors, religious leaders, and teachers. Other forms of communication identified as effective
included the delivery of health information at work settings, presentations in schools and
advertisements in public buses. The majority of participants felt informed about tuberculosis, the
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symptoms and the treatment. The majority of participants received information about TB and
also welcomed additional information about the types of tuberculosis and the side effects of the
medications.

4.4 ATTITUDES TUBERCULOSIS AND STIGMA
Vulnerabilities and Tuberculosis
The perceptions were mixed on how vulnerable and susceptible people were to get TB.
Responses on who could get TB included: anyone (18), only drug users and alcoholics (11),
persons with other health conditions like diabetes or malnourishment (14), persons living with
HIV/AIDS (4), children and seniors.
Pues una persona que este diabética es la más facilita para que se le pegue, una
persona que tenga enfermedades que tenga bajas defensas de volada la pesca
porque esa se va a través del virus que avienta uno en la saliva cuando habla
uno, cuando tose. (Male, 49)
A person who is diabetic is the easiest to become infected, a person who has low
defenses quickly catches it because that goes out through the virus that is thrown
out in the saliva when you talk, when you cough. (Male, 49)
The perception of risk of getting infected with TB before their diagnosis was low.
Reasons cited included: did not think that tuberculosis exists (a disease of the past), had no
chronic cough, felt healthy, received the vaccine (BCG) in México as a child, and TB is a disease
of the poor, homeless, or malnourished.
Porque no andaba en lugares donde probablemente y la cosa es que como la TB
lo que se ha visto ahora es lo que le digo a mi esposo… pues si le digo ya ves…
hasta la gente decente le puede pasar esto no, no más a los pobres, los que viven
en lugares feos le digo. Yo en mi casa la mantengo limpia pero este de todas
maneras vino el TB, yo no andaba así como en cantinas. (Female, 34)
Because I went around places where probably… and the thing is that TB what we
have seen now is what I tell me husband… I tell him, you see… it can happen
even to decent people, not only poor people, the ones who come from ugly places
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I tell him, I keep my house clean but TB came anyway, and I wasn’t like in bars.
(Female, 34)
Six participants’ perceived risks associated with exposure or caring for a person with TB,
excesses of alcohol or illicit drugs, diabetes or HIV/AIDS.
Reactions when Diagnosed with Tuberculosis
Reactions people had when diagnosed ranged with tuberculosis range from depression,
sadness (over what would happen to them); doubt (about getting cured), anger (over how they
were infected), and fear of rejection (spouse, family, peers and losing job). Some participants
tried to hide the TB diagnosis from other persons (not their family). Some participants felt hurt
when they were asked to sleep separately from their family during the illness. Others could not
hold, hug or kiss their children. Some participants’ lost earnings during their treatment and two
lost their jobs. They were told they could no longer work because of their condition and the risk
of infecting others.
… horrible, llore, llore y llore hasta que me canse. Me deprimí mucho no paraba
todos los días lloraba… el doctor era el que me daba ánimos era el único. Llorar
y llorar y a mis hijos pos no ni los a tocaba, trataba de decirles no me beses hasta
que el doctor me explico todo pos ya empecé a desarrollar mi vida igual que
antes. (Female, 28)
… horrible, I cried and cried and cried until I could not cry anymore. I was very
depressed and I didn’t stop every day from crying… the doctor was the only one
who encouraged me, he was the only one. Crying and crying, and I didn’t touch
my kids, I tried to tell them don’t kiss me until the doctor explained to me, and I
started living my life like before.
A Family Member or Acquaintance Shows Signs of Tuberculosis
Participants indicated that if a family member or acquaintance showed signs of TB they
would: help the person get medical services, recommend that they go to a health center or TB
Program, encourage them to get a phlegm exam, take them to the doctor themselves if they had
the means, or use their personal story with TB as a way to encourage them to seek care promptly.
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… yo lo llevaría ahí al centro de salud con mi doctor a que le hiciera una prueba.
Traerlo a la clínica, ya hice a dos de mis hermanos venir, tres de mis sobrinos
salieron positivos. Es una familia como le digo allá en México es una ignorancia
porque ya están muertos mis padres. (Female, 45)
Bring him to the clinic, I already made two of my siblings come, three of my
nephews came out positive. It’s a family like I tell you in México the ignorance
because my parents are dead. (Female, 45)
Attitudes toward Stigma and Discrimination Related to Tuberculosis
Attitudes about stigma and discrimination were explored by posing a series of openended questions followed by the administration of two validated sub scales consisting of 23
items. The participants answered questions in regard to the way that a person with tuberculosis is
treated. Questions related to the way people with HIV/AIDS were treated were also included,
since HIV/AIDS, as well as other conditions, are related to stigma and discrimination.
Stigma has to do with negative attitudes that a person has toward another person, as well
as how a person affected with a condition or disease such as tuberculosis or HIV/AIDS feels
about himself (sense of inferiority; pointed out, labeled, marked or judged for having TB or any
other disease). Persons being stigmatized often experience discrimination or are treated
differently (in a negative or diminishing way), and their human rights are violated.
A majority of the subjects indicated that a person with TB experiences rejection and is
feared as a source of infection. Respondents indicated that the social environment reacts
negatively, especially when others fear that they could get infected. A selection of statements is
included to elucidate how the participants responded to the open-ended questions. The majority
of the participants (22) agreed that a person with tuberculosis is often treated by others
differently, only a few of the interviewees (8) indicated that the society treats them normally or
without stigmatization. The differences in treatment include: perceived rejection by family
and/or society members (22) and fear of getting infected with TB (9). A number of participants
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indicated that a TB diagnosis carries social stigma. This triggers distress and can contribute to
delays in access to treatment.
Bueno uno mismo piensa que le da uno asco a la otra persona, porque se supone
que esta tuberculosa puede contagiar, no quiere uno ni hablar porque lo que sale
de la boca o de la nariz…uno le da asco a la gente… (Female, 60)
You yourself think that you repulse other people because if you have TB, you can
infect others, you don’t want to even talk because the breath comes out of the
mouth and the nose… you yourself feel you’re repulsive to others… (Female, 60)

… por el lado de la gente que no sabe nada de eso (TB) pues el trato es muy mal,
o sea como que tienen miedo, como si fueran enfermos del VIH también o sea se
retiran de las personas y creen que por con un saludo de manos o cualquier cosa
se le va contagiar. (Female, 28)
… people who don’t know anything about it (TB), well, the treatment is bad, they
are like afraid, like they were sick with HIV also they don’t want to have anything
to do with people because they think that with a handshake or some other thing
they are going to be infected. (Female, 28)
The stigmatization of TB and HIV/AIDS seemed to continue to be associated with beliefs
that TB is linked primarily with poverty, homeless, and addiction. The correlation of having TB
with being dirty or filthy and the belief that TB is transmitted through casual and physical
contact were cited as reasons why stigma continue to be so real.
Pues hasta ahorita los doctores me han tratado bien no me han rechazado todo
está bien pero la gente de fuera si te rechaza mucho… te discriminan. Pues la
sociedad… ya no es igual, no es lo mismo es muy feo, el rechazo, que te
discriminen, que no te quieran saludar que no, creen que se les va pegar eso es lo
más triste. (Male, 45)
Until now the doctors have treated me very well, they have not rejected me;
everything is OK but outside the people reject you a lot… they discriminate, they
don’t want to greet you, they think you are going to infect them; that’s very sad.
(Male, 45)

The majority of the participants (28) perceived experiences with stigmatization related to
tuberculosis. Stigmatization was described in terms of discrimination from family (distancing),
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peers (afraid of visiting for fear of contagion), and work (losing job or feeling discriminated
against); isolation from loved ones (especially children and spouse); rejection by family
members; perception that a person with TB is filthy or disgusting; and by the fear of infecting
others.
Si yo digo que si (hay estigma) todavía, yo digo que es por falta de información
hacia las personas por ejemplo en el hospital no sabemos bien las enfermeras de
cómo la TB se trata, ó sea falta mucha información hacia la comunidad, hacia
las personas porque ya ve todo el mundo te señala como, hay tienes una
enfermedad que ya no se cura ellos piensan así. (Female, 20)
I say there is stigma still, I say it’s because of lack of information, for example at
the hospital we don’t really know how TB is treated, there is a lack of information
in the community, toward the people, you see everyone points to you that you
have an incurable disease, they think like that.
Perceptions of Stigmatization Associated with HIV/AIDS
Perceptions of stigma associated with HIV/AIDS were identified. Participants reported
that having HIV/AIDS carries stigmatization and were expressed through fear of physical contact
with a person living with HIV/AIDS because of the fear of getting infected. These perceptions
were founded on beliefs on how HIV/AIDS is transmitted and on the prejudice and
discrimination against persons living with HIV/AIDS.
A ellos (VIH/SIDA) es más. Porque mucha gente cree que nomás con tocarlos ya
se van a contagiar, con estar cerca de ellos. Me gustaría que hubiera más
educación para uno. Al principio (de la epidemia de VIH) dieron información en
las escuelas. Yo llegue a ir a grupos en donde le explicaban a uno con más
detalles, ponían películas. Ya últimamente no he oído de eso porque vamos a ver
qué avanzo la medicina, ya se quito esto, ya ahora está el Internet. Hay mucha
gente que todavía lo discrimina a uno. (Female, 45)
For those with HIV/AIDS, it’s more. Because many people think that by just
touching them they are going to be infected, just by being close. I would like for
there to be more education for us. At the beginning of the HIV epidemic, they
gave out information in the schools. I went to some groups where they explained
the details, they had movies. Lately I haven’t heard of that, we are going to see
that advancement of medicine that this has stopped, there is now the internet, and
there are a lot of people who still discriminate against us. (Female, 45)
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Almost half of the participants perceived that having tuberculosis had the same stigma as
having HIV/AIDS because both diseases were serious and contagious, and in both conditions,
the persons affected were more likely to be rejected by the family and society. Participants also
indicated that both diseases were diverse, and so was the stigmatization, but not the source of the
stigma. For example, they stated that TB was curable if treated early, and HIV/AIDS was not;
tuberculosis was an external disease one gets through germs in the air, while HIV/AIDS was
primarily acquired through sexual intercourse, and no other sources of transmission were cited.
Participants reported that there was more prejudice and biases against persons living with
HIV/AIDS than those living with TB.
Experiences Associated with Stigma and Discrimination Related to Tuberculosis
Most participants indicated that a person with tuberculosis was treated differently and
negatively by others. According to the participants, a diagnosis of TB carried a negative
connotation. The negative connotation was associated with social stigma (how others see you).
More than half of the respondents indicated that they experienced rejection by others founded on
lack of understanding of the nature of the disease (transmission and cure) or felt isolated during
treatment.
More than half of the participants reported feeling useless. They also indicated that as a
result of having tuberculosis, they felt rejection or lack of understanding from others. Some
participants indicated that they became sad, depressed, humiliated or angry.
…Pues sí, una vez ahí en el Seguro (Servicio médico)…. en cuanto llegue y me
dijeron tiene TB me dijeron y ponte ese cubre bocas órale porque traes síntomas
de TB y “avientas” a la gente que estamos aquí. Si, de volada lo rechazan a uno.
(Male, 49)
… yes, once at the health clinic, they immediately as soon as I arrived they said
you have TB. They told me put on this face mask, because you have symptoms of
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TB, and you “throw” here for us people who are here. Yes, immediately they
reject you. (Male, 49)

… me agarro de llorar la depresión de llorar y de sobreproteger a mis hijos de mi
misma, pues no tomaba en los vasos de ellos, me les retiraba lo más que podía,
estaban viendo la tele ellos, yo no iba nunca y me acostaba a un lado de ellos,
por medio a hablarles en la cara o así, ni me dormía con ellos los primeros días
que yo obtuve la información, ni me dormía con ellos. (Female, 24)
… I started crying from the depression, crying and overprotecting my kids from
myself. I didn’t drink in the same cups, I withdrew as much as I could, I was
watching TV with them, I never went to bed with them for fear of speaking to
them in their face, the first days after I got the information… I didn’t sleep with
them. (Female, 24)
Some of the participants received support from their spouse or a family member, and they
did not report a much distress as those who felt little or no support during their treatment. Most
participants received some type of support from family members through their illness.
Con impotencia...me sentí humillada. Se siente uno pues mal, llora, con tristeza.
Tuve coraje y luego le dije al señor (jefe) porque me va hacer eso (correrme del
trabajo), me dio rabia perder mi trabajo por estar enferma (TB). (Female, 45)
… Impotent…I felt humiliated. You feel bad, you cry, with sadness. I had
courage and I told the man (boss) why are you going to do this to me (firing me)?
I was angry. I lost my job because I was sick with TB. (Female, 45)

Yo me he sentido menos. Hay veces que uno mismo se hace ese estigma. Uno se
siente mal. A mí no me gusta estar con mucha gente, yo me he apartado mucho de
la gente, me siento más a gusto cuando estoy solo, a parte también como estoy
verdad todavía no me acostumbro en si estar en una silla (ruedas). (Male, 22)
I have felt less of myself. Sometimes you stigmatize yourself. One feels bad. I
don’t like being with a lot of people, I feel better when I’m by myself, besides. I
haven’t gotten used to being like this in the chair (wheelchair). (Male, 22)
Some participants indicated that during the time they were isolated or in quarantine, they
felt lonely. They had few or no visitors, and the special measures taken to avoid contamination
were difficult to live with, especially when they were asked to wear a face mask. Terms used in
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Spanish to describe the face mask include la mascara, el bosal, el tapaboca, esa cosa.
Children and grandchildren were instructed to avoid contact with a person affected by
TB, utensils were frequently kept separate and sometimes spouses or family members were
asked to sleep in separate rooms. The physical and emotional demarcation of space seems
challenging, especially when physical living conditions are limited by financial distress. This
makes the distancing and separation very difficult.
A number of participants indicated that stigmatization toward persons with TB also takes
place through discrimination or rejection (primarily by family members), by labeling the person
(referring to the person as disgusting, filthy) or through fear (of infection or getting infected or
infecting others).
Pues que no se quiere arrimar a la demás gente. Como que no quieren saludar a
uno de mano. Te miran diferente, por decir piensan que se va a pegar así nomás.
Una prima anteayer llego a la casa, y no la miraba, y “que hubo” y así me
abrazo, y empezó a platicar y ya cuando se despidió y “ándele pues prima” y se
me retiro, y pues “Ándele que le vaya bien” yo se por que se retiro... eso lo hace
sentir muy mal a uno… (Male, 56)
You don’t want to get near other people. They like don’t want to give you a
handshake. They look at you differently; they think they are just going to get it
like that. A cousin day before yesterday came to the house, I hadn’t seen her and
she was like ‘Hi’ and she hugged me and started talking and when she was
leaving she said like bye but didn’t get close and so I said OK bye, I know why
she didn’t want to get close… it makes you feel very bad… (Male, 56)
One participant stated that her children were discriminated against by the school principal.
…No querían que llevara a mis hijos a la escuela porque…o sea yo me enferme
(TB) y ya no puede llevar a mis hijos a la escuela y mi esposo pos por cuidarme a
mí, no trabajo perdió el trabajo y ya ve se vino la rachita que no va a haber
trabajo en ningún lado pos horita de hecho está desempleado porque fue el lunes
y no le dieron trabajo, fue ayer y tampoco y ya le comente yo que ahora hay que
ir hoy a la escuela por las niñas y yo de hecho camino pero ya no puedo muy
bien…bueno la directora, no quería que mis hijas fueran a la escuela… el doctor
de hecho le mando un papel escrito a la directora de que ellos no estaban
contagiadas (TB), solamente así me las recibió con papel del doctor….(Female,
28)
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They didn’t want me to take my children to school because I got sick… with TB
and I couldn’t take my children to school and my husband because he was caring
for me, he didn’t go to work and lost his job and then this wave hit us that there
wasn’t work anywhere in fact he’s unemployed right now because he went on
Monday and they didn’t give him work, and he went yesterday and it happened
also and I told him that we have to go pick up the girls at school and I can’t walk
very well now… well the principal, she didn’t want my daughters to go to
school… the doctor sent a note to the principal that they didn’t have TB, that was
the only way she would take them, with the doctor’s note. (Female, 28)
The majority of respondents did not know another person with TB who had been
stigmatized or discriminated against because of their condition.
Negative Impacts of Stigma related to Tuberculosis
Traditionally, stigma related to tuberculosis and HIV/AIDS has been associated with
negative impacts and outcomes (Van Rie et al., 2008; Liefooghe et al., 1997; Armijos et al.,
2008). The present research was directed at identifying and describing both negative and positive
impacts associated with stigma, if any. Interviewers indicated that most respondents, and
especially participants with limited schooling, had more difficulty understanding the questions
on negative and positive impacts of tuberculosis, as well as HIV/AIDS related stigma. The
research team decided to reword these two questions to facilitate comprehension.
Respondents identified the following negative impacts of stigma related to tuberculosis:
(1) low self-esteem and morale, (2) depression and sadness, (3) fear of casual transmission, (4)
shame and guilt, and 5) negative emotions and feelings toward a person affected with TB.
The negative effects of stigma related to HIV/AIDS include: (1) rejection, (2) low selfesteem, and (3) depression. Among the determinants of stigma associated with HIV/AIDS (as
well as TB) is the general public’s perceived fear of infection through casual contact. Even
though there were clear differences in how TB and HIV/AIDS are transmitted, there continues to
be a perception that a person affected with either TB or HIV/AIDS is a disease vector as stated
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by Kelly, (1999). The perception of moral judgment and biases seem to be stronger for persons
living with HIV/AIDS than TB, perhaps because of the sexual nature of HIV transmission.
However, moralism seems to play a strong role in TB stigma as well.
The dimension of disclosure was important for both TB and HIV/AIDS. Several of the
participants were cautious about whom they disclosed their condition to for fear of being rejected
or judged. Disclosure of condition was primarily done with immediate family members or very
close friends. Several participants stated accurate information about tuberculosis as well as
HIV/AIDS was lacking, especially about how these diseases were transmitted. Participants
indicated that lack of information leads to prejudice and fear, and that it was not uncommon for
uninformed persons to make quick judgments and emit prejudices against people affected with
TB or HIV/AIDS. Near unanimously, interviewees stressed the importance of informing and
educating the general public and their families about these conditions in order to dispel myths
and fears.
Positive Impacts of Stigma Related to Tuberculosis and HIV/AIDS
Most said that a disease like tuberculosis hurts both physically and emotionally, however,
overcoming the disease and the social stigma could help the persons affected to think positively
about life and how to care for one’s health. It had not been easy for any of the participants to live
with tuberculosis; however, several of the respondents indicated that they became “stronger”
emotionally as a result of the TB. Paradoxically, the use of the words “stronger” and “more
positive” were cited by participants when asked about the positive impacts of their condition.
Some of the participants indicated that they are more appreciative of their health and their
families as a result of the condition. A participant who acknowledged that she used to stigmatize
people with TB and HIV in her workplace also stated that she learned to stop making judgments
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and stigmatizing others as a result of her condition.
… yo también era así...señalaba a las personas con TB… les decía, hay tiene TB!,
los señalaba…, entonces al momento de saber que yo tenía TB pues me hizo
sentir muy mal, la falta de información me hizo sentir así. Es muy importante
informarme, más que nada porque yo soy personal de salud, entonces yo hacía lo
mismo con las personas de TB… (Female, 20)
... I was also like that… I pointed out people with TB… I would say you have TB;
I pointed them out… so the moment I found out that I had TB, well, I felt really
bad. The lack of information made me feel like that. It’s very important to be
informed. More than anything because I am a health care professional; I did the
same thing to people with TB… (Female, 20)
Several of the participants indicated that the family members grew closer to each other
while with others this was the opposite.
Pues yo no me he vencido, trato de ser buen ejemplo para los demás, mi fe me
ayuda a levantarme y no dejarme vencerme por la tuberculosis y las otras
enfermedades... (Male, 96)
I have not given up, I try to be a good example to others, and my faith helps to lift
me up and to not be defeated by tuberculosis and the other illnesses. (Male, 96)

Las puede hacer fuerte como persona y salir adelante. No estar en depresión por
algo tan simple porque realmente... por ejemplo el VIH es algo muy feo. Es una
enfermedad muy, muy, fea no es como la TB. (Female, 24)
It can make you strong as a person and to get ahead. Not to be in depression
because of something so simple because really… HIV is something really ugly.
It’s a very, very ugly disease, not like TB. (Female, 24)
The majority of the participants had a positive experience with their health workers and
spoke favorably of the services and treatment “trato” they received and indicated that they
would recommend the services to other people.
Uno puede decir, esta enfermedad (TB) no va a vencerme tengo que salir
adelante, no me voy a dejar morir tengo que trabajar, tengo hijos y esto no me va
a matar ó sea yo no lo pensé de esa manera pero si hay personas que si están
solas, totalmente solas, se pueden sentir como amarradas. (Female, 45)
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You can say, this disease (TB) will not defeat me I have to go forward, I’m not
going to let it kill me, I have to work, I have kids and this is not going to kill
me...I didn’t think of it like that but there are people who are alone, totally alone,
they can feel like they are bound up. (Female, 45)

Pues a mí me han hecho muchas veces, porque… mucha gente me hace, me hacía
sentir menos pero porque creían que yo no era capaz de salir adelante… y eso a
mí me aferraba a echarle más ganas y demostrarle a la gente que si puedo.(Male,
24)
They have done it to me many times because many people make me, made me
feel less but because they thought I was not able to go forward… and that made
me give it my all to demonstrate to people that I can. (Male, 24)
Five participants indicated that there is nothing positive about the experience of having
tuberculosis or feeling stigmatized. In terms of the perceived positive impacts associated with
HIV/AIDS, the majority of respondents offered similar perspectives. Participants indicated that a
person who accepts and lives with HIV/AIDS can become stronger both emotionally and
physically, develop self-esteem, and adhere better to medical treatment. Three participants
indicated that they see nothing positive about stigma and HIV/AIDS. In addition, three
interviewees had difficulty comprehending the question and did not answer.
En que me ayudo la TB? en nada me ayudado, no ha habido nada bueno…
(Female, 20)
What did TB help me with? It has not helped me with anything; there has not
been anything good… (Female, 20)
Mitigating Stigma and Discrimination toward Persons Affected with Tuberculosis
To mitigate stigma and discrimination associated with TB, we asked participants what
could be done by health workers, family (immediate and extended), members of the society
(schools, church, work, community, etc.) and by the person affected with TB (PATB). The
responses are summarized by each sub population. The following situations were identified as
discriminatory and unfair by the participants: being treated unjustly at work, losing one’s job,
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being rejected by family, being pointed out in school or not receiving services as a result of the
health condition primarily based on fear of infection.
Health Care Workers
There was consensus that the primary responsibility that health care workers have was to
treat the person affected by TB with dignity and to offer concise information on causes,
treatment, adverse effects of medication, and the dangers of interrupting treatment, transmission,
and prevention of tuberculosis. Participants indicated that if information on TB was given to the
patient, the family, and the community at large through mass media and presentations, TB could
stop being viewed as negative and perhaps people could stop being afraid of the person with TB.
Every respondent identified the distribution and dissemination of accurate information as the
number one effort that health workers can make to eliminate the stigma associated with TB.
Pues eso lo que está haciendo ahorita (personal de salud) yo digo ellos están
preparados para ser esto. Mucha gente no está preparada. Yo me siento con mi
enfermera, como le explico… no le acabo de pagar lo que ha hecho por mi yo me
siento más que satisfecha más que contenta con mi enfermeros me han dado
mucha vida. (Female, 45)
Well, what you’re doing now (health care workers) I say they are prepared
(trained) for that. Many people are not prepared. Like I say, I sit down with my
nurse… I can’t repay what she has done for me. I feel very satisfied, very pleased
with my nurses. They have given me a lot of life. (Female, 45)
In addition, providing emotional and psychological support or services was identified as
an important strategy to help persons affected with TB and their families overcome the
negativity, rejection and isolation associated with the condition.
Pues poner atención a los clientes o pacientes. Yo se que los doctores saben
muchos y las enfermeras pero, si el paciente te va decir lo que está sintiendo
especialmente si tiene dolor si tiene este, perdida, de apetito, o si no están
comiendo si uno está viendo físicamente como esta esa persona tener un poco de
atención no ignorarlo así como lo hizo ese doctor. (Female, 24)
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Well to pay attention to the clients or patients. I know that the doctors know a lot
and the nurses but, if the patient is going to tell you what he’s feeling especially if
he has pain, loss of appetite, if they are not eating if you are seeing that that
physically how they are to pay more attention, don’t ignore him like that doctor
did. (Female, 24)
Ensuring privacy and confidentially when delivering medical care was identified as an
important action. Treating persons with respect and dignity regardless of who they are and
whether they have the means or not to pay for services was alluded to in several occasions as
important in mitigating both stigma and discrimination.
…yo pienso…lo que hacen ahorita pues está bien…porque no andan diciendo esa
tiene tuberculosis o… algo. Lo tienen a uno como guardado, eso es confidencial.
Que le dan consejos, le explican la enfermedad, le explican el tratamiento y lo
que uno puede hacer para no contagiar a la gente con la que vive, con la que
esta, con la que platica. (Female, 52)
… I think…. What they do right now is OK… because they don’t go around
saying that one has tuberculosis or something. They like put oneaway, that’s
confidential. They give you advice, they explain the disease, they explain the
treatment and what you can do to not infect the people you live with, the ones
you’re with, with who, you talk. (Female, 52)
The provision of confidential services, accurate information and orientation to patients
and families about the disease, was noted as one of the most important actions that healthcare
workers can take to mitigate discrimination. Participants indicated that no person should be
treated unfairly.
No dar diferente trato a las personas con TB. A veces se les va y si dicen a ver las
que tienen TB de este lado y las que no pues, a veces nos hacen sentir mal… en la
sala de espera… (Female, 20)
Don’t treat people with TB differently. Sometimes they make mistakes, and they
say people with TB on this side. Sometimes they make us feel bad in the waiting
room... (Female, 20)
Psychological counseling or support services should be provided. Participants felt that
once a person was discriminated by health personnel, there was nothing that could be done.
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Family Members
The single most important thing that families could do was to be informed about
tuberculosis, its forms of transmission, prevention, treatment and cure. In addition, family
members could offer moral support to the person affected with TB, be patient with the person
who is ill, and learn how to think more positive about the disease. In addition, family members
should avoid rejecting and treating differently (negatively) the person affected with TB because
of their health condition.
La familia puede dejar de tener asco y no rechazar. Como me digo mi hija no te
apures pues si nos da esta enfermedad pues ni modo, vamos y el doctor y estando
ahí nos componemos y si no, dios quiere pues nos morimos. Dijo no te apures por
eso, es una aliento muy grande, pues fíjese quien es mi hija, si fuera otra pues a
lo mejor no, a mis nietas yo no les dije y ni mi hija tampoco porque no sabíamos
como reaccionaban ellas. Y me cuidaba de no decirles, ni comer en los (mismos)
trastes pero nunca preguntaron abuelita porque se aparta de los trastes o algo,
no yo nunca me aparto o a lo mejor mi hija les dijo algo por eso no dijeron nada,
yo no sé… (Female, 54)
The family can stop being disgusted and not reject me. Like my daughter told me
don’t worry if we get the disease, we’ll go to the doctor, and there we will get
better and if God doesn’t permit, well, we will die. She said don’t worry about
that. That is a great encouragement, because she is my daughter. If it was
someone else, perhaps they wouldn’t say that. I didn’t tell my grandkids and not
even my daughter because I didn’t know how they would react. I was careful not
to tell them, and not to eat in the same dishes, but they never asked grandmother
why you separate the dishes. No I don’t separate myself, maybe my daughter said
something and that’s why they don’t say anything, I don’t know… (Female, 54)
Family members should be accepting of the persons with TB and avoid isolating them or
making them feel guilty. Family members need to be informed about the disease and provide
moral and emotional support or be referred to receive these services if needed.
Que las familias apoyen, que no anden diciendo como me dijeron a mi esposa, tú
no puedes andar durmiendo con él es mejor que te vayas retirando de
él…retíratele, déjalo a él y vente pa’ ‘ca con tus hijos que te va pegar la
enfermedad y yo estoy muy asustada, yo estuve escuchando todo por teléfono.
Uno se siente muy mal, la familia lo debe de apoyar a uno… (Male, 38)
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That the families support you, that they don’t say what they told my wife, you
can’t sleep with him, its better if you separate from him… separate, leave him and
come here with your children. He’s going to give you the disease, and I am very
scared, I was listening to everything over the phone. You feel very bad. Family
should support you… (Male, 38)
Members of Society
Being educated and informed about tuberculosis was cited as the primary action that
members of society could do to stop stigmatizing the disease and the person affected by it.
Avoiding rejection, overcoming fear through education and dispelling the unfounded beliefs
were identified as critical actions that members of the society could undertake to mitigate
rejection and discrimination against persons with tuberculosis.
Esa gente si necesita más educación, porque mi jefe como le dije, me rechazo
porque de aquí iban a explicarle a ver cómo era mi enfermedad y que era lo que
me estaba pasando y ellos se negaron. Ellos no quisieron hablar no más
escucharon lo que yo les dije tengo tuberculosas y me discriminaron. (Female,
45)
Those people do need more education. Like I told you, my boss did reject me
because they wanted (the clinic) to go and explain my disease and what was
happening to me and they denied them access. They didn’t want to talk. They just
heard what I told them I have tuberculosis and they discriminated against me.
(Female, 45)
Me gustaría que para que la gente no se sienta así como, como que tiene roña.
Que hubiera más anuncios en vez de estar anunciando las cajetillas de cigarro y
las cervezas. Que pusieran más cosas (información) en la televisión y en el radio
o sea en póster o que no crean la gente que ya no más porque se enferman y ya se
acabo el mundo. (Female, 45)

I would like that for people to not feel like that, like you have “roña” (a skin
infection like scabies). That there would be more announcements rather than
announce the cigarette packs and beer. That they put more things (information) on
TV and radio in posters so that people don’t believe that just because they get sick
and that’s the end. (Female, 45)
A number of respondents felt members of society could do nothing to eliminate
discrimination.
133

Eso de la discriminación es muy difícil, no hay nada que uno pueda hacer… A mí,
me han dicho no, retírate tienes porque tienes tuberculosis, y uno se siente muy
mal. Ahi no se puede hacer más que retirarse. (Male, 56)
Discrimination is very difficult; there’s nothing you can do… they have told me
no, go away because you have tuberculosis, and you feel very bad. You can’t do
anything but step away. (Male, 56)

Lo único que yo hago es no presentarme junto a la gente que me discrimina o sea
darle la vuelta porque ya sé que me van hacer de menos. (Male, 49)
The only thing I do is to go up to the people who discriminate against me; I just
avoid them because I know they will make me less. (Male, 49)
Persons Affected with Tuberculosis
The three most important actions that persons affected by tuberculosis could do to
eliminate stigma and discrimination were to take and adhere to treatment, get cured, and avoid
exposing others to the disease. In addition, the person could help the family and other members
of society be informed about the condition and dispel myths in order to stop feelings of being
marked or singled out as a result of the TB. In addition, seeking emotional support when needed
was frequently mentioned.
Pues yo hice muchas cosas cuando me dijeron que tenía TB, a lo mejor no están
muy bien pero como le dije, sé que tengo derechos… A principios si me sentía
muy mal pero, a mi me decían – no puedes ir a esta parte- yo me ponía mi
mascarita como le digo, yo me salía pa’ juera a caminar, a mi patio, a ver mis
plantas, me trataba y me aliviaba yo sola Hay que hacer cosas manuales, pintar,
escribir, leer un libro, educarse más en esto de, de la enfermedad, que la gente
sepa que no se acaba el mundo por estas enfermedades. (Female, 45)
I did a lot of things when they told me I had tuberculosis, maybe they are not OK,
but like I said, I know I have rights… in the beginning, I did feel very bad; they
told me, go here, I didn’t wear my face mask, like I said, I would go out walking,
to my patio, to look at my plants. I treated and healed myself. I would do manual
things like painting, writing, and reading, educating myself to know more about
the disease, and letting people know that the world will not end because of those
illnesses. (Female, 45)
Using a personal story, encouraging persons at risk to get tested for TB, talking with
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persons affected by TB, and encouraging them to complete treatment were identified as actions
to help mitigate discrimination. Also noted were avoiding being discriminatory toward others,
and not making judgments about people. A small number of participants indicated that there was
nothing that could be done to eliminate discrimination.
Overall, participants were unable to verbalize the change they would like, and their
feelings of “guilt” led them to conclude that maybe they deserved being stigmatized, and some
were even clear on having internalized stigma. While personal responsibility was emphasized in
present day society that is highly individualistic, this approach has come at a loss of any answers
related to combating stigma.
The results presented in this chapter will provide data to make evident the potential
impact of advocacy, communication and social mobilization activities. These activities have
resulted in more effective use by TB programs and health-care workers with limited resources to
increase access and utilization of health services, and to attain the mitigation of TB-related social
stigma and discrimination. When participants were asked to suggest changes that could help
overcome the stigma and discrimination, they found themselves at a loss to envision changes
beyond a certain “wishful thinking.” Indeed, they ended up “wishing” discrimination would stop
but could not think of any specific actions that could be implemented. For some, there was
nothing they could think that could be done.
Because much of the focus of studies related to stigma revolved around social and
cognitive aspects, the result has been that the proposed actions to overcome stigma focused on
the changes that an individual must undergo to overcome stigma. This approach has led to
further “blame the victim” by leaving it up to the individuals affected to solve their own
situation. In order to move beyond this approach, an analysis of what the social and structural
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conditions leading to stigmatization of individuals is necessary. Through an analysis of the social
and economic factors in which stigmatized individuals live, stigma can be understood as a
designation given to individuals rather than stigma being within the person. The important aspect
of this is that it would be conducive to look at stigma as a process rather than a “thing” as such.
This focus acknowledges that stigma is not naturally occurring, but something created by people
and as such, it can be “un-done” by those same people as part of a society.
The value of these interviews lies in their ability to demonstrate that the old
representations of tuberculosis no longer apply, even though the ideas behind them are still
present in how society views people with tuberculosis. The old labels are described in every
interview conducted and were cited as the source of the stigma and discrimination associated
with the disease.
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CHAPTER 5
PERSPECTIVES OF PERSONS AFFECTED BY TUBERCULOSIS WHO
PARTICIPATED IN THE PHOTOVOICE INTERVENTION IN
CIUDAD JUÁREZ, MÉXICO, AND EL PASO, TEXAS
INTRODUCTION
The voices, experiences and perceptions of persons affected by tuberculosis and the
stigma related to TB and HIV have not been as well documented. The findings in this chapter
are the qualitative data collected to help programs and health-care providers understand personcentered approaches and enhance or even replace disease-centered care. This chapter presents a
qualitative analysis of ten interviews that were conducted with an interview guide developed in
English and Spanish by the investigator, which contained closed and open-ended questions. Most
questions elicited open-ended responses. The analysis is qualitative and ethnographic. In the
following sections, an analysis of responses related to the impact of tuberculosis on each
participant’s life is presented. A discussion of the experience these individuals went through in
order to obtain health services, including their ordeal in getting a diagnosis, a discussion of
stigma and discrimination, and experiences in the intervention called Photovoice is presented.
The special case of an interview participant from the Netherlands and his experience will be
presented as a counterpoint and a possibility for the future of diagnosis and treatment of
tuberculosis in the United States and México.
The value of these interviews lies in their ability to demonstrate that the old stereotypes
of TB do not apply, even though the ideas behind them are still very prominent in how society
views people with tuberculosis. The old stereotypes are described in every interview conducted
and are cited as the source of the on-going stigma and discrimination associated with the disease.
The concepts of persons with TB being poor, dirty and wasted are at the heart of old
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stereotypes. Most persons afflicted with the disease do not conform to these stereotypes, yet
patients and health-care workers hang on to them with the terrible effect of perpetuating stigma
and delaying critical treatment opportunities.

5.1 RESULTS
PROFILE OF INTERVIEW PARTICIPANTS
Seven women (one was accompanying a male), and three men took part in interviews
conducted by the Investigator. Table 4 illustrates the participant characteristics. Six interviews
were conducted in Ciudad Juárez, México, and three in El Paso, Texas. Only one female and one
male do did have children. Those who have children have between two and four children.
Participant ages range between 28 and 56 years of age. Seven participants were married, two
were single. Two interviewees were born in Ciudad Juárez, two were born in other cities of the
State of Chihuahua, three in adjacent states to Chihuahua, two from central México and one
participant is originally from the Netherlands.
Five individuals currently live in Ciudad Juárez, one in Sparks, Texas and three in El
Paso, Texas. Two have lived in the United States from 1 to 5 years and two for more than five
years. The other five have never lived in the United States. The frequency with which those who
live in Ciudad Juárez cross the border into El Paso, Texas, is twice a week (2), weekly (2),
monthly (2) or twice a month (1). Only one participant has no schooling, and two have 6 years
of primary education (Primaria). One individual completed high school (Secundaria) and the
others have post secondary education and few have completed college degrees. One participant
completed a doctoral degree.
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Sex

Age

F
M
F
M
F
F
M
F

41
28
43
42
36
49
36
47

F

56

F

50

Border
Crossing
Frequency
Monthly
Occasional
Monthly

Table 4. Photovoice Participant Demographic and other Characteristics
Marital
Current
Children
Birth Place
Education
Status
Residence
Single
No
Cd. Juárez, MX
Sparks, TX
Bachelor
Married
No
Netherlands
El Paso, TX
PhD/MPH
Married
4
Zacatecas, MX
El Paso, TX
Some College
Single
4
Durango, MX
El Paso, TX
College Degree
Married
3
Toluca, MX
Cd. Juárez, MX No
Married
3
Cuauhtémoc, MX
Cd. Juárez, MX High School
Married
No
Durango, MX
Cd. Juárez, MX Elementary
Married
3
Cd. Juárez, MX
Cd. Juárez, MX Elementary
Social Work
Married
2
Zacatecas, MX
Cd. Juárez, MX
/Nurse Aid
Married
3
Santa Barbara, MX Cd. Juárez, MX Nursing
Live on
other side Occupation
of Border
Substitute
>5 years
Teacher
Research
No
Assistant
>5 years Homemaker

Income

Frequency
of Work

Own/rent
Home

Salary

Daily

Own

Salary

Daily

Rent

Stipend

Occasional

Own

Monthly

>5 years

Occasional

Occasional

Occasional

Own

No

No

Volunteer

Daily

Own

2/month

<1 year

Salary

3/week

Own

No

No

Homemaker
Home
health
Artisan

Volunteer

Daily

Shelter

Weekly

No

No

Occasional

Own

2/week

>5 years

Salary

Daily

Own

Week

No

Homemaker
TB
outreach
TB
outreach

Salary

Daily

Own

The participants living in El Paso, Texas, work sporadically and have no fixed income. In
Ciudad Juárez, two are volunteers; one is an artisan/volunteer in the shelter where he lives, and
two work as health-care providers. One participant is the owner/operator of a food stand. Four
participants earn salaries, one volunteer is paid a stipend, and one has no fixed income. Six work
daily, one three times per week, and one works sporadically. However, seven own their own
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home, one resides in a shelter and one lives in a rental apartment. Participants in these interviews
are a prism through which the diversity of Persons Affected by Tuberculosis (PATB) today
demonstrate that “everyone who breathes” may be exposed or infected by the modern
tuberculosis.

5.2 ABOUT THE EXPERIENCE OF TUBERCULOSIS
A correlation exists between economic conditions and the registered number of new cases
of tuberculosis worldwide. The World Health Organization (2009) estimates that the highest
incidence is seen in those countries with the lowest gross national products. However, in
industrialized countries, where there has been a steady decline of cases, the incidence began to
level off in the mid-1980s and then became stagnant or even increased. Mobility and
immigration from countries with high incidence of tuberculosis and difficulties in performing
epidemiological surveillance can, at least partially, help explain this rise (WHO, 2009).
For this group of interview participants, the experience of dealing with TB regularly
challenges their resilience in dealing with their lives. Despite their efforts to seek health care,
both for a diagnosis as well as treatment options, multiple factors play a role in turning the search
into a virtual “pilgrimage” (viacrucis). Common complaints which lead them to seek care are
weight loss, allergies, night sweats, laryngitis, and sore throat, and asthma, loss of appetite,
nausea, fatigue, phlegm, and coughing. The subjects in this set of interviews parade from
physician to physician, from nurse to nurse, and from private services to public health clinics
until they are eventually diagnosed and treated. For some, the pilgrimage is short -a couple of
weeks- but for most it is not uncommon to wait four to six months until someone in the long line
of health care providers thinks of TB and conduct the appropriate screening. In two of the cases,
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it took more than a year and in another case four years to finally find someone who could
interpret the symptoms correctly.
While it has been documented that multiple factors play a role in complicating the
situation for the management of TB on the U.S.-México border, among which are higher rates of
TB in México and low socioeconomic status and limited access to health care (Lobato &
Cegielski, 2001) most of the participants in these interviews have knowledge and/or access to
health care in México, a minority have access in the U.S. When faced with an unresolved need,
they cross to the other country to continue their search for medical services. Even though
frequent border crossing and travel to the U.S. from México for employment, commerce, and
leisure (Lobato and Cegielski, 2001), challenge cross-border management of TB, in these
interviews we also documented border crossings for health services. In some cases, they have the
first signs and symptoms in México and end up getting their diagnosis in the United States. In the
second case, the opposite was true:
Fue en marzo del 2006 (fui) primero que a un médico privado en Juárez, ahí(me)
dijeron que era solo una infección y (me) dieron medicamento.. Lo tome por el
tiempo prescrito pero no hubo mucha mejoría. Luego salí de vacaciones con la
familia a Acapulco. Durante este viaje ya me sentí mal… en Acapulco no aguante
mas… las flemas persistieron y decidí ir con un médico privado y fui al
hospital… de nuevo me dieron medicamento para una infección de la garganta
pero no pensaron en TB. Regrese a Juárez con un médico privado pues no tenia
seguridad social… no me hicieron gran cosa… Seguí así por unos días hasta
cuando ya no pude más…Un día cuando estaba trabajando en la construcción (El
Paso) tuve un dolor muy fuerte en el pecho… no pude seguir trabajando, le hable
a mi esposa y le dije que me iba al Hospital Thomason…deje el trabajo y me
fui…. En el Hospital Thomason me recibieron en la sala de urgencias y ahí me
diagnosticaron correctamente con TB. A partir de ese momento no regrese a
trabajar…. (Male, 42)
In March 2006 (I) went to a private doctor in (Ciudad) Juárez. There they told
(me) it was just an infection and gave (me) medicine… I took it for the time
prescribed but there wasn’t much improvement. Then we went on family vacation
to Acapulco. During the trip, I was feeling very bad…in Acapulco I could not
bear it anymore… the phlegm persisted and (I) decided to go to a private
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doctor… again they gave me medicine for a throat infection but didn’t think of
TB. We came back to Juárez to a private doctor because I did not have insurance
(Seguro Social or IMSS) and continued for a few days and could not take it
anymore until one day while working in construction (El Paso) I told them I
couldn’t work anymore and went to Thomason Hospital (El Paso County
Hospital). At Thomason’s ER, they finally diagnosed TB. After that, I could not go
back to work… (Male, 42) (This interview was conducted in Spanish).

In México, when I visited my relatives in Zacatecas, I visited two specialists, ear
nose and throat doctors… so I figured, well maybe with the experts, the
specialists, they may have a better handle on it, but I was prescribed stronger
medication for a round of antibiotics for 10 days each time I went, and it
alleviated some of the symptoms. I got my voice back, I wasn’t talking as much,
but they were very temporary. Within a month I was back to the same thing. And
so, I mean they still didn’t do any testing or took any x-rays to see if there was
any major underlying situation. It was just, “Take these three antibiotics, (and)
follow the directions….” (Female 41) (This interview was conducted in English)
For most, the ordeal of getting a diagnosis is only the beginning of an even more
disturbing experience to come, which is treatment. When describing the quality of services
received, one of the participants stated the following:
From 2002 to 2006, I visited the clinic every 2 months at least so I was getting
different medications for different things. They even thought at one point that it
was acid reflux causing me to cough at night so they put me on an anti-acid, and
so they tried different things, but every 2 months I had to go through the
recommendations and whatever pills they told me to take and then get better. But
finally in 2006, in April of 2006, they said, ‘You know we need a chest x-ray to see
what’s happening.” And I had told them in so many visits before, maybe the third
question that I was asked was “anyone in your family has TB, or do you travel to
México or any developing country?” And I said “Yes.” Because there have been
TB cases on both sides of my family. And I said yes. “Have you ever had a TB test
then?” “Yes.” “Has it come out positive?” “Yes… It was a 26 mm circle, type
circle… and they called and said, “Expect this girl because she really needs to be
seen.”…actually and the first time they told me, “It does look pretty bad”; that
was the x-ray technician. He said, “How long have you been feeling bad?” …and
he says “you had the classic symptoms. You had the physical symptoms plus the
background and everything that you’re telling me, they should have spotted it
right away.” I said, “No, I’ve been living with this for three years” and he said,
“But don’t worry, we’ll take care of you.” And then I was transferred to the nurse
and the nurse was extremely patient and explained everything, and I was crying
by then. (Female, 41) (This interview was conducted in English)
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For many, the “offense” of being given a diagnosis of TB is followed by notification to
family members and contacts that may have been exposed, which often is a second “offense.”
Stereotypes about what TB “looks like” and who the people affected with TB are having a
shocking impact on those diagnosed and their families and contacts. The idea that only “poor and
dirty” people are at risk makes receiving a diagnosis very difficult on those who consider
themselves outside of this stereotype.
…and my mom started crying, and my dad was saying, “No, no mi’ja (my
daughter), it can’t be TB. No, I know people with TB. They’re real thin and
they’re coughing up blood and oh, it can’t be TB. They got it wrong. And my
mother was just very depressed for a while and even when she got her diagnosis
of her latent TB, she didn’t take it as badly as when I told her about mine. And she
started on the doctors. “How could they not know, how could this go on, what did
they expect, how bad did it have to get, how much more obvious did it have to
be.” And then, madre (mother), did you ever think I had TB? And she said, of
course not. And I said, ‘just like you never thought of it, these professionals…
“(Female, 41) (This interview was conducted in English)
For Persons Affected by Tuberculosis (PATB) who have other conditions, diagnosed or
not, their TB cases are further complicated; co-morbidities like diabetes, HIV/AIDS, and
addictions can hinder diagnoses and complicate treatment. Two of the participants had a dual
diagnosis with HIV/AIDS and TB. TB-HIV/AIDS co-infection, for those with known HIV/AIDS
status, is estimated to be 1.7% for those born in the U.S. and 7.4% for those foreign born (CDC
MMWR, 2009). While this co-morbidity has been documented for several years, TB is often
ignored because of the overwhelming situation of treating the HIV/AIDS which can confound
their TB symptoms.
…porque yo no escuche que hablaran que había tuberculosis aquí en Juárez… y
con por el problema que traía (mi hijo)... el pediatra me dijo que pos tenía
problemas de salud pero yo no entendía que era eso… (Mi hijo) era muy listo
¿qué es eso doctor? No es un virus y ya me empezó a platicar y dijo pero después
yo me quede así porque pero nunca me dijo el doctor: “tenga cuidado con sus
hijos, así se, así se contagian, nunca me explicaron”… era muy difícil para
descubrir porque a (mi hijo) siempre le dolía que los pies, los huesos él decía que
le dolía la cabeza y ya no retomaba el medicamento que tomaba todo lo
regresaba… empezó a tener síntomas a los seis anos. Cuando empezaron a usar
cubre bocas y yo pregunte, me dieron, no sabes que tu hijo tiene tuberculosis?
Eso llevo tres o cuatro meses… empecé a entender que podía ser contagioso en la
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escuela. Siempre fui muy directa con él, le decía, cuando tosas, cúbrete la boca. El
sabia, me decía, el doctor me dijo que tengo SIDA… le decía a la gente tengo
SIDA, pero no le digan a mi mamaíta… y ellos pensaban que no iba a entender…
(Female, 36)

… I didn’t know there was Tuberculosis here in (Ciudad) Juárez… and with the
problem my son had… the pediatrician told me he had health problems, but I
didn’t understand… my son was very smart;, he would ask the doctor “what is
that doctor,” but the doctor did tell me to be careful with my kids, that’s how they
can get infected… they never explained it to me, never. It was very difficult to
discover because my son always had many pains, his feet hurt, his bones, he had
headaches and he didn’t take the medicine after he threw it up. His symptoms
started when he was 6 years old. When they started wearing facemasks and I
asked, they said, didn’t they tell you your son has TB? That took 3-4 months. I
slowly started to understand that he could be contagious when he went to school.
I was very open with him and told him, when you cough, cover your mouth. He
knew, he would tell me, “the doctor told me I have AIDS”… he told people “I
have AIDS,” but don’t tell my mommy… and they thought he wouldn’t
understand… (Female, 36) (This interview was conducted in Spanish)

Los servicios eran a veces buenos y a veces malos, como decía (mi hijo)… era
muy triste porque no podíamos conseguir nadie que nos ayudara… tenía un buen
doctor, un buen pediatra, muy amable, pero en la siguiente cita nos dice, tiene TB
y SIDA y yo sentí como que trágame tierra para esconderme, no tanto por mí,
sino por mi hijo…y les dije, para que me dieron la cita, a veces no sabía cómo
defenderme… era muy difícil porque tenía miedo que nos maltrataran, nadie lo
debía maltratar, había mucha gente buena, como él decía velos a los ojos y sabes
si te aceptan… dijo eso porque sentía el rechazo de la gente… las enfermeras, los
doctores, como que no me toques porque me vas a infectar. Me imagino que si
son doctores están preparados… alguna personas nos trataban bien pero algunas
se escondían cuando lo veían venir, corrían a esconderse… (Female, 36)
The services were sometimes good and sometimes bad, like (my son) used to say…
it was very sad because we could not get anyone to help us… we had a good
doctor, a good pediatrician, very kind, but at the next appointment he said, you
have TB and AIDS, and I felt like the earth should open for me to hide, not so
much for myself, but for my son… but I said, “you shouldn’t have given me the
appointment,” sometimes I didn’t know how to defend myself… it was very
difficult because I was afraid of being treated badly… nobody should mistreat
him, there were many good people, like he used to say look into their eyes and you
know if they accept you or not… he said that because he could feel people’s
rejection… the nurses, the doctors, like “don’t touch me because you’re going to
infect me.”. I imagine that if they are doctors you would think they would be
prepared… some people treated us well but some would hide when they saw us
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coming, they would run away…(Female, 36) (This interview was conducted in
Spanish)

…lo que pasa es que se me complico todo ciertas enfermedades de que por
ejemplo. O sea sucedió que no me pude mover, yo andaba en los vicios estaba
tirado por completo o sea no más bien se me fue el conocimiento entonces las
personas que, que se pasaban conmigo drogándose y tomando me llevaron al
hospital, le hablaron a la ambulancia que fueran a recogerme porque ya no me
pude mover me llevaron al hospital general de Chihuahua y de ahí fue donde me
diagnosticaron que el VIH, tuberculosis y no sé cuanto… me entere de las dos el
mismo día… pensé, no puede ser tan malo porque estoy vivo… entonces los
doctores me dijeron si no te cuidas podía morirme pronto de esas enfermedades.
Como me voy a cuidar viviendo en la calle, pues no uses drogas y no tomes y te
vamos a dar tratamiento esto y aquello… OK, en ese caso, dejo los vicios y
todo… vi la muerte muy cerquita…y cuando me iban a soltar me preguntaron que
si donde vivía y que si tenía familia, no tengo familia, conocemos este lugar en
Ciudad Juárez a donde van gentes con estos problemas, y me preguntaron que si
quería ir. Pues es un lugar en donde dormir, claro que quiero ir, la enfermera me
compro ropa y me dio dinero, bueno, en realidad me pusieron en el camión con
otra persona que me acompañaba y me dieron unas pastillas por si me sentía mal
durante el viaje. Me imagino que si no hubieran hecho eso ya estaría muerto, no
sabía nada de ninguna enfermedad, solo gripa, tos y esos cosas… es lógico que
me iba a morir, solo me iba a meter hasta las tapias y morirme pero el Señor es
muy grande… en la Tenda de Cristo empecé mi tratamiento de TB y VIH,
primero de TB… estoy hablando de hace tres años, después de seis meses me
dijeron que me podía quitar el cubre bocas, siempre usaba cubre bocas, Gracias a
Dios llegue un lugar en donde me explicaron los riesgos de pasar la infección,
como cuidarme, ahora entiendo muchas cosas. Son como una familia. Ya
complete mis dos anos aquí y me pidieron que me quede de voluntario pro una no
mas… complete mis dos anos y me felicitaron… hasta me case hace cuatro meses
y mi esposa y yo vamos a servir por un ano mas, voy a compartir lo poquito que
se y ella va a ayudar a bañar los pacientes y en la cocina…(Male, 36)
… what happened is that it got complicated, I had the “vices” and the people who
I was drinking and doing drugs with took me to the hospital because I got to the
point where I couldn’t move anymore… they called an ambulance and took me to
the General Hospital in Chihuahua and that is where they diagnosed me with HIV
and TB and, I don’t know what else… I found out the same day about both… I
thought, it can’t be serious because I’m alive…then the doctor told me that if I
was not careful, I had possibilities of dying soon of these diseases. “How am I
going to take care of myself living on the street?” Well just doesn’t do drugs and
don’t drink and we’ll give you treatment “like this and that…” “OK, if that is the
case, I’ll leave the “vices” and everything,”…I saw death real close… and when
they were going to release me; they asked me where I lived and if I had family. I
don’t have any family. They told me we know of this place in Ciudad Juárez
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where people with the same problem go, and they asked me if I wanted to go
there. Well there is a place to sleep of course I would like to go. The nurse bought
me clothes and gave me money, well, actually they put me on a bus and sent me
with another person and gave me some pills in case I didn’t feel well during the
trip. I imagine that if they had not done that I would have died, I didn’t know
anything about any illness, only coughs, colds, all that… so it’s logical that I was
going to die. I was going to go into ‘las tapias’ (go all in) and die, but the Lord is
great… at La Tenda de Cristo (HIV/AIDS shelter) I began my HIV and TB
treatment, first the TB… I’m talking about three years ago… after six months they
told me to take off the face mask, all that time I wore a face mask… thank God I
arrived to a place where they explained the risks of spreading the infection, how
to care for myself; now I understand more things. They are like family. I have
completed my two years here, and they have asked me to volunteer for one year
more… I completed my two years three days ago and they congratulated me… I
even got married four months ago and my wife and I will serve for a year. I will
share whatever little I know and she will help with bathing patients and helping
out in the kitchen… (Male, 36) (This interview was conducted in Spanish)
The quality of the health services received is perceived by the interview participants
according to their socioeconomic status and level of education, but all agree it can be
complicated.
Yo tenía dudas de que era tuberculosis porque mi papa acababa de morir de
enfisema, de cáncer del pulmón, así que pensé que estaba, como dicen, traumada
con su problema porque yo lo cuidaba, y a eso lo atribuí. No creía que era TB.
(Cuando me dijeron fue) me sentí muy mal porque uno de los hermanos de mi
mama murió de TB hace muchos años, pero más que nada me sentí mal por mi
ignorancia… mi ignorancia, porque no sabe uno de esta enfermedad y piensas que
es incurable porque te falta información. Me diagnosticaron en 2000 más o
menos… el diagnostico fue rápido, tenía idea de dónde ir… iba todos los días y
me tomaba el medicamento en la clínica; no termine los seis meses de tratamiento
porque me fui a Estados Unidos antes de que me hicieran la prueba para ver si ya
estaba bien. Allá me trato una doctora naturista que me trato con unos masajes
con rollos de jade que me quitaron el dolor. (Female, 49)
I had my doubts that it was (TB), because my dad had just died of emphysema, of
lung cancer, so I thought I was, as they say, traumatized with his problem
because I had cared for him, and I attributed to that. I didn’t think it was TB.
(When they told me it was) I felt very bad because one of my mother’s brothers
died of TB many years ago, but most of all I felt bad because of ignorance…my
ignorance, because you don’t know about this disease, and you think it is
incurable, so you lack information. I was diagnosed in 2000 more or less…
getting diagnosed was quick, I had an idea of where to go… I went every day and
took the medication at the clinic; I didn’t finish the six-month treatment because I
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went to the United States before I could get tested to see if it was gone. There I
was treated by a naturist doctor who treated me with jade rollers which took
away my pain. (Female, 49) (This interview was conducted in Spanish)
Two of the health care professionals in this set of interviews work for a binational project
funded by the State of Texas. The two nurses in the binational program sum up the quality of
services by saying, “we have a long way to go…”
…nos falta mucho, nos falta mucho… hay mucha falta de sensibilidad, hemos
hecho mucho para que los doctores atiendan bien a los pacientes y los traten bien
pero no estamos en el punto en que los pacientes con tuberculosis sean bien
recibidos, por ejemplo hay pacientes que son diabéticos, y seguido los doctores
están viéndolos por la tuberculosis pero no lo ve por la enfermedad, la diabetes. El
tratamiento no funciona como quisiéramos… porque no le están dando la atención
de “calidad y calidez”, como dicen, para que el paciente mejore. En la mayoría de
los casos, los pacientes tienen citas para su diabetes pero no van y me dicen, para
que, no me miden, no me pesan. No todos, algunos. Algunas veces veo pacientes
que trata de que le hagan análisis de laboratorio que están esperando 3 horas, y
que vinieron desde muy lejos, y le dicen no tiene cobertura por esto o por lo otro.
(Female, 56)
… We have a long way to go, we have a long way to go … there is a great lack of
sensitivity, there has been a lot done so that the doctors care well for the patients
and treat them well. We are not at the point where the TB patient is well received,
for example, there are patients who are diabetics, and often the doctor is seeing
(the patient) for TB but does not see (the patient) for his disease, the diabetes. The
treatment does not work like we would like it to… because they are not giving the
patient medical care that has quality and is caring (“calidad y calidez”), like they
say, so that the patient gets better. In most cases, patients have referrals for
treatment of diabetes but they don’t go and they tell me, what for, they don’t
measure me, they don’t weigh me. Not all, some. Sometimes I see a patient who
tries to get labs and has been waiting for 3 hours, and came from far away, and
they tell him you don’t have that coverage because this or that. (Female, 56)
(This interview was conducted in Spanish)

Las personas con tuberculosis no reciben servicios integrales. La mayoría de los
casos son pacientes con diabetes y les digo que si no controlan su glucosa, la
medicina que les llevo no les va a servir, pero los doctores no les dicen esto, así
que yo salgo al quite en la necesidad de cuidar su dieta, no solo como enfermera,
sino como amiga. Eso no es mi trabajo, yo solo debo llevar y supervisar y
observar el tratamiento de TB, pero yo he sido una persona con necesidades y en
su momento me han atendido bien, así que no me gusta que no me traten bien.
Eso es algo que mis padres me enseñaron, no hagas a otros lo que no quieras que
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te hagan a ti. Otras condiciones que vemos con la tuberculosis son el alcohol y la
drogadicción, y el VIH. No tengo los cuadros, pero eso es lo que he observado.
(Female, 56)
Persons with TB do not receive holistic services. The majority of cases are
patients with diabetes. I tell them that if they don’t control their glucose, the
medicine I am taking to them (TB) will do no good, but they don’t hear this from
their doctor, so I come in to the rescue (“al quite”) on the need to take care of
their diet, not only as a nurse, but as their friend. This is not in my job duties. I
am only supposed to give the TB treatment and supervise it (observe), but I have
been a person in need and at the moment they have treated me well, so I don’t like
to not be treated well. That is something my parents taught me, don’t do unto
others what you don’t want them to do to you. Other conditions we see with TB
are alcohol and drug addiction, and HIV. I don’t have the data, but this is what I
have observed. (Female, 56) (This interview was conducted in Spanish)
Health services seem unprepared to deal with the problem of dual infection or other comorbidities. Interview participants make reference to the seeming inability of health care to
provide person-centered care that focuses on providing integral services that would allow them
to attain holistic health. As economic development has progressed in México, there has been a
transition from infectious diseases to chronic diseases such as diabetes. This is known as an
epidemiologic transition. However, it appears that México now has two epidemics: diabetes and
tuberculosis. In fact, a recent study by Ponce de Leon (et al., 2004) concluded that “co-morbidity
with diabetes may increase tuberculosis rates as much as co-infection with human
immunodeficiency virus (HIV).”
An article by Pablos-Mendez, Blustein & Knirsch (1997:578) studying “the relative
contributions of diabetes mellitus to the increased prevalence of tuberculosis in Hispanics”
concluded that “Diabetes mellitus remains a significant risk factor for tuberculosis in the United
States. The association is especially notable in middle-aged Hispanics.”
In a systematic review of 13 observational studies by Jeon & Murray (2008), data
suggests that people who have type 2 diabetes might be at greater risk for contracting
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tuberculosis than people who don't have diabetes. The studies warned that, (1) type 2 diabetes,
especially with chronic high glucose levels alters the immune response to TB, (2) patients with
diabetes take longer to respond to anti-TB treatment and that, (3) patients with diabetes and TB
are more likely to develop multi-drug resistance. The information gathered and cited above needs
to be part of the efforts to improve diagnosis and management of TB patients. It is unfortunate
that the conclusion of the two nurses out in the field is so grim:
Porque, desgraciadamente (esta) fuera del área de servicios de salud, no hay el
suficiente interés en los médicos, tanto en los generales como especialistas… hay
varios casos (resulta) la multidrogo resistencia y también la falta de información
de los pacientes diabéticos. (Female, 50)
This is a growing problem because unfortunately it is outside of the health
service. Doctors are not sufficiently interested, neither generalists nor specialist,
resulting in MDR and the lack of information to diabetic patients. (Female, 50)
(This interview was conducted in Spanish).

5.3 ABOUT TUBERCULOSIS RELATED STIGMA
Cuando llevo el diagnostico a un paciente se resiste. Se resisten tener tuberculosis,
por el estigma de tener una enfermedad contagiosa…ven que es una enfermedad
de personas promiscuas; dicen yo soy muy limpio; es increíble para ellos tener
tuberculosis. Una vez que les explicamos las causas probables es un alivio para
ellos que no es por andar en malos pasos. Para ellos una persona sucia es alguien
que no tiene agua potable y no puede tener la higiene necesaria, pero ellos tiene
agua en sus casas, una regadera, no usan letrinas, tienen toda la higiene posible en
su casa, no están en esas condiciones, no soy promiscuos como un alcohólico
puede ser, o un drogadicto, tienen más conocimiento, mas información. (Female,
50)
When I give a diagnosis to a patient, they resist it. They resist having TB, because
of the stigma of having an infectious disease… they see it as a disease of
promiscuous people; they say I am very clean; it is incredible for them to have
TB. Once we explain what the probable causes are, it is a relief for them that it
isn’t due to them doing something wrong (“andar en malos pasos”). To them a
dirty person is someone who does not have potable water and doesn’t have the
necessary hygiene, but they have running water, a shower, they don’t use latrines,
they have all the possible hygiene in their house, they are not in those conditions,
they are not promiscuous like an alcoholic can be, or a drug addict, They have
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more knowledge, more information. (Female, 50) (This interview was conducted
in Spanish)

El estigma yo pienso que es, es algo que, es como un señalamiento del cual ya no
sale uno, es un como si a mí me pusieran un apodo y se me quedara ese apodo,
pero yo hiciera, como, como ese apodo yo lo hiciera parte de mi vida, es como un
estigma, es algo que uno lleva siempre. (Female, 49)
Stigma, I believe, is something like; it’s like a mark from which you cannot get
out. It’s like if they gave me a nickname and it stuck, and I would like, make that
nickname part of my life. It’s like a stigma; it’s something you carry always.
(Female, 49) (This interview was conducted in Spanish)
For Persons Affected by Tuberculosis (PATB), feelings of being less worthy, being
“pointed out” as a result of their ailment, being discriminated against and being stigmatized are
common experiences. Health care workers, family members, coworkers, friends and society in
general react to the knowledge of someone being infected by TB with rejection and fear.
Sometimes, as one of the interview participants stated, even among people infected with
HIV/AIDS, persons with a TB co-infection are stigmatized even more. This is noteworthy
because of the tremendous stigma already associated with HIV/AIDS.
… hubo una vez, no como tres veces, es que a veces en el centro de salud hubo
una doctora que quería mucho a mi hijo, hay no, nomás que lo cambiaron, cambio
mucho ahí desde ese entonces no duro mucho mi hijo pos se, se murió ¿veda’?
Este cuando fuimos a recoger el medicamento, “hay es el niño que tiene
tuberculosis”, todo el mundo se volteo, entonces yo me le quede viendo, no le dije
nada, porque en ese momento este es que muchas personas “hay pues es que lo
tiene porque lo oculta no” no?, yo no le dije nada, a la tercera vez que fui, yo le
dije al doctor, que estaba ahí encargado, no me gusta que le digan así a mi hijo, si
lo tenemos, pero no, y dijo no está bien ahorita hablo con ellos… hoy en día yo
voy a atenderme en el centro de salud…(Female, 36)
… there was a time, there were three times, sometimes at the health center there
was a female doctor who loved my son a lot. When they moved her, everything
changed a lot. My son didn’t last very long; he died, you know. When we went to
pick up his medication (someone said), there is the boy who has tuberculosis.
Everyone turned around. I only kept looking at her. I didn’t say anything; but at
that moment many people said, if he has it why hide it. I didn’t say anything until
the third time. I told the doctor in charge, I don’t like for them to talk to my son
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like that. Yes we have it, but no, and he said it’s not right; I’ll speak to them… I
don’t go to the health center anymore… (Female, 36) (This interview was
conducted in Spanish)

… sobre la tuberculosis, si hubo muchísima discriminación, muchísimo rechazo
ahí entre nosotros… Si cierta discriminación pero con los que, con los
compañeros que tienen VIH. …como nosotros, pero de las personas que iban
recientes, no sé si seria rechazo y no me lastimo ni me molesto realmente dije “¡a
caray!” si estamos en el mismo barco… llegaron pues ¿qué es el área… de
tuberculosis?, aquí es el área de VIH, … entones los escuche cuando dijeron entonces no hay que acercárnosle a ellos verdad porque nos pueden infectar o sea
pero aun no tenían información tampoco por eso les di la razón verdad, de que,
bueno no tienen información, … no nos vayan a contagiar, y apoco van a comer
también ellos dijeron, y ya les dije yo claro que vamos a ir a comer mi
enfermedad que yo ahorita traigo estoy en un tratamiento que ese tratamiento has
de cuenta que se trajeron una “lumbrita” y, pero le está cayendo una gotita de
agua que esta apagando el fuego, ese fuego ya no te puede quemar le dije, … esa
lumbre ya no te quema. (Male 36)
… about tuberculosis, yes, there was a lot of discrimination, a lot of rejection
there among us… yes, certain discrimination, but with fellow HIV patients… like
us, but from new arrivals, I don’t know if it was rejection but it didn’t hurt or
bother me really, I said, “¡a caray!” (expression which denotes surprise) if we
are in the same boat… they came in saying, is this the tuberculosis area?, this is
the HIV area, ... and then I heard them say we shouldn’t get near them because
they can infect us because they didn’t have information and that’s why I thought
they were right, well, they don’t have information, … we could get infected, and
(they also said) don’t tell me they are going to eat, and then I told them of course
we are going to eat. My illness that I have right now, I’m going through
treatment, and that treatment is like they brought a little fire, but there’s a little
drop of water falling on it that is extinguishing the fire. That fire can’t burn you, I
said, that fire can’t burn you anymore. (Male, 36) (This interview was conducted
in Spanish)
For others, even if TB is their primary diagnosis, being stigmatized is the most important
influence on their recovery, and it is usually a negative one. However, when a health-care worker
does not stigmatize a PATB, it is perceived by the PATB as the first step to recovery.
… What she (Tb Nurse) really stressed to me was if it’s TB, it’s something
curable. Like the first nurse who told me that really showed compassion, patience.
For me at that time that was the most valuable medicine I could have gotten. Even
before taking the pills. She just made me feel like, you know, you’re in the right
spot. … Thank you. And it’s not your fault because before then, it had seemed
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that the doctors felt I wasn’t doing the right thing, that I wasn’t taking the
medication correctly or that I was somehow making myself sick. (Female, 41)
(This interview was conducted in English)
Another one of the interview participants expressed the belief that being treated well by
the person in charge of making the medication available was the motivator to “act responsibly
and not give others a reason to stigmatize,” especially their family.
Porque algo importante considero yo cuando…voy a la oficina de la clínica… a
recoger las medicinas, la señora, la gran señora con todo mis respeto que está en
recepción no recuerdo su nombre que me recibía tan amable con una sonrisa, yo
iba hasta cierto punto triste pero al entrar ahí y verla a ella me hacia sonreír a mi
también y yo cada, las primeras veces yo iba… con cierto miedo o sea a una
discriminación a una mala cara etcétera pero al recibirme ella así yo decía va que
bien aquí lo tratan a uno de una buena manera, entonces ya, siempre cuando ya
iba por la medicinas con esa sonrisa y con esa actitud de saludar y ella me
saludaba incluso llegue a llevar a mis hijos varias veces a otras pruebas y ya
cuando no los llevaba me preguntaban por mis hijos y nos hicieron de verdad un
poco más liviana un poco más ligera la carga. Lógicamente hubiera habido
discriminación… por eso es tan importante acatar la orden medica verdad de
guardarse en casa cuando es una enfermedad fácil de transmitirse a otro ser
humano mi esposo ya lo mencionaba que es un acto criminal por parte de uno
cuando uno sabe que trae cierto virus o cierta enfermedad transmisible este es
muy importante guardar la medidas necesarias… nosotros de verdad nuestra vida
era estar en casa, ir por las medicinas … fines de semana igual aquí en casa
avisamos a la familia para que no vinieran, estuvimos aislados los seis durante
cuatro meses aproximadamente… y las autoridades medicas fueron quienes (nos
dijeron que ya)… podíamos hacer nuestra vida normal. Es que no hubo, no hubo
discriminación porque hubo responsabilidad de parte de nosotros…(Male, 42)
Something I consider important is when I go to the clinic office… to pick up the
medications, the lady, the great lady, with all my respect, who is at the reception,
I don’t remember her name, who greeted me with a kind smile, I went somewhat
sad but when I went in, seeing her there would make me smile too, the first times I
was… with certain fear of discrimination or a bad face, etc., but when she greeted
me that way, that was it, always when I went to get the medicine with that smile
and that attitude of greeting and she greeted me. There were several times I even
took my children for other tests, and when I didn’t take them she would ask me
about my children and the truth is that made the load a little bit lighter. Logically
there would have been discrimination… that is why it is so important to respect
the medical orders to stay home when it is an easily transmissible disease to other
human beings. My husband already said it, it is a criminal act on one’s part when
you know that you have a certain virus or a certain contagious disease it very
important to follow the necessary measures… really, our life was at home, pick up
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the medication… even during weekends, and we told our family so they wouldn’t
come, we were isolated for the six months, or the four months approximately…
and the medical authorities told us that we could go back to our normal lives.
There wasn’t, there was no discrimination because there was responsibility on
our part. (Male, 42) (This interview was conducted in Spanish)
For the rest of the group of interview participants, the issue of health-care workers not
being better informed was a painful conclusion to recognize.
Yo imagino que si son doctores yo creo que normalmente estuvieran preparados,
de los de aquí del centro de salud hubo personas que trataron muy bien a mi hijo
lo querían, pero había personas que si se acercaban mejor se escondía, se alejaba
de ellos. Eran de los que daban en la farmacia medicamento, los que daban este
los que lo pesaban, era tanto miedo que ellos no, no podían acercar con él.
(Female, 36)
I imagine that if they are doctors, I think that normally they would be prepared.
Some here at the health center, there were people who treated my son very well
and they loved him, but there were people from whom, if they came close, I hid.
He would run away from them. They were the people who gave out the
medications, the ones who weighed him. There was so much fear that they could
not get close to him. (Female, 36) (This interview was conducted in Spanish)
All of the interview participants spoke of “ignorance,” “outdated information,” “lack of
information,” as their way of explaining why so many stigmas are associated with their
condition.
The information they had about TB was outdated and mostly related to developing
countries so they did not, I don’t think they were very aware, so it wasn’t one of
the tools they could use to look at me and my symptoms. I think many of the
misdiagnoses that happened because of lack of information or thinking that it’s
not that, it’s not a current problem… (Female, 41) (This interview was conducted
in English)
… And then I hear from the back of the office, which I had never gone to at the
back part of the office. Somebody real loud saying, “Where’s this person, where’s
this patient?” And I looked around and I was the only one in the lobby, and I
said, oh, God, I hope she doesn’t mean me, I hope not, because she was very
upset, very loud and mad. And she went in and just opened the door to this
nurse’s office and said, “Huh, you can’t leave this patient in here without a face
mask. She’s supposed to cover up. We just got the positive diagnosis. She’s got to
have a face mask on!”… So she closed the door to her office and left that patient
in there, and then she went to the back and I could hear raised voices. I thought,
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“It is me who they’re talking about”. It was me the director was talking about,
and that was my first moment where I felt discriminated against, where I felt like
a thing rather than a person. (Female, 41) (This interview was conducted in
English)
Further complicating the public discussion of tuberculosis as a treatable disease is the
already complex situation of perceptions of racism among groups who may be statistically at
most risk such as Hispanics, Mexican-origin individuals.
This was co-workers and a group of older ladies that my mother and I used to see
in the community center in my neighborhood. And because of the contact
information follow-up, they had had to be tested; there was very negative
reaction, especially from older people. They wanted to know why they were, first,
if they were being targeted because they were Hispanic. You think we’re dirty,
you think since we’re immigrants and that’s why you want to point us out as
having TB. That was the community sentiment. (Female, 41) (This interview was
conducted in English)
The health-care workers who participated in these interviews confirmed patients’
complaints regarding the stigmatizing and discriminatory attitudes of health-care professionals
who deal with TB patients.
Pues es que el estigma y la discriminación viene desde nosotros como
servidores… porque el que el paciente vaya a la consulta y no lo quiere hacer,
porque no lo quieren ver… Es que porque no los quieren porque no aceptan
todavía ellos la enfermedad, o sea como que para ellos es engorroso el estar
viéndolos porque el paciente de tuberculosis lleva una serie de estudios, una serie
que implica tiempo de manera que para ellos yo me imagino no lo sé que tienen
miedo de contagiarse o no se… (Linda)
Well, because the stigma and discrimination comes from us, the providers…
because that the patient goes in for a doctor’s visit and doesn’t want to do it,
because they don’t want to see him… they don’t want to see him because they
don’t accept the disease yet, that is like for them it’s bothersome to see TB
patients because you have to do several studies which involve their time and I
imagine they are afraid of being infected, or I don’t know… (Female, 56) (This
interview was conducted in Spanish)
In addition, even when patients receive information about their condition, it is perceived
as “impersonal” and done merely to “go through the motions.” The consequences of not having a
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person-centered approach from diagnosis to discharge negatively affect the way in which a
person affected by TB perceives him/herself in the therapeutic process. It is also affects whether
they feel in charge of the process and if what they do matters.
Todo eso me explicaron pero como si estuvieran haciendo algo, como le diré,
como algo que estuvieran leyendo no fue algo personalizado no fue algo mas a
nivel como persona…como que en forma muy general…yo siento que la atención
fue buena, no mucho pero fue buena, lo que yo sentí es que me falto mas
información a mi… (No sentí que me hayan hecho) mala cara no, pero si me sentí
inferior. (Female, 49)
All of that they explained but like they were doing something, how can I tell you, it
was, like something they were reading. It wasn’t something personalized, not like
at a level of a person… like in a very general form… I feel the care was good, not
a lot but it was good. What I felt is that I didn’t have enough information… (I
didn’t feel that) they made an ugly face, no, but I felt inferior. (Female, 49) (This
interview was conducted in Spanish)
The fear of discrimination and being stigmatized not only hurts patients emotionally and
hinders recovery, but also can lead to dangerous behavior, such as finding mechanisms to
conceal the condition, resulting in possible infection of others, and most importantly, a missed
opportunity for detecting, treating or being able to follow contacts for testing.
… porque nadie investigó eso (los contactos) nadie investigó (Female, 49)
… because no one investigated this (the contacts) nobody investigated. (Female,
49) (This interview was conducted in Spanish)

…y cuando a mi me dijeron, me dijeron que fuera por mis resultados, por mis
radiografías, las estaba dando una, una muchacha que yo conocía en un trabajo y
entonces me dijo, “¿son tuyas las radiografías?,” y le dije que no… entonces me
dijo ¿de quién son? de mi mama… (me dio) vergüenza… (Patricia)

My co-workers, I was told by people in the clinic not to tell them because they had
been tested and there had been negative reactions about it. (Rita)

… and when they told me, they told me to go pick up my results, for my x-rays, a
woman I know from a job was giving them out and then she said, are your x-rays
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yours, and I said no… then she said, who’s are they, my mother’s… I felt
ashamed… (Female, 49) (This interview was conducted in Spanish)

… (Deje de trabajar) por 6 meses… ya no regrese ahí… porque por lo mismo,
porque me daba vergüenza, aquí yo pensaba… yo ya no regreso ahí, mejor busco
otro trabajo… (No batalle para conseguir otro trabajo) porque si me hubieran
preguntado si había tenido una enfermedad como la tuberculosis… no pos no les
hubiera dicho… por vergüenza...y porque pos a lo mejor no me iban a dejar
trabajar. (Female, 47)
… (I stopped working) for six months… I didn’t return there… because of the
same thing, I felt ashamed, I thought… I won’t go back there, better to find
another job… (It wasn’t difficult to get another job) because if they had asked me
if I had had a disease like tuberculosis… well, I wouldn’t have told them…
because of shame… and because maybe they wouldn’t allow me to work. (Female,
47) (This interview was conducted in Spanish)

…a mi no me dijeron nada mas yo sabía que era contagioso…si a mi mama le
hubieran platicado yo pienso que no me hubiera arrimado a la niña tan chiquita
como estaba. (Female, 47)
… they didn’t tell me anything, but I knew it was contagious… if they had talked
to my mother. I think she wouldn’t have allowed my little girl near me, as little as
she was. (Female, 47) (This interview was conducted in Spanish)
Family members may themselves become weary of their infected relative, but mostly
they become protective of the information for the sake of the rest of the family members and the
risk of being stigmatized themselves.
… my mother had intentionally kept it from (the rest of the family). She told me
specifically, ‘don’t tell, don’t tell them’… ‘Cause she had a feeling. She was
always against me talking to anyone about it from the beginning… I mean I
wanted to say it to the world, shout it from the rooftops. Especially because I felt
like once I started talking to my relatives, if only my “tía” (aunt) Aurora had told
me about her son and if only Aunt Rosa had told me about her. All these things,
so I wanted to be very open about it. (Rita)
I have a sister, (and) yes… she wouldn’t tell me directly, but she would move
away from me and when I coughed or when I got into her station wagon she
opened all the windows and she would make sure she wasn’t around me when I
talked, that we wouldn’t be facing each other… I felt horrible…because I felt
rejected… it hurt my feelings. It makes me sad because, I understood her and I
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understood also that it was because of lack of information. (I didn’t feel rejected)
by anyone (else) because in fact we didn’t make it public. (Female, 49) (This
interview was conducted in Spanish)
Por parte de mí de una hermana que yo tengo, si… ella no me decía directamente,
pero se retiraba de mi y cuando yo tosía o cuando me subía yo a su camioneta ella
abría todos los vidrios y procuraba que cuando yo hablara este no estar no cerca
de mí, si no, no directamente que estuviéramos así enfrente de una con otra… yo
me sentía fatal… porque me sentía rechazada… me da sentimiento, me da, me da
tristeza porque, yo a ella la entendí yo entendí que también era por falta de
información. (No sentí rechazo) de nadie (mas) porque de hecho yo no, no lo
divulgamos nosotros. (Female, 49)
It is unusual, but interesting, to point out that one participant revealed his strategy for
“fighting back” stigma and rejection in the health-care system was to assert himself as a person.
(En los servicios de salud sentí discriminación) ciertas ocasiones no siempre,
pero, ni todas las personas, ciertas personas hacen un gesto y comparo yo ahí
distingo inmediatamente… (le dije al doctor) me da coraje porque estoy sintiendo
discriminación aquí con usted porque a las personas casi le ofrece un refresco, un
café, hasta un dulce y a nosotros casi nos dice pa’ que vinieron, y porque ahorita
que me toca estar a mí, o algo así siento yo le digo, porque tenemos VIH…
(ahora) ya el doctor pasa y ya me saludas, el otro día me lo encontré,… y luego
me dice adiós güero… y le dije- adiós doc, Dios lo bendiga doc (doctor)… tuve
que llegar a eso porque la discriminación es muy fuerte…(Male, 36)
I felt discrimination in the health services) sometimes, not always, but, from not
all the people. Certain people make a certain gesture, and I compare and
distinguish immediately… (I told the doctor) it makes me angry because I’m
feeling discrimination here with you because to others you offer them a soft drink,
coffee, even sweet bread, and to us you say why did you come, and it’s our turn
next, and we have HIV… (now) the doctor walks by and he greets me now. I saw
him the other day… and he says hi “guero” (friendly nickname for people with
light skin or hair)… and I said, “Hi Doc”, God bless you, Doc… I had to get to
that because discrimination is very strong… (Male, 36) (This interview was
conducted in Spanish)

5.4 ABOUT PARTICIPATION IN THE VOICES AND IMAGES OF TB PHOTOVOICE
INTERVENTION (PROJECT)
“It was amazing to think that without TB this would not have been a possibility.
And before joining Photovoice, I had not thought of any one thing, any positive
thing coming out of me having TB. TB Photovoice was a Godsend. It was my only
157

outlet during those three months. I saw how much I could touch people with my
story.” (Female, 41)
The participants offer the best description of the TB Photovoice Project known as Border
Voices and Images of TB. Participants describe the project as valuable in their recovery and
personal growth. Whether a participant is someone who has dealt with the infection, or is a
family member or even a health-care worker who has not had the infection, Photovoice helped
them identify their feelings about tuberculosis and the stigma attached. Most importantly, their
status as human beings deserving of rights as people and as patients was reinforced.
En Fotovoz… pues aprendí a que… que no tenemos por qué avergonzar de eso,
porque pues a cualquier persona le puede pasar ya sea rico o pobres, sucio o
limpio… (Female, 47)
In Photovoice, well, I learned that we don’t have to feel shame about it, because it
can happen to any person, rich or poor, dirty or clean…(Female, 47) (This
interview was conducted in Spanish)

… aprendí el derecho de las personas, porque no sabía yo en ese momento no
sabía que tenía derechos, teníamos voz para defendernos (de los doctores)…
porque ellos son los que saben todos… aprendí a defender a defenderme como
paciente como
persona, a pedir el medicamento, que no me falte el
medicamento… (Female, 36)
… I learned the rights of people, because I didn’t know at that moment that I had
rights, that we had a voice to defend ourselves (from the doctors)… because they
are the ones who know everything… I learned to defend myself as a patient as a
person, to request my medication, that I don’t lack my medication… (Female, 36)
(This interview was conducted in Spanish)

I learned how to identify as a person and as a patient… I think Photovoice opened
the way… it was good for me because what I feel came out… (Female, 36) (This
interview was conducted in Spanish)
Aprendí como identificarte como persona, como paciente… Fotovoz me dio me
abrió el camino… a mi me sirvió de mucho porque saco lo que siento… (Female,
36)
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The recovery is described as both physical and emotional by the Photovoice participants
and expressed as the result of sharing with others in a similar situation and identifying
themselves as part of the group. Discovering a common experience is seen by participants as an
important element.
… al principio casi todas las fotos (Proyecto de Fotovoz) yo observaba que eran
como algo trágico lo que retratábamos, después ya era algo mas motivacional…
empezamos aprender muchas cosas que todo nos motivaba a tomar fotos de vista
desde otro ángulo, de verdad que fue algo muy interesante. (Female, 43)
… in the beginning almost all the photos (Photovoice Project) I saw were like
something tragic what we were photographing. Later they were more
motivational…We started learning many things which motivated us to take photos
from another angle, it was really something very interesting. (Female, 43) (This
interview was conducted in Spanish)

… pos yo creo que ahí aprendí muchas cosas o sigo aprendiendo más cosas… de
Fotovoz, de cómo me sentía yo, yo sabía que me sentía triste, pero nunca me
imagine que todos los que estaban a mí alrededor se sentían así como yo me
sentía. (Female, 36) (This interview was conducted in Spanish)
… well I believe I learned many things, and I keep learning more things… from
Photovoice, about how I felt. I knew I felt sad, but I never imagined that everyone
who was surrounding me felt the way I felt. (Female, 36)

Para mí, yo pensaba que la tuberculosis le daba por decir a las personas que vivían
de bajo de los puentes (como a los vagabundos)… a la gente muy sucia, yo
pensaba que la tuberculosis era mortal, pensaba que la tuberculosis era una
palabra que yo nunca iba tener relación con ella. (Female, 43)
For me, I thought that tuberculosis affected people who lived under bridges (like
a homeless person)… very dirty people. I thought that tuberculosis was fatal. I
thought tuberculosis was a word I would never have anything to do with.
(Female, 43)

… aprendí a que hay más gente como uno y que no debe uno de ocultarlo,
(debemos) tener más información… sobre más personas, casos que hayan
sucedido este así como los míos, para uno atreverse a hablar ya de ello y no
ocultarlo, no callárselo. (Female, 49)
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… I learned that there are more people like us and that you shouldn’t hide it, (we
should) have more information… I learned about more people, cases which have
happened like mine, to dare to speak about it and not hide it, not stay silent.
(Female, 49) (This interview was conducted in Spanish)

… no sé yo cual será la labor de una psicóloga, pero yo siento que fuimos como
un poco psicólogos todos … dicen que cuando va uno al psicólogo saca uno sus
problemas… entonces cada vez que hablábamos nosotros y que expresábamos lo
que sentíamos de las fotos, yo sentía que me quitaba una carga de encima.
(Female, 49)
… I don’t know what the job of a psychologist is, but I feel that we were all a little
bit psychologists…They say that when you go to the psychologist you bring out
your problems… then each time we spoke and expressed what we felt what we
thought of the photos, I felt a load was taken off of me. (Female, 49) (This
interview was conducted in Spanish)
Photovoice gave participants the opportunity to communicate their inner thoughts and
feelings to others within an emotionally safe workshop setting. They did this through a
participatory method of dialogues, selecting photographs that most accurately reflected their
concerns and perspectives on tuberculosis, and their communities for discussions. They
contextualized or told stories, and then identified the issues and themes that emerged.
Participants shared their reflections with the group and defined the meaning of their images using
the SHOWeD technique (Wallerstein, 1994). Participants describe the SHOWeD technique as
“difficult” because they realize that they may have to reveal some of their most intimate feelings
and thoughts, but in all cases, they also describe the experience of the exercise to be of great
value in allowing them to communicate without words. In a sense, all participants, regardless of
their personal or professional backgrounds feel they are on a level playing field.
Yo diría que (Voces e Imágenes) es cómo, que es sacar uno todo lo que uno
siente, de lo que fue rechazado, lo que fue el estigma, todo lo que paso uno, es
sacarlo uno pero plantarlo en una sola foto… (Female, 49)
I would say that (Voices and Images) is like bringing out everything you feel, of
how you have been rejected, what stigma was like, everything you went through.
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It’s bringing it out to put it in one photo… (Female, 49) (This interview was
conducted in Spanish)

Everyone was the same there, the male doctor, the female doctor, the nurse… I
felt very good because it was like if we were all friends. (Female, 56) (This
interview was conducted in Spanish)
Pues ahí todos eran parejos, el doctor, la doctora, la enfermera… pues me sentí
muy a gusto porque era como si hubiéramos sido todos amigos. (Female, 56)

Voices and Images, I see it as a way to get to know the patient as a person,
besides as a patient. Of how a patient feels who has had tuberculosis… and that
the image says what they are feeling, it’s something very specific and I think it’s
very nice. (Female, 50) (This interview was conducted in Spanish)
Voces e Imágenes, yo lo veo como una forma de conocer al paciente como
persona, aparte de paciente. De cómo se siente un paciente que ha padecido
tuberculosis y… que esa imagen diga lo que él está sintiendo, es algo muy
especifico y se me hace muy bonito. (Female, 50)
As participants go through the photo experience, they indicated that they feel encouraged
to reveal how they see the world. Moreover, they also learn more about tuberculosis.
… yo no creí (que la tuberculosis) fuera tan… porque yo casi no había oído hablar
de la tuberculosis, era raro que se escuchara sobre la tuberculosis por eso también
el estigma…pues cuando me la detectaron yo supe que todavía existía… (Female,
47)
… I didn’t think (that tuberculosis) was so… because I hardly heard anything
about tuberculosis, it was rare to hear about tuberculosis and the stigma as
well… well when I was diagnosed, I knew it still existed… (Female, 47) (This
interview was conducted in Spanish)
(Antes de Fotovoz no sabía cosas de la tuberculosis)… hoy ya se, más o menos
bien… si yo quiero estar bien tengo que tomar los medicamentos. (Mi hijo)
decía manda un mensaje diciendo: el TB si es curable, no dejes que te arrebate la
vida… (Female, 36)
(Before Photovoice I didn’t know things about tuberculosis)… today I know, more
or less… if I want to be well, I have to take my medication. My son would say
send a message saying: TB is curable, don’t let it take your life away…(Female,
36) (This interview was conducted in Spanish)
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Participants perceived impacts throughout their lives: impacts on their family, on their
lives at work, and even in their communities as a result of Photovoice and revealed by their
description of the impact. There are perceived individual impacts throughout their lives: impacts
on their family, on their lives at work, and even in their communities as a result of Photovoice:
… lo que más me gusto de voces e imágenes fue el hecho de que me hayan hecho
que me hicieron salir de esa oscuridad donde estaba yo, donde me encontraba,
estaba en un callejón sin salida… es como un arma que yo traigo a mi favor que
es con la que estoy abriendo camino o simplemente haciendo a un lado lo que sé
que no debe estar ahí. (Male, 36)
What I liked most about Voices and Images was that they made me come out of
the darkness I was in, like a dead end… it’s like a weapon that I have in my favor
in which I’m opening the way or simply putting aside what should not be there.
(Male, 36) (This interview was conducted in Spanish)
Participants speak of personal and professional growth:
(Aprendí) estar creciendo como persona, como enfermera, como compañera. Y te
digo estar creciendo porque nunca se termina de aprender… algo muy íntimo
dentro de esas sesiones de Voces e Imágenes que a veces ni a mis hermanos ni a
mis papas les he compartido algo tan íntimo como aquí. (Female, 50)
(I learned) to grow as a person, as a nurse, as a partner. I tell you to grow
because you never stop learning… something is very intimate in the Voices and
Images sessions. Sometimes I have not even shared with my siblings or my
parents something so intimate. (Female, 50) (This interview was conducted in
Spanish)

… a pesar de que yo había trabajado mucho con pacientes… no es lo mismo estar
concentrada… estar oyendo lo que decían los pacientes porque ellos decían como
sentían… para mí fue como enriquecer, porque así cuando llego con los
pacientes, que platico con ellos, me acuerdo de lo que se platicaba en Fotovoz…
(Female, 56)
… even though I had worked with TB patients for a long time… it’s not the same
when you concentrate and listen to what the patients talk, about how they felt…
for me it was enriching… because now when I speak to patients, I remember what
was said in Photovoice… (Female, 56) (This interview was conducted in
Spanish)
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Compartí (con ellos) su vida personal, escucharles, compartí esa intimidad con
ellos. (Female, 50)
I shared (with them) their personal life, to listen, to share that intimacy with them.
(Female, 50)
The transformative “magic” of the photos and stories can be best understood by their
words regarding the photos they “liked” best and why.
(During the first week I took a photo)… of the dove… she was on the floor… she
was dead… because that is how I felt when they gave me the diagnosis, and I said
it at that moment, I think I even wrote it on that photo because that is how I felt.
and after I started giving it my all and gradually overcame it with the help of my
family. (Then I looked for)… a white dove (that was flying because it represented
for me)… that I had been liberated, that I had overcome all my complexes, my
traumas, my stigmas. (Female, 49) (This interview was conducted in Spanish)
(Durante la primera semana tome una foto)… de la paloma… estaba en el piso
tirada… estaba muerta… porque era como me sentía yo cuando me dieron el
diagnostico y lo dije en ese momento, creo que hasta lo escribí en esa foto porque
así me sentía yo, y después como le fui echando ganas y como lo fui superando yo
poco a poco con la ayuda de mi familia. (Después busque)… una paloma blanca
(que estuviera volando porque representaba para mí)… que me había liberado,
que ya había superado todos mis complejos, mis traumas, mis estigmas. (Female,
49)

Tengo una (foto favorita)… uno que estaba tapado, así como escondido así detrás
de…. porque en cierto modo se siente uno así… escondido, que no lo vea uno
nadie, se hace para un lado… yo me llegué a sentir así. (Female, 49)
I have (a favorite photo)… someone who was covered, like hiding behind…
because in a way you feel like that… hidden, you don’t want anyone to see you,
you step to the side… I felt like that. (Female, 49) (This interview was conducted
in Spanish)

Me llamo mucho la atención una foto de los compañeros la de los escalones…
arriba hay una luz de esperanza… si llegaba, lograba llegar ahí ya podía lograr
muchas cosas más… porque me esforcé al subir esas escaleras por eso me
recuerdo mucho esa imagen, esa foto. (Male, 36)
I was drawn to a photo by one of the others about the stairs… at the top there was
a light of hope… and if I managed to get there I could get many more things…
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because I made the effort to climb those stairs I remember that image, that photo.
(Male, 36) (This interview was conducted in Spanish)

(I remember the photo of a ferris wheel) because that was the one that filled me.
One day, we were with a patient and I said stop, stop because I want to take that
picture. Because that speaks of the ferris wheel that goes up, and that is always
life’s plan in all respects, not only in tuberculosis, in any situation in your life,
because maybe today I have money, tomorrow not, maybe today I have health,
tomorrow not, it is like life, the ferris wheel. (Female, 47) (This interview was
conducted in Spanish)
(Me acuerdo de una foto de la rueda de la fortuna) porque esa fue la como que
mas me lleno. Un día íbamos con un paciente y le digo párate, párate porque yo
quiero tomar esta. Porque eso habla de que la rueda de la fortuna es hacia arriba, y
ese siempre es el plan de la vida en todos los aspectos, no nada más en
tuberculosis, en cualquier padecimiento, en cualquier situación de tu vida, porque
a lo mejor ahora tengo dinero, mañana no, a lo mejor ahora tengo salud, mañana
no, eso es como la vida, la rueda de la fortuna. (Female, 47)

La (foto) que más me gusto, y que así me azoto al máximo fue la del carrito
rojo… esa foto, y lo recuerdo porque constantemente vivo, en esta foto una forma
de plasmar mi impotencia, mi coraje, mi desilusión, mi frustración sobre todo, mi
impotencia y frustración. El paciente me está necesitando, no es porque yo quiera,
es porque el paciente me está necesitando y no tiene a nadie más que nosotros.
Esa es mi frustración… así es mi impotencia… por eso recuerdo esa foto, cuando
lo vi, dije así me siento como ese carrito… (Female, 50)
The (photo) I liked best, which struck me to the max was the one of the little red
car… that photo, and I remember it because I live it constantly, there is a way to
reflect my impotence, my anger, my disillusionment, my frustration but most of all
my impotence and frustration. The patient needs me, not because I want to, it’s
because the patient needs me and has no one but us. That is my frustration… that
no one else will help him… that is my impotence… that is why I remember that
photo, when I saw it I said that is how I feel, like that little red car… (Female, 50)
(This interview was conducted in Spanish)

… de mis fotos, la que me gusto mucho fue la de una, donde esta una amiga mía
en silla de ruedas…porque ella a pesar de todas sus limitaciones le echaba muchas
ganas, muchas ganas y esa un poco me veía yo reflejada en ella…de hecho… las
mismas frases todo lo que venía ahí en las fotos se puede aplicar a diferentes
enfermedades no nomás a la TB. (Female, 49)
… of my photos, the one I liked most was of a friend of mine in a wheelchair…
because despite all her limitations, she gave it her all, and I felt reflected a little
164

in her… in fact the same phrases and everything you can see in the photos can be
applied to all illnesses not only TB. (Female, 49) (This interview was conducted
in Spanish)
Participants had a hard time finding anything to say when asked what they did not like
about the experience. Following are some of the comments they made.
Me disgusto…el hecho de que hubiera ciertos compañeros que sus parejas les
impidieran que siguieran adelante con su proyecto sabiendo que es un proyecto
muy importante… (Male, 36)
I disliked the fact that there were some participants whose partners did not allow
them to continue with the Project even though they knew it was an important
project… (Male, 36) (This interview was conducted in Spanish)

Bueno (lo que cambiaria seria) las fotos porque siempre andábamos a la carrera
porque mucho tiempo no teníamos…claro que nosotros hubiéramos querido tener
más tiempo. Era que nosotros después de nuestro trabajo nos quedábamos, tres,
cuatro horas… (Female, 56)
(What I would change would be) the photos because we were always in a hurry
because we didn’t have a lot of time… of course we would have liked to have
more time. It was that we had to stay after work for three, four hours… (Female,
56) (This interview was conducted in Spanish)

Lo que menos me gusto, para mí, que a veces se hacía muy larga, estaba muy
entusiasmada la reunión, pero para mí se alargaba mucho, pegado con el trabajo y
que tengo que ir con mi muchachito, se me hacía muy largo… (Female, 50)
What I liked the least, for me, was that sometimes it was very long, the meeting
was very lively, but for me it was too long, together with work and that I have to
go take care of my little one, it seemed too long… (Female, 50) (This interview
was conducted in Spanish)
Participants also commented about the things that were most difficult for them during the
project.
Pues es que no se me hizo difícil a mí…será porque me ayudo mucho hablar con
los demás y compartir experiencias que eran para ellos sus fotos, lo que
significaba y luego mis fotos compartirlas con ellos. (Female, 49)
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Well it didn’t seem hard for me…maybe because it helped a great deal to speak to
others and share experiences about their photos, what they meant and then share
my photos with them. (Female, 49) (This interview was conducted in Spanish)
Participants were able to identify multiple impacts to their lives, especially impacts to
their personal lives.
A mí (me impacto) bueno pues yo creo que ya lo dije algunas veces, fue como la
forma, la manera de sacar uno todo lo que trae adentro, eso fue y ponerlo,
expresarlo uno y compartir las experiencias con los demás, y decir uno no estoy
solo como estoy yo o como estuve. (Female, 49)
I was impacted; well I think I told you several times, it was like the form, the way
of getting everything out that is inside. That was it, and to put it, for one to
express it and share the experiences with others, and to say I am not alone like I
am or have been. (Female, 49) (This interview was conducted in Spanish)

Si me impacto porque el descubrir que yo podía manifestar mis sentimientos con
una fotografía para… (Female, 50)
Yes, it impacted me because to discover that I could manifest my feelings with a
photograph… (Female, 50) (This interview was conducted in Spanish)

No, yo había manifestado mis sentimientos a través de escritura e ideas, pues lo
que yo he vivido pero… en una imagen eso fue algo novedoso para mí. Y describí
como las demás personas tienen tanta sensibilidad…ni la puedo yo descubrir si no
es a través de una imagen… pero a través de una imagen, y yo a veces me sentí
chiquitita porque ellos tenían una sensibilidad que no necesitaban escuela ni
necesitaron para explicar con que intensidad… (Female, 50)
No, I had manifested my feelings through writing and ideas, what I have lived,
but… in an image it was new to me. And I described how the other people have so
much sensitivity… I can’t even discover it if it is not through an image… but
through the image, and I sometimes felt so little because they had the sensitivity
and they did not need school (education) and they did not need it to explain how
intense…(Female, 50) (This interview was conducted in Spanish)

Para mí, voces e imágenes me dejo que yo me puedo acordar de un escenario que
yo tuve tuberculosis… (y pude hablar). Si, y no me importa salir en el periódico,
en la televisión o donde sea, porque Voces e Imágenes me enseño que hay que
hacer, que hay que levantar la mano, levantar la voz para que el mundo nos oiga
que la tuberculosis existe y que los médicos entiendan… (Male, 42)
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For me, Voices and Images left with me that I can now remember a scenario when
I was told that I had tuberculosis… (and I could speak). Yes, and I don’t mind
being in the newspaper, on TV or wherever, because Voices and Images taught
me what we must do, to raise your hand, raise your voice so that the world hears
that tuberculosis exists and that the doctors understand…(Male, 42) (This
interview was conducted in Spanish)

Creo que me dejo un valor tan grande y poderoso para mí porque yo no tenía, no
tenía el valor de pararme enfrente de un doctor y decirle lo que paso lo que estaba
pasando alrededor de mi hijo y yo… (Female, 36) (This interview was conducted
in Spanish)
I believe it left me such great courage and was powerful for me because I didn’t
have, I didn’t have the courage to stand in front of a doctor and to tell him what
was happening around my son and me… (Female, 36)

And to end up going to another country (South Africa) to talk to the people that
had the most impact on decisions made about TB treatment, research and all that,
to be representing like a group or whole country, two countries, was something
unimaginable to me. (Female, 41) (This interview was conducted in English)

… pues yo pienso que en todo me ha favorecido en todo, pues que puedo decirte
que no me haya favorecido, me favorece tanto, en cómo, en una cosa, eso de que
como tratar con los demás compañeros, como hablar con los demás
compañeros… o sea me hicieron sentir en este programa, me hicieron sentir que
valía tanto como los que estaban a mi alrededor… (Male, 36)
… I believe that it has benefited me in everything, there is nothing I can tell you
that did not benefit me, so much, in one thing, that of treating the other
participants, how to speak with the other participants… that is that they made me
feel in this program, they made me feel that I was as worthy as the people around
me… (Male, 36) (This interview was conducted in Spanish)
Participants spoke of the perceived impact of Photovoice on their families.
(Mi familia)… ellos me ayudaban mucho a buscar fotos… ellos me decían, yo
hablaba por teléfono con ellos y una de las veces me ayudaron a buscar fotos,
pues de hecho lo de la paloma también ellos estuvieron de acuerdo, y una ventana
también… donde por esa ventana no pasa la luz… ellos me escribían, ayudaban.
(Female, 49)

167

(My family)… they helped me a lot in looking for photos… they would tell me, I
would call them on the phone, in fact they gave the idea about the dove and a
window too… where light did not come through… they would write to me, help
me. (Female, 49) (This interview was conducted in Spanish).

(Fotovoz) fue lo que yo le dije a mi sobrina, le dije mira mi’ja yo estuve en este
proyecto, dije porque vemos mucha gente ignorante que pensamos que porque
tenemos esa enfermedad… ya todos nos van a señalar y todos van a hablar de
nosotros… y esto es para que cualquiera que te diga algo tu le enseñas esto y dile
que no sea ignorante porque aquí puede aprender lo que es la tuberculosis, y que
no nada más tu o a que a cualquiera le puede dar… (Female, 56)
(Photovoice) was like I told my niece, I said look I was in this project, because we
see many ignorant people, we think that because we have the disease… everyone
is going to point us out, that they are going to talk about us… and this is so that
anyone who says something you can show them this and tell them not to be
ignorant because here they can learn what tuberculosis is, and that not only you
but anyone can get it… (Female, 56) (This interview was conducted in Spanish)
Participants spoke of impacts in their communities and in other areas of their lives.
Bueno yo creo que mediante los foros que se consiguieron mediante voces e
imágenes para que los dirigentes, como representantes del gobierno, que puedan
dar los fondos o presupuestos para atacar a esa enfermedad verdad, es muy
buena… (Female, 43)
I think that through the forum that we had for the leaders through Voices and
Images. It was like government representatives who can get the funding or budget
to attack that illness is very good… (Female, 43)

I think the place where I saw immediate effects, I don’t want to say that it was
because of me, but I was invited to Washington D.C. last July (RESULTS
International, an advocacy organization) and attended what I call activist book
camp because it was eight days of very intense training with a group called result.
I haven’t joined them officially, but they do want me back. And they gave me a lot
of information on how to be more effective. I saw how much I could touch people
with my story. Two weeks after I was there, there was a passing of a bill where
millions of dollars were put into malaria, TB and HIV education and research.
(Female, 41) (This interview was conducted in English)

… So all of that made me feel, “Yes, I can make an impact,” and that’s the latest
thing that I have felt rewarded for in a way. TB has its ups and downs but this is
one of the rewards. (Female, 41) (This interview was conducted in English)
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… (my family now asks) but what does this mean really?” Okay, let’s go to the
doctor and find out. So I think there they’re not taking things at face value
anymore, especially with medical professionals. So I like that, that has been a
really good positive thing. (Female, 41) (This interview was conducted in
English)

(Como resultado de mi participación en Fotovoz) por ejemplo… reconozco más el
estigma y la discriminación. (Female, 49)
(As a result of my participation in Photovoice) for example… I recognize stigma
and discrimination more. (Female, 49) (This interview was conducted in Spanish)

Pues ya no, ya no, no pienso como antes de Fotovoz, que la hacen a uno sentirse a
veces hasta culpable, hasta como si uno provocara la enfermedad. (Female, 49)
Well I don’t think like before Photovoice, that they make you feel even guilty at
times, even like you provoked the disease. (Female, 49) (This interview was
conducted in Spanish)

(If someone starts talking negatively about a person with tuberculosis or says
something in a belittling way) I tell them that they have to become informed, and
that it’s curable. First of all, the majority of the people think that tuberculosis is
an incurable disease and I make them see that it is curable and that we have to be
informed first, to give an opinion. (Female, 49) (This interview was conducted in
Spanish)
(Si alguien por ejemplo empieza a hablar mal de una persona con tuberculosis o le
dice de alguna manera despreciable) yo les digo que tienen que informarse y que
tiene cura, primero que nada la mayoría de la gente piensa que la tuberculosis es
una enfermedad que no tiene cura y yo les hago ver que tiene cura y que hay que
informarnos primero, para poder dar una opinión. (Female, 49)

(Aprendí todo eso) por… las pláticas que tuvimos, por la forma en que se hizo las
pláticas que nos hacían entrevistas y todos… muchos llorábamos, muchos reímos,
muchos hicimos… sacamos nuestros sentimientos a flote. (Female, 47)
(I learned all of that) through… the discussions that we had, by the way the
discussions were done, that they interviewed us and we all… a lot of us cried, a
lot of us laughed, a lot of us did… we brought our feeling to the surface. (Female,
47) (This interview was conducted in Spanish)

169

For some individuals, there were additional benefits.
Si yo pienso que el hecho de que voces e imágenes nos llevara ante personas
importantes que deciden lo que se hace con los recursos para las instituciones de
salud, nos ha ayudado para que nosotros le podamos decir a las personas, usted
valla a tal parte y exija que los medicamentos se los den, y valla a tal parte y exija
que le den atención inmediata, porque nosotros sabemos que hay recursos para
eso… (Female, 43)
I think that the fact that Voices and Images took us to important people who
decide what to do with the resources that go to the health agencies, has helped us
to tell the people, go to this place and demand the medication, they have to give
them to you, and go to this place and demand immediate attention, because we
now know there are resources for that…(Female, 43)(This interview was
conducted in Spanish)
Changes participants would like to see in the Photovoice Project.
… pos yo no cambiaria de Fotovoz nada, me gusto todo lo que hacíamos,
trabajamos en, cuando teníamos la reunión éramos muy unidas y entendíamos los
dolores de las personas, entendíamos como vivían, y lo que me gusto mas fue que,
que era privado, que lo que platicábamos ahí, era confidencial no estábamos este
divulgando, porque yo llegaba a mi casa y si platicaba lo que yo hacía pero ya de
sentimental o de que así confidencial no… (Female, 36)
… I would not change anything about Photovoice. I liked everything we did, and
we worked on. When we had the meetings we were very united, and we
understood the pain of people, we understood how they lived, and what I liked
most was that it was private, that what we talked about there, was confidential
and we were not divulging, like I would go home and tell them what we discussed
except the emotional or confidential moments, not that…(Female, 36) (This
interview was conducted in Spanish)

(What I would change is) the length of it, maybe make it a little longer. Maybe a
few weeks to prepare the photos, I think. And I felt a little rushed to put it together
for a presentation. I think that maybe if it would start maybe during the summer
and have a few more weeks with photographs and then more time to prepare,
once, to put it together… and working on our narratives, I think. Because most of
it was like you talk and say, talk about whatever you want in whatever way you
want. And that was great talking to each other, but once we were presenting it in
public to professionals, to people that are used to just hearing the facts, to maybe
tidy it up a little or make it hit the highlights more than rattling on. I know a lot
of us did that. We went on and on. (Female, 41) (This interview was conducted in
English)
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(Lo que cambiaria de Voces e Imágenes) que se haya acabado tan pronto… me
hubiera gustado que hubiera seguido más…me hubiera gustado que hubiera
seguido dos, tres meses más. (Female, 49)
(What I would change about Voices and Images) is that it was over too soon… I
would have liked it to have continued more… I would have liked for it to go on for
two, three more months. (Female, 49) (This interview was conducted in Spanish)

… me gustaría que hubiera más gente involucrada…en el grupo…como
participantes, yo pienso que hay mucha gente y que de algún modo, no se dio
mucho a conocer, para ser nosotros el grupo más grande, porque éramos un grupo
y a veces no podíamos asistir unos y ya este demeritaba mucho…y cuando no
podíamos asistir todos, por el trabajo o por una cosa, entonces me hubiera sido,
que se hubiera dado más conocer. (Female, 49)
… I would have liked it that more people became involved… in the group…as
participants. I think that there are a lot of people and that in some way, there
wasn’t a lot of promotion, and yet we were the largest group, because we were a
group and sometimes we couldn’t all go and that would lessen it… and when we
couldn’t all go, because of work or some other thing, then I would have liked it to
be promoted more. (Female, 49) (This interview was conducted in Spanish)

(Lo que cambiaria seria que) trataría de juntar más, más gente… porque pues en
si mi enfermedad no estuvo tan grave como las de otras personas que yo oí… a
los 2 o 3 meses yo ya me sentía mucho mejor, y yo oía aquí que unos ya tenían
años o tratándose y todavía seguían con el problema… pues (quisiera decirle) al
mundo que, que puede, que apoye, que ayude, que porque nadie somos inmunes,
que cualquiera sea rico o pobre, nos puede pasar y vamos a necesitar la ayuda.
(Female, 47) (This interview was conducted in Spanish)
(What I would change would be) to try to get more people… because if my disease
was not as serious as other people’s that I heard, I felt much better in 2-3 months,
and I heard that some of them had been in treatment for years and they still had
problems… well, (I would like to tell) the world that they can to give support and
help, because none of us are immune, that anyone, rich or poor, it can happen to
us, and we are going to need help. (Female, 47)

(Cambiaria) que el grupo no fuera tan grande, que fuera por ejemplo, de unas
cuatro, cinco gentes, más chico, para que el compartir de cada uno fuera más
profundo, fuera más rápido y no estar con que ya me tengo que ir y todavía nos
falta tanto y ya no estoy escuchado realmente el compartir de la otra persona. A
mí me llego a suceder. (Female, 50)
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(What I would change would be) that the group would not be so big, for example,
four or five people, smaller, so that the sharing would be deeper, faster and not
have to be I have to leave and there’s still so much to do and I’m really not
listening to the sharing of the others. That happened to me. (Female, 50) (This
interview was conducted in Spanish)
Individuals identified additional experiences related to their participation in the
Photovoice Project. Experiences ranged from the need for psychological and counseling services
for the PATB to the need for both the United States and the Mexican government to work
together in a binational manner to fund, treat and cure PATB.
(Es importante un tratamiento psicológico), porque así como queda la caverna que
se hace en el pulmón que jamás se va reestructurando completo queda una cicatriz
ahí adentro, yo pienso que del subconsciente queda una lastimadura
considerable… (Male, 42)
(Psychological services are important) because in the same way that there is a
cavernous hole in the lung that never really restructures itself completely, there is
a scar inside, I think that there is a considerable wound in the subconscious…
(Male, 42) (This interview was conducted in Spanish)

…fíjese, yo, yo pienso en esto, en cuestión de la salud no hay fronteras, ni hay
una bandera que, que pueda limitar la entrada o salida de un virus o una
enfermedad, en el caso de México está la situación de la fiebre y diarrea… la
organización mundial de la salud yo siento que debería ser una cosa más fuerte
que ni las naciones unidas… pero en la cuestión de la salud pues todos somos
seres humanos y todos necesitamos el mismo planeta, entonces no hay quien este
más protegido no debería de haber quien este más protegido que otro sino todos…
(Female, 43)
… I think about this, in questions of health there are no borders, there is no one
flag that can limit the entry or exit of a virus or illness. In the case of México
doing there is the case of fever and diarrhea… the World Health Organization I
feel should be something stronger than the United Nations… but in questions of
health, we are all human beings, and we all need the same planet, so no one
should be more protected, but all… (Female, 43) (This interview was conducted
in Spanish)
… bueno pues que fue una experiencia que me ayudo, que me ayudo mucho, me
ayudo a conocer gente con los mismos problemas de nosotros porque hay un
momento dado que cree uno cuando le dan a uno la noticia que nomás es uno y
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está mal decirlo verdad, pero como el dicho ese de que el mal de uno es el mal de
muchos, ya la hace uno sentirse mejor, no porque estén mal los otros si no porque
dice uno, no estoy solo en esto. (Female, 49)
… well, it was an experience that helped me, helped me a lot. It helped me to meet
people with the same problems as myself because there is a point when you are
given the news and it’s only you, and it’s wrong to say this, but, like that saying
about your problem being a problem of many, but it makes you feel better, not
because the others are sick, but because you say, I’m not alone on this. (Female,
49) (This interview was conducted in Spanish)

… por supuesto que lo recomendaría al mundo entero no nada más a personas
afectadas, a afectadas y no afectadas como dice usted, a todo mundo le
recomendaría, a los afectados porque, le voy a decir el porqué a los afectados
aprenderían muchísimas cosas que yo he aprendido, y sé que les daría el mismo
valor que me dio a mí y sé que agarrarían las mismas fuerzas o a lo mejor mas,
porque tal vez pueda hay otras personas que traen mas pero que no pueden
hacerlo porque no saben cómo, traen muchísimo material que no saben cómo
manejarlo, entonces yo pienso que es importante que tanto a los afectados que se
den cuenta para que sepan defenderse de los no afectados y a los no afectados
para que no afecten tanto a los que ya estamos afectados. (Male, 36)
… of course I would recommend it to the whole world not only for affected
people, but also for affected and not affected. I’m going to tell you why the
affected would learn many things I have learned, and I know it would give them
the same courage I have gotten and they would get as much strength or even
more, because there may be people who have more but they don’t know how. They
have a lot of material but don’t know how to manage it. So I think it is important
that the affected learn how to defend themselves from those not affected and for
the not affected so that it doesn’t affect those of us who are already affected.
(Male, 36) (This interview was conducted in Spanish)

(El impacto a mi comunidad fue) pues si porque yo ya les digo que yo padecía esa
enfermedad… ya no me da pena. (Female, 47)
(The impact to my community was) well, because I told them I had the disease…
I’m not embarrassed. (Female, 47) (This interview was conducted in Spanish)
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About the Voices and Images Intervention (Project)
I would like to discuss the fact that there is so much co-infection… the fact that
TB doesn’t occur just by itself. A lot of times it comes along and who suffer these
conditions, have a propensity to develop and contract TB more. People with HIV,
people with diabetes, people that have hepatitis C, drug use, alcoholism, all of
those things, like we’ve said so many times: the treatment for that person that will
encompass those conditions needs to be more integrated. (Female, 41) (This
interview was conducted in English)
Everything was really positive. The actual experience, working with the groups
and the photographs, I would change nothing; just more time, time constraints.
(Female, 41) (This interview was conducted in English)

(In a year) I want to be home, with my family. I would like to be trained to work
with poor people to tell them about tuberculosis… in their language, to help them
understand, without complications, to be understood by people of little means,
because I always say; what we need is more information. (Female, 49) (This
interview was conducted in Spanish)
(En un año) quiero estar en mi casa, ya con mi familia. Me gustaría mucho estar
capacitada… en una forma de poder llegar a la gente muy humilde, a hacerles
saber que es la tuberculosis… yo informarles pero que en su en lenguaje de ellos,
en su entendimiento de ellos, sin mucho complicación, hacerme entender con la
gente muy humilde, porque yo siempre digo que aquí lo que es, es falta de
información. (Female, 49)

(En un año) me gustaría estar trabajando, estar en mi casa, con mis hijos en lo
que sea me importa trabajar nada mas, y este, convivir con mis hijos y con mi
esposo. (Female, 56)
(In a year) I would like to be working, to be at home, with my children. I just want
to work, it doesn’t matter doing what, and to be with my children and my
husband. (Female, 56) (This interview was conducted in Spanish)

Entre mis compañeros si (tuvo impacto) porque ¿Qué andas haciendo? Y ya les
platicábamos de que se trataba y empezaron, algunos, que eran más apáticos,
empezaron ya a ver a los pacientes mejor, y ahora que han traído las maquetas, las
fotos, y que se han puesto en las unidades, algunas unidades si se han, como te
quiero decir, ya se han sensibilizado mas sobre los pacientes. (Female, 56)
Among my fellow workers (it had impact) they would ask why? What are you
doing? And we would tell them what it was, and they started, some, who were less
interested, they started to look at the patients in a better was. Now that they have
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brought the models, and the photos and they have put them in the units. Some of
the units have, how can I tell you, have been sensitized more about the patients.
(Female, 56) (This interview was conducted in Spanish)

(In the next few years I see myself) doing something different or…basically I see
myself still teaching and still being involved … But I see myself going back
gaining more, finding out more about what the situation is now because I know
statistics hopefully have changed and improved; and so I will educated myself to
the current situation, TB situation and funding. And now with this AH1N1
situation it brought back so many memories seeing all these people with the face
mask. It brought back, first of all, all the feelings of stigma I told you guys
sending you in the mail, “Did you ever think there would be so many people out
in public with their face mask?” And I don’t think that they are feeling any
stigma. I wonder why couldn’t we all just gone out with our face mask when you
had to wear them as the TB affected people. (Female, 41) (This interview was
conducted in English)
About the tenth interview
By a series of chance circumstances, one of the interview participants was a student at a
local university on a scholarship going through a doctoral program. On a visit to the building
where the researcher advertised the project, he read about Photovoice and thought it would be
interesting for him to participate. This student from the Netherlands had been infected by his
sister, and had received treatment in the health care system of the Netherlands.
None of his responses were included in the analysis presented above and left for the
conclusion intentionally. Many aspects of his experience are completely different, but not all.
Surprisingly, his sister was originally misdiagnosed and had to go through testing for three
months until she could get a correct diagnosis –that she had pulmonary tuberculosis. By then,
many family members and an undisclosed number of other people were infected, had to be tested
and treated.
Eventually she went to the hospital and they asked her to cough up the phlegm,
the sputum and they put it in a culture and then it turned out that it was
tuberculosis. That was like five or sixth months after she showed her first
symptoms. By that time she had developed active tuberculosis and I was infected
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as well as half of my family. I tested positive on the skin test and I took six months
of medication. So for me, by that time I hadn’t shown any symptoms yet, it was
more her that showed symptoms. (Male, 28)
Because TB is a fairly rare disease in Holland, the event became national news, some
with the intent to warn people that TB is still affecting people in the country, and some
sensationalizing the story, given that the PATB was a nurse in the neonatology department of the
only hospital in the small town. Where the story takes a very different turn is in the treatment and
the care received from the health care system in the Netherlands. The interview participant
realized after listening to the stories of the U.S.-México participants, that they had received the
most respectful and effective healthcare possible. However, he also acknowledged that because
there is a high socioeconomic and educational levels in Holland, the supervision of treatment
trusts that the patients will follow the treatment indications and remain adherent with very little
intervention from the health-care system. The follow-up of contacts is a high priority and a
population that stays fairly stable with almost no internal and very little international migration
facilitates the task.
(Once my sister was diagnosed) we had to (get treatment), even though it was not
like we were in quarantine… she could be in her own house, but she, it’s a little
bit nicer in Holland because we have a little less problem with patient’s mobility
and stuff (poverty and migration). (Male, 28)
Stigma does exist, but was experienced minimally by the participant, even though he
acknowledges that he believes that his sister’s experience must have been far more difficult and
he recognizes that there is still some ignorance about the disease among some groups of people
who believe tuberculosis is strictly an underdeveloped countries problem. In the case of the
Netherlands, the participant believes that some people may still think that people affected by TB
are responsible somehow for their infection, indicating some bad choices made by them.
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Once there is an outbreak, they try to control it very, very rapidly and they really
do everything they can to identify all the cases, just because it can spread very
quickly. And there’s a specific sub-set of the health system that has to do with
that, with like infectious diseases and stuff. So I think that because there was
already such a specific structure already in place, they already knew what the
pathways would be and how everything was going to happen. I think that made it
easier and the staff was, to me, maybe because I wasn’t infectious, that may have
helped, they were always friendly and professional. (Male, 28)
For this participant, the Photovoice experience was a learning opportunity of a different
kind. It became part of his professional learning and an experience to replicate to “make a
difference.”
(As a result of participating in Photovoice I learned) definitely, first of all, that a
large portion of the world was infected with tuberculosis: second, that it’s not
necessarily a problem of underdeveloped countries but that it can arise
anywhere; third, the extent in which people are treated as outcasts and are
personally blamed for something they had no part, and the necessity of treating
people, both in their medication but also in a support group, Photovoice really
made me aware of that… Being here on the border, there is a huge difference
between El Paso and Juárez, the large amount of poverty, the number of people
living, that you can see from your house, who don’t have running water and
electricity. It’s just blows my mind the ignorance and money spent on this side of
the border and impossibility of doing anything about it. It’s just crazy to me, why
is life worth more on this side of the border than on the other side of the border,
and it really is that way. (Male, 28)
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CHAPTER 6
MEASURING TUBERCULOSIS RELATED STIGMA: VALIDATION OF
TWO SUBSCALES WITH MEXICAN-ORIGIN GROUPS
INTRODUCTION
The purpose of the current investigation was to examine the use of the validated TB and
HIV/AIDS stigma scales developed by Van Rie and colleagues (2008), and translated by Moya
and colleagues in 2009, among 217 TB patients from three regions in México. These scales were
used to measure the phenomena of stigma related with TB and HIV/AIDS at the community and
individual level in groups of Mexican-origin individuals. To demonstrate its psychometric
properties, we first performed factor analysis to identify the items of the scale that loaded best.
No items from the scales were excluded from this analysis. The internal consistencies by
Cronbach Alpha indices were very good to excellent. This investigation quantified tuberculosis
related stigma from the community perspective -like attitudes and actions of the community
toward persons affected with TB-and from the person affected by TB perspectives-like their
feelings and experiences of living with TB in México. The factor analysis illustrated that TBrelated stigma was observed among the sample of participants affected with tuberculosis. Most
of the effect measures and adjusted mean differences were small, less than 1 in the relative scale.
Most of effects were not consistent across the scales, and few were statistically significant.

6.1 RESULTS
Information was collected on a convenience sample of 217 adults (18 years and older) of
Mexican-origin diagnosed with tuberculosis under treatment or completed treatment in the past
six months in five locations in México. Trained interviewers administered the standardized
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questionnaires (Appendix 4) to these subjects who met the inclusion criteria at local health
centers in North, Central, and South Mexican locations.
Participant Demographics and Characteristics
Table 5 shows the demographic characteristics of the sample in terms of sex, age,
educational level, marital status, and socio-economic status. Table 6 shows the distribution of
other clinical characteristics like diagnosis for TB, type of TB, time to diagnose, health insurance
coverage, perceived health status, perceived self-control and support during TB treatment.
Table 5. Distribution of Participant Demographics
Category (n)*
Sex (207)
Age (185)

Marital Status (210)

Occupation (208)

Earning Wages (173)
Employment Status (146)

Years of Education (201)

Home Ownership (182)

Characteristic
Male
Female
18 – 20 years
21 – 30 years
31 – 40 years
41 – 50 years
51 – 60 years
61 – and over
Single
Common Law
Married
Divorced
Other
Informal
Formal
Home
Unemployed
Disabled
Student
Yes
No
Regularly employed
Occasionally employed
Unemployed
< 6years
6 years
> 6 years
Own
Don’t own

Number (Percent)
129 (62.3)
78 (37.7)
14 ( 7.6)
48 (25.9)
39 (21.1)
43 (23.2)
23 (12.4)
18 ( 9.7)
92 (43.8)
26 (12.4)
59 (28.1)
7 ( 3.3)
26 (12.4)
90 (43.3)
14 ( 6.7)
45 (21.6)
51 (24.5)
2 ( 1.0)
6 ( 2.9)
65 (37.6)
108 (62.4)
62 (42.5)
20 (13.7)
64 (43.8)
46 (22.9)
59 (29.4)
96 (47.8)
72 (39.6)
110 (60.4)

Population interviewed = 212. Numbers indicate actual responses provided.
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Table 6. Distribution of Participant Clinical Characteristics
Category (n)*

Characteristic

Number
(Percent)

TB Diagnosis (209)

First Time
Subsequent

182 (87.1)
27 (12.9)

Type of Case (212)

New
Subsequent
MDR-TB

179 (84.4)
30 (14.2)
3 (1.4)

Type of TB (209)

Pulmonary
Extra-pulmonary

186 (89.0)
23 (11.0)

Time to Diagnosis (176)

< 6 months
6 months and over

132 (75.0)
44 (25.0)

Health Care Type (181)

Seguro Popular
Seguridad Social
Private Insurance

37 (20.4)
143 (79.0)
1 (0.5)

Perceived Health Status (180)

Good
Not very good

111 (61.7)
69 (38.3)

Perceived Health Status 6 Months Ago (181)

Good
Not very good

61 (33.7)
120 (66.3)

Perceived Self Health Control Score (182)

< 8 points
8 points and over

61 (33.5)
121 (66.5)

Felt Supported During Treatment for TB(182)

Yes
No
Population interviewed = 212. Numbers indicate the actual responses provided

174 (95.6)
8 (4.4)

Characteristics by Study Locations
Tables 7 and 8 illustrate a comparison between the distributions of participants’
demographics and characteristics by the three study locations. The Northern region consists of
the States of Baja California, Sonora, Chihuahua, Coahuila, Nuevo León and Tamaulipas. The
Central region includes Zacatecas, Michoacán, Veracruz, Guerrero and Jalisco. The Southern
region is Oaxaca and Chiapas.
More men (59.7%) than women participated. More than half of the observed population
was from the Northern Mexican region (55.3%), about a third (32.5%) from the Central region,
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and the rest (12.1%) from the Southern region. The proportion of participants by age group and
region showed more participants 50 years and younger in the Northern Mexican region (57.1%,
48.7%, and 52.4%, respectively). Participants 51-60 years old and 61 years and older, had a
higher proportion in the Central region (47.8%, and 61.1%, respectively). The Southern region
had the smallest proportions on all age groups. The proportions of single, living in common law
and married participants were higher in the Northern region (65.2%, 61.5%, and 48.3%
respectively). Divorced participants had a higher proportion in the Central region (71.4%).
Southern region had the lowest proportions of participants in all marital statuses.
Table 7. Distribution of Participant Demographics by Study Location
Characteristic
( n )*

North
Region
Number (%)

Central
Region
Number (%)

South Region
Number (%)

Probability
value (p)

Sex (206)
Male
Female

83 (64.3)
31 (40.3)

36 (27.9)
31 (40.3)

10 (7.8)
15 (19.5)

0.002

Age (184)
18 – 20 years
21 – 30 years
31 – 40 years
41 – 50 years
51 – 60 years
61 + years

8 (57.1)
36 (75.0)
19 (48.7)
22 (52.4)
7 (30.4)
6 (33.3)

5 (35.7)
5 (10.4)
12 (30.8)
19 (45.2)
11 (47.8)
11 (61.1)

1 (9.1)
7 (14.6)
8 (20.5)
1 (2.4)
5 (21.7)
1 (5.6)

0.001

Marital Status (209)
Single
Common Law
Married
Divorced
Other

60
16
28
2
9

19 (20.7)
6 (23.1)
23 (39.7)
5 (71.4)
16 (61.5)

13 (14.1)
4 (15.4)
7 (12.1)
0 (0)
1 (3.8)

0.003

(65.2)
(61.5 )
(48.3)
(28.6)
(34.6)

School Years (201)
< 6 years
24 (53.3)
16 (35.6)
5 (11.1)
6 years
42 (70.0)
12 (20.0)
6 (10.0)
> 6 years
45 (46.9)
37 (38.5)
14 (14.6)
0.077
Population interviewed = 212. Numbers in parenthesis indicate the actual responses provided
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Continuation of Table 7. Distribution of Participant Demographics by Study Location
Characteristic
( n )*

North
Region
Number (%)

Central
Region
Number (%)

South Region
Number (%)

Probability
value (p)

Occupation (207)
Informal
Formal
Home
Unemployed
Disabled
Student

56 (62.2)
6 (42.9)
14 (31.8)
35 (68.6)
0 (0)
5 (83.1)

23 (25.6)
3 (21.4)
21 (47.7)
16 (31.4)
2 (100)
1 (16.7)

11 (12.2)
5 (35.7)
9 (20.5)
0 (0)
0 (0)
0 (0)

0.000

Earning Wages (172)
Yes
No

40 (61.5)
61 (57.0)

15 (23.1)
34 (31.8)

10 (15.4)
12 (11.2)

0.414

Employment Status (145)
Regularly
35 (56.5)
14 (22.6)
13 (21.0)
Occasionally
7 (35.0)
12 (60.0)
1 (5.0)
Unemployed
38 (60.3)
24 (38.1)
1 (1.6)
0.000
Population interviewed = 212. Numbers in parenthesis indicate the actual responses provided

Table 8. Distribution of Participant Clinical Characteristics by Study Location
Characteristic (n)*

North
Region
Number (%)

Central
Region
Number (%)

South
Region
Number (%)

Probability
value (p)

TB Diagnosis (208)
First time
Subsequent

97 (53.6)
16 (59.3)

61 (33.7)
9 (33.3)

23 (12.7)
2 (12.0)

0.709

Type of TB Case (211)
New
Subsequent
MDR-TB

95 (53.4)
19 (63.3)
2 (66.7)

61 (34.3)
9 (30.0)
0 (0)

22 (12.4)
2 (6.7)
1 (33.3)

0.466

Type of TB (208)
Pulmonary
Extra-pulmonary

109 (58.9)
4 (17.4)

51 (27.6)
19 (82.6)

25 (13.5)
0 (0)

0.000

Time to Diagnosis (175)
< 6 months
6 months and over

76 (58.0)
19 (43.2)

40 (30.5)
18 (40.9)

15 (11.5)
7 (15.9)

0.232

Health Care Type (180)
13 (35.1)
24 (64.9)
0 (0)
Seguro Popular
82 (57.7)
39 (27.5)
21 (14.8)
Servicios de Salud/SSA
Private Health Insurance
1 (100)
0 (0)
0 (0)
Population interviewed = 212; numbers indicate the actual responses provided
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0.000

Continuation of Table 8. Distribution of Participant Clinical Characteristics by Study Location
North
Region
Number (%)

Central
Region
Number (%)

South
Region
Number (%)

Perceived Health Status Six
Months Ago (180 )
Good
Not very good

32 (52.5)
64 (53.8)

27 (44.3)
35 (29.4)

2 (3.3)
20 (16.8)

Perceived Health Status
at time of interview (179)
Good
Not very good

52 (47.3)
43 (62.3)

37 (33.6)
25 (36.2)

21 (19.1)
1 (1.4)

Perceived Self-Control
(Health) Score (181 )
< 8 points
8 points and over

39 (65.0)
57 (47.1)

16 (26.7)
47 (38.8)

5 (8.3)
17 (14.0)

Characteristic (n)*

Felt Supported During TB
Treatment (181 )
Yes
89 (51.4)
62 (35.8)
22 (12.7)
No
7 (87.5)
1 (12.5)
0 (0)
Population interviewed = 212. Numbers indicate the actual responses provided

Probability
value (p)

0.013

0.002

0.074

0.130

The distribution of the characteristics across participants by region with their respective
probability values (p-values) are showed in Tables 7 and 8. The following seven characteristics
of the participants show significant statistically difference (p<0.05): Perceived health status at
the time of interview (now), health insurance type, employment status, occupation, marital
status, age group, and sex.
The following two characteristics followed with probability values between > 0.05, <
0.10 p-values: perceived health control; and school years. Finally, the following characteristics
were above the > 0.10 probability value: time to diagnosis, type of TB case, TB diagnosis, felt
supported, home ownership, and earning wages.
Socioeconomic Characteristics
Respondents with less than six years of formal education, those who completed 6 years of
formal education, and the ones who had more than 6 years of formal education were higher in the
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Northern region (53.3%, 70.0%, 46.9%, respectively), followed by the Central region (35.6%,
20.0%, 38.5%, respectively), and lowest in the Southern region (11.1%, 10.0, 14.6%,
respectively).
Participants with informal occupations had a higher proportion in the Northern region
(62.2%), followed by the Central region (25.6), and smallest proportion in the Southern region
(12.2%). Participants with formal education had a higher proportion in the Northern region
(42.9%), followed by Southern region (35.7%), and smallest proportion in the Central region
(21.4%).
Unemployed participants had a higher proportion in the Northern region (68.6%),
followed by unemployed in the Central region (31.4%). There were no unemployed participants
in the Southern region. Participants who reported being students had a higher proportion in the
Northern region (83.1%), followed by student participants in the Central region (16.7%). There
were no student participants in the Southern region. There were 2 disabled participants in the
Central region. No disabled participants were reported in the North or South regions.
Participants who reported earning wages at the time of the interview had a higher
proportion in the Northern region (61.5%), followed by participants from the Central region
(23.1%), and the lowest proportion was reported at the Southern region (15.4%). Similar
distribution was reported for the participants who reported not earning wages for the 3 regions.
Participants from the Northern region reported being employed regularly at a higher
proportion (56.5%) than participants from the Central and Southern regions (22.6% and 21.0%,
respectively). Participants occasionally employed had a higher proportion in the Central region
(60.0%), followed by participants from the Northern region (35.0%) and participants from the
Southern region (5.0%). Unemployed participants had a higher proportion in the Northern region
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(60.3%), followed by unemployed participants from the Central region (38.1%), and the
Southern region (1.6%).
Participants from the Northern region reported a higher home ownership (58.3%),
followed by participants from the Central region (31.9%) and participants from Southern region
(9.7%). Similarly, participants from the Northern region reported no home ownership at a higher
proportion (49.5%), followed by participants from the Central region (36.7%) and participants
from the Southern region (13.8%).
Health Insurance and Tuberculosis
A higher proportion of participants (64.9%) reported having Seguro Popular (Popular
Health Insurance) in the Central region, followed by participants from the Northern region.
There were no participants who reported having Seguro Popular from the Southern States.
Participants from the Northern region had a higher proportion of Seguridad Social (Servicios de
Salud) (57.7%), followed by participants from the Central region (27.5%) and participants from
the Southern region (14.8%). There was only one participant from the Northern region who
reported having private medical insurance.
Participants with pulmonary tuberculosis had a higher percentage in the Northern region
(58.9%), followed by participants from the Central region (27.6%) and participants from the
Southern region (13.5%). Participants with extra-pulmonary tuberculosis had a higher proportion
in the Central region (82.6%), followed by participants from the Northern region (17.4%). There
were no reports of extra-pulmonary tuberculosis in the Southern region.
Participants diagnosed for the first time with tuberculosis and participants with
subsequent tuberculosis diagnosis had a similar distribution pattern, higher in the Northern
region, followed by participants in the Central region and lastly, participants from the Southern
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region. Participants with less than six months of time to diagnosis at the time of interview had a
higher proportion in the Northern region (58.0%), followed by participants from the Central
region (30.5%) and participants from the Southern region (11.5%). Participants with six or more
months of time to diagnosis had a higher proportion in the Northern region (43.2%), followed by
participants from the Central region (40.9%) and participants from the Southern region (15.9%).
New cases of tuberculosis were reported at a higher proportion in the Northern region
(53.4%), followed by participants from the Central States (34.3%), and participants from the
Southern region (12.4%). Subsequent cases of tuberculosis where reported at a higher proportion
in the Northern region (63.3%), followed by participants from the Central region (30.0%), and
participants from the Southern region (6.7%). Multi-Drug Resistant (MDR) TB cases were
reported at a higher proportion in the Northern region (66.7%), followed by participants from the
Southern region (33.3%). There were no reports of MDR-TB cases in the Central region.
Perceived Health Status
Participants who perceived having a good health status at the time of interview had a
higher proportion in the Northern region (47.3%), followed by participants from the Central
region (33.6%) and participants from the Southern region (19.1%). Similarly, participants who
perceived not having very good health now had a higher proportion in the Northern region
(62.3%), followed by participants from the Central region (36.2%) and participants from the
Southern region (1.4%). Participants who perceived having a good health status six months ago
had a higher proportion in the Northern region (52.5%), followed by participants from the
Central region (44.3%) and participants from the Southern region (3.3%). Similarly, participants
who perceived not very good health six months ago had a higher proportion in the Northern
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region (53.8%), followed by participants from the Central region (29.4%) and participants from
the Southern region (16.8%).
Participants with less than eight score points (score ranged from 0 to 10, 10 being the
highest score or the most self-control) on perceived self-control (health) had a higher proportion
in the Northern region (65.0%), followed by participants from the Central region and participants
from the Southern region (8.3%). Participants with less than eight points score were also higher
in the Northern region, followed by participants from the Central region (38.8%), and
participants from the Southern region (14.0%). Participants who felt supported during
tuberculosis treatment had a higher proportion in the Northern region (51.4%), followed by
participants from the Central region (35.8%) and participants from the Southern region (12.7%).
Participants who did not feel supported during tuberculosis treatments had a higher proportion in
the Northern region (87.5%), followed by participants from the Central region (12.5%). There
were no reports in the Southern region of participants who did not feel supported during
tuberculosis treatment.

6.2 STANDARDIZED STIGMA SCORES
The calculation of the standardized stigma scores for the four scales is shown in Figure 5.
The standardized stigma scores were distributed normally with mean scores (standard deviation)
of 28.9 (8.7) for the community perspectives toward tuberculosis; 28.3 (8.2) for the person
affected by tuberculosis; 29.4 (9.0) for community perspectives toward HIV/AIDS; and 34.3
(7.5) for person affected by TB perspectives toward HIV/AIDS scales respectively.
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Figure 5. Standardized Stigma Scores for the Four Subscales
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45.45

48.48

6.3 FACTOR ANALISIS
Factor analysis demonstrated high loadings of most items (0.30 or higher) from the
principal component analysis. Items with an absolute value loading of 0.40 or greater were kept
if they loaded on one factor only; this decision was based on literature by Raubenheimer (2004)
and on the values used by Van Rie et al., (2008) in the Tuberculosis and HIV/AIDS Stigma
Study in Thailand. Tables 9 and 10 present the two stigma sub scales, item factor loadings.
Table 9. Loading Values for Tuberculosis Stigma Scales by Item of Importance
Loading
I. Community Perspectives toward Tuberculosis (Con’t)
Value*
Algunas personas no quieren beber o comer con familiares que tienen tuberculosis.
0.812
Some people may not want to eat or drink with relatives who have tuberculosis.
Algunas personas tratan de no tocar a otras con tuberculosis.
Some people try not to touch others with tuberculosis.

0.773

A algunas personas no les gusta beber o comer con amigos/as que padecen TB.
Some people may not want to eat or drink with friends who have tuberculosis.
Si alguien tuviera TB, algunas personas de la comunidad se comportarían diferentes
con él/ella por el resto de su vida.
If a person has tuberculosis, some community members will behave differently
towards that person for the rest of his/her life
Algunas personas se sienten incómodas al estar cerca de quienes padecen tuberculosis.
Some people feel uncomfortable about being near those with tuberculosis.

0.717

Algunas personas no quieren hablar con quienes tienen tuberculosis.
Some people do not want to talk to others with tuberculosis.

0.701

Algunas personas no quieren que sus hijos jueguen con niños que tienen TB
Some people do not want those with tuberculosis playing with their children.

0.699

Algunas personas le tienen miedo a quienes tienen tuberculosis.
Some people are afraid of those with tuberculosis

0.647

Algunas personas mantienen su distancia de aquellas con tuberculosis.
Some people keep their distance from people with tuberculosis.

0.569

Algunas personas piensan que quienes padecen TB son desagradables o indeseables.
Some people think that those with tuberculosis are disgusting.

0.531

Algunas personas prefieren que quienes padecen TB no vivan en su comunidad.
Some people prefer not to have those with TB living in their community

0.085
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0.763
0.741

II. Person’s affected with TB (Patient’s) Perspective toward Tuberculosis
Algunas personas con TB tienen miedo de decirle a sus familiar es que tienen la
enfermedad.
Some people who have tuberculosis are afraid to tell their family that they have
tuberculosis.

Loading
Value*

0.799

Algunas personas con TB tienen miedo de ir a las clínicas de TB o a los centros de
salud por temor que otros los vean.
Some people who have tuberculosis are afraid of going to TB clinics because other
people may see them there.

0.771

Algunas personas con TB tienen miedo de decirles a otros que tiene la enfermedad
pues pueden pensar que también tienen SIDA.
Some people who have tuberculosis are afraid to tell others that they have
tuberculosis because others may think that they also have AIDS.

0.678

Algunas personas con TB se sienten culpables de haber contraído la enfermedad por
fumar, tomar o por otras conductas irresponsables.
Some people who have tuberculosis feel guilty for getting tuberculosis because of their
smoking, drinking, or other careless behaviors.

0.673

Algunas personas con TB están preocupadas porque podrían tener SIDA.
Some people who have tuberculosis are worried about having AIDS.

0.436

Algunas personas con TB se sienten culpables por ser una carga para su familia.
Some people who have tuberculosis feel guilty because their family has the burden of
caring for them.

0.386

Algunas personas que tienen TB son cuidadosas al escoger a quien decirle que
padecen la enfermedad.
Some people who have tuberculosis will choose carefully who they tell about having
tuberculosis.

0.266

Algunas personas con TB pierden a sus amigos/as cuando les comentan que tienen la
enfermedad.
Some people who have TB lose friends when they share with them they have
tuberculosis.

0.264

Algunas personas con TB guardan su distancia de otras para evitar contagiarlas con
gérmenes de la enfermedad.
Some people who have TB keep their distance from others to avoid spreading
tuberculosis germs.

0.241

Algunas personas con TB tienen miedo de decirles a otros, que no son miembros de su
familia, que tienen la enfermedad.
Some people who have TB are afraid to tell those outside their family that they have
tuberculosis.

0.212

Algunas personas con TB se sienten solas.
Some people who have tuberculosis feel alone.

0.043

Algunas personas con TB se sienten lastimadas por la manera en que los demás
reacciónan cuando se enteran que tienen la enfermedad.
Some people who have TB feel hurt because of how others others react when they find
out they have TB.

-.003
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Table 10. Loading Values for HIV/AIDS related Stigma Scales by Item of Importance
Loading
III. Community Perspective Toward HIV/AIDS
Values*
Algunas personas no quieren que sus hijos jueguen con niños que tienen el VIH/SIDA.
0.811
Some people do not want those with HIV/AIDS playing with their children.
Algunas personas guardan su distancia ante una persona con VIH/SIDA.
Some people keep distance from people with VIH/AIDS.

0.782

Algunas personas le tienen miedo a quienes tienen VIH/SIDA.
Some people are afraid of those with HIV/AIDS.

0.776

Algunas personas se sienten incómodas al estar cerca de alguien con VIH/SIDA.
Some people feel uncomfortable being near those with HIV/AIDS.

0.760

Algunas personas tratan de no tocar o tener contacto con quienes tienen VIH/SIDA.
Some people try not to touch others with HIV/AIDS.

0.728

Algunas personas prefieren que las personas con VIH/SIDA no vivan en su
comunidad.
Some people prefer not to have those with HIV/AIDS living in their community.
Si alguien tuviera VIH/SIDA, algunas personas de la comunidad se comportarían
diferentes con él/ella por el resto de su vida.
If a person has HIV/AIDS, some community members will behave differently toward
that person for the rest of his or her life.
Algunas personas piensan que quienes tienen VIH/SIDA son desagradables o
indeseables.
Some people think that those with HIV/AIDS are disgusting.
Algunas personas no quieren hablar con otras personas sobre el VIH/SIDA.
Some people do not want to talk to others with HIV/AIDS
Algunas personas piensan que las personas que tienen VIH/SIDA son sucias.
Some people think that people with HIV/AIDS are unclean.
Algunas personas piensan que las personas con VIH/SIDA se lo merecen.
Some people think that people with HIV/AIDS get what they deserve.
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0.720

0.704

0.691

0.639

0.411
0.042

IV. Person’s affected with TB (Patient’s) Perspective toward HIV/AIDS

Loading
Values*

Algunas personas con VIH/SIDA tratan de mantener su enfermedad en secreto.
Some people who have HIV/AIDS try very hard to keep the issue of having AIDS a
secret.

0.835

Algunas personas con VIH/SIDA tienen miedo de decirles a otros, que no son sus
familiares, que tiene VIH/SIDA.
Some people who have HIV/AIDS are afraid to tell those outside their family that they
have AIDS.

0.816

Algunas personas con VIH/SIDA se preocupan de que otros digan su secreto.
Some people who have HIV/AIDS worry that others will reveal their secret.

0.815

Algunas personas que tienen VIH/SIDA son cuidadosas al escoger a quien decirle que
tienen la enfermedad.
Some people who have HIV/ AIDS will chose carefully who they tell about having
AIDS.
Algunas personas con VIH/SIDA tienen miedo de que otros miembros de su
comunidad comenten que tiene la enfermedad.
Some people who have HIV/ AIDS are afraid that other people in the community will
talk about them having AIDS.
Algunas personas que tienen VIH/SIDA se sienten lastimadas por la manera en que
otras reacciónan cuando se enteran que tienen la enfermedad.
Some people who have HIV/AIDS feel hurt because of how others react to knowing
they have AIDS.

0.736

0.691

0.498

Algunas personas con VIH/SIDA pierden a sus amigos cuando les comentan que
tienen SIDA.
Some people who have HIV/AIDS lose friends when they share with them they have
AIDS.

0.330

Algunas personas con VIH guardan su distancia de otras para evitar el contagio del
virus que ocasiona el SIDA.
Some people who have HIV/AIDS keep their distance from others to avoid spreading
the AIDS virus.

0.264

Algunas personas con VIH/SIDA tienen miedo de ir a las clínicas de atención para
VIH/SIDA o a los centros de salud por temor a que otros los vean.
Some people who have HIV/AIDS are afraid to go to the clinic or AIDS program
because they are afraid that others might see them there

0.183

Algunas personas con VIH/SIDA se sienten culpables porque su familia tiene la carga
o responsabilidad de cuidarlos.
Some people who have AIDS feel guilty because their family has the burden of caring
for them.
Algunas personas con VIH/SIDA se sienten solas.
Some people who have HIV/AIDS feel alone.
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0.086

0.061

Low loading factors were found in both scales for the following items: “Some people
who have TB (or HIV/AIDS) feel alone” (0.043 for TB item and 0.061 for HIV/AIDS item), and
“Some people who have TB keep their distance from others to avoid spreading TB germs (or
HIV/AIDS virus)” (0.241 for TB item and 0.264 for HIV/AIDS item).
Among the items with low loading values are the ones that related to isolation for TB (or
HIV/AIDS); loneliness; loss of friends because of condition (TB), perception of burden to family
because of HIV/AIDS; preference that those with HIV/AIDS live outside of their community;
fear of accessing AIDS care; and judgment about what people with HIV/AIDS deserve.
Additional research to investigate why these absolute item values are low is recommended.
Factors Associated with Tuberculosis Stigma
The effect measures of adjusted mean differences (MD) along with 95% confidence
intervals (CI) from summed stigma scores are shown in Tables 11 and 12. As expected, most
effects are small, less than 1 in the relative scale, and most of these effects were not consistent
across the scales and few were statistically significant.
These findings have important implications for developing health literacy interventions to
reduce stigma primarily among oral literate participants. In this study, factors that may contribute
to higher perceptions of stigma include informal occupations, and unemployment and disability.
However conclusions are difficult to make because socioeconomic factors show small values and
few were statistically significant.
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Table 11. Adjusted Mean Differences* of Participant Characteristics
Category
Sex

Age

Marital Status

Earning Wages

Home
Ownership

Years of
Education

Occupation

Employment
Status

Community
TB Scores
MD (95% CI)

Characteristic

Male
Female

0
.174 (-.016,.364)
0

18 – 20 y
21 – 30 y
31 – 40 y
41 – 50 y
51 – 60 y
61 & over

.289 (-.064,.641)
.297 (-.065,.658)
.259 (-.098,.616)
.230 (-.164,.623)
.198 (-.215,.612)

Single
Common Law
Married
Divorced
Other

-.015 (-.307,.277)
-.181 (-.401,.038)
.155 (-.361,.671)
.062 (-.231,.354)

Yes
No

0

0
-.034 (-.242,.175)

Yes

0

No

.044 (-.125,.213)

> 6 years

0

6 years
< 6 years

.022 (-.198,.242)
.090 (-.149,.328)

Formal
Informal
Home
Unemployed
Disabled
Student

0

Regularly
Occasionally
Unemployed

-.025 (-.400,.349)
-.148 (-.546,.251)
-.175 (-.568,.218)
-1.214 (-2.199,-.229)
-.548 (-1.183,.088)

0
-.194 (-.468,.081)
-.162 (-.352,.028)

Community
HIV/AIDS Scores
MD (95% CI)
0
-.012 (-.212,.188)
0
.151 (-.249,.550)
.147 (-.264,557)
-.012 (-.433,.409)
.011 (-.459,.482)
.000 (-.538,.539)
0
-.204 (-.487,.079)
-.156 (-.398,.085)
.292 (-.318,.)901
-.112 (-.469,.244)

0
-.065 (-.256,.127)

0
-.036 (-.238,.166)

0
-.178 (-.401,.045)
.062 (-.187,.312)
0
.080 (-.352,.511)
-.130 (-.672,.412)
.115 (-.422,.653)
.070 (-1.110,1.250)
.132 (-.627,.891)

0
-.431 (-.719,-.143)
-.100 (-.422,.223)

*From Summed Stigma Scores
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Person
TB Scores
MD (95% CI)
0
.078 (-.075,.231)
0
.394 (.096,.692)
.289 (-.021,.600)
.446 (.133,.759)
.199 (-.159,.557)
.193 (-.205,.592)
0
-.143, (-.369,.083)
-.193 (-.379, -.007)
-.053 (-.526, .421)
.018 (-.243, .278)

0
.005 (-.170,.181)

0
-.002 (-.176,.173)

0
.006 (-.192,.204)
-.066 (-.286,.154)
0
.082 (-.297,.461)
.170 (-.296,.637)
.313 (-.157,.784)
.058 (-.981,1.096)
-.038 (-.713,.637)

0
-.219 (-.473,.035)
-.121 (-.387,.146)

Person
HIV/AIDS Scores
MD (95% CI)
0
-.097 (-.300,.107)
0
.320 (-.086,.726)
.302 (-.115,.719)
.379 (-.050,.809)
.216 (-.263,.694)
-.042 (-.589,.505)
0
-.246 (-.539,.047)
.005 (-.241,.250)
.468 (-.152,1.088)
.112 (-.251,.474)

0
.028 (-.167,.224)

0
.092 (-.114,.298)

0
-.346 (-.581,-.111)
-.393 (-.657,-.130)
0
.181 (-.272,.634)
.123 (-.446,.691)
.015 (-.549,.579)
.835 (-.403,2.074)
-.033 (-.830,.764)

0
-.040 (-.349,.268)
.246 (-.093,.586)

Table 12. Adjusted Mean Differences* by Participant Clinical Characteristics
Community
TB Scores

Community
HIV/AIDS Scores

Person
TB Scores

Person
HIV/AIDS Scores

Category

Characteristic

MD (95% CI)

MD (95% CI)

MD (95% CI)

MD (95% CI)

TB Diagnosis

First time
Subsequent

0
.071 (-.200,.343)

0
. 021 (-.376,.334)

0
.005 (-.322,.332)

0
.000 (-.385,.385)

Type of TB

Pulmonary
Extra pulmonary

0
-.151 (-.443,.141)

0
.084 (-.163,.332)

0
-.041 (-.269,.187)

0
.148 (-.120,.417)

Type of Case

New
Subsequent
MDR-TB

0
.122 (-.139, .382)
-.078 (-.847,.690)

0
.380 (.036,.723)
.536 (-.137,1.209)

0
.182 (-.135,.498)
.098 (-.523,.718)

0
.223 (-.149,.595)
.549 (-.182,1.279)

Time to
Diagnosis

< 6 months

0

0

6 months +
Health Care
Type

IMSS Social Security
Seguro Popular
Private Medical
Insurance

Perceived
Health Status

Perceived
Health Status
Six Months Ago

Perceived Self
Health Control
Score

Felt Supported
During
Treatment

0
-.083 (-.274,.107)
0
-.092 (-.112,.296)
.881 (-.229,1.991)

Good

0

Not good

.008 (-.165,.180)

Good

0

Not good
Yes

0
-.039 (-.231,.153)
0
-.092 (-.318,.133)
-.299 (-1.424,.826)

0

.067 (-.109,.244)
0
-.130 (-.326,.066)
-.161 (-1.168,.845)

-.119 (-.331,.093)
0
-.189 (-.428,.050)
-.598 (-1.779,.583)

0

0

.002 (-.152,.155)

.097 (-.083,.278)

0

0

0

.109 (-.059,.278)

.051 (-.112,.213)

.021 (-.129,.172)

.011 (-.165,.188)

0

0

0

0

-.241 (-.406,-.075)

No

-.165 (-.339,.009)

-.150 (-.318,.018)

-.084 (-.240,.072)

-.198 (-.381,-.015)

Yes
No

0
. 147 (-.257,.550)

0
.048 (-.329,.425)

0
-.204 (-.555,.147)

0
.030 (-.380,.440)

*From Summed Stigma Scores

Female participants had a higher tuberculosis stigma score for both Community and TB
Patient Perspective Scales compared to males, MD 0.174 (CI -0.016, 0.364), MD 0.078; (-0.075,
0.231) respectively, and for both Community and Patient Perspective Scales. Female respondents
had lower HIV/AIDS stigma scores than males MD -0.012 (CI -0.212, 0.188), MD -0.097 (CI 0.300, 0.107) respectively.
Almost all participants 21 years of age and older had higher TB stigma and HIV stigma
scores in both Community and Patient Scales compared to participants 18 – 20 years old. The
exceptions were the age group 41-50 years for Community HIV/AIDS Stigma Scale MD -0.12
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(CI-0.433, 0.409), and the age group 61 years and over for PATB HIV/AIDS Stigma Scale MD 0.42 (CI-0.589, 0.505). Only the age group 21-30 for the PATB Stigma Scale was statistically
significant MD 0.394 (CI 0.096, 0.692).
Participants in common-law marriages had lower stigma perceptions in all scales
compared to single participants. Married participants also had lower stigma perceptions in all
scales, except in the PATB perspectives on the HIV/AIDS Stigma Scale, compared to single
participants. On the other hand, divorced participants had higher stigma perceptions in all scales,
except in the PATB Stigma Scale. Although no significant differences were found, respondents
who reported no earning wages had a lower stigma perception for the Community TB and
HIV/AIDS Scales, and higher stigma perceptions for the PATB and HIV/AIDS Scales.
Respondents who reported no home ownership had higher stigma perception for Community TB
and Person HIV/AIDS Scales than home owners. Compared to home owners, respondents who
reported no home ownership had lower stigma perceptions on the Community HIV/AIDS and
TB patient Scales respectively.
Participants who completed 6 years of education had higher stigma perceptions on the
Community TB and PTAB TB Scales than participants with more than six years of education,
and lower stigma perceptions on the Community HIV/AIDS and Person Affected by TB
HIV/AIDS Scales compared to participants with more than 6 years of education. The less
educated the participants, the more perceived stigma found in this study.
Respondents with informal occupations had higher stigma perceptions on all scales,
except for the Community TB Stigma Scale, than respondents with formal occupations.
Respondents with home occupations had higher stigma perception on the TB patient and TB
patient HIV/AIDS Stigma Scales than respondents with formal occupations. Unemployed and
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disabled participants shared higher stigma perceptions on the Community HIV/AIDS, TB
patient, and TB patient HIV/AIDS, and lower stigma perception on the Community TB Stigma
Scale compared to respondents with formal occupations. Although no significant differences
were found, lower socio-economic status persons (earning no wages or unemployment) had
higher stigma perceptions for the TB patient and HIV/AIDS scales.
Unemployed and occasionally employed respondents had lower stigma perceptions on all
Stigma Scales except the unemployed participants for the TB patient HIV/AIDS Stigma Scale,
than regularly employed participants.
Participants with “Seguro Popular” (Popular Health Insurance Program) and participants
with private medical insurance had lower stigma perceptions on all Stigma Scales except
participants with private medical insurance on the Community TB Stigma Scale as compared
with participants with Seguridad Social (Public Health Insurance).
Participants with subsequent TB diagnosis had higher stigma perceptions on all Stigma
Scales, as compared to respondents with first time diagnosis of tuberculosis, except on the PATB
Stigma Scale, which shows no difference.
Individuals with extra-pulmonary TB had higher stigma perceptions on the Community
and TB patient HIV/AIDS Stigma-related Scales, and lower stigma perceptions on the
Community and TB. Persons affected by TB related Scales as compared to participants with
pulmonary tuberculosis.
Participants classified as subsequent and MDR-TB cases, had higher stigma perceptions
on all Stigma Scales compared to new TB case participants, except the MDR-TB participants on
the Community TB Stigma Scale.
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Participants diagnosed with tuberculosis six or more months ago had lower stigma
perceptions on all related Scales except on the TB patient Stigma Scale as compared to
participants with diagnosis with TB at less than six months ago.
Participants whose perceived health status was not good had higher stigma perception on
all Scales except on the Community HIV/AIDS Stigma-related Scale, when compared to
participants with a perceived good health status,
Participants whose perceived health status six months ago was “not good” had higher
stigma perception score on all Stigma-related Scales compared to participants whose perceived
health status 6 months ago as was “good.” Respondents with no perceived self-control had lower
stigma perceptions on all Stigma related Scales than respondents with perceived self health
control. Compared to respondents who felt supported during treatment, respondents who felt no
support during treatment had higher stigma perception on all scales except on the TB patient
Scale.

6.4 SCORE DISTRIBUTIONS AND CRONBACH’S ALPHA VALUES
Table 13 illustrates the score distributions and Cronbach’s alpha values for the
Community and Persons Affected by TB (PATB) and HIV/AIDS Stigma-related Scales. The
Community Perspectives toward Tuberculosis Stigma Scale was based on 11 items and 95% of
participants (203) rated all items. Cronbach’s alpha was 0.911, indicating a high correlation
between items in the scale. Tukey’s test of non-additivity was 0.103 (p value = 0.70) indicating a
linear relationship of items to the total score.
The Community Perspectives toward HIV/AIDS Stigma Scale was based on 11 items and
94% of participants (199) rated all items. Cronbach’s alpha was 0.912, indicating a high
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correlation between items. Tukey’s test of non-additivity was 0.324 (p value = 0.10) indicating a
linear relationship of items to the total score.
The Person Affected by Tuberculosis Perspectives toward Tuberculosis Stigma Scale was
based on 12 items and 95% (202) rated all the items. Cronbach’s alpha was 0.876, indicating a
high correlation between the items in the scale. Tukey’s test of non-additivity was 2.720 (p value
= 0.001), indicating multiplicative interaction between the cases and the items.
The Person Affected by Tuberculosis Perspectives toward HIV/AIDS Stigma Scale was
based on 11 items and 94% (199) responded to all the items. Cronbach’s alpha was 0.888,
indicating a high correlation between items in the scale. Tukey’s test of non-additivity was 1.263
(p value = 0.564), indicating a linear relationship of items to the total score as illustrated in Table
11.
Table 13. Score Distributions and Cronbach’s Alpha Values for Community
and Person Affected by TB and HIV/AIDS Stigma-Related Scales
Community
Tuberculosis
TB Patient
Community
Perspectives
Patient
Perspectives
Perspectives
Values
toward
Perspectives
toward
toward TB
HIV/AIDS
toward TB
HIV/AIDS
(11 items)
(11 items)
(12 items)
(11 items)
n (number of
203
199
202
199
individuals)
Cronbach’s
alpha**
Tukey’s
estimate
(p value)

0.911

0.912

0.876

0.888

0.103(p=0.70)

0.324(p=0,10)

2.720(p=0.001)

1.263(p=0.56)

**Based on standardized items

Cronbach’s alphas for the scales were 0.911 for the community perspectives toward TB
scale, 0.876 for the PATB perspectives toward tuberculosis scale, 0.912 for the community
perspectives toward HIV/AIDS scale, and 0.888 for the PATB perspectives toward HIV/AIDS
scale.
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All standardized stigma scores for the four scales were normally distributed with mean
scores (standard deviation) of 28.95 (8.75) for the community perspectives toward tuberculosis,
28.30 (8.20) for the person(s) affected by TB perspectives toward tuberculosis, 29.37 (9.02) for
the community perspectives toward HIV/AIDS, and 34.34 (7.56) for the person(s) affected by TB
perspectives toward HIV/AIDS scales, this being the largest (Table 14).
Table 14. Standardized Sum of Scores for Tuberculosis and HIV/AIDS Stigma Scales
Person
PATB
Community
HIV/AIDS
Affected with
Perspectives
TB
Community
TB (PATB)
toward
Perspectives
Perspectives
Perspectives
HIV/AIDS
Sum of Scores (SS)
6,136
5,971
6,138
7,108
Mean

28.95

28.30

29.37

34.34

8.75

8.20

9.02

7.56

Percentile 25

24.24

23.61

25.76

30.30

Percentile 50

28.79

29.17

28.79

33.33

Percentile 75

33.33

33.33

33.33

37.88

Items

11

12

11

11

N

212

211

209

207

Standard deviation

Standardized sum of scores were calculated by the following formula: SS50 = (SSraw x 50)/(n x 3)

6.5 DISCUSSION
The study sought to determine the effectiveness and validity of the TB and HIV/AIDS
sub scales with adults living with tuberculosis of Mexican-origin. The results of the study
determined that the scales developed and validated by Van Rie (2008) and translated to Spanish
for this investigation have good overall internal consistency among sub-populations studied. The
psychometric characteristics of this study scales were similar to the ones that the study by Van
Rie et al., (2008) had (Appendix 8).
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These scales addressed stigma in the context of México. The items that Van Rie and
colleagues (2008) represented as key causes of stigma (fear of causal transmission or being
contagious, willingness to interact with individuals affected with TB, moral values of shame,
blame, guilt and judgments) and consequences of stigma (negative emotions and feelings toward
persons affected with TB, disclosure and discrimination) were evidenced in the investigation.
The scales encompass both community member and individual perspectives by people with TB
and this multidimensional focus is valuable to understanding and measuring stigma.
Results also identified some similarities between the stigma related to tuberculosis and
HIV/AIDS. Items related to fear of infection through casual contact (eating or drinking with
relatives and friends; touching others) were the most significant determinants of stigma in both
tuberculosis and HIV/AIDS based on the absolute loading factors. The item expressed as “Some
people do not want those with HIV/AIDS playing with their children” loaded third highest,
which is very interesting given the important differences in the modes of transmission between
TB and HIV/AIDS. The same item for TB loaded high.
The investigation revealed that participants perceived that the community stigmatizes
because of the nature of how tuberculosis is contracted and how persons affected with TB are
perceived as vectors of the condition or a disease like tuberculosis, and therefore they should be
kept away to avoid infection or transmission. The item on the TB patient perceptions toward
HIV/AIDS as expressed in “Some people who have HIV/AIDS keep their distance from others to
avoid spreading the AIDS virus,” loaded low. This can probably be explained by reflecting on
the knowledge and understanding on how HIV/AIDS is transmitted. The dimension of disclosure
(or secrecy) of either of the two conditions was highly prominent. In both the tuberculosis and
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the HIV/AIDS scales the item: “Some people who have tuberculosis (or HIV/AIDS) are afraid to
tell their family (or those outside their family) that they have the condition” loaded high.
Maintaining the diagnosis of TB (or HIV/AIDS) in secrecy rated very high as well. These
perceptions are consistent with the work of (Kelly 1999; Nyblade 2005; Sengupta et al., 2006)
that indicates that moral judgment and fear of disclosure are associated with delayed care and
stigmatization.
The concept of guilt was stated in the following items: “Some people who have TB feel
guilty for getting tuberculosis because of their smoking, drinking and other careless behaviors”
or “Some people think that those with TB (or HIV/AIDS) are disgusting.” The HIV/AIDS scale
item: “Some people prefer not to have those with HIV/AIDS living in their community”
indicated strong moral values and norms as well as punishment and judgment. Discrimination
perceptions were also disclosed in: “If a person has HIV/AIDS (or TB), some community
members will behave differently toward the person for the rest of his/her life” or “some people
do not want to talk to others with HIV/AIDS.”
The consequences of shame or guilt could be an important root cause in delaying access
to health services in a timely fashion as expressed in the following item: “Some people with TB
are afraid of going to TB clinics because other people may see them there.” This item indicated
that there is embarrassment and judgment represented in having tuberculosis and seeking care
from a TB clinic. Among the items with low loading values are the ones that related to isolation
for TB (or HIV/AIDS); loneliness; loss of friends because of condition (TB), perception of
burden to family because of HIV/AIDS; preference that those with HIV/AIDS live outside of
their community; fearful to access AIDS care; and judgment about what people with HIV/AIDS
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deserve. Additional research to investigate why these absolute item values are low is
recommended.
Limitations
Some limitations of the study should be noted. First, the sample was not randomly
selected. It was a convenience sample, which limits the ability to draw representation to the
general tuberculosis patient population or draw conclusions on the impact of perceptions of
stigma related to TB and HIV. Secondly, the focus on the study is on one population, persons
affected with tuberculosis under treatment. It is possible that the level of stigma may be higher or
lower in other sub-groups like community members, or persons affected by TB and not in
treatment. In addition, differences in language and culture need to be acknowledged and
carefully assessed for any measurement scale. Study participants were volunteers. It may be
possible that non-volunteer or randomly selected participants may have different perspectives
toward tuberculosis and HIV/AIDS related stigma.
Implications
Findings from this study could help us advance and have a better understanding of the
factors that influence health-seeking behaviors and work on designing and implementing stigma
reduction and elimination interventions. Understanding how individuals affected by TB and
stigma are influenced by what family members, friends, and other members of their social
networks tell them about the disease and its treatment is important. Understanding these
influences can provide vital insights into how TB is experienced by the persons affected by TB
and others. These findings could also help programs and health-care providers to use personcentered approaches instead of disease-centered care.
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CHAPTER 7
CONCLUSION AND IMPLICATIONS
This study examines the experiences and perspectives on the disease of tuberculosis from
the vantage point of Persons Affected by Tuberculosis. This chapter triangulates data from three
different studies, integrates findings and presents conclusions and implications for future
research. This thesis concludes that tuberculosis in many respects is a social illness and that
socioeconomic differentials and inequalities are strongly associated with the burdens of the
disease. The research illustrates that tuberculosis and TB-related stigma are significant barriers to
health- seeking behaviors and access to health care. There is, however, little consensus about
how to define, measure or mitigate these phenomena.
In this study, I examined the research literature on the conceptualization and
measurement of stigma. Qualitative and quantitative research methods were used to explore the
perspectives and experiences of Mexican-origin Persons Affected by Tuberculosis in treatment
or who had completed treatment. Goffman’s theoretical framework on stigma (1963) and a
related conceptualization of stigma (Link & Phelan, 2002) were used to guide this research.
Stigma adversely affects persons with tuberculosis and their health seeking behaviors as
has been illustrated here among Mexican-origin groups with TB. The subjective experience of
living with TB is profound and shapes the way that PATB interact with family members, health
care providers and the public. Evidence indicates that behavioral, psychological and
environmental factors are major determinants of health (Navarro, 2004; Marmont & Bell, 2009).
Tuberculosis related stigma is a widespread phenomenon and occurs in every country and
region of the world (UNAIDS, 2000a:5). The multidimensional aspects of TB related stigma
discussed here are corroborated by other researchers (Pungrassami et al., 2010; Weiss &

205

Ramakrishna, 2006). In addition to stigma related influences, health seeking behaviors were
found to be influenced by numerous factors such as: low perception of risk; lack of information
about sources of treatment; procrastination in seeking services (once feeling ill); unmanageable
pain; false perceptions of feeling healthy; fear of rejection; lack of health insurance; financial
difficulties; outright denial and/or the lack of transportation.
Given these many issues, behavioral health outcomes need to be understood in terms of
the layers of social context in which individuals are able and willing to obtain, maintain and
complete treatment. Theories of beliefs and behaviors alone will not in themselves address the
issues of TB related stigma. Individual decision-making and behavior were seen here to be
mediated by culture and social-structural elements (e.g. poverty, inequalities), which affect
availability, acceptability, accessibility and affordability of health and human services.

7.1 STUDY ON THE PERSPECTIVES FROM PERSONS AFFECTED BY TB IN
CIUDAD JUÁREZ, MÉXICO AND EL PASO, TEXAS
Conclusion
The value of these interviews lies in their ability to demonstrate that the old
representations of tuberculosis no longer apply, even though many beliefs inherent in them are
still present in societal views of people with tuberculosis. The old labels appear in every
interview conducted and are cited as the source of the stigma and discrimination associated with
the disease. Issues relating to diagnoses, treatment experiences, access to medical care,
awareness of tuberculosis information resources, and attitudes about TB related stigma and
discrimination were discussed. Study participants reported traditional beliefs and myths about
TB as symptoms and the multiple ways of contracting tuberculosis (e.g. through the air when
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someone coughs, by sharing meals and utensils with someone that has TB, by having physical
contact with person with TB (handshake, kissing, or touching the person) or through sexual
intercourse. Yet perceptions of vulnerability and susceptibility to acquiring TB were mixed.
They described many variations of stigma associated with TB and HIV/AIDS. They also
reported on trusted and popular sources of health information and TB.
Participants reported delays in obtaining a diagnosis of TB and obtaining adequate and
timely treatment on either (or both) side of the U.S-México Border. The participants also
summarized their own attitudes and behaviors related to seeking treatment. Most of the
participants identified financial barriers to pay for medical care and lack of health insurance
coverage. Participants displayed an array of emotional and psychological distress due to their
deteriorated physical and emotional condition as a result of TB. The majority delayed care
because they did not feel very ill or because they became accustomed to the cough and fatigue.
The lack of information on where to seek medical care was identified as one of the
primary reasons for not seeking treatment. All participants reported delays in seeking TB care
for several months (up to two years) between the onset of the symptoms and the initiation of the
TB treatment in both study locations. In addition, delays were attributed to self-medication and
seeking medications from pharmacies. In other cases, participants sought care from a physician
or a clinic where they received another diagnosis, which contributed to further delays in
treatment. Other participants delayed care to the point at which they no longer could endure the
pain or discomfort and sought care at a hospital emergency room where they were initially
diagnosed, hospitalized (for up to two weeks) and then referred to TB clinic for treatment. The
decision to seek medical care was particularly influenced by family members who encouraged
the interviewees to seek treatment.
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In this study, 25 percent of the participants had a dual diagnosis of DM and TB. Several
studies have suggested that diabetes mellitus increases the risk of active TB (Ponce de Leon et
al., 2004; Jeon & Murray, 2208). The rising prevalence of DM and TB in TB-endemic areas (e.g.
México) adversely affect TB control (Castellanos, 2009). None of these participants were targets
for interventions such as active case finding and treatment for latent TB in an effort to diagnose,
detect and treat DM in order to have a beneficial impact on TB care as illustrated in a systematic
review of 13 observational studies (Jeon & Murray, 2008). Dual diagnosis with HIV/AIDS was
particularly distressful to the participants.
The majority of participants in both study locations were not offered support services
during TB treatment. Therapy focused exclusively on the administration of medication and
medical consultations. This finding reiterates the importance of interdisciplinary approaches to
capitalize on the six month (105 dosage visits) regimen and to utilize a person-centered care
approach. Relationships with health care providers were perceived as very good to excellent in
both study locations.
The majority of the participants experienced rejection and were feared as a source of
infection. This illustrates that the social environment reacts negatively, especially when others
fear that they could get infected. The stigmatization of TB and HIV/AIDS seems to continue to
be associated with beliefs that TB is linked primarily with poverty, homelessness and addiction.
The majority of participants experienced stigmatization related to TB and HIV/AIDS.
Stigmatization is described in terms of discrimination from family (distancing); peers (afraid of
visiting for fear of contagion); and work (losing job or feeling discriminated against); isolation
from loved ones (especially children and spouse); rejection by family members; perceptions that
a person with TB is filthy or disgusting and by fear of infecting others. The perceptions of
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stigma associated with HIV/AIDS are founded on beliefs on how HIV/AIDS is transmitted and
on the prejudice and discrimination against persons living with HIV/AIDS. According to the
participants, a diagnosis of TB carries a negative connotation associated with social stigma.
The negative impacts of stigma related to TB were described. They include low selfesteem, morale, depression and sadness, fear of causal transmission, shame and guilt. Also of
importance are the positive impacts of stigma related to TB and HIV/AIDS which were
described as overcoming the disease (TB) and social stigma, thus fostering a positive attitude
about life and how to care for one’s health. For some participants, the experience of living with
TB was said to have made them ‘stronger’ emotionally and helped them to have a ‘more positive
outlook on life. They also observed that they were ‘more appreciative of their health and their
families’. Only a minority of participants stated that there was nothing positive about the
experience of having TB or feeling stigmatized.
The results of the study provide examples of the huge potential for advocacy,
communication and social mobilization activities. These activities have resulted in more
effective use by TB programs and health care workers with limited resources to increase access
and utilization of health services, and to attain the mitigation of TB-related social stigma and
discrimination. When participants were asked to suggest changes that could help overcome
stigma and discrimination, they found themselves at a loss and were unable to envision changes
beyond a certain “wishful thinking”. Indeed, they ended up “wishing” discrimination would
stop, but could not think of any specific actions that could be implemented. For some, there was
nothing they could think of that can be done. Overall, participants were unable to verbalize the
changes they wanted and their feelings of “guilt” appeared to influence them to conclude that
they might deserve to be stigmatized. In fact, some were clear on having internalized stigma.
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Because much of the focus of studies related to stigma revolves around social and
cognitive aspects of the disease, the result has been that the proposed actions to overcome stigma
focus on the changes needed at an individual level. This approach has led to further “blame the
victim” by leaving it up to the individuals affected to solve their own situation. In order to move
beyond this approach, an analysis of what the social and structural conditions leading to
stigmatization of individuals is necessary. Through an analysis of the social and economic
factors in which stigmatized individuals live, stigma can be understood as a designation assigned
to individuals rather than being within the person. The important aspect of this is that it would
be conducive to looking at stigma as a process rather than a thing as such. This focus
acknowledges that stigma is not naturally occurring, but something created by people and as
such it can be “un-done” by those same people as part of a collective which comprises society.

7.2 STUDY ON THE PERSPECTIVES FROM PERSONS AFFECTED BY TB WHO
PARTICIPATED IN THE PHOTOVOICE INTERVENTION IN CIUDAD JUÁREZ,
MÉXICO, AND EL PASO, TEXAS
Conclusion
The analytical purpose of this research was to explore the perspectives of persons
affected by TB and the extent to which the objectives of the Photovoice intervention were
reached, thereby illustrating changes in awareness, empowerment, and social action by TB
Photovoice participants. The study illustrates that valuable changes occurred in terms of
awareness, empowerment and social action by individuals affected by TB in El Paso, Texas and
Ciudad Juárez, México. The findings provide support for the premise that tuberculosis was a
stigmatized state of being and that community, social and border conditions and services were
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identified as essential themes and issues to participants living with TB. Participants identify the
need to conduct ongoing TB prevention and education in the study locations with populations at
risk for TB and HIV, persons affected by diabetes, migrant and mobile communities in a binational manner. Additionally, participants agreed that once an individual is properly diagnosed,
timely and person-centered services are needed on both sides of the border. A critical factor that
enhanced interest among the participants was the ability to share feelings, stories, and
perspectives, receive support from peers and not be judged.
Furthermore, the intervention provides confirmation that Photovoice can be successful as
an advocacy, communication and empowerment strategy for marginalized populations. The
study offers findings on the important contributions for both augmenting the conceptual
understanding of the impact of tuberculosis on participants and for suggesting tools for policy
change and improved delivery of health and humans services in a region that is as challenging
and dynamic as the U.S.-México border region. The findings of the study provide a glimpse of
how individuals affected by TB perceived their community. The research demonstrate how these
perspectives can be used by individuals affected by TB and empower them to ‘bridge a power
gap’ between those affected by a disease and those in power to change policy related to the
disease. The following is a list of the most salient aspects of their testimony.
(1) Awareness of the unfairness of being stigmatized, the meaning of being stigmatized,
their feelings about being stigmatized.
(2) Knowledge of their rights as people regardless of being infected with TB, their rights
as a person to be diagnosed and treated, their rights to demand fair treatment from
health care providers and to receive support from their own families.
(3) Empowering themselves by recognizing and understanding their own feelings they
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experienced healing by expressing their feelings through the photographs and also by
getting to know the other participant’s stories.
(4) Understanding that being in a peer group can be a strategy to combat their isolation.
(5) Being motivated to adhere to their treatment and to be free of TB.
(6) Acknowledgement that even though there is a lack of knowledge that TB it is curable
disease. They felt empowered because now they could tackle the stigma.
(7) Finding a voice through photography, a voice which can be heard despite socioeconomic or educational status.
(8) Increased knowledge of tuberculosis and the health-care structure to deal with it. In
particular, because this project took place in a border bi-national setting, knowledge
of the international efforts and their failings and limitations as well as their potential
to address the problem.
(9) Experiencing themselves as agents of their own lives and their disease through the
experience of presenting their stories to decision makers, and in some cases seeing
changes in policy or commitments from policy makers for change.
(10) In the case of health-care workers, gaining a better understanding of the person
affected by tuberculosis needs.

7.3 STUDY ON THE VALIDATION OF THE TB AND HIV/AIDS STIGMA SCALES
FOR USE WITH MEXICAN-ORIGIN GROUPS
One of the study aims was to examine the use of the validated TB and HIV/AIDS stigma
scales developed by Van Rie and colleagues (2008), and translated by Moya and colleagues
(Lomeli & Lusk) in 2009, among 217 TB patients from three regions in México and to determine

212

the effectiveness. The scales used to measure the phenomena of stigma related with TB and
HIV/AIDS at the community and individual affected with TB level with Mexican-origin
populations demonstrated strong psychometric properties. Factor analysis to identify the items of
the scale that loaded best was performed. No items from the original scales were excluded. The
internal consistency indices were very good to excellent (Cronbach’s alphas). The results of the
study determine that the scales developed and validated by Van Rie (2008) and translated into
Spanish for this investigation have good overall internal consistency among sub populations
studied.
This investigation quantify TB related stigma from the community perspective (attitudes
and actions of the community toward persons affected with TB) and patient (personal)
perspectives (feelings and experiences of PATB) in México. Tuberculosis related stigma was
observed among the sample of participants affected with tuberculosis. Most of the effect
measures were small, less than 1 in the relative scale and most of these effects were not
consistent across the scales and few were statistically significant. Female participants have
higher tuberculosis stigma score for both community and TB patient perspective scales as
compared to males. This finding is consistent with the work of Ngamvithayapong et al., (2001);
Uplakar et al., (1999) and WHO (2008).
It appears that individuals younger than 21 years of age had lower TB and HIV stigma in
both subscales as compared to older participants. Participants living in a marital or partnership
relationship seem to indicate lower stigma perceptions on all scales, which is consistent with
other studies by Jaramillo (1999) and Somma et al., (2008). Although no significant differences
were found, lower socio economic status (earning no wages or unemployment) had higher stigma
perceptions for the TB patient and HIV/AIDS scales. There are studies that indicate that financial
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problems and economic distress were found to increase stigma (Pungrassami et al., 2010;
Somma et al., 2008). The less educated the participants, the more perceived stigma was found in
this study. This finding has important implications for developing health literacy interventions to
reduce stigma primarily among oral literate participants. In this study, factors that may contribute
to higher perceptions of stigma include informal occupations, unemployment and disability.
However conclusions are difficult to make because socioeconomic factors show small values and
few were statistically significant.
The items that Van Rie and colleagues (2008) represented as key causes of stigma (fear
of causal transmission or being contagious, willingness to interact with individuals affected with
TB, moral values of shame, blame, guilt and judgments) and consequences of stigma (negative
emotions and feelings toward persons affected with TB, disclosure and discrimination) are
evidenced in the investigation. The scales encompass both community member and individual
perspectives by people with TB. This multidimensional focus is valuable to understanding and
measuring stigma. Results also identify some similarities between the stigma related to
tuberculosis and HIV/AIDS. Items related to fear of infection through casual contact (eating or
drinking with relatives and friends or touching others) were the most significant determinants of
stigma in both tuberculosis and HIV/AIDS based on the absolute loading factors. The item
expressed as ‘Some people do not want those with HIV/AIDS playing with their children’ loaded
third highest, which is very interesting given the important differences in the modes of
transmission between TB and HIV/AIDS. The same item for TB loaded high.
Consistent with Van Rie et al., (2008), the investigation reveal that participants perceive
that the community stigmatizes because of the nature of how tuberculosis is contracted and how
persons affected with TB are perceived as vectors of the condition or a disease like tuberculosis
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and therefore they should be keep away to avoid infection or transmission. The item on the TB
patient perceptions toward HIV/AIDS as expressed in ‘Some people who have HIV/AIDS keep
their distance from others to avoid spreading the AIDS virus’ loaded low. This may be explained
by reflecting on the knowledge and understanding of how HIV/AIDS is transmitted. The
dimension of disclosure (or secrecy) of either of the two conditions are highly prominent. In the
tuberculosis and the HIV/AIDS scales, the item: ‘Some people who have tuberculosis (or
HIV/AIDS) are afraid to tell their family (or those outside their family) that they have the
condition’ loaded high.
Maintaining the diagnosis of TB (or HIV/AIDS) in secrecy rated very high as well. These
perceptions are consistent with the work of Kelly (1999); Nyblade (2005); Sengupta et al.,
(2006) that indicates that moral judgment and fear of disclosure are associated with delayed care
and stigmatization. The concept of guilt as stated in the following items: ‘Some people who
have TB feel guilty for getting tuberculosis because of their smoking, drinking and other careless
behaviors’ or ‘Some people think that those with TB (or HIV/AIDS) are disgusting.’ The
HIV/AIDS scale item: ‘Some people prefer not to have those with HIV/AIDS living in their
community’ indicate strong moral values and norms as well as punishment and judgment.
Discrimination perceptions were also disclosed as expressed in: ‘If a person has HIV/AIDS (or
TB), some community members will behave differently toward the person for the rest of his/her
life’ or ‘some people do not want to talk to others with HIV/AIDS.’
The consequences of shame or guilt can be an important root cause in delaying access to
health services in a timely fashion as expressed in the following item: ‘Some people with TB are
afraid of going to TB clinics because other people may see them there.’ This item indicates that
there is embarrassment and judgment represented in having tuberculosis and seeking care from a
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TB clinic. Among the items with low loading values are the ones that related to isolation for TB
(or HIV/AIDS); loneliness; loss of friends because of condition (TB), perception of burden to
family because of HIV/AIDS; preference that those with HIV/AIDS live outside of their
community; fearful to access AIDS care; and judgment about what people with HIV/AIDS
deserve. Additional research to investigate why these absolute item values are low is
recommended.

7.4 LIMITATIONS
These three studies are subject to some limitations. First, no gold standard exists for
measuring TB stigma, TB knowledge, and health seeking behaviors. A more complete
assessment of stigma, knowledge, attitudes and health practices would require use of
standardized, quantitative instruments, extensive interviews and further qualitative analysis. The
validation of the TB and HIV/AIDS scale does not offer sufficient data to assess the true
meaning of the stigma scores of the scales. Although several statistically significant associations
were found, there are no independent data to validate the public health significance of the stigma
scores with knowledge. Second, the three samples were not randomly selected, which limits the
ability to draw representation to the general tuberculosis patient population or to draw
conclusions about the impact of perceptions of stigma related to TB and HIV/AIDS. Study
participants were volunteers. It may be possible that non-volunteer or randomly selected
participants may have different perspectives toward tuberculosis and HIV/AIDS related stigma.
Third, the focus of the studies was on a single population, persons affected with tuberculosis
under treatment or that completed treatment for TB. It is possible that the level of stigma may be
higher or lower in other sub-groups like community members or persons affected by TB and not
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in treatment. Fourth, differences in language and culture need to be acknowledged and carefully
assessed for any measurement scale and for findings that are most applicable in Mexican-origin
and border bi-national settings. Generalization of results may be limited in low- and middleincome communities that carry the greatest burden of TB. Fifth, discrimination was only
examined as it directly related to stigma. Broader aspects of discrimination pertaining to TB
were not explored.

7.5 IMPLICATIONS
The study findings will help scholars and programs to move from understanding stigma
and its discourse to implementing reduction strategies and interventions. It also validates a
measurement tool initially developed by Van Rie et al., (2008) and adapted to Spanish for use
with Mexican-origin groups. This allows scholars and health workers to measure tuberculosis
and HIV/AIDS stigma to design intervention strategies that will ameliorate it. Study findings
have implications for: (1) informing health services and decision makers about how persons
affected with tuberculosis in the United States-México Border interpret their illness and stigma,
(2) research on health related stigma and interventions, (3) expanding and informing healthrelated theory on tuberculosis stigma and individual and structural stigma reduction
interventions.
Based on the study findings regarding the causes and sustainability of stigma, it would be
useful to guide health and social interventions to reduce its effects and ensure that PATB receive
crucial preventive, diagnostic and treatment services that are free of stigma and discrimination.
As the discussion on the study clearly demonstrates, TB and HIV/AIDS stigma are linked to the
actions and attitudes of families, communities and societies. Therefore, the focus on stigma and
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discrimination should not be only on individuals, but also on related and underlying social
processes. The analysis of stigma related to TB and HIV/AIDS should also address the possible
responses to TB related stigma and discrimination. A conceptual framework is required that is
grounded in the understanding that stigma and discrimination are social processes (Parker &
Aggleton, 2002) that can be resisted and challenged by social action.
New approaches are needed to investigate ways of understanding TB and HIV/AIDS
stigma and how these are related, that take into account the social, cultural, political and
economic determinants. Novel interventions and programs are necessary that respond to TB and
HIV/AIDS related stigma and which engage communities and societies and those directly
stigmatized and discriminated.
Also necessary is the further development of conceptual frameworks (Parker & Aggleton,
2002) that build on exploratory and hypothesis generating studies (e.g. studies on the
environmental or structural factors, social determinants) to inform research studies (e.g. local
social processes and processes that cut across cultures) and research to inform policy and
strategy (e.g. priorities for intervention) and policy oriented studies to inform program
implementation.
An interdisciplinary approach to tuberculosis care is essential, one which combines
strengths of medical sciences and social and behavioral sciences and that looks at structural
causes of inequalities (Ogden, 1999; 2009; Kawamura, 2009; Paluzzi, 2004; Sumartajo, 1993;
Ogden, Walt & Lush, 2003). The findings can also help advance the understanding of the factors
that influence access and health seeking behaviors and help to design and implement stigma
reduction and elimination interventions. It is essential to have an understanding of how
individuals affected by TB and stigma are influenced by what family, friends and other members
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of their social networks tell them about the disease and its treatment or how they perceive or
internalize stigma. Understanding these influences can provide vital insights into how TB is
experienced, as well as an understanding of its diagnosis, treatment, and cure. These findings
can also help programs and health care providers to use person-centered approaches instead of
disease-centered care.
In addition, the findings presented in this investigation provide an exploration of the
validation of the tuberculosis and HIV/AIDS subscales for use with Mexican-origin populations.
The data collected have already served as groundwork for the first Tuberculosis Knowledge,
Attitudes and Practices (KAP) National Survey in México funded by USAID which initiated the
fall of 2009. Preliminary and unpublished results from the TB Stigma Study have been presented
at local, state and national conferences and at the 40th International UNION Conference on
Tuberculosis and Lung Disease in México. In addition, two manuscripts will be submitted for
publication in peer reviewed journals.
The investigation findings can also serve as the basis for future stigma measurement
research with Mexican-origin populations in other countries to facilitate design of reduction
interventions involving similar populations on other geographical contexts. Further research is
needed to examine how the stigma items may fit together, and to explore why certain scale items
did not factor well. The administration of this instrument and its subscales to larger and
randomly selected populations may serve to improve our understanding of TB and HIV related
stigma. We expect that in future research on the phenomena of TB and TB related stigma as well
as a stigma measurement scale will be further tested for reliability and validity. In addition, the
experiences of the persons affected by TB that participated in the semi-structured interviews and
the Voices and Images of TB (Photovoice) interviewees provided some evidence for the
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effectiveness of advocacy and communication strategies that literally put ‘a human face and
voice to a health problem’ and focus not only on increasing awareness, but also aim to obtain
public commitments of those in positions to influence policy.
Theoretical approaches ought to address core factors that may affect tuberculosis seeking
behaviors and adherence, such as power relationships and social meanings (Ingham, Woodcock
& Stenner, 1992; Gebhardt & Maes, 2001) as well as the possibility that behavior associated
with risk may involve more than one person (Bloor, 1995). Systematic documentation on the
multiple dimensions of empowerment in areas like tuberculosis, stigma, and vulnerable
populations in various cultural settings is needed. Additionally, stigma reduction interventions
and empowerment models have been carried out, but their effectiveness is often not known. This
is partly because the impact of stigma and empowerment and the tools to measure it in the
context of vulnerable populations have not been available, particularly in cultural settings like in
the U.S-México border region.
This study reiterates the importance of an interdisciplinary framework that uses both
qualitative and quantitative inquiry to document the domains and dimensions of TB related
stigma, discrimination and empowerment. Case studies and in-depth interviews can help to show
the synergy between the several dimensions of empowerment. A core recommendation from this
study is that mitigating stigma and discrimination and empowering individuals affected by TB or
other health illness is a multifaceted strategy that is embedded in complex environments and
cultural settings. The possibility of developing a generic set of stigma assessment instruments
given the similarity in the consequences of stigma in various cultural settings and crosscutting
applicability needs to be researched.
Drawing on the experience of advocacy, communication and social mobilization rather
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than just individual behavior change is important. Priority should be given to strategies that focus
on strengthening the capacity of stigmatized and marginalized groups. Empirical evidence
indicate that some of the most effective strategies in mitigating stigma are those where the
affected communities have mobilized themselves to fight stigma, discrimination and oppression
(Daniel & Parker, 1993). Examples relevant to HIV/AIDS include the Greater Involvement of
People Living With or Affected by HIV/AIDS principle which promotes the active involvement
of person living with HIV/AIDS in policy and decision making processes to promote
empowerment and encourage positive perceptions and support organization and networks and
increase recognition of their existence, needs and rights. Participation and empowerment of
persons affected by TB needs to be enhanced so that persons affected by TB use their voice to
tell their story and increase activism and create a movement like the HIV/AIDS community.
Finally, I hope that this study contributes to promoting an expanding field of research
which is highly needed in order to develop valid instruments to measure and describe stigma, to
understand the mix of contextual factors, and the perspectives of persons affected by TB and
intervention strategies.
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participant. Federal regulations require each participant receive a copy of the signed consent
document.
Please note that any revision to previously approved materials must be approved by this office
prior to initiation. Please use the appropriate revision forms for this procedure. All SERIOUS
and UNEXPECTED adverse events must be reported to this office. Please use the appropriate
adverse event forms for this procedure. All FDA and sponsor reporting requirements should also
be followed. Please report all NON-COMPLIANCE issues or COMPLAINTS regarding this
study to this office. Please note that all research records must be retained for a minimum of three
years after termination of the project.
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Based on the risks, this project requires Continuing Review by this office on an annual basis.
Please use the appropriate renewal forms for this procedure.
If you have any questions, please contact Lola Norton at 915-747-8841 or irb.orsp@utep.edu.
Please include your study title and reference number in all correspondence with this office.
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APENDIX 2
GLOSSARY OF ACRONYMS
CDC – Centers for Disease Control and Prevention. Manages the national TB registry in the
United States.
CENAVECE – National Center for Epidemiological Vigilance and Disease Control (Centro
Nacional de Vigilancia Epidemiológica y Control de Enfermedades). This institute, under the
Sub secretary of Preventive Health and Health Promotion, is charged with monitoring
epidemiology and infectious diseases in México.
DGE – General Directory of Epidemiology (Direccion General de Epidemiologia). Among other
epidemiological functions, this division of CENAVECE manages México’s national TB
registry and compiles statistics on morbidity, mortality and risk factors for the disease.
DOTS – Directly Observed Therapy, Short course. This is a World Health Organization
supported program that incorporated five components: Direct supervision of treatment, adequate
laboratory capacity for performing sputum analysis, a steady supply of first0line tuberculosis
medications, an information system for documenting causes and treatment completion rates, and
political will.
HIV/AIDS – Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome. ICE–
U.S. Immigration and Customs Enforcement. This is the enforcement branch created when
INS separated after the Department of Homeland Security was created.
ICF - International Classification of Functioning, Disability and Health of the World Health
Organization.
IMSS – Mexican Social Security Institute (Institude Mexicano de Seguro Social). Provides
health services for around 43 million formally employed Mexicans and their families.
INEGI – Instituto Nacional de Estadística y Geografía. Best-known by INEGI (National
Institute of Statistics and Geography) is an autonomous agency of the Federal Mexican
government
dedicated
to
the
collection
and
organization
of statistical, demographic, geographical and economic information on the country.
ISSSTE – Institute of Security and Social Services for State Worker (ISSSTE – Instituto de
Seguridad y Servicios Sociales de los Trabajadores del Estado). Provides services in 14 areas,
including health care, for public employees.
KAP – Knowledge, Attitude and Practices. This is a set of survey instrument used to identify
how a group of people think about disease.
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MMWR - Morbidity and Mortality Weekly Report. This is a weekly epidemiological digest for
the United States published by the Centers for Disease Control and Prevention
PAHO – Pan American Health Organization. Is an international public health agency with
over 100 years of experience working to improve health and living standards of the people of the
Americas. Serves as the Regional Office for the Americas of World Health Organization and as
the health organization of the Inter-American System.
PATB – Person affected by tuberculosis. Terms used to refer to person living or affected directly
or indirectly by tuberculosis. Terms used instead of patient.
PAR – Participatory Action Research. Is a participatory, democratic process concerned with
developing practical knowledge in the pursuit of worthwhile purposes, grounded in participatory
values that bring together action and reflection, theory and practice in the pursuit of practical
solutions to issues. (Reason & Bradbury, 2001).
PCI – Project Concern International. Is a non-profit, humanitarian Non-governmental
organziation based in San Diego, California, with global bases of operation in eleven countries
and five continents established in 1961 with the goal of providing health and poverty solutions to
children
and
communities
around
the
world.
http://en.wikipedia.org/wiki/Project_Concern_International - cite_note-3
PIMSA – Programa de Investigación en Migración y Salud. A Research Program on Migration
and Health that encourages binational cooperation by requiring researchers from the U.S. to
partner with researchers from México.
SOLUCION TB Project – Strengthening Observed Therapy Linking Up Community-based
Integrated Outreach Network for TB Control of Project Concern International works in13 states
in México in response to the USAID/México Community Based DOT and Social Mobilization
TB Action Program
SSA – Secretary of Health (Secretaria de Salud). Provides public health services and health care
for otherwise underserved and uninsured Mexicans.
Seguro Popular – The Mexican Seguro Popular (Mexican Popular Health Insurance Program)
project is a government healthcare initiative with broad political support, which aims to provide
social security benefits to underprivileged members of the population, in place since 2004. It is
considered the basis for the wider implementation of social support throughout México.
TB – Tuberculosis. A disease caused by bacteria called Mycobacterium tuberculosis. The
bacteria can attack any part of your body, but they usually attack the lungs. TB disease was once
the leading cause of death in the United States.
MDR-TB – Multi-Drug Resistant Tuberculosis. MDR-TB is a major public health problem that
threatens the success of DOTS, the World Health Organization recommended treatment
approach for detection and cure of TB, as well as global tuberculosis control.
248

WHO – World Health Organization. WHO has over 190 countries. The organization constitution
consists of: “attaining the highest possible level of health is a basic right of every human being,
regardless of race, religion, and political convictions, economic and social status.”
UACJ –Autonomous University of Ciudad Juárez (Universidad Autónoma de Ciudad Juárez) is
a public educational university in Ciudad Juárez.
UTEP – University of Texas at El Paso is a public, coeducational university, and a component of
the University of Texas System. Located on the northern bank of the Rio Grande in El Paso,
Texas, it is the largest university in the nation with a majority Mexican-American student
population.
USMBHC – United States-México Border Health Commission. Created as a binational health
commission in 2000, with the signing of an agreement by the Secretary of Health and Human
Services of the U.S. and the Secretary of Health of México. The mission is to provide
international leadership.
USMBHA – United States-México Border Health Association. Created in 1943 to bring together
persons and institutions actively engaged or interested in binational health activities between the
U.S. and the United Mexican States. The Association closed its doors in January 2010.
USAID – United States Agency for International Development. Is the U.S. federal government
agency primarily responsible for administering civilian foreign aid. Created in 1961 by executive
order to implement development assistance programs in the areas authorized by the Congress in
the Foreign Assistance Act of 1961.
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APENDIX 3
GLOSSARY OF STIGMA AND DISCRIMINATION
RELATED TO TUBERCULOSIS (TB)
Developed based on the terms used by participants in the Tuberculosis and Stigma Study:
Impacts on Health Seeking Behaviors and Access in Ciudad Juárez, México and
El Paso, Texas
(Moya et al., 2009)
Stigma
Stigma generates a
condition, attribute,
feature or behavior
which makes the
bearer be included in
a social category
toward whose
members a negative
response is generated
and are seen as
unacceptable or
inferior (Link &
Phelan, 2001; Link et
al., 2003)

People can also
internalize stigma
(internalized stigma)
and believe they
deserve to be
discriminated against
or treated badly

TB related terms
A negative attribute
To be pointed out
To be pointed to
To be marked
To turn away from
you or turn their back
on you
To get strange or ugly
looks

Discrimination
Has diverse origins and
varied expressions

Terms
Unworthy and
inferior treatment

Deteriorates life in
society between people,
marginalizes those who
are most likely to suffer
it, and limits their
human development and
the employment of their
fundamental rights.

Indifference

Ways of being or
behaving that in
different socialization
and education are
learned to be seen as not
valid or deserving of
respect

That which limits
development

To see or treat with
contempt
They stop talking to
you

To be treated as if you
had filth
People are wary of
you
Use words such as
infected by TB,
consumed to refer to
the affected person,
that they feel
revulsion, it is like
being pestilent
To give you names
(despicable, anorexic,
consumed, twisted)
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Stigma
Discrimination and
stigma related to TB
infection and/or
HIV/AIDS is a
persistent problem in
the world’s health
services, particularly
in those countries
which have a great
number of TB and/or
HIV/AIDS cases.
Stigma and
discrimination are
causes of the poor
quality of service
delivered to people
living with TB and/or
HIV/AIDS (or
suspected) which
makes them move
away from health
services and limiting
their access to usage.

TB related terms
To be crossed out
Marked
Scarred
To have a defect
To be infected
In the dark
Forgotten

To believe to deserve
to be treated poorly as
a result of the illness
To be the object of
fear

Discrimination
People or groups are
treated differently by
reason of a specific
feature, which makes
their rights vulnerable.
Attitudes of scorn and
intolerance are
manifested toward
someone due to their
belonging to a group
considered as different
and less worthy.
To favor a hostile and
humiliating environment
toward those who, by
reason of stereotypes,
consider themselves
inferior.

Terms
Marginalize
That they withdraw
from you
Withdraw
Turn the other way
That they move
away from you due
to fear

To be treated as
second class
citizens
Different treatment
Bad treatment

To be afraid of
rejection

To be disgusting

Scorned

To feel dirty

Inferior treatment

Belong to a certain
group

They don’t look
you in the eye

To be made less

They don’t give you
respect

Relegated

Violate human
rights

Thrown away
Exiled

Close the doors

To be like listless
Give out sparks

To be fired without
justification

Separated from
society

Deny access to
services

To feel despised

Close doors in your
nose
To be “dissed”
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GLOSARIO DE ESTIGMA Y DISCRIMINACIÓN
RELACIONADO CON LA TUBERCULOSIS (TB)
Desarrollado de acuerdo a los términos utilizados por participantes del Estudio sobre
Tuberculosis y Estigma: Impactos en las Conductas de Búsqueda de Servicios de Salud y
Acceso en Ciudad Juárez, México, y El Paso, Texas
(Moya et al., 2009)
Términos
Estigma
relacionados
Discriminación
Términos
con la TB
El estigma genera una Un atributo negativo
Tiene orígenes y
Trato indigno e
condición, atributo,
expresiones diversas.
inferior
Que te señalen, te
rasgo o
Deteriora
la
convivencia
apunten o te marquen
Indiferencia
comportamiento que
entre personas, margina a
Que te saquen la
hace que su portador
quienes se encuentran más Mirar o tratar con
vuelta o te den la
sea incluido en una
propensos a sufrirla, limita desprecio
espalda
categoría social hacia
su desarrollo humano y el Te dejen de
cuyos miembros se
Que te vean raro o feo disfrute de derechos
hablar
genera una respuesta
fundamentales.
Que te traten como si
negativa y se les ve
tuvieras roña
como inaceptable o
inferior (Link &
Que se escame la
Phelan, 2001; Link et gente
al., 2003)
La gente puede
Que se usen palabras Formas de ser y actuar
Eso que limita el
también interiorizar el como tuberculosos,
que, en distintas espacios
desarrollo
estigma (estigma
tísico para referirse a de socialización y
interiorizado) y creer la persona afectada,
educación, aprendidas a
que ellos/as merecen
que les des asco, es
ver como no validas ni
ser discriminados o
como sentirse
merecedoras de respeto.
tratados mal
apestado. Que te den
nombres
(despreciables,
anoréxico, tísico,
chueco)
La discriminación y el Tachar o estar
Se trata diferente a la
Marginar
estigma relacionados
tachado
persona o grupo en razón
Que se retiren de
con la TB y/o el VIH
de algún rasgo especifico, ti
Marcado
es un problema
lo cual vulnera sus
persisten te en los
Cicatrizado
Alejen
derechos. Se manifiestan
servicios de salud de
actitudes de menosprecio e Que saquen la
Tener algún defecto
todo el mundo,
intolerancia hacia alguien vuelta
particularmente en
Estar infectado(a)
debido a su pertenencia a
países que tienen gran
Se hagan a un
un grupo considerado
A obscuras
numero de casos de
lado por temor
como distinto y menos
TB y/o VIH/SIDA.
En el olvido
valioso.
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Estigma
El estigma y la
discriminación son
causa de una pobre
calidad de atención a
las personas que
viven con TB y/o
VIH/SIDA (o que se
sospecha) alejándolas
de los servicios de
salud y limitando el
acceso a su
utilización.

Términos
relacionados
con la TB
Creer merecer ser
tratado mal como
resultado de la
enfermedad
Ser objeto de temor

Discriminación

Términos

Se propicia un ambiente
hostil y humillante hacia
quienes, en razón de
estereotipos, se consideran
inferiores.

Ser tratado como
ciudadanos de
segunda clase
Trato diferente
Mal trato

Tener miedo al
rechazo

Dar asco

Menospreciado

Sentirse sucio

Trato inferior

Pertenecer a un grupo
determinado
Hacer de menos

No te ven a los
ojos cuando te
atienden

Relegado

No te den respeto

Arrumbado
Exiliado

Violen los
derechos
humanos

Estar como apagado

Cerrar las puertas

Dar flechazos

Despedirte
injustificadamente

Apartado de la
sociedad

Negar acceso a
servicios

Sentirse despreciado

Cierren las
puertas en las
narices
Hagan el fuchi
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APENDIX 4
SEMI-STRUCTURED INTERVIEW GUIDES
Interviewer __________________

Interviewee ID # __________

Questions 1 through 5 include data to be obtained from the participant’s record, prior
written Informed Consent.
Q1. Date ______

____, 200__

Q2. Place of interview
□ Ciudad Juárez, CHIH., México

□ El Paso, Texas

Q3. Type of TB case:
1. New
2. Failed
3. Re admission
4. Abandoned treatment
Q4. Is this a bi-national case?
1. Yes
2. No
9. Don’t know
Q5. What kind of treatment is the person receiving or received?
1. Primary (DOT) treatment (6 months)
2. Primary re-treatment
3. Standardized re-treatment
4. Individualized re-treatment
5. Other (please explain): ________________________
9. Don’t know
0. Did not answer
SECTION A: SOCIAL-DEMOGRAPHIC, GENERAL AND HOUSEHOLD DATA
Q6. Sex
1. M
2. F
OQ7. How old are you? ____ (age)
Q8. What is your marital status?
1. Single
2. Unmarried union (common-law)
3. Married
4. Divorced
5. Widow/widower
6. Separated
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Q9. Native of:
Country
State
City / County

_______________
_______________
_______________

IF NATIVE OF OTHER STATE, GO TO Q10
OQ10. How long have you been living in the locality where the interview is taking place?
Years: ___ X times 12 if the answer was in years or write months if the answer was in months.
Total of months: ______

(Write zero if not applicable)

Q11. Where do you live?
Country _______________
State
_______________
City
_______________
Q12. Have you ever lived on the other side of the border?
1. Yes
2. No
9. Does not know
0. Did not answer
Q13. How long did you live on the other side of the border?
1. Less than a year
2. From 1 to 5 years
3. More than 5 years
9. Does not know
0. Did not answer
Q14. How often do you cross the border?
1. Everyday
2. Weekly
3. Monthly
4. Every 6 months
5. Annually
6. Does not cross
9. Does not know
0. Did not answer
OQ15. Highest level of education completed: _________________
OQ16. Occupation? ________________________________
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Q17. Do you have a salary?
1. Yes
2. No
9. Does not know
0. Did not answer
Q18. Do you work?
1. Everyday
2. Weekly
3. Monthly
4. Occasionally
5. Does not work/ Unemployed
6. Retired
7. Disabled
8. Other (please explain):__________________________________________________
9. Does not know
0. Did not answer
Q19. Do you…
1. Live in your own house?
2. Pay your own house?
3. Rent?
4. Live with a family member?
5. Live with friends?
6. Don’t have a house?
8. Other (please explain): ___________________
9. Does not know
0. Did not answer
OQ20. How many rooms does the house have?

__________

OQ21. How many live in the household? ________ (total) ____ adults ____ children/youth
SECTION B: TUBERCULOSIS DIAGNOSIS
Q22. How long were you diagnosed (with TB)?
1. Num. of weeks
_______
2. Num. of months _______
3. Num. of years
_______
Q23. Have you suffered from tuberculosis previously?
1. Yes
2. No
9. Does not know
1. Did not answer
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IF ANSWERED YES, in what year were you diagnosed (with TB)? ______
OQ24. When did (TB) signs and symptoms show for the first time?
(Try to get the most accurate date)
OQ25. How long did it take you to look for medical care (for TB)? (Write the answer)
Q26. Where did you go first to receive treatment?
1. A medical institution (clinic, health center)
2. A drug store
3. A private doctor
4. A folk healer
5. Looked for a treatment on his/her own (herbs, acupuncture, etc.).
6. Nowhere, bore the symptoms
7. Other (please explain): ___________________________________________________:
9. Does not know
0. Did not answer
OQ27. When did you enter the (TB) program for the first time? (Write the answer)
OQ28. If the first time, you did not go to a Health Center (in Juárez) or to a Health
Department in El Paso, why? (Write the answer)
Q29. Where did you were detected (with TB)?
1. Health center or clinic (outpatient)
2. Hospital
3. Screening program in community
4. Through a TB contact investigation (contact of a person affected by TB)
5. Pharmacy
6. CERESO, jail or detention facility
9. Does not know
0. Did not answer
Q30. Where were you diagnosed with tuberculosis?
1. City __________
2. State __________
3. Country __________
9. Does not know
0. Did not answer
Q31. Do you know what type of tuberculosis you have and/or had?
1. Pulmonary
2. Extra-pulmonary
3. Other (please explain): _________________________________________________
9. Does not know
0. Did not answer
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Q32. What month____ and year ____ did you start your treatment (for TB)?
Q33. If you have not completed your treatment, how long will it take you to complete it?
1. Less than a month
2. 1 to 3 months
3. 3 to 6 months
4. More than 6 months
5. Have completed treatment
9. Does not know
0. Did not answer
OQ34. What kind of problems or difficulties has the TB caused you? (Write the answer)
Q35. Do you suffer from any other condition such as…?
1. Diabetes
2. HIV/AIDS
3. Cancer
4. Hepatitis
5. Addictions (illegal drugs)
6. Alcohol
7. Depression
8. A combination of the above
9. Other (please describe)
10. None
88. Does not know
00. Did not answer
Q36. Have you ever had an HIV test?
1. Yes
2. No (go to Q40)
9. Does not know
0. Did not answer
Q37. Did you get your test results?
1. Yes
2. No
9. Does not know
0. Did not answer
OQA38. How did you feel when you got your results? (Write the answer)
Q39. Are you currently receiving medical care for your HIV condition?
1. Yes
2. No
9. Does not know
0. Did not answer
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SECTION C. KNOWLEDGE ON TUBERCULOSIS
Q40. Before you were diagnosed (with TB), have you ever heard about TB? (Do not read
the options)
1. Yes
2. No
9. Does not know
0. Did not answer
Q41. In your opinion, how serious is tuberculosis?
(Read the options and mark one answer only)
1. Very serious
2. Somewhat serious
3. Not that serious
9. Does not know
0. Did not answer
Q42. How serious do you consider the issue (of tuberculosis) in your community, city,
town? (Read the options and mark only one answer)
1. Very serious
2. Somewhat serious
3. Not that serious
9. Does not know
0. Did not answer
Q43. What are the (tuberculosis) signs (symptoms, indicators or indications) and
symptoms? (Do not read. Mark every option mentioned by the interviewee)
1. Cough
2. Cough lasting less than two weeks
3. Cough with blood
4. Cough with phlegm
5. Loss of weight
6. Fever
7. Evening or night fever
8. Fever with no apparent cause lasting less than seven days
9. Chest pain
10. Short of breath
11. Constant fatigue
88. Other(s) (please explain):______________________________________________________
99. Does not know
00. Did not answer
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Q44. In which ways can someone get tuberculosis?
(These are individual questions, read each one separately)

a. By a handshake
b. Through air, when someone with TB coughs or
sneezes
c. Sharing meals
d. Eating from the same plate
e. Touching something in a public place
(door knobs, handles in public transportation, etc.)

2
2

Does not
know
3
3

Did not
answer
4
4

2
2
2

3
3
3

4
4
4

Yes

No

1
1
1
1
1

OQ45. Please probe. Is there any other way of getting it (tuberculosis)?
(Please try to obtain an explanation on the way of getting TB based on the person’s answer):
Q46. How can a person prevent from getting the disease (tuberculosis)? (Mark every answer
mentioned, without reading)
1. Avoiding handshakes
2. Covering your mouth and nose when coughing or sneezing
3. Avoid sharing meals
4. Washing your hands alter touching something in public places
5. Closing the house’s windows
6. Opening the windows, having good ventilation
7. Having a good nutrition
8. Praying
88. Other (please explain):
99. Does not know
00. Did not answer
Q47. In your opinion, who can get tuberculosis?
(Mark all answers mentioned, without reading)
1. Anyone
2. Poor people
3. Homeless people
4. Alcoholics
5. People addicted to drugs (drug addicts)
6. People suffering from HIV/AIDS
7. People with diabetes
8. People who have been in prison
9. Other (please explain): __________
99. Does not know
00. Did not answer
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Q48. Can tuberculosis be cured?
1. Yes
2. No
9. Does not know
0. Did not answer
Q49. How can a person suffering from tuberculosis be cured?
(Mark every answer mentioned, but do not read them)
1. Herbs remedies
2. Resting at home without taking any medicine
3. Praying
4. Medication prescribed by a doctor or by a health center
5. Tuberculosis medication administered by the health center staff
8. Other (please explain): ____________________________________________________
9. Does not know
0. Did not answer
SECTION D. EXPERIENCE WITH TB TREATMENT AND MEDICAL CARE
Q50. Your health status today is: (read options)
1. Excellent
2. Very good
3. Good
4. Average
5. Bad
8. Other: (please explain): ______________________________________________________
9. Does not know
0. Did not answer
Q51. You are affiliated to:
1. ISSSTE or IMSS
2. Seguro Popular (México)
3. Private health insurance plan
4. Public Health Services (e.g. Centro de Salud in Juárez or Public Health Clinics)
5. Medicaid
6. Medicare
7. None
8. Other (please explain): ________________________
9. Does not know
0. Did not answer

261

Q52. Where do you usually go to receive medical care?
(Mark every answer mentioned, but do not read the options)
1. Private clinic
2. Public clinic or public hospital
3. Folk healer or homeopath
4. Clinic administered by a non-governmental agency
8. Other (please explain): _______________________________________________
9. Does not know
0. Did not answer
Q53. How long does it take you to the clinic, health center or hospital where you get
medical care?
1. 10 to 30 minutes
2. 30 to 60 minutes
3. 60 to 120 minutes
4. More than two hours
8. Other (please explain): _____________________________________________________
9. Does not know
0. Did not answer
OQ54. How do you get to the health services location?
Q55. How often do you look for medical care (not for tuberculosis)?
(Mark only one answer, do not read the options)
1. Twice a year or more
2. Once a year
3. Less than once a year, but at least twice in the last five years.
4. Once in the last five years
5. Never in the last five years
8. Other (please explain): ________________________________________________________
9. Does not know
0. Did not answer
Q56. Who do you talk with about your disease (tuberculosis)? (Do not read the options.
Mark every answer mentioned)
1. Doctor or any worker in the health area
2. Husband/wife /significant other
3. Father/mother
4. Child/children
5. Any other relative (siblings, uncles, aunts, cousins).
6. Close friend
7. Nobody
8. Other (please explain): _______________________________________________________
9. Does not know
0. Did not answer
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Q57. Who was the most supportive person during your disease (tuberculosis)? (Do not read
the options. Mark every answer mentioned)
1. Doctor or any worker in the health area
2. Husband/wife/significant other
3. Father/mother
4. Child/children
5. Any other relative (siblings, uncles, aunts, cousins).
6. Close friend
7. Nobody
8. Other (please explain): ________________________________________________
9. Does not know
0. Did not answer
OQ58. What kind of support have you received from your family? (Write the answer)
OQ59. What kind of support have you received from the health services?
(Write the answer)
Q60. Did they (health providers) explain to you how does the medication (for tuberculosis)
work?
1. Yes
2. No
9. Does not know
0. Did not answer
Q61. Did they explain to you the (negative or secondary) effects of the medication?
1. Yes
2. No
9. Does not know
0. Did not answer
Q62. Did they explain to you the importance of continue taking your medication?
1. Yes
2. No
9. Does not know
0. Did not answer
Q63. Did they offer you support services? (You can provide examples such as counseling,
food pantry, guidance, social work services, legal aid, etc.)
1. Yes
2. No (Go to Q66)
9. Does not know
0. Did not answer
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Q64. How would you rate the quality of support services provided to you?
1. Excellent
2. Very good
3. Good
4. Average
5. Bad
8. Other (please explain): ___________________
9. Does not know
10. Did not receive support services
00. Did not answer
Interviewer, ask if there are any additional comments:
Q65. Did you provide you a letter of rights and responsibilities of a person with TB?
1. Yes (Ask if it was explained) ___ Yes ___ No ___ Does not know ___ Did not answer
2. No
9. Does not know
0. Did not answer
Q66. What would you do if you suspect that one of your relatives or acquaintances shows
tuberculosis symptoms? (Do not read the options. Mark every applicable answer)
1. Would go to a health center or medical institution
2. Would go to a drug store
3. Would look for a folk healer
4. Would look for alternative treatment options on my own (herbs, etc.)
8. Other (please explain): _________________________________________________
9. Does not know
0. Did not answer
Q67. How often do you go to a health center or medical institution (due to tuberculosis)?
(Please mark one of the options)
1. Only when I have an appointment
2. When I think my treatment is not working
4. When I am concerned about my treatment
5. When I have a sickness symptom
6. As soon as I get sick and think my symptoms could be related to my TB
7. I would not see the doctor unless he/she comes to see me
8. Other (Please explain): _________________________________________________
9. Does not know
0. Did not answer
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Q68. Why do you think that some people do not go to a health center to receive medical
attention (for tuberculosis)? (Please mark every answer that applies. Do not read the options)
1. They are not sure where to go
2. Cost
3. Problems with transportation/distance to the clinic
4. They don’t trust health workers, such as doctors
5. They don’t like the health workers attitude
6. They cannot get out of work (work hours overlap with the medical institutions operation
hours)
7. They don’t want to accept something is wrong
8. Because of the waiting time (long waiting time)
9. Does not know
0. Did not answer
If there were other answers (please explain): _______________________________________
Q69. How expensive has your (tuberculosis) treatment been?
(Please mark one answer. Read the options)
1. It is free of charge
2. It has a reasonable cost
3. It is somewhat/moderately expensive
4. It is very expensive
9. Does not know
0. Did not answer
Interviewer (a): If the interviewee gives an amount, write it here: _____________
Q70. How would you rate the quality of medical attention you have received
(for tuberculosis)?
1. Excellent
2. Very good
3. Good
4. Average
5. Bad
8. Other (Please explain): ___________________
9. Does not know
0. Did not answer
Interviewer (a): Ask if there are any comments:
SECTION E: AWARENESS ON TB AND INFORMATION RESOURCES
Q71. Before having TB, did you think you could get sick with tuberculosis?
(Ask the interviewee to explain his/her answer)
1. Yes (Why?) ________________________
2. No (Why?) ________________________
9. Does not know
0. Did not answer
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Q72. What was your reaction when you were diagnosed (with tuberculosis)?
(Do not read the options. Mark every answer mentioned)
1. Fear
2. Surprise
3. Shame
4. Pity
5. Sadness or hopelessness
6. Relief
8. Other (Please explain): ______________
9. Does not know
0. Did not answer
Q73. Do you feel well-informed now (about TB)?
1. Yes
2. No
9. Does not know
0. Did not answer
Q74. Would you like to have more information (about TB)?
1. Yes
2. No
9. Does not know
0. Did not answer
Q75. Where did you first hear about TB? (Mark only one. Do not read)
1. Newspapers and magazines
2. Radio
3. TV
4. Billboards
5. Brochures, posters and other printed material
6. Health workers or professionals
7. Family, friends, neighbors, and coworkers
8. Religious leaders
9. Teachers
10. Internet
88. Other (please explain) ___________________________________________________
99. Does not know
00. Did not answer
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Q76. Where do you currently obtain health information? (These are individual questions,
read each one separately)

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
88.

Newspapers and magazines
Radio
Television
Billboards
Brochures, posters and other printed material
Health workers
Family, friends, neighbors, and colleagues
Religious leaders
Teachers/School
Internet
Other (Please explain): _____________________

NO

YES

DOES
NOT
KNOW

DID NOT
ANSWER

1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2

9
9
9
9
9
9
9
9
9
9
9

0
0
0
0
0
0
0
0
0
0
0

OQ77. Which information sources you trust most? (Leave open and write answer)

Q78. Is there any information on TB available for the community?
[MARK EVERY ANSWER THAT APPLIES – PLEASE READ]

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
88.

Newspapers and magazines
Radio
Television
Billboards
Brochures, posters and other printed material
Health workers
Family, friends, neighbors, and colleagues
Religious leaders
Teachers/School
Internet
Other (Please explain): _____________________
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NO

YES

DOES
NOT
KNOW

DID NOT
ANSWER

1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2

9
9
9
9
9
9
9
9
9
9
9

0
0
0
0
0
0
0
0
0
0
0

Q79. How effective is each one of the TB related information sources in reaching the
community?
NOT
ALL
AT ALL

NOT
MUCH

VERY
MUCH

DID NOT
ANSWER

DOES
NOT
KNOW

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

0
0
0
0
0

9
9
9
9
9

1
1

2
2

3
3

0
0

9
9

1
1
1
1

2
2
2
2

3
3
3
3

0
0
0
0

9
9
9
9

1.
2.
3.
4.
5.

Newspapers and magazines
Radio
Television
Billboards
Brochures, posters and other printed
material
6. Health workers
7. Family, friends, neighbors, and
colleagues
8. Religious leaders
9. Teachers/School
10. Internet
11. Other (Please explain): _____________

OQ80. What is your biggest concern when you think about TB? (Write exact answer)
SECTION F: ATTITUDES ABOUT STIGMA AND DISCRIMINATION RELATED
WITH TB
Interviewer: Start by explaining the interviewee that you will ask some open-ended questions
about his/her experience with tuberculosis and in regard with the way they treat people with the
disease. Questions related to the way persons with HIV/AIDS are treated will also be included,
since HIV/AIDS, as well as other conditions, are related to the stigma and discrimination issue
we will discuss next.
Stigma has to do with negative attitudes that one person has toward another or how does a
person suffering with a condition or disease such as TB or HIV feel (if he/she feels useless,
inferior, pointed out, or marked for having TB or any other disease). People being pointed out
often experience discrimination or are treated differently (in a negative way) and their human
rights are violated.
OQ81. How do you see the way a person with tuberculosis is treated?
(Write answer literally)
OQ82. Are others treating you in a different way? (Write exact answer)
Q83. Do you think there is stigma towards a person with tuberculosis?
1. Yes (why?)
2. No (why?)
9. Does not know
0. Did not answer
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Q84. Do you think there is stigma towards a person with HIV/AIDS?
1. Yes (why?)
2. No (why?)
9. Does not know
0. Did not answer
Q85. Do you think having tuberculosis has the same stigma as having HIV/AIDS?
1. Yes (why?)
2. No (why?)
9. Does not know
0. Did not answer
OQ86. Have you ever felt worthless or pointed out as a result of having tuberculosis?
(Write literally)
OQ87. What made you feel that way? (Write literally)
OQ88. How did you feel? (Write literally)
Q89. Do YOU know another person with tuberculosis that has been affected by the stigma
or discrimination (i.e. being treated unfairly by health services; lost his/her job; being
rejected by family; being pointed out in school; or that for that reason is not receiving
medical services)?
1. Yes
2. No
9. Does not know
0. Did not answer
SECTION G. PERCEPCIONS TOWARD TUBERCULOSIS AND STIGMA
Instructions to read out loud: From now on, I shall read the statements, which explain about
how your community feels towards people with TB. After I read each statement, please answer
whether you agree or disagree that such events occur in your community. If you agree, I will ask
how you agree, agree or strongly agree. If you disagree, I will ask how you disagree, disagree or
strongly disagree. You can refuse to answer any questions that make you feel uncomfortable.
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G1 COMMUNITY’S PERCEPTION TOWARD TUBERCULOSIS
Strongly
Disagree

Items
Q90.Some people prefer not to have those with TB
living in their community.
Q91.Some people keep their distance from those with
TB.
Q92. Some people think that those who suffer from
TB are unpleasant or undesirable.
Q93.Some people feel uncomfortable when being near
those who have TB.
Q94.Some people do not want their children playing
with kids who have tuberculosis.
Q95. Some people do not want to talk to those TB.
Q96. If a person has TB, do you think that some
people in the community will behave differently
toward him/her for the rest of their lives?
Q97. Some people do not like to drink or eat with
friends who suffer from TB.
Q98. Some people try not to touch others with TB
Q99. Some people do not want to drink or eat with
relatives who have TB.
Q100. Some people are afraid of those with TB
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Disagree

Agree

Strongly
Agree

G1 COMMUNITY’S PERCEPTION TOWARD TUBERCULOSIS
Strongly
Disagree

Items

Disagree

Agree

Strongly
Agree

Q101. Some people who have TB feel guilty because
their family has the burden of caring for them
Q102. Some people with TB keep their distance away
from others to prevent transmitting germs of the
disease.
Q103. Some people with TB feel alone.
Q104. Some people who have TB feel hurt of how
others react to knowing they have TB
Q105. Some people with TB lose friends when they
share with them they have that disease.
Q106. Some people with TB are worried about having
AIDS.
Q107. Some people with TB are afraid to tell those
outside their family that they have TB
Q108. Some people who have TB will choose
carefully who they tell about having TB.
Q109. Some people who have TB are afraid of going
to TB clinics because other people may see them
there.
Q110. Some people with TB are afraid to tell their
relatives they have this disease.
Q111. Some people with TB are afraid to tell others
they have this disease, because other may think that
they also have HIV/AIDS.
Q112. Some people with TB feel guilty for getting the
disease because of their smoking, drinking or other
careless behaviors.
OQ113. How can stigma affect a person with TB in a negative way? (Write literally)
OQ114. How can stigma affect a person with HIV/AIDS in a negative way? (Write literally)
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OQ115. How can stigma affect a person with TB in a positive way? (Write literally)
OQ116. How can stigma affect a person with HIV/AIDS in a positive way? (Write literally)
OQ116. In order to mitigate (eliminate) stigma or rejection towards people affected with
TB, what can be done by…? (Read each statement separately and write literally)
1. Health workers and professionals
2. Family
3. Society (school, work, community, etc.)
4. The person with TB
OQA117. In order to eliminate discrimination against people affected with TB, what can be
done by…? (Read each statement separately and write literally)
1. Health workers, professionals
2. Family
3. Society (school, work, community, etc.)
4. The person with TB
OQ118. Do you want to add any comments?
OQ119. Do you have any question about this study?
Thanks for your participation!
Interviewer’s remarks and observations:

Sources: Van Rie et al., Measuring stigma associated with tuberculosis and HIV/AIDS in
southern Thailand: exploratory and confirmatory factor analysis of two new scales. Tropical
Medicine & International Health, 2008, 12; 10, 21-30. Translation into Spanish, Moya et al.,
2008.
Notes: Developed in partnership with PIMSA Project Research team: Moya, Lusk, Ramos,
Acosta and Puga. February 2009. Ciudad Juárez, México. Field tested in Spanish by: Daniel
and Luisa (Compañeros A.C.), Margarita (Jurisdicción No. 2/PCI Solución TB Expansión) and
Delia (UACJ) February 2009. Translated by Victoria Garcia, Department of Linguistics and
Translations, UTEP. March 6, 2009.
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GUÍA DE ENTREVISTA SEMI-ESTRUCTURADA
Entrevistador/a __________________

No. de ID __________

Las preguntas 1 a 5 son datos que se obtendrán del expediente de participante previo
consentimiento informado por escrito.
P1. Fecha ______ de ____ 200__
P2. Localidad de entrevista
□ Ciudad Juárez, CHIH. México

□ El Paso, Texas

P3. Tipo de caso de TB:
1. Nuevo
2. Fracaso
3. Reingreso
4. Abandono
P4. ¿Es caso binacional?
1. Si
2. No
9. No sabe
P5. ¿Qué esquema de tratamiento recibe o recibió?
1. Primario acortado (6 meses)
2. Re-tratamiento primario
3. Re-tratamiento estandarizado
4. Re-tratamiento individualizado
5. Otro (favor de explicar): ________________________
9. No sabe
0. No contestó
SECCION A: DATOS SOCIODEMOGRÁFICOS, GENERALES Y DE RESIDENCIA
P6. Sexo
1. M
2. F
P7. ¿Cual es su edad?____ (en años cumplidos)
P8. ¿Cual es su estado civil?
1. Soltero/a
2. Unión libre
3. Casado/a
4. Divorciado
5. Viudo/a
6. Separado
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P9. Usted es originario de:
País _______________
Estado _______________
Municipio/Condado _______________
EN CASO DE SER ORIGINARIO DE OTRA ENTIDAD PASE A LA P10
P10. ¿Cuanto tiempo tiene de residir en la localidad de la entrevista?
Años: ___ X por 12 si son años o anotar meses si la respuesta fue en meses.
Total de meses: ______ (Poner ceros si no aplica)
P11. ¿Cual es su lugar de residencia?
País
_______________
Estado _______________
Ciudad _______________
P12. ¿Ha vivido del otro lado de la frontera?
1. Sí
2. No (Pase a la P14)
9. No sabe
0. No contestó
P13. ¿Durante cuanto tiempo vivió en el otro lado de la frontera?
1. Menos de 1 año
2. De 1 a 5 años
3. Más de 5 años
9. No sabe
0. No contestó
P14. ¿Con que frecuencia cruza la frontera?
1. Diario
2. Semanal
3. Mensual
4. Cada 6 meses
5. Anualmente
6. No cruza
9. No sabe
0. No contestó
PA15. Último año de estudios terminado: _________________ (Sondear)
PA16. ¿A qué se dedica? ________________________________

274

P17. ¿Recibe salario?
1. Sí
2. No
9. No sabe
0. No contestó
P18. ¿Trabaja?
1. Diario
2. Semanal
3. Mensual
4. Ocasional
5. No trabaja/Desempleado/a
6. Pensionado/a
7. Discapacitado/a
8. Otro (favor de explicar):___________________
9. No sabe
0. No contestó
P19. ¿Vive en casa….?
1. Propia
2. Esta pagando casa propia
3. Renta
4. Con familiares
5. Con amigos
6. No vivienda
8. Otro (favor de explicar): ___________________
9. No sabe
0. No contestó
PA20. ¿Cuántos cuartos tiene la vivienda?

__________

PA21. ¿Cuánto adultos ____ y cuántos niños/jóvenes _____ viven en su hogar? _____ total.
SECCION B: DIAGNÓSTICO DE TUBERCULOSIS
P22. ¿Cuanto hace que le dieron el diagnostico (de TB)?
1. No. de semanas _______
2. No. de meses _______
3. No. de años
_______
P23. ¿Padeció tuberculosis anteriormente?
5. Sí
6. No
10. No sabe
2. No contestó
EN CASO AFIRMATIVO, ¿En qué año le diagnosticaron (TB)? ______
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PA24. ¿Cuánto hace que le empezaron los signos y síntomas (de TB) por primera vez?
(Obtenga la fecha mas exacta)
PA25. ¿Cuánto tiempo le tomó buscar atención medica (por la TB)? (Escriba la respuesta)
P26. ¿A dónde acudió por primera vez para recibir tratamiento?
1. Acudió a una institución médica.
2. Acudió a una farmacia.
3. Acudió con un médico particular.
4. Acudió a un curandero tradicional.
5. Solicitó un tratamiento por su cuenta (hierbas, acupuntura etc.).
6. A ningún lugar, se aguanto los síntomas.
7. Otro (favor de explicar): ___________________:
9. No sabe
0. No contestó
PA27. ¿Cuándo ingreso al programa (de TB) por 1era vez? (Escriba la respuesta)
PA28. Si no fue a un Centro de Salud (Juárez) o Departamento de Salud en El Paso por
primera vez, ¿por qué? (Escribir la respuesta)
P29. ¿En que lugar le hicieron la detección (por TB)?
1. Consulta externa en un Centro de Salud o clínica
2. Hospital
3. Pesquisa
4. Examen de contactos
5. Farmacia
6. CERESO o Reclusorio
9. No sabe
0. No contestó
P30. ¿En dónde le dieron el diagnóstico de tuberculosis?
1. Ciudad __________
2. Estado __________
3. País
__________
9. No sabe
0. No contestó
P31. ¿Sabe que tipo de tuberculosis tiene y/o tuvo?
1. Pulmonar
2. Extra-pulmonar
3. Otra (favor de explicar): ___________________
9. No sabe
0. No contestó
P32. ¿En qué mes____ y año ____ inició su tratamiento (por TB)?
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P33. ¿Si aun no termina su tratamiento cuanto tiempo le falta para terminarlo?
1. Menos de un mes
2. Entre 1 a 3 meses
3. Entre 3 a 6 meses
4. Más de 6 meses
5. Ya termino tratamiento
9. No sabe
0. No contesto
PA34. ¿Qué problemas o dificultades le ha ocasionado a usted la TB? (Escribir la respuesta)
P35. ¿Tiene usted alguna otra condición de salud como…?
1. Diabetes
2. VIH/SIDA
3. Cáncer
4. Hepatitis
5. Adicciones (drogas ilícitas)
6. Alcohol
7. Depresión
8. Mas de un padecimiento
9. Otras (describir)
10. Ninguna
88. No sabe
00. No contestó
P36. ¿Alguna vez se ha hecho la prueba de VIH?
1. Sí
2. No (pase a la P40)
9. No sabe
0. No contestó
P37. ¿Le dieron su resultado (de la prueba de VIH)?
1. Sí
2. No
9. No sabe
0. No contestó
PA38. ¿Cómo se sintió cuando le dieron los resultados? (Escribir la respuesta)
P39. ¿Está recibiendo servicios médicos para su condición de VIH?
(Solo preguntar si manifestó ser VIH +)
1. Sí
2. No
9. No sabe
0. No contestó
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SECCIÓN C. CONOCIMIENTO SOBRE LA TUBERCULOSIS
P40. Antes de ser diagnosticado/a (con TB) ¿había oído hablar de la TB?
(No lea las opciones)
1. Sí
2. No
9. No sabe
0. No contestó
P41. En su opinión ¿Qué tan grave es la tuberculosis?
(Lea las opciones y marque solo una respuesta solamente)
1. Muy grave
2. Algo grave
3. No tan grave
9. No sabe
0. No contestó
P42. ¿Qué tan serio considera que es el problema (de la tuberculosis) en su comunidad,
ciudad, municipio? (Lea las opciones y marque una sola respuesta)
1. Muy serio
2. Algo serio
3. No tan serio
9. No sabe
0. No contestó
P43. ¿Cuáles son los signos o síntomas de la tuberculosis?
(No lea. Marque todo lo que se mencione)
1. Tos
2. Tos que dura menos de dos semanas
3. Tos con sangre
4. Tos con flemas
5. Pérdida de peso
6. Fiebre
7. Fiebre en las tardes o noches
8. Fiebre sin causa aparente que dure menos de siete días
9. Dolor en el pecho
10. Falta de aliento
11. Fatiga constante
88. Otro(s) (favor de explicar):_______________________________________________
99. No sabe
00. No contestó

278

P44. ¿De qué manera puede una persona contraer la tuberculosis? (Son preguntas
individuales, lea cada uno por separado)
a) A través de un saludo de manos
b) A través del aire cuando tose o estornuda una
persona con TB
c) Cuando se comparten los alimentos
d) Cuando se come del mismo plato
e) Al tocar alguna cosa en un lugar público (Perillas
de las puertas, agarraderas en un transporte, etc.)

Si

No

No Sé

No
Contesto

1

2

3

4

1

2

3

4

1
1

2
2

3
3

4
4

1

2

3

4

PA45. Favor sondear ¿Existe otra manera de contraerla (la tuberculosis)? (Favor de
obtener una explicación de la forma de contraer la TB según la diga la persona que contesta):
P46. ¿De qué manera puede una persona evitar enfermarse (de la tuberculosis)?
(Marque todas los que se mencionen, sin leer)
1. Evitando saludar de mano
2. Cubriéndose la boca y la nariz cuando tose o estornude
3. Evitando compartir alimentos
4. Lavándose las manos después de tocar alguna cosa en un lugar público
5. Cerrando las ventanas de la casa
6. Abriendo las ventanas, ventilando bien
7. A través de una buena nutrición
8. Orando
88. Otro (favor de explicar):
99. No sabe
00. No contestó
P47. En su opinión, ¿Quién puede contraer la tuberculosis?
(Marque todas los que se mencionen, sin leer)
1. Cualquiera
2. Las personas pobres
3. Las personas sin hogar
4. Los/as alcohólicos/as
5. Los/las personas que usan drogas ilícitas (drogadictos/as)
6. Las personas que padecen VIH/SIDA
7. Las personas que tienen diabetes
8. Las personas que han estado en prisión
9. Otro (favor de explicar): __________
99. No sabe
00. No contestó

279

P48. ¿Puede curarse la tuberculosis?
1. Sí
2. No
9. No sabe
0. No contestó
P49. ¿De qué manera se puede curar una persona que padece tuberculosis?
(Marque todas las que se mencionen, pero no las lea)
1. Remedios a base de hierbas
2. Descansar en casa sin tomar medicinas
3. Orando
4. Medicamentos recetados por un medico o en un centro de salud
5. Medicamentos para la tuberculosis administrados por el personal del centro de salud
8. Otra (favor explicar): ___________________
9. No sabe
0. No contestó
SECCION D. EXPERIENCIA CON EL TRATAMIENTO Y LA ATENCIÓN MÉDICA
EN TB
P50. Su estado de salud actual (Marque la que le mencione, sin leer)
1. Excelente
2. Muy bueno
3. Bueno
4. Regular
5. Malo
8. Otro: (favor de explicar): _________________________
9. No sabe
0. No contestó
P51. ¿Donde está usted inscrito para recibir servicios médicos?
(Marque la que le mencione, sin leer)
1. ISSSTE o IMSS (México)
2. Seguro Popular (México)
3. Seguro medico privado (EUA o México)
4. Servicios de Salud (SSA) o Clínica Comunitaria o Servicios de Salud públicos (El Paso)
5. Medicaid (EUA)
6. Medicare (EUA)
7. Ninguno
8. Otro (favor de explicar): ________________________
9. No sabe
0. No contestó
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P52. ¿A donde acude usualmente para atenderse?
(Marque todas las que se mencionan, pero no lea las opciones)
1. Clínica privada
2. Clínica pública u hospital público
3. Curandero tradicional u homeopático
4. Clínica administrada por una agencia no gubernamental
8. Otro (favor de explicar): _______________________________________________
9. No sabe
0. No contestó
P53. ¿Cuánto tiempo le toma llegar a la clínica, centro de salud u hospital donde se
atiende?
1. De 10 a 30 minutos
2. Entre 30 y 60 minutos
3. Entre 60 a 120 minutos
4. Más de dos horas
8. Otro (favor de explicar): _______________________________
9. No sabe
0. No contestó
PA54. ¿Cómo llega usted a los servicios de salud?
P55. ¿Con qué frecuencia busca atención médica que no sea por tuberculosis?
(Marque solo una, no lea las opciones)
1. Dos veces al año o más
2. Una vez al año
3. Menos de una vez al año pero por lo menos dos en los últimos cinco años
4. Una vez en los últimos cinco años
5. Nunca en los últimos cinco años
8. Otro (favor de explicar): _______________________________
9. No sabe
0. No contestó
P56. ¿Con quién habla de su enfermedad (tuberculosis)?
(No lea las opciones. Marque todos los que se mencionen)
1. Médico/a o un trabajador/a en el área de la salud
2. Esposo/a o Compañero/a sentimental
3. Padre/madre
4. Hijo/hijos
5. Otro miembro de su familia (hermanos/as, tíos/as, primos/as)
6. Amigo/a cercano
7. Nadie
8. Otro (favor de explicar): ___________________
9. No sabe
0. No contestó
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P57. ¿De quién recibe o recibió el mayor apoyo durante su enfermedad (tuberculosis)?
(No lea las opciones. Marque todos los que se mencionen)
1. Médico/a o un trabajador/a en el área de la salud
2. Esposo/a
3. Padre/madre
4. Hijo/hijos
5. Otro miembro de su familia (hermanos/as, tíos/as, primos/as)
6. Amigo/a cercano
7. Nadie
8. Otro (favor de explicar): ___________________
9. No sabe
0. No contestó
PA58. ¿Que tipo de apoyo ha recibido de parte de su familia? (Escribir la respuesta)
PA59. ¿Que tipo de apoyo ha recibido de parte de los servicios de salud?
(Escribir la respuesta)
P60. ¿Le explicaron como funcionan los medicamentos para la tuberculosis?
1. Si
2. No
9. No sabe
0. No contestó
P61. ¿Le explicaron los efectos (adversos o secundarios) de los medicamentos?
1. Si
2. No
9. No sabe
0. No contestó
P62. ¿Le explicaron la importancia de no dejar de tomar sus medicamentos?
1. Si
2. No
9. No sabe
0. No contestó
P63. ¿Le ofrecieron servicios de apoyo? (puede proporcionar ejemplos como consejería,
despensas, psicología, trabajo social, asesoría legal, etc.)
1. Si (Pregunte) Cuales: __________________________________________________
2. No (Pase a la P66)
3. Ninguno
9. No sabe
0. No contestó
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P64. ¿Cómo calificaría usted la calidad del los servicios de apoyo que le han brindado?
1. Excelente
2. Muy bueno
3. Bueno
4. Regular
5. Malo
8. Otro (Favor de explicar): ___________________
9. No sabe
10. No recibió servicios de apoyo
00. No contestó
Entrevistador, pregunte si hay algún otro comentario:
P65. ¿Le dieron la carta de derechos y responsabilidades de la persona afectada por la TB?
1. Si (Pregunte si se la explicaron) ___ Si ___ No ___ No sabe ___ No contesto
2. No
9. No sabe
0. No contestó
P66. ¿Qué haría si sospechara que alguno de sus familiares o conocidos muestra síntomas
de tuberculosis? (Sondee, escriba la respuesta)
P67. ¿Cada cuando va usted a un centro de salud o institución médica (por su
tuberculosis)? (Favor de marcar una de las opciones)
1. Cuando tengo cita únicamente
2. Cuando pienso que no está funcionando mi tratamiento
4. Cuando tengo alguna duda sobre mi tratamiento
5. Cuando tengo algún síntoma de enfermedad
6. Tan pronto me enfermo y pienso que mis síntomas pudieran estar relacionados con mi TB
7. No iría con el médico/a a menos que ellos me vengan a buscar
8. Otro (Favor de explicar): ___________________
9. No sabe
0. No contestó
P68. ¿Cuál es el motivo por el cual cree usted que algunas personas no van a un centro de
salud o institución médica a recibir atención médica para la tuberculosis?
(Favor de marcar todas las que apliquen. No lea las opciones)
1. No están seguros a donde ir
2. El costo
3. Problemas con el transporte/distancia a la clínica
4. No confían en los empleados de salud, como los médicos
5. No les gusta la actitud de los empleados médicos
6. No pueden salir del trabajo (las horas de trabajo se empalman con las horas de oficina de las
instituciones médicas)
7. No quieren darse cuenta que algo anda mal
8. Por el tiempo de espera (le hacen esperar mucho)
9. No sabe
0. No contestó
Si contesto, Otro (Favor de explicar):___________________________
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P69. ¿Qué tan caro ha sido su tratamiento (de tuberculosis)?
(Favor de marcar uno. Lea las opciones)
1. Es gratuito
2. Tienen un costo razonable
3. Es algo/moderadamente caro(s)
4. Es muy caro(s)
9. No sabe
0. No contestó
Entrevistador (a): Si quien responde dice alguna cantidad, anote la cifra aquí: ___________
P70. ¿Cómo calificaría usted la calidad de la atención médica que ha recibido
(tuberculosis)?
1. Excelente
2. Muy buena
3. Buena
4. Regular
5. Mala
8. Otro (Favor de explicar): ___________________
9. No sabe
0. No contestó
Entrevistador(a): Pregunte si hay algún otro cometario:
SECCIÓN E: DONDE OBTIENE INFORMACIÓN
P71. ¿Antes de desarrollar la TB, creía usted que podía enfermarse de tuberculosis?
(Pídale a quien responda que explique su respuesta)
1. Sí (¿Porque?)
2. No (¿Porque?)
9. No sabe
0. No contestó
P72. ¿Cuál fue su reacción cuando le diagnosticaran tuberculosis?
(No lea las opciones. Marque todas los que se mencionen)
1. Temor
2. Sorpresa
3. Vergüenza
4. Pena
5. Tristeza o desesperanza
6. Alivio
8. Otro (Favor de explicar):
9. No sabe
0. No contestó
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P73. ¿Qué tan informado se siente ahora sobre la tuberculosis?
1. Sí
2. No
9. No sabe
0. No contestó
P74. ¿Desearía poder obtener más información (sobre la TB)?
1. Sí
2. No
9. No sabe
0. No contestó
P75. ¿Dónde escuchó hablar de la TB por primera vez? (Marque solo una. No leer)
1. Periódicos y revistas
2. Radio
3. TV
4. Anuncios Panorámicos o en espectaculares
5. Folletos, pósters y otro material impreso
6. Trabajadores/as del área de la salud
7. Familia, amistades, vecinos y compañeros de trabajo
8. Líderes religiosos
9. Maestros/as
10. Internet
88. Otro (Favor de explicar):
99. No sabe
00. No contestó
P76. ¿Dónde obtiene usted actualmente información de salud?
(Son preguntas individuales, lea cada uno por separado)

1. Periódicos y revistas
2. Radio
3. Televisión
4. Anuncios panorámicos
5. Folletos, pósters y otro material impreso
6. Trabajadores del área de la salud
7. Familia, amigos, vecinos y colegas
8. Líderes religiosos
9. Maestros/Escuela
10. Internet
11. Otro (Favor de explicar): ______________

285

NO

SI

NO SABE

NO
CONTESTO

1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2

9
9
9
9
9
9
9
9
9
9
9

0
0
0
0
0
0
0
0
0
0
0

PA77. ¿Cuáles son las fuentes de información en que más confía?
(Dejar abierto y escribir respuesta)
P78. ¿Existe información disponible sobre la TB para la comunidad?
MARQUE TODOS LOS QUE CORRESPONDAN-LEER

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.

Periódicos y revistas
Radio
Televisión
Anuncios panorámicos
Folletos, pósters y otro material impreso
Trabajadores del área de la salud
Familia, amigos, vecinos y colegas
Líderes religiosos
Maestros/Escuela
Internet
Otro (Favor de explicar): ______________

NO

SI

NO SABE

NO
CONTESTO

1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2

9
9
9
9
9
9
9
9
9
9
9

0
0
0
0
0
0
0
0
0
0
0

P79. Voy a mencionar varias fuentes de información relacionadas con la TB, que tan
adecuadas son para hacerle llegar la información a la comunidad
(Marque todas las que correspondan – Leer)
NADA

POCO

MUCHO

NO
CONTESTO

NO
SABE

1
1
1
1

2
2
2
2

3
3
3
3

0
0
0
0

9
9
9
9

1

2

3

0

9

1
1
1
1
1
1

2
2
2
2
2
2

3
3
3
3
3
3

0
0
0
0
0
0

9
9
9
9
9
9

1.
2.
3.
4.
5.

Periódicos y revistas
Radio
Televisión
Anuncios panorámicos
Folletos, pósters y otro material
impreso
6. Trabajadores del área de la salud
7. Familia, amigos, vecinos y colegas
8. Líderes religiosos
9. Maestros/Escuela
10. Internet
11. Otro (Favor de explicar): ___________

PA80. ¿Qué es lo que más le preocupa cuando piensa en la TB? (Escribir respuesta textual)
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SECCION F: ACTITUDES SOBRE ESTIGMA Y DISCRIMINACION RELACIONADAS
CON LA TB
Entrevistador/a: indicie por explicar al entrevistado/a que se van a hacer varias preguntas abiertas
sobre su experiencia con la tuberculosis y sobre el trato que le dan a las personas con
tuberculosis. También se harán algunas preguntas sobre el trato que reciben las personas con el
VIH/SIDA, pues el VIH/SIDA así como otras condiciones se relaciona con el tema de estigma y
la discriminación del que vamos a platicar a continuación.
El estigma tiene que ver con las actitudes negativas (desprecio) que tiene una persona hacia otra
o el cómo se siente la persona que tiene una condición o enfermedad como al TB o el VIH (por
ejemplo si se siente menos, inferior, señalada o marcada por tener TB o alguna otra enfermedad.
Las personas que son señaladas a menudo experimentan discriminación o se les trata diferente
(de manera negativa) y sus derechos humanos son violados.
PA81. ¿Cómo ve usted el trato que se le da a una persona con tuberculosis?
(Escribir la respuesta textual)
PA82. ¿El trato que le dan los demás es diferente? (Escribir la respuesta textual)
P83. ¿Usted cree que se da el estigma hacia una persona con tuberculosis?
1. Si (¿por qué?) _______________________
2. No (¿por qué?) _______________________
9. No sabe
0. No contestó
P84. ¿Usted cree que se da el estigma hacia una persona con VIH/SIDA?
1. Si (¿por qué?) _______________________
2. No (¿por qué?) _______________________
9. No sabe
0. No contestó
P85. ¿Piensa usted que tener tuberculosis tiene el mismo estigma que tener VIH/SIDA?
1. Si (¿por qué?) _______________________
2. No (¿por qué?) _______________________
9. No sabe
0. No contestó
PA86. ¿Alguna vez se ha sentido usted menos o señalado como resultado de su
tuberculosis? (Sondear y escribir textualmente)
PA87. ¿Qué lo hizo sentir así? (Sondear y escribir textualmente)
PA88. ¿Cómo se sintió? (Sondear y escribir textualmente)
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P89. ¿Conoce UD otra persona con tuberculosis que ha sido afectada por el estigma o la
discriminación (por ejemplo que se le ha tratado injustamente por los servicios de salud, o
que haya perdido su empleado, o que su familia lo haya rechazado, o que en la escuela lo
señalen, o que por eso haya dejado de recibir servicios médicos?
(Sondear y escribir textualmente)
SECCIÓN G. PERCEPCIÓNS SOBRE LA TUBERCULOSIS Y EL ESTIGMA
Instrucciones para leerse en voz alta: A continuación leeré varios enunciados que explican el
sentir de la gente en la comunidad hacia las personas con tuberculosis. Después de leer cada uno
le pido que responda si está de acuerdo o en desacuerdo en que tales situaciones ocurran en su
comunidad. Si está de acuerdo, le preguntaré que tanto está de acuerdo o en desacuerdo. Usted
puede negarse a contestar cualquier pregunta(s) en caso de sentirse incomodo(a).
G1 PERCEPCIÓN DE LA COMUNIDAD SOBRE LA TUBERCULOSIS
Totalmente
en
desacuerdo

Enunciados
P90. Algunas personas prefieren que quienes
padecen TB no vivan en su comunidad.
P91. Algunas personas mantienen su distancia de
aquellas con tuberculosis.
P92. Algunas personas piensan que quienes
padecen TB son desagradables o indeseables.
P93. Algunas personas se sienten incómodas al
estar cerca de quienes tienen TB.
P94. Algunas personas no quieren que sus hijos
jueguen con niños que tienen tuberculosis.
P95. Algunas personas no quieren hablar con
quienes tienen tuberculosis.
P96. Si alguien tuviera TB, usted cree que
algunas personas se comportarían diferentes con
él/ella por el resto de su vida.
P97. Algunas personas no les gustan beber o
comer con amigos/as que padecen TB.
P98. Algunas personas tratan de no tocar a otras
con TB
P99. Algunas personas no quieren beber o comer
con familiares que tienen TB.
P100. Algunas personas le tienen miedo a
quienes tienen tuberculosis.
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En
desacuerdo

De
acuerdo

Totalmente
de acuerdo

GII PERCEPCIÓN DE LA PERSONA AFECTADA POR LA TUBERCULOSIS
Totalmente
en
desacuerdo

Enunciados
P101. Algunas personas con TB se sienten
culpables por ser una carga para su familia.
P102. Algunas personas con TB guardan su
distancia de otras para evitar contagiarlas con
gérmenes de la enfermedad.
P103. Algunas personas con TB se sienten
solas.
P104. Algunas personas con TB se sienten
lastimadas por la manera en que los demás
reaccionan cuando se enteran que tienen la
enfermedad.
P105. Algunas personas con TB pierden a sus
amigos/as cuando les comentan que tienen esa
enfermedad.
P106. Algunas personas con TB están
preocupadas por que podrían tener sida.
P107. Algunas personas con TB tienen miedo
de decirles a otros que no son de su familia que
tienen la enfermedad.
P108. Algunas personas que tienen TB son
cuidadosas al escoger a quien decirle que
padecen la enfermedad.
P109.Algunas personas con TB tienen miedo
de ir a las clínicas de tuberculosis o a los
centros de salud por temor a que otros los vean.
P110. Algunas personas con TB tienen miedo
de decirles a sus familiares que tienen la
enfermedad.
P111. Algunas personas con TB tienen miedo
decirles a otros que tienen la enfermedad pues
pueden pensar que también tienen VIH/sida.
P112. Algunas personas con TB se sienten
culpables de haber contraído la enfermedad por
fumar, tomar o por otras conductas
irresponsables.

289

En
desacuerdo

De
acuerdo

Totalmente
de acuerdo

PA113. ¿Cómo puede el estigma afectar ‘negativamente’ a una persona con TB?
(Sondear y escribir textualmente)
PA114. ¿Cómo puede el estigma afectar ‘negativamente’ a una persona con VIH/SIDA?
(Sondear y escribir textualmente)
PA115. ¿Cómo puede el estigma afectar ‘positivamente’ a una persona con TB?
(Sondear, y escribir textualmente)
PA116. ¿Cómo puede el estigma afectar ‘positivamente’ a una persona con VIH/SIDA?
(Sondear y escribir textualmente)
PA116. ¿Para eliminar el estigma o rechazo hacia las personas afectadas con TB, qué puede
hacer? (Lea cada una por separado y escriba textualmente)
1. El personal de salud: __________________________
2. La familia: __________________________
3. La sociedad (escuela, trabajo, comunidad, etc.): __________________________
4. La persona afectada con TB: __________________________
PA117. ¿Para eliminar la discriminación hacia las personas afectadas con TB, qué puede
hacer? (Lea cada una por separado y escriba textualmente)
1. El personal de salud: __________________________
2. La familia: __________________________
3. La sociedad (escuela, trabajo, comunidad, etc.): __________________________
4. La persona afectada con TB: __________________________
PA118. ¿Tiene algún otro comentario que agregar?
PA119. ¿Tiene alguna pregunta sobre este estudio?
¡Gracias por su participación!
Observaciones del/a Entrevistador/a

Fuentes: Van Rie et al. Measuring stigma associated with tuberculosis and HIV/AIDS in
southern Thailand: exploratory and confirmatory factor analysis of two new scales. Tropical
Medicine & International Health, 2008, 12; 10, 21-30. Traducción al español, Moya et al., 2008.
Notas:
Desarrollado por equipo PIMSA: Moya, Lusk, Ramos, Acosta, y Puga. Febrero 2009.
Probada en Campo por Daniel, Margarita, María Luisa y Delia (PIMSA). Febrero 2009.
Traducción: Victoria García, Departamento de Lingüística y Traducciones de UTEP. En proceso
programada para el 6 de marzo 2009.
Actualizada por equipo PIMSA 25 de marzo 2009.
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APENDIX 5
INTERVIEW GUIDE FOR BORDER TB VOICES AND IMAGES
PARTICIPANTS IN CIUDAD JUÁREZ, MÉXICO, AND EL PASO, TEXAS
Interviewee ID ______
SECTION A: SOCIAL-DEMOGRAPHIC, GENERAL AND HOUSEHOLD DATA
Q1. Sex
1. M
2. F [Go to OQ.1.A]
OQ1.A. If female: ¿Do you have children?  Yes  No

OQ1.B. How many? ______

OQ2. ¿How old are you? ____ (age)
Q3. ¿What is your marital status?
1. Single
2. Unmarried union (common-law)
3. Married
4. Divorced
5. Widow/widower
6. Separated
Q4. ¿Where were you born? (Native of):
Country ____________ State ____________

City or County _______________

Q5. Where do you live?
Country ____________ State _______________ City _______________
Q6. ¿Have you ever lived on the other side of the border?
1. Yes
2. No [Go to Q8]
9. Does not know
0. Did not answer
Q7. ¿How long did you live on the other side of the border?
1. Less than a year
2. From 1 to 5 years
3. More than 5 years
9. Does not know
0. Did not answer
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Q8. ¿How often do you cross the border?
1. Everyday
2. Weekly
3. Monthly
4. Every 6 months
5. Annually
6. Does not cross
9. Does not know
0. Did not answer
OQ9. Highest level of education completed: _________________
OQ10. Occupation ________________________________
Q11. ¿Do you have a salary or have a source of income?
1. Yes
2. No
9. Does not know
0. Did not answer
Q12. ¿How frequent do you work?
1. Everyday
2. Weekly
3. Monthly
4. Occasionally
5. Does not work/ Unemployed
6. Retired
7. Disabled
8. Other (please explain):__________________________________________________
9. Does not know
0. Did not answer
Q13. Do you…
1. Live in your own house?
2. Pay your own house?
3. Rent?
4. Live with a family member?
5. Live with friends?
6. Don’t have a house?
8. Other (please explain): ___________________
9. Does not know
0. Did not answer
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SECTION B: ABOUT YOUR EXPERIENCE WITH TUBERCULOSIS
OQ14. When did (TB) signs and symptoms show for the first time? (Write the answer)
OQ15. When were you diagnosed with tuberculosis for the first time? (Write the answer)
OQ16. How long did it take you to look for medical care (for TB)? (Write the answer)
OQ17. Where were you diagnosed with Tuberculosis? (Write the answer)
OQ18. How would you describe the medical services received during your treatment?
(Good, bad, quality of services, effective, person centered, free of stigma or discrimination,
free, expensive…). (Write the answer)
OQ19. Did you receive any additional services such as counseling, a food basket, social
services, etc. during your TB treatment? (Write the answer)
OQ20. How do you describe your experience with tuberculosis? (Exp. difficult, adequate,
encountered discrimination, experienced stigma, isolation, received support…).
(Write the answer)
OQ21. ¿What were your reactions and feelings when you were diagnosed with
tuberculosis? (Write the answer)
OQ22. ¿How did tuberculosis affect your personal life? (Write the answer)
OQ23. ¿How did tuberculosis affect your family life? (Write the answer)
OQ24. ¿How did tuberculosis affect your school or work? (Write the answer)
SECCTION C: ABOUT STIGMA RELATED TO TUBERCULOSIS
OQ25. About stigma and discrimination related to TB: Have you ever feel less worthy,
stigmatized or pointed out as a result of Tuberculosis? Please describe how you felt
(Write the answer)
A. By the health personnel or health workers? (Write the answer)
B. By your family? (Write the answer)
C. By coworkers or friends (school or work)? (Write the answer)
D. By society? (Write the answer)
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SECCION D: ABOUT YOUR PARTICIPATION IN THE VOICES AND IMAGES OF TB
PHOTOVOICE PROJECT
Q26. How would you describe the TB Voices and Images Project? (Write the answer)
Q27. Before you knew the TB Voices and Images Project, what did you think about TB?
(Write the answer)
Q28. As a result of the TB Voices and Images project, what did you learn about
Tuberculosis? (Write the answer)
Q29. ¿Did you learn something more than TB as a result of your experience with the TB
Voices and Images Project, what was that learning about? (Write the answer)
Q30. ¿How is it that the TB Voices and Images experience help you on that learning?
(Write the answer)
Q31. ¿What did you like the most from the TB Voices and Images experience?
(Write the answer)
Q32. ¿What did you liked the least from the TB Voices and Images experience?
(Write the answer)
Q33. ¿What was the hardest in participating in the TB Voices and Images experience?
(Write the answer)
Q34. What impacts has the TB Voices and Images Project had in: (Write the answer)
A. Your personal life?
B. In your family?
C. At school?
D. In your community?
E. At work?
F. In other areas?
Q35. Did you get any other benefit as a result of your participation in the TB Voices and
Images project? If so, how did it benefit you? (Such as knowing more about health
services, use of health services, more access, overcoming stigma or discrimination,
advocacy for better services, etc.). (Write the answer)
Q36. What would you change about the TB Voices and Images Project?
Q37. Is there anything related to your experience with TB that you would like to share?
Q38. Is there anything about the TB Voices and Images Project that you would like to
share?
Thank you very much for your participation
Rev. 5.5.09. Developed and translated by Moya. Revised by Lusk, Shedlin, Ramos on 5.4.09
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GUÍA DE ENTREVISTA PARA PARTICIPANTES DE VOCES E
IMÁGENES EN CIUDAD JUÁREZ, MÉXICO, Y EL PASO, TEXAS
Código de ID: _______
SECCION A: DATOS SOCIODEMOGRÁFICOS, GENERALES Y DE RESIDENCIA
P1. Sexo
1. M
2. F [Pase> P1A]
P1.A. Si es mujer: ¿Tiene hijos?  Si  No

P1B. ¿Cuantos? _________

P2. ¿Cuál es su edad?____ (en años cumplidos)
P3. ¿Cuál es su estado civil (o patrón de cohabitación)?
1. Soltero/a
2. Unión libre
3. Casado/a
4. Divorciado
5. Viudo/a
6. Separado
P4. ¿En donde nació?
País _______________

Estado _______________ Municipio/Condado_______________

P5. ¿Cuál es su lugar de residencia?
País
_______________ Estado _______________ Ciudad
P6. ¿Ha vivido en el otro lado de la frontera?
1. Sí
2. No [Pase>P8]
9. No sabe
0. No contestó
P7. ¿Durante cuánto tiempo vivió en el otro lado de la frontera?
1. Menos de 1 año
2. De 1 a 5 años
3. Más de 5 años
9. No sabe
0. No contestó
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_______________

P8. ¿Con que frecuencia cruza la frontera?
1. Diario
2. Semanal
3. Mensual
4. Cada 6 meses
5. Anualmente
6. No cruza
9. No sabe
0. No contestó
P9A. Último año de estudios terminado: _________________ (Sondear)
P10A. ¿A qué se dedica? ________________________________
P11. ¿Percibe salario/honorarios o remuneración por trabajo realizado?
1. Sí
2. No
9. No sabe
0. No contestó
P12. ¿Trabaja?
1. Diario
2. Semanal
3. Mensual
4. Ocasional
5. No trabaja/Desempleado/a
6. Pensionado/a
7. Discapacitado/a
8. Otro (favor de explicar):___________________
9. No sabe
0. No contestó
P13. ¿Vive en casa….?
1. Propia
2. Está pagando casa propia
3. Renta
4. Con familiares
5. Con amigos
6. No vivienda
8. Otro (favor de explicar): ___________________
9. No sabe
0. No contestó
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SECCION B: SOBRE LA EXPERIENCIA CON LA TUBERCULOSIS
P14A. ¿Cuando tuvo los primeros síntomas de la tuberculosis? (Escriba textualmente)
P15A. ¿En qué fecha le diagnosticaron tuberculosis? (mes y año) (Escriba textualmente)
P16A. ¿Cuánto tiempo le tomo buscar servicios médicos por esos síntomas?
(Escriba textualmente)
P17A. ¿Donde le dieron su diagnostico? (Escriba textualmente)
P18A. ¿Cómo describiría usted los servicios médicos que recibió durante su tratamiento?
(buenos, malos, efectivos, de calidad, centrados en la persona, libres o no de estigma o
discriminación, gratis, caros…) (Escriba textualmente)
P19A. ¿Recibió algún otro servicio que no fuera medico como conserjería, apoyo de
despensas, asistencia social, etc. durante su tratamiento por TB? (Escriba textualmente)
P20A. ¿Cómo describiría usted su experiencia con la tuberculosis? [Ej. Fue fácil, difícil,
tuvo problemas, fue discriminado/a, experimento estigma rechazo, le brindaron apoyo…]
(Escriba textualmente)
P21A. ¿Qué sentimientos le genero el recibir un diagnostico de Tuberculosis?
(Escriba textualmente)
P22A. ¿Cómo le afecto la tuberculosis su vida personal? (Escriba textualmente)
P23A. ¿Cómo le afecto su vida familiar? (Escriba textualmente)
P24A. ¿Cómo le afecto sus estudios o su trabajo? (Escriba textualmente)
SECCION C: SOBRE EL ESTIGMA RELACIONADO CON LA TUBERCULOSIS
P25A. Sobre estigma y discriminación relacionada con la tuberculosis: ¿Alguna vez se
sintió menos, estigmatizado, o señalado como resultado de la tuberculosis? Describa como
se sintió: (Escriba textualmente)
a. ¿Por el personal de los servicios de salud?
b. ¿Por la familia?
c. ¿Por los compañeros o amigos (escuela o trabajo)?
d. ¿Por la sociedad?
SECCION C: SOBRE SU PARTICIPACION EN VOCES E IMÁGENES DE LA TB
P26A. ¿Cómo describiría usted el proyecto de voces e imágenes en la tuberculosis?
(Escriba textualmente)
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P27A. ¿Qué pensaba usted sobre la tuberculosis antes de conocer del Proyecto de Voces e
Imágenes? (Escriba textualmente)
P28A. ¿Qué fue lo que usted aprendió sobre la tuberculosis como resultado de Voces e
Imágenes? (Escriba textualmente)
P29A. ¿Aprendió algo más allá de la TB como resultado de Voces e Imágenes, y de ser así
qué fue lo que aprendió? (Escriba textualmente)
P30A. ¿Y cómo fue que la experiencia de Voces e Imágenes le sirvió en ese aprendizaje?
(Escriba textualmente)
P31A. ¿Qué es lo que más le gusto o encontró útil de Voces e Imágenes?
(Escriba textualmente)
P32A. ¿Qué fue lo que menos le gusto de Voces e Imágenes? (Escriba textualmente)
P33A. ¿Qué fue lo más difícil de participar en Voces e Imágenes? (Escriba textualmente)
P34A. ¿Qué impactos tuvo Voces e Imágenes en su vida personal? (Escriba textualmente)
a. ¿En su familia?
b. ¿En su escuela?
c. ¿En su comunidad?
d. ¿En su trabajo?
e. ¿En la sociedad?
P35A. ¿Obtuvo algún otro beneficio como resultado de su participación en Voces e
Imágenes? ¿Cómo le beneficio? (ej. Conocimiento y/o utilización de servicios de salud,
mejor acceso, abogacía por mejores servicios, etc.) (Escriba textualmente)
P36A. ¿Qué cambiaria o mejoraría usted de Voces e Imágenes? (Escriba textualmente)
P37A. ¿Algo más que le gustaría compartir sobre su experiencia de tuberculosis?
(Escriba textualmente)
P38A. ¿Algo más que le gustaría compartir sobre Voces e Imágenes? (Escriba textualmente)

Muchas gracias por su participación.
Elaborado: Moya, E. 5.1.09 - Revisiones: Shedlin, Ramos y Lusk 5.4.09 - Traducción al Ingles:
Moya, E. 5.4.09
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APENDIX 6

E

M

L

#

TUBERCULOSIS AND HIV/AIDS STIGMA SCALES STUDY IN MÉXICO
Interviewer
a. Date ____of ____ 200__
b. Interview location
State
Mun.
Locality

c. Sex  M (1)

e. Type of Case
New
(1)
Contact (2)
Failure
(3)
Relapse (4)
Reenroll (5)
Abandon (6)
MDR-TB  (7)

 F (2)

f. Dx de TB
___ # of weeks
___ # of months
___ 12 months or
more

d. Dx of TB
1st  (1)
2da  (2)
3ra  (3)
o. Affiliated
IMSS
ISSSTE
Seguro Popular
Private Medical
Insurance
Servicios de Salud

(1)
(2)
(3)
(4)
(5)

p. Living/Housing
Own
(1)
Mortgage  si (2)
Rent
(3)
Live w/family (4)
Live w/friends (5)
Homeless
(6)

g. Type of TB
Lung
(1)
Meníngea (2)
Intestinal (3)
Ósea
(4)
Ganglionar(5)
Other
(6)

j. Marital status
Single
 (1)
Common law  (2)
Married
 (3)
Divorced
 (4)
Widow
 (5)
Separated
 (6)

h. Age _____

k. Native of
State Munic. Locality.

i. Last year of
studies
completed

q. Health status
Excellent  (1)
Very good  (2)
Good
 (3)
Fair
 (3)
Poor
 (4)

r. Health status
six months ago
Excellent  (1)
Very good  (2)
Good
 (3)
Fair
 (3)
Poor
 (4)

l. Occupation
m. Income
yes (1)  no(2)
n. Employment
Daily
(1)
Weekly
(2)
Monthly
(3)
Occasional (4)
Unemployed (5)

s.
How
much
control do you feel
have over your
health (score from
0 to 10)
_____
t. Do you feel
supported in TB Dx?

yes (1)  no(2)

I. Community perspectives toward tuberculosis
Instructions: From now on, I shall read the statements, which explain about how your community feels towards people with
tuberculosis. After I read each statement, please answer whether you agree or disagree that such events occur in your
community. If you agree, I will ask how you agree, agree or strongly agree. If you disagree, I will ask how you disagree,
disagree or strongly disagree. You can refuse to answer any questions that make you feel uncomfortable. Thank you.
Strongly
Disagree

Items
1. Some people prefer not to have those with tuberculosis living in their
community
2. Some people keep their distance from people with tuberculosis
3. Some people think that those with tuberculosis are disgusting
4. Some people feel uncomfortable about being near those with tuberculosis
5. Some people do not want those with tuberculosis playing with their children
6. Some people do not want to talk to others with tuberculosis
7. If a person has tuberculosis, some community members will behave differently
towards that person for the rest of his/her life
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Disagree Agree

Strongly
Agree

Strongly
Disagree

Items

Disagree Agree

Strongly
Agree

8. Some people may not want to eat or drink with friends who have tuberculosis
9. Some people try not to touch others with tuberculosis
10. Some people may not want to eat or drink with relatives who have tuberculosis
11. Some people are afraid of those with tuberculosis
II. Patient perspectives toward tuberculosis
Instructions: From now on, I shall read the statements, which explain about how people with TB feel. After I read each
statement, please answer whether you agree or disagree that a persons affected by TB in your community feel like that. If you
agree, I will ask how you agree, agree or strongly agree. If you disagree, I will ask how you disagree, disagree or strongly
disagree. You can refuse to answer any questions that make you feel uncomfortable.
Strongly
Disagree

Items
1.

Some people who have tuberculosis feel guilty because their family has the
burden of caring for them
2. Some people who have tuberculosis keep their distance from others to avoid
spreading TB germs
3. Some people who have tuberculosis feel alone
4. Some people who have tuberculosis feel hurt of how others react to knowing
they have tuberculosis
5. Some people who have tuberculosis lose friends when they share with them
they have tuberculosis
6. Some people who have tuberculosis are worried about having AIDS
7. Some people who have tuberculosis are afraid to tell those outside their
family that they have tuberculosis
8. Some people who have tuberculosis will choose carefully who they tell about
having tuberculosis
9. Some people who have tuberculosis are afraid of going to tuberculosis clinics
because other people may see them there
10. Some people who have tuberculosis are afraid to tell their family that they
have tuberculosis
11. Some people who have tuberculosis are afraid to tell others that they have
tuberculosis because others may think that they also have AIDS
12. Some people who have tuberculosis feel guilty for getting tuberculosis
because of their smoking, drinking, or other careless behaviors
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Disagree

Agree

Strongly
Agree

III. Community perspectives towards HIV/AIDS
Instructions: From now on, I shall ask you about people with HIV/AIDS. I shall read the statements, which explain about how
your community feels about people with HIV/AIDS. After I read each statement, please answer whether you agree or disagree
that such events occur in your community. If you agree, I will ask how you agree, agree or strongly agree. If you disagree, I will
ask how you disagree, disagree or strongly disagree. You can refuse to answer any questions that make you feel uncomfortable.
Strongly
Disagree

Items

Disagree

Agree

Strongly
Agree

1. Some people prefer not to have those with AIDS living in their community
2. Some people keep distance from people with AIDS
3. Some people think that those with AIDS are disgusting
4. Some people feel uncomfortable being near those with AIDS
5. Some people do not want those with AIDS playing with their children
6. Some people do not want to talk to others with AIDS
7. If a person has AIDS, some community members will behave differently
towards that person for the rest of his or her life
8. Some people try not to touch others with AIDS
9. Some people are afraid of those with AIDS
10. Some people think that people with AIDS are unclean
11. Some people think that people with AIDS get what they deserve
IV. Patient perspectives towards HIV/AIDS
Instructions: From now on, I shall read the statements which explain about how people with HIV/AIDS feel. After I read each
statement, please answer whether you agree or disagree that people with HIV/AIDS in your community feel like that. If you
agree, I will ask how you agree, agree or strongly agree. If you disagree, I will ask how you disagree, disagree or strongly
disagree. You can refuse to answer any questions that make you fell uncomfortable.
Strongly
Disagree

Items
1. Some people who have AIDS feel guilty because their family has the burden of
caring for them
2. Some people who have AIDS keep their distance from others to avoid
spreading the AIDS virus
3. Some people who have AIDS feel alone
4. Some people who have AIDS feel hurt because of how others react to knowing
they have AIDS
5. Some people who have AIDS lose friends when they share with them they
have AIDS
6. Some people who have AIDS are afraid that other people in the community
will talk about them having AIDS
7. Some people who have AIDS will chose carefully who they tell about having
AIDS
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Disagree

Agree

Strongly
Agree

Strongly
Disagree

Items
8. Some people who have AIDS try very hard to keep the issue of having AIDS
a secret
9. Some people who have AIDS worry that others will reveal their secret
10. Some people who have AIDS are afraid to tell those outside their family that
they have AIDS

Interviewer notes:
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Disagree

Agree

Strongly
Agree

ESCALAS DE ESTIGMA DE LA TB Y VIH/SIDA DEL ESTUDIO EN MÉXICO
Entrevistador/a

a. Fecha ____de ____ 200__
b. Localidad de entrevista
Edo
Mun. Localidad

c. Sexo  M (1)  F (2)
d. Dx de TB
 (1)
1ra vez
 (2)
2da vez
3era vez
 (3)

o. Afiliación a
IMSS
(1)
ISSSTE
(2)
Seguro Popular (3)
Seguro Medico
privado
(4)
Servicios de Salud (5)

e. Caso
Nuevo
Contacto
Fracaso
Recaída
Reingreso
Abandono
MDR-TB

(1)
(2)
(3)
(4)
(5)
(6)
 (7)

g Tipo de TB
Pulmonar (1)
Meníngea (2)
Intestinal (3)
Ósea
(4)
Ganglionar (5)
(6)
Otro

f. Dx de TB
___ # de semanas
___ # de meses
___ mas de 1año

h. Edad _____

p. Vive en casa
Propia
(1)
Pagando (2)
Renta
(3)
Con familiares(4)
Con amigos (5)
No vivienda (6)

q. Estado de
salud actual es

Excelente  (1)
Muy bueno
(2)
Bueno

(3)
(4)
Regular
Malo

(5)

i. Ultimo año de estudios
terminado

l. Ocupación

j. Estado civil:
Soltero/a  (1)
Unión libre  (2
Casado/a
 (3)
Divorciado (4)
Viudo/a
 (5)
Separado
 (6)
k. Originario de
Edo. Mun. Localidad.

m. Percibe salario
 si (1)  no (2)

r. Estado de salud hace seis
mese fue
Excelente  (1)
Muy bueno  (2)
Bueno
 (3)
Regular
 (3)
Malo
 (4)

n. Trabaja
Diario
Semanal
Mensual
Ocasional
Desempleado

(1)
(2)
(3)
(4)
(5)

s. Que tanto control
siente que tiene UD
sobre su salud (010) ________
t. Se siente solo o
apoyado
en
su
tratamiento
solo (1)
apoyado (2)

I. Percepción de la comunidad sobre la tuberculosis
Instrucciones: A continuación leeré varios enunciados que explican el sentir de la gente en la comunidad hacia las personas
con tuberculosis. Después de leer cada uno le pido que responda si está de acuerdo o en desacuerdo en que tales situaciones
ocurran en su comunidad. Si está de acuerdo, le preguntaré que tanto está de acuerdo o en desacuerdo. Usted puede negarse
a contestar cualquier pregunta(s) en caso de sentirse incomodo(a). Gracias por su participación.
Totalmente en
En
De
Totalmente de
Enunciados
Desacuerdo
Desacuerdo
Acuerdo
Acuerdo
1. Usted cree que algunas personas prefieren que quienes
padecen tuberculosis no vivan en su comunidad.
2. Usted cree que algunas personas mantienen su distancia
de aquellas con tuberculosis.
3. Usted cree que algunas personas piensan que quienes
padecen tuberculosis son desagradables o indeseables.
4. Usted cree que algunas personas se sienten incómodas al
estar cerca de quienes tienen tuberculosis.
5. Usted cree que algunas personas no quieren que sus hijos
jueguen con niños que tienen tuberculosis.
6. Usted cree que algunas personas no quieren hablar con
quienes tienen tuberculosis.
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Enunciados

Totalmente en
Desacuerdo

En
Desacuerdo

De
Acuerdo

Totalmente de
Acuerdo

7.

Si alguien tuviera tuberculosis, usted cree que algunas
personas de la comunidad se comportarían diferente con
él/ella por el resto de su vida.
8. Usted cree que algunas personas no les gusta beber o
comer con amigos/as que padecen tuberculosis.
9. Usted cree que algunas personas tratan de no tocar a
otras con tuberculosis
10. Usted cree que algunas personas no quieren beber o
comer con familiares que tienen tuberculosis.
11. Usted cree que algunas personas le tienen miedo a
quienes tienen tuberculosis.
II. PERCEPCIÓN DE LA PERSONA AFECTADA POR LA TUBERCULOSIS
Instrucciones: A continuación leeré varios enunciados que explican el sentir de una persona con tuberculosis. Después de leer cada uno
le pido que responda si está de acuerdo o en desacuerdo en que las personas afectadas por la tuberculosis se sientan de esa manera. Si
está de acuerdo, le preguntaré que tanto está de acuerdo o en desacuerdo. Usted puede negarse a contestar cualquier pregunta(s)

en caso de sentirse incomodo(a).
Enunciados

Totalmente en
Desacuerdo

1.

Usted cree que algunas personas con tuberculosis se
sienten culpables por ser una carga para su familia.
2. Usted cree que algunas personas con tuberculosis
guardan su distancia de otras para evitar contagiarlas
con gérmenes de la enfermedad.
3. Usted cree que algunas personas con tuberculosis se
sienten solas.
4. Usted cree que algunas personas con tuberculosis se
sienten lastimadas por la manera en que los demás
reaccionan cuando se enteran que tienen la enfermedad.
5. Usted cree que algunas personas con tuberculosis
pierden a sus amigos/as cuando les comentan que
tienen esa enfermedad.
6. Usted cree que algunas personas con tuberculosis están
preocupadas por que podrían tener sida.
7. Usted cree que algunas personas con tuberculosis
tienen miedo de decirle a otros que no son de su familia
que tienen la enfermedad.
8. Usted cree que algunas personas que tienen
tuberculosis son cuidadosos al escoger a quien decirle
que padecen la enfermedad.
9. Usted cree que algunas personas con tuberculosis
tienen miedo de ir a las clínicas de tuberculosis o a los
centros de salud por temor a que otros los vean.
10. Usted cree que algunas personas con tuberculosis
tienen miedo de decirle a sus familiares que tienen la
enfermedad.
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En
Desacuerdo

De
Acuerdo

Totalmente de
Acuerdo

Enunciados

Totalmente en
Desacuerdo

En
Desacuerdo

De
Acuerdo

Totalmente de
Acuerdo

11. Usted cree que algunas personas con tuberculosis
tienen miedo decirle a otros que tienen la enfermedad
pues pueden pensar que también tienen VIH/sida.
12. Usted cree que algunas personas con tuberculosis se
sienten culpables de haber contraído la enfermedad por
fumar, tomar o por otras conductas irresponsables.
III. PERCEPCIÓN DE LA COMUNIDAD SOBRE EL VIH/SIDA
Instrucciones: A continuación leeré varios enunciados que explican el sentir de la comunidad hacia las personas con
VIH/sida. Después de leer cada uno le pido que responda si está de acuerdo o en desacuerdo en que tales situaciones
ocurran en su comunidad. Si está de acuerdo, le preguntaré que tanto está de acuerdo o en desacuerdo. Usted puede
negarse a contestar cualquier pregunta(s) en caso de sentirse incomodo(a).
Enunciados

Totalmente en
Desacuerdo

1. Usted cree que algunas personas prefieren que las
personas con VIH/sida no vivan en su comunidad.
2. Usted cree que algunas personas guardan su distancia
ante una persona con VIH/sida.
3. Usted cree que algunas personas piensan que quienes
tienen VIH/sida son desagradables o indeseables.
4. Usted cree que algunas personas se sienten incómodas
al estar cerca de alguien con VIH/sida.
5. Usted cree que algunas personas no quieren que sus
hijos jueguen con niños que tienen el VIH/sida.
6. Usted cree que algunas personas no quieren hablar con
otras personas sobre el VIH/sida.
7. Si alguien tuviera VIH/sida, usted cree que algunas
personas de la comunidad se comportarían diferente
con él/ella por el resto de su vida
8. Usted cree que algunas personas tratan de no tocar o
tener contacto con quienes tienen VIH/sida.
9. Usted cree que algunas personas le tiene miedo a
quienes tienen VIH/sida
10. Usted cree que algunas personas piensan que las
personas con VIH/sida son sucias.
11. Usted cree que algunas personas piensan que las
personas con VIH/sida se lo merecen.
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En
Desacuerdo

De
Acuerdo

Totalmente de
Acuerdo

IV. PERCEPCIÓN DE LAS PERSONAS QUE TIENEN VIH/SIDA EN LA COMUNIDAD
Instrucciones: A continuación leeré varios enunciados que explican el sentir de las personas que tienen VIH/sida. Después
de leer cada uno le pido que responda si está de acuerdo o en desacuerdo en que las personas en su comunidad que tienen
VIH/sida se sientan de esa manera. Si está de acuerdo, le preguntaré que tanto está de acuerdo o en desacuerdo. Usted
puede negarse a contestar cualquier pregunta(s) en caso de sentirse incomodo(a).
Enunciados

Totalmente en
Desacuerdo

1. Usted cree que algunas personas con VIH/sida se
sienten culpables por que su familia tiene la carga o
responsabilidad de cuidarlos/as.
2. Usted cree que algunas personas con VIH guardan su
distancia de otras para evitar el contagio del virus que
ocasiona el sida.
3. Usted cree que algunas personas con VIH/sida se
sienten solas.
4. Usted cree que algunas personas que tienen VIH/sida
se sienten lastimadas por la manera en que otras
reaccionan cuando se enteran que tienen la
enfermedad.
5. Usted cree que algunas personas con VIH/sida
pierden a sus amigos/as cuando les comentan que
tienen la enfermedad.
6. Usted cree que algunas personas con VIH/sida tienen
miedo de que otros miembros de su comunidad
comenten que tienen la enfermedad.
7. Usted cree que algunas personas que tienen VIH/sida
son cuidadosos al escoger a quien decirle que tienen la
enfermedad.
8. Usted cree que algunas personas con VIH/sida tratan
de mantener su enfermedad en secreto.
9. Usted cree que algunas personas con VIH/sida se
preocupan de que otros digan su secreto.
10. Usted cree que algunas personas con VIH/sida tienen
miedo de decirle a otros que no son sus familiares que
tienen VIH/SIDA.
11. Usted cree que algunas personas con VIH/sida tienen
miedo de ir a las clínicas de atención de la enfermedad
o a los centros de salud por temor a que otros los
vean.
Gracias por su participación
Observaciones y anotaciones de entrevistador/a:
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De
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Totalmente
de Acuerdo

APENDIX 7
UNIVERSITY OF TEXAS AT EL PASO (UTEP) INSTITUTIONAL
REVIEW BOARD INFORMED CONSENT FORM FOR RESEARCH
INVOLVING HUMAN SUBJECTS
Protocol Title: Study on Tuberculosis-Related Stigma: Impacts on Health-Seeking Behaviors
and Access in Ciudad Juárez, México, and El Paso, Texas
Principal Investigators: Mark W. Lusk, EdD, and Eva M. Moya, LMSW, PhD (c)
UTEP College of Health Sciences, Interdisciplinary Health Sciences PhD Program
Introduction
As an adult affected by tuberculosis who is either in treatment or who completed tuberculosis
treatment in the past six months, you are being asked to take part voluntarily in the research
project described below. Please take your time making a decision and feel free to discuss it with
your friends and family. Before agreeing to take part in this research study, it is important that
you read the consent form that describes the study. Please ask the study researcher or the study
staff to explain any words or information that you do not clearly understand. You must be 18
years old or older to participate in this study.
Why is this study being done?
You have been asked to take part in a research study of tuberculosis related stigma and the
impacts on health seeking behaviors and access in the El Paso-Ciudad Juárez region. The
purpose of the study is to find how people with tuberculosis feel about the disease, their
knowledge, their attitudes and health practices towards tuberculosis. The study is under the
leadership of Dr. Mark W. Lusk, Principal Investigator and Eva Moya, College of Health
Sciences UTEP Doctoral Candidate.
What is involved in the study?
About 30 people will be enrolling in this study in the El Paso, Texas and Ciudad Juárez, México.
You were contacted by a program personnel; he/she selected you from a list of persons affected
with tuberculosis. If you agree to take part in this study, you will be asked questions to learn
about your views on these issues. This will be a one time interview and will last between 60 and
90 minutes. The interview will be conducted in either English or Spanish. The interview will be
held at the TB Program (El Paso or Ciudad Juárez) or at an interview location of your choice at a
convenient day and time for you. The interview will be digitally recorded and your answers will
remain confidential.
What are the risks and discomforts of the study?
There are no known risks to take part in this study. There may be times when you find it difficult
to talk about your condition and your experience with tuberculosis and stigma. If at any time you
feel uncomfortable, you can stop and take a break and resume the interview when it feels alright
to do so. You can stop the interview completely and the researcher will follow up with you and
suggest support that you might find helpful to you.
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What will happen if I am injured in this study?
The University of Texas at El Paso and its affiliates do not offer to pay for or cover the cost of
medical treatment for research related illness or injury. No funds have been set aside to pay or
reimburse you in the event of such injury or illness. You will not give up any of your legal rights
by signing this consent form. You should report any such injury to Dr. Mark W. Lusk, principal
investigator's 915-747-8588 mwlusk@utep.edu and to Lola Norton of the Institutional Review
Board (IRB) at UTEP at 915-747-8841 or lola@utep.edu.
Are there benefits to taking part in this study?
There will be no direct benefits to you for taking part in this study. This research may help us
understand the views, concerns and experiences of persons affected with tuberculosis and stigma.
What other options are there?
You can decide: 1) not to participate in the study, 2) not to answer any of the questions you do
not want to answer, 3) end the interview at any time. There will be no penalties involved if you
choose not to take part in this study.
Who is paying for this study?
Funding for this study is provided by the Programa de Investigación en Migración y Salud.
What are my costs?
There are no direct costs. You will be responsible for travel to and from the research site and any
other incidental expenses.
Will I be paid to participate in this study?
When the interview is over, we will give you a $20 gift card for taking part in this study.
What if I want to withdraw, or am asked to withdraw from this study?
Taking part in this study is voluntary. You have the right to choose not to take part in this study.
If you do not take part in the study, there will be no penalty.
If you choose to take part, you have the right to stop at any time. However, we encourage you to
talk to a member of the research group so that they know why you are leaving the study. If there
are any new findings during the study that may affect whether you want to continue to take part,
you will be told about them. The researcher may decide to stop your participation without your
permission, if he or she thinks that being in the study may cause you harm, or you may be
uncomfortable with some of the questions remember that the study may be stopped at any time.
It is important to stress that if you choose not to participate in the interview or to end it any time,
it will not interfere with or affect the services you receive.
Who do I call if I have questions or problems?
You may ask any questions you have now. If you have questions later, you may call
Eva M. Moya, 915-253-6466, moyaevam@earthlink.net.
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If you have questions or concerns about your participation as a research subject, please contact
Lola Norton of the Institutional Review Board at UTEP at (915-747-8841) or by email at
lola@utep.edu.
What about confidentiality?
Your part in this study is confidential. None of the information will identify you by name and
only by a code number. The information you provide will not be shared with health personnel,
since it will only be reported as overall results.
The results of this research study may be presented at meetings or in publications; however, your
identity will not be disclosed in those presentations. All records will be stored in a secure office
by the study directors and the interview will be audio/digitally recorded.
Authorization Statement
I have read each page of this paper about the study (or it was read to me). I know that being in
this study is voluntary and I choose to be in this study. I know I can stop being in this study
without penalty. I will get a copy of this consent form now and can get information on results of
the study later if I wish.
Participant Name: ____________________________

Date: _________________________

Participant Signature: ____________________________

Time: ________________________

Consent form explained/witnessed by: ______________________________________________
Signature
Printed name: __________________________________________________________________

Date: ____________________________

Time: ____________________________
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CONSEJO DE REVISIÓN INSTITUCIONAL DE LA UNIVERSIDAD DE
TEXAS EN EL PASO (UTEP) FORMA DE CONSENTIMIENTO
INFORMADO PARA UNA INVESTIGACIÓN QUE INVOLUCRA
SUJETOS HUMANOS
Título del Protocolo: Estudio sobre el Estigma Relacionado con la Tuberculosis:
Impactos en los Conocimientos de Búsqueda de Servicios de Salud y Acceso en Ciudad Juárez,
México, y El Paso , Texas
Investigadores Principal: Mark W. Lusk, D. Educación, Departamento de Trabajo Social,
Facultad de Ciencias de la Salud de UTEP y Mtra. Eva M. Moya, Doctorante, Colegio de
Ciencias de Salud, UTEP.
Introducción
Como adulto y persona afectada con tuberculosis que recibe atención médica o que terminó su
tratamiento por tuberculosis en los pasados 6 meses, se le ha solicitado que participe de manera
voluntaria en el proyecto de investigación que abajo se describe. Le pedimos que se tome el
tiempo necesario para decidir y que se sienta en completa libertad de discutirlo con sus amigos y
familia. Antes de aceptar su participación en este estudio de investigación, es importante que lea
la Forma de Consentimiento Informado que describe el estudio. Por favor pídale al
investigador(a) o al personal de la investigación que le explique cualquier palabra o información
que no entienda del todo. Usted deberá de tener 18 años de edad y mayor para poder participar
en este estudio.
¿Por qué se realiza este estudio?
Se le ha pedido que participe en este estudio porque es mayor de 18 años y ha sido afectado(a)
por la tuberculosis y está recibiendo tratamiento o completó el tratamiento para la tuberculosis en
los últimos seis meses. El propósito de este estudio es conocer el punto de vista de las personas
afectadas con tuberculosis acerca de la enfermedad, conocimientos, actitudes y prácticas de
salud. El estudio se encuentra a cargo del Dr. Mark Lusk, Investigador Principal y la Mtra. Eva
M. Moya, Co-investigadora.
¿Qué involucra el estudio?
Cerca de 30 personas serán inscritas en el estudio de la región fronteriza de El Paso-Ciudad
Juárez. Usted fue contactado por el personal del Programa de Tuberculosos, de acuerdo a un
registro de pacientes. Si acepta participar en este estudio, el equipo de investigación le hará
algunas preguntas para conocer su punto de vista sobre estos temas. Su tiempo de participación
será de entre 60 a 90 minutos para la entrevista personal que se realizará en una sola ocasión. La
entrevista se llevará a cabo en inglés o español. La entrevista será en la clínica o Programa de
Tuberculosis o algún otro lugar y en una fecha y horario que sea conveniente para usted. Sus
respuestas serán grabadas y permanecerán de manera confidencial.
¿Cuáles son los riesgos y molestias del estudio?
No existen riesgos conocidos que se asocien con esta investigación. Puede que haya momentos
durante la entrevista en los cuales se sienta incomodo/a al conversar sobre su condición y sus
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experiencias relacionadas con la tuberculosis y el estigma. Si en cualquier momento usted se
siente incomodo/a, usted puede pasar la entrevista y regresar a ella cuando usted se sienta listo/a.
Usted puede parar la entrevista en su totalidad y el investigador/a le dará seguimiento y podrá
sugerir algún apoyo.
¿Qué sucederá si resulto lesionado/a en este estudio?
La Universidad de Texas en El Paso y sus afiliados no ofrecen ningún pago ni cubren el costo del
tratamiento médico por lesiones o daños relacionados con la investigación. No se ha establecido
ningún fondo para pagarle o reembolsarle en caso de daño o lesión. No se le privará de ningún de
sus derechos legales al firmar esta Forma de Consentimiento. Debe reportar cualquier lesión al
Dr. Mark W. Lusk, Investigador Principal al teléfono (915) 747-8588 mwlusk@utep.edu y a Lola
Norton del Consejo de Revisión Institucional (IRB por sus siglas en inglés) en UTEP al teléfono
(915) 747-8841 o al correo electrónico: lola@utep.edu.
¿Habrá algún beneficio por participar en este estudio?
No habrá ningún beneficio directo para usted por participar en este estudio. Esta investigación
puede ayudarnos a conocer y aumentar el conocimiento sobre las experiencias que las personas
afectadas por la tuberculosis tienen.
¿Qué otras opciones existen?
Usted puede decidir: 1) no participar en este estudio, 2) no contestar ninguna de las preguntas
que no desee contestar 3) y dar por terminada la entrevista en cualquier momento. No recibirá
ninguna sanción si decide no tomar parte en el mismo.
¿Quién paga por este estudio?
Mediante fondos externos:
Los fondos para este estudio son proporcionados por UTEP y el Programa de Investigación en
Migración y Salud.
¿Cuál es el costo para mí?
No hay ningún costo directo. Usted será responsable de sus gastos de transporte hacia y del sitio
de la investigación y de otros gastos relacionados.
¿Recibiré algún pago por participar en este estudio?
Una vez que concluya la entrevista, usted recibirá $20 dólares por su participación en este
estudio de investigación.
¿Y si deseo retirarme o se me pide que me retire de este estudio?
Usted tiene el derecho de decidir no tomar parte en este estudio y si así fuera no será sancionado.
Si decide participar, tiene el derecho de dejar de hacerlo en cualquier momento. Sin embargo, le
pedimos que hable con un miembro del grupo de investigación para que sepa la razón por la que
deja el estudio. Si durante la investigación hubiera algún nuevo resultado que pudiera afectar su
decisión de continuar participando, se le dará a conocer.
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El/la investigador(a) puede decidir, sin su autorización, que usted deje de participar si él o ella
consideran que continuar en el estudio puede ocasionarle algún daño o que usted se pueda sentir
incómodo con algunas de las preguntas, recuerde que en cualquier momento se puede detener
entrevista.
Es importante enfatizar que si en cualquier momento, usted decide no participar en la entrevista o
terminarla, esto no interferirá o afectará los servicios que recibe.
¿A quién puedo llamar en caso de que tuviera alguna pregunta o problema?
Usted puede hacer ahora cualquier pregunta que tenga. Si posteriormente tuviera alguna
pregunta, puede comunicarse con Eva M. Moya, al teléfono (915) 253-0466,
moyaevam@earthlink.net.
Si tuviera alguna pregunta o duda sobre su participación como sujeto de investigación, favor de
comunicarse con Lola Norton del Consejo de Revisión Institucional en UTEP al (915) 747-8841
o por correo electrónico con lola@utep.edu.
¿Cómo se maneja la confidencialidad?
Su participación en este estudio es confidencial. Ninguna información lo identificará por su
nombre, únicamente por un número de código. La información que usted nos proporcione no
será compartida con el personal médico, ya que ésta solo se reportará mediante resultados
generales. Los resultados de este estudio de investigación pueden ser presentados en reuniones o
en publicaciones, sin embargo, su identidad no se dará a conocer en dichas presentaciones.
Todos los registros se guardarán en un archivo seguro por los directores de la investigación y la
entrevista no será audio grabado.
Declaración de Autorización
He leído (o me fue leída) cada página de este documento sobre el estudio.
Sé que mi
participación es voluntaria y he decidido tomar parte en el mismo. Sé que puedo dejar de
participar en la investigación sin recibir ninguna sanción. Se me dará una copia de esta Forma de
Consentimiento ahora y, si lo deseo, puedo obtener posteriormente información sobre los
resultados de la investigación.
Nombre del Participante: _____________________ Fecha: _____________________________
Firma del Participante: ____________________________ Hora: ________________________
Forma de Consentimiento explicada/atestiguada por: __________________________________
Firma
Nombre impreso: _______________________________________________________________

Fecha: ____________________________

Hora: ____________________________
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ID: _____

INFORMED CONSENT
Research Study on Tuberculosis Stigma: Impact on
Health-Seeking Behaviors and Access in Ciudad Juárez, México, and El Paso, Texas

You are invited to participate in a research study called “Stigma related to Tuberculosis: Impact
on Health-Seeking Behaviors and Access in Ciudad Juárez, México, and El Paso, Texas”
conducted by Dr. Mark W. Lusk and LMSW Eva M. Moya from the University of Texas at El
Paso, and Dr. Delia Puga from the Autonomous University of Ciudad Juárez. The interview will
last 60 to 90 minutes approximately.
The main purpose of the project is to know your experience and opinion on Tuberculosis, your
feeling towards the way an individual with Tuberculosis is treated, and your view about the
Health Care Services that have been provided to him. Questions will be made to know your
opinion on these issues, some are open questions. You are encouraged to make any question you
might have about the study.
Your information will be kept confidential and a number or code, not your name will be used to
identify your answers. The information shared by you will be informed to the Health Services
Staff since it only reflects the overall outcomes.
You may decide: (1) to take part in the study; (2) refuse to answer any question you don’t wish
to answer; (3) stop taking part in the interview at any time.
It is important to consider that your decision to take part in the interview or stop it at any
moment will not change the services that are available to you. Once the interview is completed
and as an appreciation for taking part, you will receive from the Interviewer a compensation for
your time.
This study (100345/1-2) has been approved by the Institutional Review Board (IRB) of the
University of Texas in El Paso. Any question related to the study or your rights as a participant
will be answered in El Paso by: Mark Lusk, (915) 747-8588 or Eva Moya, (915) 253-6466. In
Cd. Juárez: Delia Puga Antúnez, 656-611-8512 or María Elena Ramos, Programa Compañeros
A.C., at telephone 656-11-37-92.
I have received a copy of the Informed Consent Form. I have read the Informed Consent Form
or it has been read to me and I understand this information.
______________________________
Signature of Participant

Date ______, 2009

I have explained the study procedure in which the participant has decided to take part and a
signed photocopy of this consent has been given to him/her.
_________________________
Interviewer’s Name

Date _______, 2009
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Código: ____

CONSENTIMIENTO INFORMADO
Estudio de Estigma de la Tuberculosis: Impactos en las Conductas relacionadas con
Búsqueda de Servicios de Salud y el Acceso en Ciudad Juárez, México, y El Paso, Texas
Por medio de la presente, se le invita a participar en el estudio “Estigma relacionado con la
Tuberculosis: Impactos en las Conductas de Búsqueda de Servicios de Salud y Acceso en Ciudad
Juárez, México, y El Paso, Texas” bajo la dirección del Dr. Mark W. Lusk, Mtra. Eva M Moya
de la Universidad de Texas en El Paso y la Dra. Delia Puga de la Universidad Autónoma de
Ciudad Juárez. La entrevista tomará aproximadamente de 60 a 90 minutos.
El propósito de este estudio es conocer su experiencia y opinión sobre la tuberculosis, su sentir
sobre su participación en el proyecto de Voces e Imágenes de la TB. Se le harán preguntas para
conocer su opinión respecto a estos temas, la mayoría de las preguntas son abiertas. Por favor
haga cualquier pregunta que usted desee sobre el estudio.
Su información se mantendrá confidencial y sus respuestas serán identificadas únicamente por un
número o código y no por su nombre. La información que usted comparta no será comunicada al
personal de salud ya que solo se reportarán los resultados de manera general.
Usted puede decidir: (1) no participar en el estudio; (2) no responder a cualquier pregunta que no
quiera contestar;(3) parar la entrevista en cualquier momento.
Es importante recordarle que si usted decide no participar en la entrevista o detenerla en
cualquier momento, esto no afectará de ninguna manera los servicios que usted recibe. Una vez
que termine la entrevistas y como agradecimiento por su participación, usted recibirá del
Entrevistador/a una compensación por su participación.
Este estudio (100345/1-2) ha sido aprobado por el Comité de Revisión Institucional (IRB) de la
Universidad de Texas en El Paso. Cualquier pregunta sobre esta investigación o sobre los
derechos que como participante del estudio usted tenga puede dirigida en El Paso: con Mark
Lusk, (915) 747-8588 o con Eva Moya, (915) 253-6466. En Cd. Juárez: con Delia Puga Antúnez,
656-611-8512 o con María Elena Ramos, Programa Compañeros A.C., al tel. 656-11-3792.
He recibido una copia del consentimiento informado. He leído o se me ha leído el
consentimiento informado y entiendo esta información.
______________________________
Firma del o la participante

Fecha __de ______ del 2009

He explicado el procedimiento de investigación del estudio en el cual el/la participante ha
decidido participar y le he entregado una copia del consentimiento informado.
_________________________
Nombre del Entrevistador(a)

Fecha ___de _____ del 2009
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Código: ____

CONSENTIMIENTO INFORMADO
Estudio de Medición de Estigma de la Tuberculosis y del VIH/SIDA en México
Por medio de la presente, se le invita a participar en el estudio “Escalas de Estigmas de la
Tuberculosis y del VIH/SIDA” bajo la dirección del Dr. Mark W. Lusk, la co-dirección de la
Mtra. Eva M .Moya, Universidad de Texas en El Paso Colegio de Ciencias de Salud y Proyecto
de SOLUCION TB Expansión de Project Concern Internacional, y de la Dra. Blanca Lomeli,
Directora de SOLUCION TB Expansión de Project Concern Internacional. La entrevista tomará
aproximadamente de 30 minutos.
El propósito del estudio es conocer las perspectivas de la comunidad hacia las personas con
tuberculosis y VIH/SIDA y el sentir de una persona con tuberculosis y VIH/SIDA. Se le harán
algunas preguntas para conocer su opinión respecto a estos temas. Por favor haga cualquier
pregunta que usted desee sobre el estudio.
Se hará todo lo posible por mantener esta información confidencial y anónima. Sus respuestas
serán identificadas únicamente por un número de código y nunca por su nombre. La información
que usted proporcione no será compartida con el personal de salud ya que solo se reportará como
resultados generales.
Usted puede decidir: (1) no participar en el estudio; (2) no responder a cualquier pregunta que no
quiera contestar; (3) parar la entrevista en cualquier momento.
Es importante recalcar que si usted decide no participar en la entrevista o detenerla en cualquier
momento, esto no interferirá o afectará los servicios que usted recibe.
Este proyecto ha sido revisado por el Comité de Revisión Institucional (IRB) de la Universidad
de Texas en El Paso y por el Proyecto SOLUCION TB Expansión de Project Concerní
Internacional. Cualquier pregunta sobre esta investigación o sobre los derechos como
participante de investigación puede ser dirigida a el Dr. Mark W. Lusk, (915) 747-8588 o con la
Mtra. Eva Moya, SOLUCION TB Expansión, (915) 253-6466.
He recibido una copia del consentimiento informado. He leído y entiendo esta información.
______________________________
Firma del o la participante

Fecha __de ______ del 2008.

He explicado el procedimiento de investigación en el cual el participante ha decidido participar y
le he entregado una copia del consentimiento informado.
_________________________
Nombre del Entrevistador(a)

Fecha ___de _____ del 2008

**ESCALAS DE ESTIGMA EN TUBERCULOSIS Y VIH/ SIDA EN LAS PÁGINAS SIGUIENTES***
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APENDIX 8
TUBERCULOSIS AND HIV/AIDS STIGMA SCALES BACKGROUND
Background
In 2007, Dr. Van Rie and colleagues developed two scales to measure tuberculosis (TB) and
HIV/AIDS stigma using exploratory and confirmatory factor analyses. The scales initially were
validated using exploratory factor analysis among 480 TB patients in southern Thailand. Each
scale is comprised of two subscales to examine the community perspectives and patient
perspectives related to the two infectious diseases. The scales were subsequently administered to
300 health community members in the confirmatory factor analysis.
Scale Characteristics
Internal consistency – Cronbach’s alpha
Reliability analysis was conducted on each subscale among both groups of participants using
Cronbach’s alpha measure of inter-item consistency. The scales had very good internal
consistency.
Cronbach’s coefficient alpha for each scale by participant group
TB patients
Stigma subscale
(n=480)

Community members
(n=300)

Community perspectives towards TB

0.88

0.85

Patient perspectives toward TB

0.82

0.79

Community perspectives toward
HIV/AIDS

0.91

0.85

Patient perspectives toward HIV/AIDS

0.83

0.87

Test-retest reliability
Of the 480 TB patients to whom the subscales were administered, 15 of them were retested
within 30 days to assess test-retest reliability. No community members were retested. The
reliability values for the TB scales were fair to good:
• community perspectives towards tuberculosis; r=0.64, p=0.01
• patient perspectives towards tuberculosis; r=0.46, p=0.10
The reliability values for the HIV/AIDS scales were not well correlated:
• community perspectives towards HIV, r=0.33, p=0.22
• patient perspectives toward HIV, r=0.40, p=0.14
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Stigma score distributions
The standardized stigma scores for each of the four scales were normally distributed. The mean
(standard deviation) for each scale was:
•
•
•
•

community perspectives toward tuberculosis: 27.9 (7.5)
patient perspectives toward tuberculosis: 27.6 (6.1)
community perspectives toward HIV/AIDS: 28.2 (7.8)
patient perspectives toward HIV/AIDS: 32.9 (5.9)

Calculating Standardized Stigma Scores
1. Each set of stigma scales was assessed on a four-point likert scale which was scored with the
response categories: (0) strongly disagree, (1) disagree, (2) agree, and (3) strongly agree;
higher responses were related to higher stigma.
2. No items were reverse coded.
3. For each scale, all the scale item responses were summed to create the summary score
(SSraw).
4. Before comparing scores across scales, a standardized score needs to be created because each
scale has a different number of items. Any form of standardizing will work (item-adjusted,
10-point scale, etc). We chose to standardize all scores to a 50-point scale using the following
equation: SS50 = SSraw×50, where n equals the number of items on the subscale being
calculated, n ×3 and 3 = the maximum value for any one item on the scale. Standardized
scores range from 0 to 50.
5. As an example, if a participant responded strongly disagree to 1 item, disagree to 4 items,
agree to 5 items, and strongly agree to 1 item on the “Community Perspectives towards
HIV/AIDS” subscale, the standardized stigma score would be calculated as:
SS50=SSraw × 50 = [(1×0)+(4×1)+(5×2)+(1×3)] × 50 = 27.3
n ×3
11×3
Citation: Van Rie A, Sengupta S, Pungrassami P, Balthip Q, Choonuan S, Kasetjaroen Y,
Strauss R, Chongsuvivatwong V. (2008). Measuring stigma associated with tuberculosis
and HIV/AIDS in southern Thailand: exploratory y and confirmatory factor analyses of
two new scales. Tropical Medicine & International Health 13(1), 21-30.
The authors welcome copies of manuscripts and conference presentations generated from
the use of these stigma scales in order to track its use and assess its validity and reliability
in other populations.
Please send your correspondences to Annelies Van Rie, PhD, The University of North
Carolina-Chapel Hill, USA. Tel: (919) 966.1420, Fax: (919) 966.2089 Email:
vanrie@email.unc.edu.
On September 17, 2008 Dr. Van Rie and colleagues gave permission to Eva M Moya c/o
USMBHA and PCI to use the tuberculosis and HIV/AIDS scales.
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ANTECEDENTES DE LAS ESCALAS DE ESTIGMAS
DE LA TUBERCULOSIS Y DEL VIH/SIDA
Antecedentes
En el año 2007, la Dra. Van Rie y sus colegas desarrollaron dos escalas para medir los estigmas
sobre la Tuberculosis (TB) y el Virus de Inmunodeficiencia Humana (VIH)/sida utilizando el
análisis exploratorio y el factorial confirmatorio. Las escalas se validaron inicialmente utilizando
el análisis factorial exploratorio entre 480 personas afectadas con TB al sur de Tailandia. Cada
escala está compuesta de dos subescalas que examinan las perspectivas de la comunidad y de la
persona afectada en relación con las dos enfermedades infecciosas. Las escalas fueron
administradas posteriormente a 300 miembros de la comunidad mediante el análisis factorial
confirmatorio.
Caracteristicas de la Escala
Consistencia Interna – Alfa de Cronbach
El análisis de confiabilidad fue realizado en cada subescala entre los dos grupos de participantes
utilizando el índice Alfa de consistencia interna de Cronbach. Las escalas tuvieron muy buena
consistencia interna.
Coeficiente del Alfa de Cronbach para cada escala por grupo de participante
Personas
Miembros de la
Subescala de Estigmas
afectadas con TB
comunidad
(n=480)
(n=300)
Perspectiva de la comunidad hacia la
0.88
0.85
tuberculosis
Perspectiva de la persona afectada con TB
0.82
0.79
hacia la tuberculosis
Perspectiva de la comunidad hacia el
0.91
0.85
VIH/ SIDA
Perspectiva de la persona afectada hacia el
0.83
0.87
VIH/ SIDA
Confiabilidad de las pruebas tomadas de nuevo
De las 480 personas afectadas con tuberculosis a quienes les fueron administradas las subescalas,
15 de ellos fueron probados de nuevo dentro de un periodo de 30 días para evaluar la
confiabilidad de las nuevas pruebas. A ninguno de los miembros de la comunidad se les
administró una prueba de nuevo.
Los valores de confiabilidad para las escalas de tuberculosis fueron buenos dentro de lo que
cabe:
• perspectivas de la comunidad hacia la tuberculosis; r=0.64, p=0.01
• perspectivas del paciente hacia la tuberculosis; r=0.46, p=0.10
Los valores de confiabilidad para las escalas de VIH/sida no se correlacionaron bien:
• perspectivas de la comunidad hacia el VIH, r=0.33, p=0.22
• perspectivas del paciente hacia el VIH, r=0.40, p=0.14
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Distribuciones del índice del estigma
Los índices estandarizados del estigma para cada una de las cuatro escalas fueron distribuidos
normalmente. El promedio (desviación estándar) para cada escala fue:
• perspectivas de la comunidad hacia la tuberculosis: 27.9 (7.5)
• perspectivas de la persona afectada hacia la tuberculosis: 27.6 (6.1)
• perspectivas de la comunidad hacia el VIH/ sida: 28.2 (7.8)
• perspectivas de la persona afectada hacia el VIH/sida: 32.9 (5.9)
CÁLCULO DE LOS ÍNDICES ESTANDARIZADOS DE LOS ESTIGMAS
1. Cada serie de escalas de estigmas fue evaluada basada en una escala likert de cuatro puntos,
que fue calificada con las categorías de respuesta: (0) totalmente en desacuerdo,
(1) en desacuerdo, (2) de acuerdo y (3) totalmente de acuerdo;
2. Las respuestas más altas se relacionaban con mayores estigmas
3. Ningún dato se codificó al contrario.
4. Para cada escala se sumaron todas las respuestas de los datos de la escala para resumir el
resultado (SSraw).
5. Antes de comparar los resultados entre escalas, se necesita crear un resultado estándar ya que
cada escala cuenta con un número diferente de datos. Cualquier forma de estandarización
funcionará (adaptada a los datos, escala de 10 puntos, etc.) Las autoras eligieron estandarizar
todos los resultados a una escala de 50 puntos utilizando la siguiente ecuación: SS50 =
SSraw × 50, donde n equivale al número de datos que están siendo calculados en la
subescala, n ×3 y 3 = al valor máximo para cualquier dato en la escala. Los resultados
estándar oscilan entre 0 y 50.
6. Por ejemplo, si un participante respondió que estaba totalmente en desacuerdo con un dato,
en desacuerdo con 4 datos, de acuerdo con 5 datos y totalmente de acuerdo con un dato en la
subescala de “Perspectivas de la Comunidad hacia el VIH/SIDA”, el resultado estandarizado
del estigma podría calcularse de la siguiente manera:
SS50=SSraw × 50= [(1×0)+(4×1)+(5×2)+(1×3)] × 50 = 27.3
n ×3
11×3
Mención: Van Rie A, Sengupta S, Pungrassami P, Balthip Q, Choonuan S, Kasetjaroen Y, Strauss R,
Chongsuvivatwong V. (2008). Medidas de estigma asociadas con tuberculosis y VIH/ Sida en el sur de
Tailandia: análisis factorial exploratorio y confirmatorio de las dos escalas nuevas. Medicina Tropical y
Salud Internacional (Tropical Medicine & International Health) 13(1), 21-30.
Las copias de los manuscritos y de las presentaciones en las conferencias generadas por el uso de estas
escalas de estigmas son bienvenidas y se usan para seguir su uso y evaluar su validez y confiabilidad en
otros grupos de personas. Dirección de correo: Annelies Van Rie, PhD, la Universidad de Carolina del
Norte Chapel Hill, EE.UU. Tel: (919) 966.1420, Fax: (919) 966.2089, correo electrónico:
vanrie@email.unc.edu.
El 17 de septiembre del 2008 la Dra. Van Rie otorgó permiso a Eva M. Moya c/o USMBHA y PCI para
utilizar la escala de estigmas de la tuberculosis y del VIH/sida.
El 1ero de octubre del 2008 se presento el primer borrador en español a coordinadores/as de
SOLUCION TB Expansión y se obtuvo retroalimentación. El 16 de octubre se actualizo y presento a
los coordinadores/as de proyecto para llevar acabo una primera consulta para probar el instrumento en
español. El 6 de noviembre se recibieron las primeras 30 encuestas en español de la fase piloto.
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